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Abstract 
Higher total fruit and vegetable intake (FV) is associated with a lower CVD risk, 
however, the relative importance of particular fruits or vegetables (subgroups) is unknown. 
The association between coffee, tea intakes, and CVD risk is also inconsistent. FV, coffee, and 
tea are (poly)phenol-rich foods commonly consumed in the UK. This thesis studied the 
association between these food groups, their respective subgroups and CVD mortality, 
incidence, and blood pressure (BP) in the UK Women’s Cohort Study (UKWCS) and the 
National Diet and Nutritional Survey Rolling Programme (NDNS RP). 
Survival analysis was applied to calculate the risk of CVD mortality, and CVD incidence 
with increasing FV, coffee and tea intake in the UKWCS. The odds of being hypertensive 
were assessed using logistic regression in the UKWCS (self-reported) and the NDNS RP 
(measured). Measured BP levels were also investigated in the NDNS RP using multivariate 
regression. Aspects of methodology were explored between dietary assessments in the 
UKWCS using the Kappa statistic. 
Overall, CVD risk was lower with higher intakes of FV, especially for total fruit, berries, 
citrus and grapes, but not for total vegetable. Greater intakes of total vegetables, fruit 
vegetables, and pomes were associated with a lower incidence of self-reported BP. Systolic 
BP was lower with increasing FV intake while diastolic BP lowered with a greater pome 
consumption. Attenuated associations in subpopulations with CVD risk factors suggest that 
protective effects are more apparent in healthy subpopulations. Coffee and tea intakes were 
not associated with the risk of CVD in either UK populations. 
The FFQ in the UKWCS was able to rank the participants by low and high intakes, 
providing evidence for significant and null associations detected above. Novel findings from 
the total phenolic content within fruit juices and concentrates from the UK highlights the 
importance of updating Phenol Explorer, to accurately estimate (poly)phenol intake in the 
future. Implementation of RCTs based on hypotheses generated here would aid the 
determination of causal links between FV subgroups such as berries, citrus, pomes, grapes, 
and fruit vegetables and CVD risk. 
 
 6 
 
Contents 
Intellectual property and publication statement ................................................................................................... 2 
Acknowledgements ............................................................................................................................................................ 4 
Abstract ................................................................................................................................................................................... 5 
Contents .................................................................................................................................................................................. 6 
List of figures ........................................................................................................................................................................ 9 
List of tables ........................................................................................................................................................................ 12 
Abbreviations ..................................................................................................................................................................... 17 
Chapter 1 Introduction and Objectives .................................................................................................................... 19 
1.1 Cardiovascular disease overview ........................................................................................................................ 19 
1.2 (Poly)phenols overview ........................................................................................................................................... 31 
1.3 Aims and objectives ................................................................................................................................................... 54 
Chapter 2 General methodology ................................................................................................................................. 57 
2.1 Abstract ............................................................................................................................................................................ 57 
2.2 UK Women’s Cohort Study: Study design ........................................................................................................ 57 
2.3 National Diet and Nutrition Survey Rolling Programme: Study design ............................................ 65 
2.4 Statistical methodology ............................................................................................................................................ 72 
2.5 Model building .............................................................................................................................................................. 75 
2.6 UK Women’s Cohort Study: Dietary intakes of (poly)phenol-rich foods and participant 
characteristics ............................................................................................................................................................... 82 
2.7 National Diet and Nutrition Survey: Dietary intakes of (poly)phenol rich foods and 
participant characteristics ...................................................................................................................................... 95 
2.8 Discussion .................................................................................................................................................................... 101 
2.9 Summary ...................................................................................................................................................................... 103 
Chapter 3 Fruit and vegetable intake and cardiovascular disease mortality in the UK Women’s 
Cohort Study ....................................................................................................................................................... 104 
3.1 Abstract ......................................................................................................................................................................... 104 
3.2 Background ................................................................................................................................................................. 105 
3.3 Method ........................................................................................................................................................................... 107 
3.4 Results ........................................................................................................................................................................... 114 
3.5 Discussion .................................................................................................................................................................... 127 
3.6 Summary ...................................................................................................................................................................... 132 
 7 
 
Chapter 4 Fruit intake and incidence of cardiovascular disease in the UK Women’s Cohort Study133 
4.1 Abstract ......................................................................................................................................................................... 133 
4.2 Background .................................................................................................................................................................. 134 
4.3 Methods ......................................................................................................................................................................... 134 
4.4 Results ............................................................................................................................................................................ 138 
4.5 Discussion ..................................................................................................................................................................... 153 
4.6 Summary ....................................................................................................................................................................... 156 
Chapter 5 Coffee and tea intake and cardiovascular disease mortality in the UK Women’s Cohort 
Study ...................................................................................................................................................................... 157 
5.1 Abstract ......................................................................................................................................................................... 157 
5.2 Background .................................................................................................................................................................. 157 
5.3 Method ........................................................................................................................................................................... 158 
5.4 Results ............................................................................................................................................................................ 162 
5.5 Discussion ..................................................................................................................................................................... 170 
5.6 Summary ....................................................................................................................................................................... 174 
Chapter 6 Fruit, vegetable intake and the incidence of self-reported blood pressure in the UK 
Women’s Cohort Study .................................................................................................................................... 175 
6.1 Abstract ......................................................................................................................................................................... 175 
6.2 Background .................................................................................................................................................................. 176 
6.3 Methods ......................................................................................................................................................................... 177 
6.4 Results ............................................................................................................................................................................ 181 
6.5 Discussion ..................................................................................................................................................................... 189 
6.6 Summary ....................................................................................................................................................................... 192 
Chapter 7 Coffee, tea intake and incidence of self-reported blood pressure in the UK Women’s 
Cohort Study ....................................................................................................................................................... 193 
7.1 Abstract ......................................................................................................................................................................... 193 
7.2 Background .................................................................................................................................................................. 193 
7.3 Methods ......................................................................................................................................................................... 195 
7.4 Results ............................................................................................................................................................................ 198 
7.5 Discussion ..................................................................................................................................................................... 204 
7.6 Summary ....................................................................................................................................................................... 207 
Chapter 8 Fruit, coffee and tea intake in the UK Women’s Cohort Study: Impact of dietary 
assessment methods ........................................................................................................................................ 208 
8.1 Abstract ......................................................................................................................................................................... 208 
8.2 Background .................................................................................................................................................................. 209 
8.3 Method ........................................................................................................................................................................... 210 
 8 
 
8.4 Results ........................................................................................................................................................................... 213 
8.5 Discussion .................................................................................................................................................................... 221 
8.6 Summary ...................................................................................................................................................................... 225 
Chapter 9 (Poly)phenols in processed fruit beverages in UK: Evaluation of its importance in 
dietary collection methods ........................................................................................................................... 226 
9.1 Abstract ......................................................................................................................................................................... 226 
9.2 Background ................................................................................................................................................................. 226 
9.3 Materials and methods .......................................................................................................................................... 227 
9.4 Results and Discussion .......................................................................................................................................... 232 
9.5 Summary ...................................................................................................................................................................... 252 
Chapter 10 Fruit, vegetable intake and blood pressure measurements within adults in the 
National Diet and Nutrition Survey Rolling Programme (2008 – 2012) ..................................... 253 
10.1 Abstract ......................................................................................................................................................................... 253 
10.2 Background ................................................................................................................................................................. 253 
10.3 Method ........................................................................................................................................................................... 254 
10.4 Results ........................................................................................................................................................................... 260 
10.5 Discussion .................................................................................................................................................................... 269 
10.6 Summary ...................................................................................................................................................................... 272 
Chapter 11 Final Discussion ...................................................................................................................................... 273 
11.1 State of the art ............................................................................................................................................................ 273 
11.2 Novel findings from this thesis .......................................................................................................................... 273 
11.3 Summary of thesis findings ................................................................................................................................. 274 
11.4 Summary discussion ............................................................................................................................................... 275 
11.5 Strengths and limitations ..................................................................................................................................... 278 
11.6 Recommendations for future work ................................................................................................................. 280 
11.7 Summary of conclusions ....................................................................................................................................... 284 
Bibliography .................................................................................................................................................................... 285 
Appendix A Chapter 3 sensitivity analyses ........................................................................................................ 302 
Appendix B Chapter 4 sensitivity analyses ........................................................................................................ 308 
Appendix C Chapter 5 sensitivity analyses ........................................................................................................ 314 
Appendix D Chapter 6 sensitivity analyses ........................................................................................................ 315 
Appendix E Chapter 7 sensitivity analyses ........................................................................................................ 319 
Appendix F Chapter 10 sensitivity analyses ..................................................................................................... 320 
  
 9 
 
 
List of figures 
Figure 1.1 Summary of cardiovascular disease types ............................................................................................................. 19 
Figure 1.2 Total number of fatal CVD deaths in men and women within various age groups in the UK, 
2010 [15] ....................................................................................................................................................................................... 22 
Figure 1.3 The skeletal structure of flavonoid subclasses .................................................................................................... 32 
Figure 1.4 The skeletal structure of anthocyanidin and substitution sites .................................................................. 37 
Figure 1.5 The skeletal structure of flavanone and respective substitution sites ..................................................... 40 
Figure 1.6 The skeletal structure of flavonol and respective substitution sites ........................................................ 44 
Figure 1.7 The skeletal structure of hydroxycinnamic acid and respective substitution sites ........................... 48 
Figure 1.8 Flavan-3-ol monomers [(+)-catechin and (-)-epicatechin], where * are rare forms of flavan-3-
ol monomers, its hydroxylated forms [(+)-gallocatechin and (-)-epigallocatechin] and subsequent 
forms after esterification [(-)-epicatechin-3-O-gallate and (-)-epigallocatechin-3-O-gallate] [100] 50 
Figure 1.9 Thesis flowchart ................................................................................................................................................................. 56 
Figure 2.1 Study design for the UKWCS ......................................................................................................................................... 58 
Figure 2.2 An extract from the FFQ showing the categories on the frequency of consumption ........................ 59 
Figure 2.3 An example from the UKWCS four-day food diary on recording food items and portion sizes ... 60 
Figure 2.4 An example from the UKWCS four-day food diary entry on recording homemade recipes and 
supplements ................................................................................................................................................................................. 61 
Figure 2.5 Questions from the UKWCS four-day food diary on dietary preferences ............................................... 62 
Figure 2.6 Questions from the UKWCS four-day food diary on dietary preferences (continued)..................... 62 
Figure 2.7 A table in the UKWCS food diary for ready-made/packaged foods ........................................................... 63 
Figure 2.8 An extract from the phase 2 questionnaire on self-reported illnesses .................................................... 64 
Figure 2.9 Main survey design framework for the NDNS RP ............................................................................................... 66 
Figure 2.10 An example of recording supplement intake from the NDNS RP [174] ................................................ 68 
Figure 2.11 An example of the four-day food diary entry from the NDNS RP [174] ................................................ 68 
Figure 2.12 An example of recording a homemade dish recipe from the NDNS RP [174] .................................... 69 
Figure 2.13 A portion size estimation guide provided in the four-day food diary in the NDNS RP ................. 70 
Figure 2.14 ‘Life size’ glass, spoon and typical drink sizes in mL within the four-day food diary in the 
NDNS RP (not life-sized here) ............................................................................................................................................. 70 
Figure 2.15 Photographs of typical portion sizes of commonly consumed foods within the NDNS RP food 
diary [174] .................................................................................................................................................................................... 71 
Figure 2.16 Example of a direct acyclic graph containing confounders (blue) and a collider (grey) .............. 73 
Figure 2.17 Causal diagram showing associations between potential confounders between fruit, 
vegetable, coffee and tea intake and CVD outcome ................................................................................................... 80 
 10 
 
Figure 2.18 Causal diagram showing associations between potential confounders between fruit, 
vegetable, coffee and tea intake and hypertension ................................................................................................... 81 
Figure 2.19 Distribution of total fruit, vegetable, coffee and tea intakes in histograms prior to the 
application of exclusion criteria .......................................................................................................................................... 85 
Figure 2.20 Decision flowchart for the inclusion of food items from the NDNS Nutrient Databank for 
division into FV subgroups .................................................................................................................................................... 95 
Figure 3.1 Boxplot of total fruit intake, including dried fruits and fruit juice, prior to exclusion criteria 
application .................................................................................................................................................................................. 108 
Figure 3.2 Summary flowchart of the current study exclusion criteria and analysis plan ................................. 111 
Figure 3.3 Summary flowchart of the current study exclusion criteria and analysis plan ................................. 112 
Figure 3.4 Survival probability for quintiles of total fruit intake on total CVD mortality plotted over time113 
Figure 4.1 Summary flowchart of the current study exclusion criteria and analysis plan ................................. 137 
Figure 5.1 Summary flowchart of the current study exclusion criteria and analysis plan for coffee ............ 161 
Figure 5.2 Summary flowchart of the current study exclusion criteria and analysis plan for tea .................. 162 
Figure 6.1 Summary flowchart for the current study exclusion criteria and analysis plan ............................... 180 
Figure 7.1 Summary flowchart of the current study exclusion criteria and analysis plan ................................. 197 
Figure 9.1 Standard curves for gallic acid, caffeic acid, catechin, cyanidin-3-O-rutinoside and delphinidin-
3-O-rutinoside using the Folin-Ciocalteu assay expressed as absorbance measured at 765 nm. ... 233 
Figure 9.2 Response of various concentrations of sodium metabisulphite, fructose, glucose and sucrose 
using Folin-Ciocalteu assay expressed as absorbance measured at 765 nm. ............................................ 234 
Figure 9.3 Total phenolic content in gallic acid equivalents for cranberry juices measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3). Samples that share a 
different alphabet expressed as significantly different using one-way ANOVA and Bonferroni 
post-hoc test (p<0.05). .......................................................................................................................................................... 238 
Figure 9.4 Total phenolic content in gallic acid equivalents for mixed fruit juices measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3, *replicates = 4) .......... 239 
Figure 9.5 Total phenolic content in gallic acid equivalents for fruit smoothies measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3) ........................................... 240 
Figure 9.6 Total phenolic content in gallic acid equivalents and estimated vitamin C content for orange 
concentrates measured by the Folin-Ciocalteu assay, expressed as mean and standard deviation 
(replicates = 4) ......................................................................................................................................................................... 241 
Figure 9.7 Total phenolic content in gallic acid equivalents and estimated vitamin C content for 
blackcurrant concentrates measured by the Folin-Ciocalteu assay, expressed as mean and 
standard deviation (replicates = 4, *replicates = 3) ............................................................................................... 243 
Figure 9.8 A section of the chromatogram of compounds delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside using 0.1% formic acid solvents (both A and B). .............................................................................. 244 
Figure 9.9 A section of the chromatogram of compounds delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside using 0.5% formic acid solvents (both A and B). .............................................................................. 245 
Figure 9.10 Standard curves for cyanidin-3-O-rutinoside and delphinidin-3-O-rutinoside quantified by 
HPLC, expressed in mean and standard deviation in nmol (replicates = 3) ............................................... 245 
 11 
 
Figure 9.11 Standard curves for ascorbic acid and nicotinic acid quantified by HPLC, expressed in mean 
and standard deviation in nmol (replicates = 3) ...................................................................................................... 246 
Figure 9.12 Example HPLC chromatograms of myricitrin, delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside, and their respective UV absorption spectras from Ribena No Added Sugar sample ..... 248 
Figure 9.13 Amount of cyanidin-3-O-rutinoside and delphinidin-3-O-rutinoside quantified using HPLC in 
blackcurrant concentrates in comparison to blackcurrant fruit from Phenol Explorer, expressed 
as mean and standard deviation (replicates = 9) ..................................................................................................... 248 
Figure 9.14 Example HPLC chromatograms of ascorbic acid and nicotinic acid, and their respective UV 
absorption spectras from Ribena No Added Sugar sample................................................................................. 249 
Figure 9.15 Scatter graph showing the association and correlation between ascorbic acid and total 
anthocyanin content quantified by HPLC in blackcurrant concentrates ...................................................... 250 
Figure 9.16 Amount of ascorbic acid quantified using HPLC in blackcurrant concentrates, expressed as 
mean and standard deviation (replicates = 9) .......................................................................................................... 250 
Figure 10.1 Summary flowchart of the current study exclusion criteria and analysis plan ............................... 258 
Figure 10.2 Histogram of studentised residuals for a fully-adjusted multiple linear regression model 
investigating fruit intake and BP (mmHg) .................................................................................................................. 258 
Figure 10.3 An inverse normal plot (Q-Q plot) for a fully-adjusted multiple linear regression model 
investigating fruit intake and BP (mmHg) .................................................................................................................. 259 
Figure 10.4 Scatter plot of residuals versus fitted values for a fully-adjusted multiple linear regression 
model investigating fruit intake and BP (mmHg) .................................................................................................... 259 
 
 12 
 
List of tables 
Table 1.1 CVD risk factors in the order of severity (the top being the most severe risk) in various regions 
around the world [36] ............................................................................................................................................................. 24 
Table 1.2 The classification and skeletal structure of (poly)phenols .............................................................................. 32 
Table 1.3 Pharmacokinetics on major (poly)phenol classes summarised from Manach et. al [108] ............... 34 
Table 1.4 Summary of the biological activities of (poly)phenol subclasses from Manach et. al [108] and 
Del Rio et. al [109] ..................................................................................................................................................................... 34 
Table 1.5 Substitution pattern and approximate distribution of major anthocyanidins across food 
sources [121]................................................................................................................................................................................ 37 
Table 1.6 Distribution of major anthocyanins across commonly consumed berries, and estimated total 
phenolic content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 
g fresh weight [111] .................................................................................................................................................................. 38 
Table 1.7 The substitution pattern of major flavanones and its glycosides ................................................................. 40 
Table 1.8 Distribution of major (poly)phenol classes across commonly consumed drupes, and estimated 
total phenolic content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in 
mg/100 g fresh weight [100, 111] ..................................................................................................................................... 41 
Table 1.9 Distribution of major (poly)phenol classes for apples and pears, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean and standard deviation in mg/100 g fresh 
weight [100, 111] ....................................................................................................................................................................... 42 
Table 1.10 Distribution of major (poly)phenol classes across commonly consumed tropical fruits, and 
estimated total phenolic content using Folin-Ciocalteu assay, expressed as mean (standard 
deviation) in mg/100 g fresh weight [111] ................................................................................................................... 42 
Table 1.11 The substitution pattern of major flavonols ......................................................................................................... 44 
Table 1.12 Distribution of major flavonols in Allium vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] ................................................................................................................................................................................................. 44 
Table 1.13 Distribution of major flavonols in Brassicaceae vegetables, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh 
weight [111] ................................................................................................................................................................................. 45 
Table 1.14 Distribution of major (poly)phenols in fruit vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] ................................................................................................................................................................................................. 46 
Table 1.15 Distribution of major (poly)phenols in pod vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] ................................................................................................................................................................................................. 46 
Table 1.16 Distribution of major (poly)phenols in stalk and root vegetables, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh 
weight [111] ................................................................................................................................................................................. 47 
Table 1.17 The substitution pattern of major hydroxycinnamic acids ........................................................................... 48 
 13 
 
Table 1.18 Objectives of the thesis matching the aims met in the stated chapters .................................................. 55 
Table 2.1 Correlation between variables included in the model ....................................................................................... 76 
Table 2.2 Univariate analyses of potential confounders and CHD, stroke and cardiovascular disease 
outcome [HR (95% CI)] .......................................................................................................................................................... 76 
Table 2.3 Baseline total fruit, fruit subgroups, coffee, tea and respective subgroups from the FFQ grouped 
according to suggested categorisation in the Phenol Explorer prior to the application of exclusion 
criteria ............................................................................................................................................................................................. 83 
Table 2.4 Baseline total vegetable and vegetable subgroups from the FFQ grouped according to suggested 
categorisation in the Phenol Explorer prior to the application of exclusion criteria ............................... 84 
Table 2.5 Correlations between total fruit and fruit subgroups intake assessed from the baseline FFQ 
prior to the application of exclusion criteria................................................................................................................ 86 
Table 2.6 Correlations between vegetable and vegetable subgroups intake assessed from the baseline 
FFQ prior to the application of exclusion criteria ...................................................................................................... 86 
Table 2.7 Baseline characteristics of all UKWCS participants by quintiles of total fruit intake prior to the 
application of exclusion criteria (expressed as mean and SD for continuous variables, % and 95% 
CI for categorical variables).................................................................................................................................................. 89 
Table 2.8 Baseline characteristics of all UKWCS participants by quintiles of total vegetable intake prior 
to the application of exclusion criteria (expressed as mean and SD for continuous variables, % 
and 95% CI for categorical variables) ............................................................................................................................. 90 
Table 2.9 Baseline characteristics of all UKWCS participants by quintiles of total coffee intake prior to 
the application of exclusion criteria (expressed as mean and SD for continuous variables, % and 
95% CI for categorical variables) ...................................................................................................................................... 91 
Table 2.10 Baseline characteristics of all UKWCS participants by quintiles of black tea intake prior to the 
application of exclusion criteria (expressed as mean and SD for continuous variables, % and 95% 
CI for categorical variables).................................................................................................................................................. 92 
Table 2.11 Baseline characteristics of all UKWCS participants by completion of phase 2 questionnaire 
prior to the application of exclusion criteria (expressed as mean and SD for continuous variables, 
% and 95% CI for categorical variables) ........................................................................................................................ 94 
Table 2.12 Fruit subgroup intakes within adults (aged >19 years) in the NDNS RP grouped according to 
derived categories of fruit prior to the application of exclusion criteria (n = 2073) ............................... 96 
Table 2.13 Vegetable subgroups within adults (aged >19 years) in the NDNS RP grouped according to 
derived categories of vegetables prior to the application of exclusion criteria (n = 2073) .................. 97 
Table 2.14 Correlations between total fruit and fruit subgroups intake assessed from the food diary prior 
to the application of exclusion criteria ............................................................................................................................ 98 
Table 2.15 Correlations between total vegetables and vegetable subgroups intake assessed from the food 
diary prior to the application of exclusion criteria ................................................................................................... 98 
Table 2.16 Correlation between total fruit and total vegetable intake assessed from the food diary prior 
to the application of exclusion criteria ............................................................................................................................ 98 
Table 2.17 Baseline characteristics of participants by tertiles of total FV intakes prior to the application 
of exclusion criteria, expressed as mean and standard deviation for continuous variables, 
percentage and 95% CI for categorical variables .................................................................................................... 100 
 14 
 
Table 3.1 Schoenfeld residuals of covariates in the full-adjusted model for total fruit intake on total CVD 
mortality. ..................................................................................................................................................................................... 113 
Table 3.2 Baseline characteristics for CHD mortality, stroke mortality and non-fatal cases, expressed as 
mean and standard deviation for continuous variables, percentage and 95% CI for categorical 
variables ...................................................................................................................................................................................... 115 
Table 3.3 Baseline characteristics of total fruit intake expressed as mean and standard deviation for 
continuous variables, percentage and 95% CI for categorical variables, for participants in UKWCS 
including dietary habit, lifestyle habits, socio economic status and medical history ............................ 116 
Table 3.4 Baseline characteristics for CHD mortality, stroke mortality and non-fatal cases for the analysis 
of vegetable consumption, expressed as mean and standard deviation for continuous variables, 
% and 95% CI for categorical variables ....................................................................................................................... 117 
Table 3.5 Baseline characteristics of participants in UKWCS by quantiles of total vegetable intake, 
expressed as mean and standard deviation for continuous variables, percentage and 95% CI for 
categorical variables, including dietary habits, lifestyle habits, socio-economic status and medical 
history ........................................................................................................................................................................................... 118 
Table 3.6 Total fruit intake, fruit subgroup intake and cardiovascular mortality risk (expressed as HR 
and 99% CI) ............................................................................................................................................................................... 121 
Table 3.7 Total vegetable, and vegetable subgroup intake and cardiovascular mortality risk (expressed 
as HR and 95% or 99% CI) ................................................................................................................................................. 125 
Table 4.1 The classification of coronary heart disease and stroke categories by ICD10 codes ....................... 135 
Table 4.2 Total fruit, fruit subgroup intake and the risk of myocardial infarction, acute coronary 
syndrome and chronic coronary event incidence (expressed as HR and 95% CI) ................................. 140 
Table 4.3 Total fruit, fruit subgroup intake and the risk of haemorrhagic, ischaemic and unclassified 
stroke incidence (expressed as HR and 95% CI) ..................................................................................................... 144 
Table 4.4 Total fruit, fruit subgroup intake and the risk of total coronary heart disease, total stroke and 
total cardiovascular disease incidence (expressed as HR and 95% CI) ....................................................... 148 
Table 5.1 Baseline characteristics for CHD mortality, stroke mortality and non-fatal cases for the analysis 
of coffee consumption, expressed as mean and standard deviation for continuous variables, % 
and 95% CI for categorical variables ............................................................................................................................. 164 
Table 5.2 Baseline characteristics for CHD mortality, stroke mortality and non-fatal cases for the analysis 
of tea consumption, expressed as mean and standard deviation for continuous variables, % and 
95% CI for categorical variables ...................................................................................................................................... 165 
Table 5.3 Baseline characteristics of total coffee intake, expressed as mean and standard deviation for 
participants in the UKWCS including dietary habit, lifestyle habits, socio economic status and 
medical history ......................................................................................................................................................................... 166 
Table 5.4 Baseline characteristics of black tea intake, expressed as mean and standard deviation for 
participants in the UKWCS including dietary habit, lifestyle habits, socio economic status and 
medical history ......................................................................................................................................................................... 167 
Table 5.5 Total coffee, tea intake and cardiovascular mortality risk (expressed as HR and 95% CI)........... 169 
Table 6.1 Matrix to define BP status for participants with follow-up ........................................................................... 177 
Table 6.2 Baseline characteristics of participant by self-reported HBP incidence, prevalence, recovered 
and non-cases. .......................................................................................................................................................................... 182 
 15 
 
Table 6.3 Baseline characteristics of participants by total FV intakes expressed as mean and standard 
deviation for continuous variables, percentage and 95% CI for categorical variables after the 
application of exclusion criteria ....................................................................................................................................... 183 
Table 6.4 Total fruit, total vegetable, FV subgroup intake and odds of self-reported HBP incidence ........... 185 
Table 7.1 Baseline characteristics of participant by self-reported HBP incidence, prevalence, recovered 
and non-cases ............................................................................................................................................................................ 200 
Table 7.2 Baseline characteristics of participants by total coffee intakes, expressed as mean and standard 
deviation for continuous variables, percentage and 95% CI for categorical variables after the 
application of exclusion criteria ....................................................................................................................................... 201 
Table 7.3 Baseline characteristics of participants by total tea intakes, expressed as mean and standard 
deviation for continuous variables, percentage and 95% CI for categorical variables after the 
application of exclusion criteria ....................................................................................................................................... 202 
Table 7.4 Total black tea, coffee and coffee subgroup intake and odds of self-reported HBP incidence ..... 203 
Table 8.1 Total number of food codes within each investigated dietary variable from the food diary and 
baseline FFQ (% of food codes in FFQ over total number of food codes used in food diary) ............. 211 
Table 8.2 Interpretation of Kappa statistics [330] ................................................................................................................. 212 
Table 8.3 Baseline characteristics of women who completed the baseline FFQ and fully coded food diaries
 .......................................................................................................................................................................................................... 213 
Table 8.4 Differences between nutrient and dietary intakes of fruit, coffee and black tea variables derived 
using the FFQ and food diaries, by paired t-test† or Wilcoxon signed-rank test‡ (n = 2120) ............. 214 
Table 8.5 Correlations between the mean intake of total fresh fruit, fruit subgroup, coffee and black tea 
from the FFQ and food diary .............................................................................................................................................. 214 
Table 8.6 Degree of agreement between the mean intake of total fresh fruit, fruit subgroup, coffee and 
black tea from the FFQ and food diary .......................................................................................................................... 215 
Table 8.7 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical fruit, 
coffee and tea quintiles by FFQ and food diary consumption quintiles ........................................................ 217 
Table 8.8 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from the 
baseline FFQ and food diary ............................................................................................................................................... 218 
Table 8.9 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical fruit, 
coffee and tea quintiles by FFQ and food diary consumption quartiles........................................................ 219 
Table 8.10 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from 
the baseline FFQ and food diary ....................................................................................................................................... 220 
Table 8.11 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical fruit, 
coffee and tea quintiles by FFQ and food diary consumption tertiles ........................................................... 220 
Table 8.12 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from 
the baseline FFQ and food diary ....................................................................................................................................... 221 
Table 9.1 Detailed extraction methods for different categories of fresh and commercial samples from 
supermarkets (Leeds, UK). .................................................................................................................................................. 229 
Table 9.2 The format of the spiking trial ..................................................................................................................................... 230 
 16 
 
Table 9.3 Total phenolic content of pineapple juices from Phenol Explorer and the current study 
measured by the Folin-Ciocalteu assay expressed as mean (standard deviation) ................................. 235 
Table 9.4 Total phenolic content of a blackcurrant concentrate (BHJ), gallic acid, ascorbic acid, and spiked 
BHJ samples with gallic acid and ascorbic acid measured using the Folin-Ciocalteu assay, 
expressed as mean and standard deviation ............................................................................................................... 235 
Table 9.5 Total phenolic measured by Folin-Ciocalteu assay by sample group, expressed as mg/serving 
size (250 mL) without ascorbic acid correction ...................................................................................................... 242 
Table 10.1 Correlation between variables included in the model .................................................................................. 255 
Table 10.2 Univariate analyses of potential confounders and BP (mmHg) and odds ratio of hypertension 
per unit increment for continuous variables or by category for categorical variables ......................... 256 
Table 10.3 Participant characteristics by total FV intake in the NDNS RP  adult population ........................... 261 
Table 10.4 Characteristics by HBP status in the NDNS RP adult population ............................................................ 262 
Table 10.5 Total FV, total fruit and fruit subgroup intakes and change in SBP and DBP (mmHg) within 
adults in the NDNS cohort ................................................................................................................................................... 264 
Table 10.6 Total vegetable, vegetable subgroup, total fruit juice, and dried fruit intakes and change in 
SBP and DBP (mmHg) within adults in the NDNS cohort.................................................................................... 265 
Table 10.7 Odds of HBP and FV intakes and fruit, vegetable subgroup intakes within adults in the NDNS 
RP cohort ..................................................................................................................................................................................... 268 
Table 11.1 Summary of key findings from this thesis .......................................................................................................... 274 
 17 
 
Abbreviations 
ACS Acute coronary syndrome 
ANOVA Analysis of variance 
BMI Body mass index 
BP Blood pressure 
CAPI Computer assisted personal interview 
CBG Cyctosolic β-glucoside 
CCE Chronic coronary event 
CE Capillary zone electrophoresis 
CHD Coronary heart disease 
CI Confidence interval 
COMT Catechol-O-methyltransferase 
COX-2 Cyclo-oxygenase 
CVD Cardiovascular disease 
CY3RUT Cyanidin-3-O-rutinoside 
DAG Directed acyclic graph 
DASH Dietary Approaches to Stop Hypertension 
DBP Diastolic blood pressure 
DF Dried fruit (UKWCS) 
DINO Diet in Nutrients Out 
DP3RUT Delphinidin-3-O-rutinoside 
eNOS Endothelial nitric oxide 
EPIC European Prospective Investigation into Cancer and Nutrition 
FDF Fresh and dried fruit (UKWCS) 
FF Fresh fruit (UKWCS) 
FFJ Fresh fruit and juice (UWKCS) 
FFQ Food frequency questionnaire 
FJ Fruit juice (UKWCS) 
FSA Food Standards Agency 
FV Fruit and vegetable 
GAE Gallic acid equivalents 
HBP High blood pressure 
HDL-C High-density lipoprotein cholesterol 
HES Hospital Episode Statistics 
HNR Human Nutrition Research 
HPLC High-performance liquid chromatography 
HR Hazard ratio 
HS Haemorrhagic stroke 
ICD International Classification of Diseases 
iNOS Inducible nitric oxide synthase 
IS Ischaemic stroke 
K Kappa statistic 
Kw Weighted Kappa statistic 
LDL-C Low-density lipoprotein cholesterol 
LPH Lactase phloridizin hydrolase 
MA Meta-analysis 
MFP Main food provider 
MI Myocardial infarction 
MINAP Myocardial Ischaemia Nutritional Audit Project 
 18 
 
MRC Medical Research Council 
MY3RNS Myricetin-3-O-rhamnoside 
NDNS RP National Diet and Nutritional Survey Rolling Programme 
NHS National Health Service 
NO Nitric oxide 
NS-SEC National Statistics Socio-Economic Classification 
OR Odds ratio 
PAF Postcode address file 
PAR Population attributable risk 
PSU Primary sampling unit 
RCT Randomized controlled trial 
SBP Systolic blood pressure 
SES Socio-economic status 
SR Systematic review 
TF Total fruit (UKWCS) 
TPC Total phenolic content 
UK United Kingdom 
UKWCS UK Women's Cohort Study 
US United States 
USDA United States Agricultural Database 
USt Unclassified stroke 
 
Chapter 1 
19 
 
Chapter 1  
Introduction and Objectives 
1.1 Cardiovascular disease overview 
Cardiovascular disease (CVD) is a collection of diseases that includes coronary heart 
disease (CHD), cerebrovascular disease and peripheral vascular disease (Figure 1.1). CHD 
and cerebrovascular disease are conditions caused by narrowing and occlusion of blood 
vessels supplying the heart and brain respectively [1]. These are caused by the continuous 
development of atheromatous plaques in blood vessels during the life course, which 
progress on towards atherosclerosis with increasing severity. Atherosclerosis is a chronic 
condition and is the major cause leading to CVD (described below). Despite the decreasing 
trends in the recent decade, CVD is still the leading cause of mortality in Europe, United 
Kingdom and other developing countries. It is also accountable for >80% of CVD mortality 
worldwide [2]. 
1.1.1 Cardiovascular disease types and pathogenesis 
1.1.1.1 Overview 
 
Figure 1.1 Summary of cardiovascular disease types 
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As mentioned above, atherosclerosis is the underlying disease which causes CHD and 
stroke events. It is a condition for the development of lesions or plaques on the arterial wall, 
and is responsible for the majority of CVD cases. Development could begin in young 
adulthood as atheroma due to natural lipid accumulation (such as fatty deposits and 
cholesterol) in the blood vessels, or endothelial injury and inflammation [3]. Macrophages 
react by engulfing up the lipids and become foam cell macrophages, which results in the 
formation of lesions termed ‘fatty streaks’ [4]. In the later stages, accumulation of ‘fatty 
streaks’ leads to the formation of fibrous plaques with a necrotic core, caused by dying 
macrophages that are engorged with lipids [4, 5]. A plaque with a large necrotic core 
occludes the blood vessels, causing a disruption in blood flow and eventually ruptures when 
it becomes unstable, triggering the formation of a blood clot or thrombus [4, 6]. 
1.1.1.2 Coronary heart disease 
Acute coronary and cerebrovascular events occur when blood flow is obstructed in 
the blood vessels located in the myocardial or cerebral tissues, causing significant amount 
of damage to the heart or brain. CHD consists of angina, silent ischaemia, unstable angina, 
myocardial infarction (MI), arrhythmias, heart failures and sudden death [5]. These 
conditions are almost always due to atheromatous narrowing and occlusion of the arterial 
vessel. Angina occurs when plaques formed through atherosclerosis cause the arterial wall 
to thicken, and restrict or slow down blood supply to the heart muscles, while MI is caused 
by a thrombus occluding the flow of blood within the heart after it reaches a certain size [5]. 
1.1.1.3 Cerebrovascular Disease 
Cerebrovascular disease, commonly known as stroke, manifests as ischaemic stroke 
and haemorrhagic stroke. The majority of strokes are identified by ischaemic stroke. 
Ischaemic strokes are caused by occlusion of the cerebral arteries by formation of 
atherosclerosis (as mentioned previously), or by thromboembolism, where the occlusion is 
caused by a thrombus from a cardiac origin such as a recent MI. This form of stroke is also 
known as cardioembolic stroke. Cardioembolic stroke may also be accelerated by the 
formation of atherosclerotic plaque in intracerebral arteries [7] and is accountable for 20% 
of strokes [3]. The cerebral damage caused is irreversible, and stroke in this form is more 
common in Western countries. Haemorrhagic stroke is the rupturing of blood vessels in the 
brain, causing the release of blood directly into the brain and is thought to be less common 
[7]. 
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1.1.2 Cardiovascular disease in the UK 
In the last few decades, the rates of CVD mortality and incidence in developed 
countries have declined [6, 8-11]. The overall CVD mortality rates for under 75s in the UK 
has fallen from 155,000 in 1961, to 45,000 in 2009 [12]. Overall age standardized death 
rates for CHD (under 65 years) have also declined in men from 143/100,000 in 1980 to 
33/100,000 in 2010, and in women from 36/100,000 in 1980 to 8/100,000 in 2010 [10]. 
However, CHD mortality rates in the UK have not been decreasing as quickly as other 
developing countries [13], and may be stabilising, especially in younger adults of both sexes 
[9, 14]. Incidence rates are reported to have continuously declined in both men and women 
across all age groups since 1979 [12]. However, prevalence rates have not followed the 
same decline as mortality and incidence rates, and have increased over the last few decades. 
Prevalence of CVD for men reached its peak in the mid-2000s at 11.9%, remaining rather 
stable. The prevalence rate for women also peaked in the mid-2000s, but has declined since 
then [15]. Despite the positive outlook in decreasing mortality and incidence rates, 
cardiovascular disease is still the leading cause of death in the UK today, where 1 in 3 deaths 
are accounted for. Approximately 1.6 million men and 1 million women were living in the 
UK with CVD in 2010. Furthermore, it is also a main cause of premature mortality (over 
25,000 cases), and a financial burden on the country, costing £19 billion a year in the UK 
[15]. Socioeconomic inequality gradients have also persisted among CHD mortality rates, 
and worsened, where the most deprived areas in the UK have the highest rates of CHD 
hospital admissions [15]. 
1.1.3 Cardiovascular disease risk factors 
Several modifiable risk factors are known to be strongly associated with CVD. 
Hypertension, diabetes, physical activity, high alcohol use, abnormal lipid profiles, current 
smoking, abdominal obesity, high risk diet and psychosocial stress were reported in the 
INTERHEART study to account for more than 90% of population attributable risk (PAR) 
globally for the risk of MI [16]. The INTERSTROKE study also observed a similar set of risk 
factors mentioned previously for ischaemic stroke. In particular, significant risk factors for 
intracerebral haemorrhagic stroke were hypertension, smoking, waist-to-hip ratio, diet and 
alcohol intake [17]. Thus, unmodifiable CVD risk factors such as age, sex, ethnicity/race and 
family history of CVD, only contribute a minor component, making CVD a largely modifiable 
disease. 
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1.1.1.4 Overview of unmodifiable CVD risk factors 
It is well known that increased age leads to a higher fatal CVD risk. There are also 
marked differences between sex. Figure 1.2 depicts a sharp increase in the number of fatal 
CVD deaths past 65 years, where 74% of total CVD deaths occur in the 75+ age group 
compared to other age groups in the UK [15]. Men are also more likely to encounter CVD 
before 65 years than women. However, the total number of deaths drastically increases in 
women, and overtakes men after 65 years of age exponentially [15]. A Finnish cohort clearly 
demonstrated the same concept [18], where difference in rates of CHD incidence were the 
largest between sexes at 25 to 49 years, and narrowed as age increased. Both CHD mortality 
and incidence also increased with age. 
 
Figure 1.2 Total number of fatal CVD deaths in men and women within various age groups in the UK, 
2010 [15] 
Aging is clearly unmodifiable, unavoidable, and is associated with a natural 
progressive deterioration of the cardiac system and its functions. These age-associated 
changes include (but are not limited to), an increase in vascular intimal thickness (the 
thickness of innermost two layers of the artery, tunica intima and tunica media) and 
vascular stiffness [19], which may be associated with the development of atherosclerosis 
and increased systolic blood pressure (SBP), as well as stroke risk respectively [20]. 
Deterioration of the cardiac structure (left ventricle wall thickness and left atrial size) also 
increases the likelihood of heart failure, arrhythmia and reduces diastolic and systolic 
function [21]. 
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In terms of sex, previous studies have focused on studying the association between 
men and CVD risk more than in women [22], as it was considered to be a ‘man’s disease’ in 
the past [23]. However, this is no longer the case as women are equally, if not, possibly more 
likely to be susceptible to CVD [23]. In addition, the population of elderly women is 
increasing [13, 24]. The absolute number of women who develop CVD is also higher than 
men in the UK (91,500 and 87,528 respectively) [15], as well as in other countries [23, 25]. 
As the burden of CVD shifts towards women, there is a call to investigate sex differences and 
CVD risk in addition to the underrepresentation of women in randomized controlled trials 
(RCTs) [26]. Fundamental differences between sex involve factors such as hormonal 
changes which stem from pregnancy and the menopause [27]. Oestrogen supplementation 
was formerly proposed as a candidate for primary or secondary prevention of CHD in 
postmenopausal women, due to plausible mechanisms to raise ‘good cholesterol’ levels 
(high density lipoprotein), improve arterial compliance and coronary flow reserve [25]. 
However, RCTs propose that ingestion of oestrogen (alone or with progestin) may not be 
beneficial, and might even be harmful [28, 29]. On the other hand, recent observational 
studies showed no differences between menopausal status and risk of CVD [30]. 
Alternatively, a review suggests it is more likely that post-menopausal women experience a 
delayed onset of CHD rather than acceleration of CHD at the age of menopause compared to 
men, whose decreasing androgen levels cause a deceleration of CVD deaths [31]. Thus men 
are exposed to the disadvantage of premature CVD, while women suffer approximately 10 
years later. This is also demonstrated in a modelling study that reached a similar conclusion 
[32]. In fact, the study reported a steady increase in mortality throughout all ages in women, 
instead of a sudden increase at menopausal age. Summarizing the evidence above, it would 
seem the role of menopausal status in women changed drastically over the last decade, and 
perhaps might not play such an important role in the development of CVD throughout the 
life course. Emphasis should be placed across all age groups, especially when mortality rates 
seem to be equalizing, and maybe even increasing over the past decade within young adults 
aged 35 to 44 years [13]. 
Other unmodifiable risk factors for CVD include race/ethnicity and family history of 
diseases. Prior studies as well as the INTERHEART study have established that parental 
history of CHD is associated with higher risk of developing CHD [33]. The odds of CVD was 
also 45% greater for participants with a sibling history of CVD in the Framingham Offspring 
study [34]. Observed differences are most likely due to the higher likelihood of sharing 
similarities in genetic traits. This is because approximately 50% of the genetic variation is 
shared between biologically related first-degree relatives (parents, siblings and offspring). 
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Likewise, subpopulations living within the same geographical region are also more likely to 
share genetic similarities [35], and are thus more susceptible to certain modifiable CVD risk 
factors than others from a different geographical region (Table 1.1). 
Table 1.1 CVD risk factors in the order of severity (the top being the most severe risk) in various regions 
around the world [36] 
East Asia 
Pacific 
Eastern Europe and 
Central Asia 
Latin America 
Middle East and 
North Africa 
South Asia 
Sub-Saharan 
Africa 
Hypertension Smoking Smoking Obesity Hypertension Hypertension 
Smoking Obesity Obesity 
Low fruit and 
vegetable intake 
Diabetes 
Low fruit and 
vegetable intake 
Obesity Hypertension 
Abdominal 
obesity 
Physical 
inactivity 
Smoking 
Physical 
inactivity 
Hyperlipidaemia 
Hypercholestero-
lemia 
Hypertension Hypertension 
Overweight/ 
Obesity 
Overweight/ 
Obesity 
Diabetes 
Low fruit and 
vegetable intake 
Diabetes 
Hypercholestero-
lemia 
High waist-to-hip 
ratios 
Smoking 
 
Physical inactivity 
Hypercholestero-
lemia 
Diabetes Abdominal obesity 
 
 
Stress 
 
Smoking 
Lipids 
(Hyperlipidaemia) 
 
 Diabetes   Physical inactivity  
 
 
  Low fruit and 
vegetable intake 
 
Different ethnic groups could also live in the same region, where prevalence of CVD 
risks, such as hypertension, diabetes and obesity varies with racial/ethnic groups [37]. 
Blacks (African-Americans, African/Caribbean in UK) have exhibited higher prevalence of 
hypertension [37] and stroke [38] in contrast to the White ethnic groups. In comparison to 
European women, Chinese women (by race) have higher BP, and Chinese people in general 
exhibit higher rates of stroke. However, rate of CHD in Chinese was similar to, or lower than 
Caucasians [39]. South Asians (Indians, Sri Lankans, Bangladeshis, Nepalese and Pakistanis) 
are more prone to a higher prevalence of diabetes, CHD (especially MI) and CVD in general 
compared to non-South Asians or White Europeans. [38, 39]. As before, genetic factors are 
likely to contribute to the differences between South Asians (which were most widely 
studied compared to other ethnic groups) and Europeans, in terms of the distribution of 
body fat, amount of muscle and fat mass, and waist-to-hip ratio. Specifically, South Asians 
may have a smaller frame and thinner limbs, but the waist-to-hip ratio is greater than their 
UK counterparts [39]. Healthy South Asians also have higher levels of pro-thrombotic 
factors, homocysteine and fibrinogen compared to Europeans, which may raise the 
likelihood of developing risk factors such as diabetes, or initiating atherogenesis [39]. 
Genome-wide association techniques have provided evidence for the genotype-
phenotype relationship in association to CVD risk, however discovered genetic markers do 
not improve CVD prediction in comparison to parental history [35]. Other factors such as 
early life stress and nutrition, environmental factors, perhaps unmeasured factors that 
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parental/sibling history have accounted for, could also explain the differences observed for 
parental/siblings history, as well as racial/ethnic groups [33, 39]. 
1.1.1.5 Modifiable CVD risk factors 
1.1.1.5.1 High blood pressure or hypertension 
Hypertension is a clinical condition when BP is elevated beyond 140/90 mmHg. It is 
a major risk factor that relates directly to an increased risk of CVD [15]. High blood pressure 
(HBP) is also associated with the highest percent of attributable deaths (13%) to CVD 
mortality compared to other risk factors [6]. In a Korean cohort, women had a hazard ratio 
of 1.88 (95% CI 1.35, 2.61) and 2.26 (95% CI 1.49, 3.41) for CVD and stroke respectively if 
they had hypertension, in comparison to normotensives [40]. Women from the 
INTERHEART study experienced almost three-fold the odds of acute MI when compared to 
normotensives. In addition, 22% of men and women from Western Europe and 25% of men 
and women from Central and Eastern Europe had acute MI with history of hypertension 
[41]. 
Hypertension is also associated with age. The prevalence of hypertension increases 
with age [15]. A meta-analysis (MA) of one million adults showed that for adults aged from 
40 – 69 years old, a 20 mmHg increase in SBP or a 10 mmHg increase in diastolic blood 
pressure (DBP) is equivalent to a two-fold increase in CVD risk [42]. The prevalence of 
hypertension varies with geographical locations. Prevalence of hypertension on average in 
United Kingdom is 13.6%, where the highest prevalence is in the West Midlands at 14.6%. 
London has the lowest prevalence of hypertension at 11%, suggesting hypertension may 
also be related to some variables related to social economic status. 
1.1.1.5.2 Diabetes 
Type 2 diabetes is a condition when insulin produced in an individual is unable to 
maintain and regulate normal blood glucose levels due to insulin resistance. Long term 
insulin resistance leads to increased insulin secretion to counter insensitive insulin 
receptors, and could eventually result in a total loss of insulin secretion and pancreatic β-
cell function. It is an independent risk factor for CVD risk, and often co-exists together with 
other conditions, such as hypertension [43]. The Framingham Study reported a two-fold 
increase in CVD incidence in male subjects with diabetes after 20 years of follow up, in 
comparison to non-diabetic male subjects, while the increase in CVD incidence in female 
subjects was three-fold, compared to non-diabetic female subjects [44]. However, a Finnish 
cohort found no statistically significant difference between the two groups for risk of 
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myocardial infarction [45]. A Dutch cohort also demonstrated that male and female subjects 
with diabetes, but without previous CVD events has the same risk as women without 
diabetes, but with previous CVD events [46]. In the INTERHEART case-control study, odds 
ratio of acute myocardial infarction was 4.26 (95% CI 3.51, 5.18) in female subjects, and 
2.67 (95% CI 2.36, 3.02) in male subjects [41]. This indicates females are at higher risk than 
males if they are diabetic. A recent study conducted in Scotland also reported an increased 
risk of all-cause and CVD mortality in diabetic subjects as compared to non-diabetic subjects 
[47]. The prevalence of type 2 diabetes increases with age, and is more common in female 
than male subjects. Prevalence also varies with geographical locations in UK. Wales has the 
highest prevalence at 7% for men and 6% for women [15]. Type 2 diabetes is also associated 
with social economic status. Areas with more deprivation tend to have higher rates of 
diabetes [48]. 
1.1.1.5.3 Hypercholesterolemia/Lipid profile 
Hypercholesterolemia is a condition where there are high levels of cholesterol in the 
blood. It can be hereditary, known as familial hypercholesterolemia. Hypercholesterolemia 
accelerates the formation of atherosclerosis, which can lead to MI. A Swedish study also 
reported an increased risk of CVD mortality within male subjects with 
hypercholesterolemia [49]. In addition, a Dutch cross-sectional study also determined that 
elevated LDL-cholesterol (LDL-C) levels and lowered HDL-cholesterol (HDL-C) levels can 
contribute to an increased risk of familial hypercholesterolemia [50]. In a MA of cohort 
studies, lower total cholesterol was also associated with lower risk of ischaemic heart 
disease mortality [51]. Prevalence of hypercholesterolemia increases with age, and 
manifestation of this disease is higher in male subjects. It also varies with geographical 
location, as female subjects in East Midlands had the highest prevalence of 
hypercholesterolemia. Income seems to be related to prevalence of hypercholesterolemia, 
where a higher income is associated with lower levels of HDL-C [15]. 
1.1.1.5.4 Obesity 
Overweight and obesity, particularly abdominal obesity are established independent 
risk factors for the risk of CVD, hypertension, high blood cholesterol and diabetes [15]. 
Results from the 26-year follow up from the Framingham Heart study demonstrated that 
obesity was a long-term predictor for CVD incidence [52]. Relative to men, the strength of 
obesity as a risk factor was higher in women, as only age and BP were more powerful 
predictors. However, authors pointed out that more women were extremely overweight in 
Chapter 1 
27 
 
comparison to men, and apparent excess weight in men is more likely to be a result of 
muscularity [52]. A 44-year follow up of the Framingham study also revealed a higher 
relative risk between 1.13 to 1.38 for total CVD in overweight and obese participants [53]. 
In particular, women from the Nurses’ Health Study who were overweight or obese had a 
relative risk of 1.3 (95% CI 0.9, 1.9) and 3.3 (95% CI 2.3, 4.5) for CHD compared to the 
reference [Body mass index, (BMI) <21] [54]. In addition, controlling for history of medical 
conditions such as diabetes, hypertension and hypercholesterolemia attenuated the 
strength of association, indicating that a combination of being overweight/obese and one of 
the former conditions could result in a several-fold increase in relative risk of CHD [54]. 
When adipose tissue is concentrated in the abdomen (abdominal obesity), the 
adverse effect of obesity increases further [15]. The INTERHEART study reported a 
significant adverse association between waist-to-hip ratio and risk of MI globally, and this 
association was stronger than the relationship between BMI and MI risk [55]. The PAR for 
the top two quantiles of greater waist-to-hip ratio (24%) was also higher than BMI (7.7%) 
[55]. The authors proposed various hormonal and biochemical factors which may lead to 
higher visceral fat, lower skeletal mass and insulin resistance (risk factor for diabetes) [55]. 
Obesity may also increase with age in general, and susceptibility of obesity is partly 
hereditary (40% to 70%), but influenced by diet and the environment [15, 56]. The obesity 
epidemic is global, but especially serious in disadvantaged groups in high-income countries, 
and among wealthy middle-aged women in low-income countries [56]. Within the UK, two-
thirds of men are obese or overweight, while obesity rates vary in women depending on 
income. Men from West Midlands were most likely to be obese/overweight (72%), while 
women from East and East Midlands have the highest prevalence (63%) in comparison to 
other regions [15]. Obesity may also vary by ethnic groups, where Chinese men had lowest 
prevalence of obesity by BMI relative to the general population. However, when using waist-
to-hip ratio as comparison, differences were removed entirely due to the natural variation 
of body shapes within ethnic groups, related to storage of fat in different places in the body 
[15]. 
1.1.1.5.5 Smoking 
Cigarette smoking is known to be a major risk factor for CVD. Proposed mechanisms 
by which smoking affects health include the promotion of atherosclerosis [57], thrombosis 
and elevation of serum total cholesterol [58]. Smoking may also cause an increase in lipid 
peroxidation, and increase the uptake of LDL-C by macrophages [59]. These macrophages 
turn into foam cells that contribute to the development of lesions and plaques, leading to 
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possibility of atherosclerosis. Other possible mechanisms include oxidative stress, 
mitochondrial damage [58], and increased risk in other diseases, such as type 2 diabetes 
[43] and hypertension. Prevalence of smoking the UK had remain relatively stable since 
2003 among adults aged 16 years and above, where one in five are currently smokers [60]. 
Smoking prevalence within men (22%) is higher than women (17%) in the UK.  The amount 
of risk contributing to the development of CVD is also dependant on when smoking was 
initiated, when cessation occurred and how long did cessation last for. According to Shields 
et. al [61], men were more likely to be smokers than women in a Canadian cohort. There 
were also more male smokers in a Korean cohort [40]. However, within developed 
countries, the proportion of female smokers has increased, reflected in higher rates of lung 
cancer in women compared to previous years [62]. Nevertheless, both studies suggested a 
reduction in the risk of cardiovascular mortality if smoking ceases or the number of 
cigarettes smoked per day decreased. This concept is also supported by a systematic review 
(SR) by Critchley et. al [63], which indicated that quitting smoking is strongly associated 
with a reduced CVD mortality. 
1.1.1.5.6 Physical activity 
From observational studies, higher physical activity is reported in multiple studies 
from various countries to be associated with a lower risk of CVD, where 150 min/week or 
75 min/week of moderate aerobic exercise and vigorous aerobic exercise is strongly 
associated with a reduced risk respectively [64]. Further evidence from the 40-year follow 
up of the Framingham Heart study observed that long-term physical activity is protective 
against CVD mortality relative to long-term physical inactivity. This is also seen in men for 
CVD incidence, but not for women [65]. Physical activity levels are relatively low in the UK 
for both men and women. Nutritional surveys indicate Scottish men and women report the 
most exercise, at 45% and 33% respectively above recommended levels of physical activity 
[15]. However, using objective accelerometer data, only 6% of men and 4% women met the 
recommended levels, relative to previous reported averages of 39% and 29% for men and 
women respectively. By ethnic group, British South Asians are less likely to be physically 
active in comparison to White counterparts, contributing to >20% excess of CHD mortality 
[66]. 
1.1.1.5.7 Other potential risk factors 
The effects of residence can already be seen in previous sections discussing the 
prevalence of biological risks in different areas of UK. Education seems to also be associated 
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with modification of behavioural risks, where lower educational level is linked to higher 
risk of CVD. Increased level of intelligence and influencing lifestyle behaviours were some 
of the possible explanations offered [67]. Occupation is also suggested to have an inverse 
association with CVD risk. In Marmot et. al [68], male subjects who had clerical and office-
support jobs had an odds ratio of 1.50 (95% CI 0.98, 2.29)as compared to subjects who had 
administrative jobs. However, a statistically significant relationship was not observed in the 
former publication. Social economic status can also influence other risk factors, as shown in 
Lawlor et. al [69]. It can affect behaviours such as smoking and physical activity, which in 
turn influences obesity levels. In Lawlor et. al [69] involving analyses of three age cohorts 
of Australian women, the most advantageous social economic status was seen to have an 
inverse relation with physical activity, obesity and physical activity [69]. However, 
relationships between smoking and socio-economic status (SES) varied between the three 
cohorts. This is indicative that there is no definite positive or negative association between 
social economic factors and other behavioural risks. Therefore, the adjustment of these 
variables has to be considered carefully. 
1.1.1.5.8 Dietary components and patterns 
Research on dietary intake and CVD mortality was initiated in the late 1950s in the 
Seven Countries Study, focusing on fat and cholesterol intake, giving way to the ‘diet-heart 
hypothesis’ [70]. Other nutrients such as vitamin B (B6, B12, folate), C, E and carotenoids 
were also investigated over time, however, evidence for the supplementation or increased 
intake of these single nutrients was either inconclusive, or not recommended for the 
prevention of CVD [70]. 
While single nutrients could possibly play a mechanistic role in vivo, it is consumed as 
a complex food matrix with other nutrients, and may interact with or act synergistically with 
other food components. Thus, leading to investigation of whole foods, dietary patterns and 
CVD risk. Food components such as fatty fish (high in mono- and poly-saturated fats), fruits 
and vegetables (FVs) [fibre, ‘antioxidants’, (poly)phenols] whole grain (fibre) and moderate 
amounts of alcohol in the form of wine [(poly)phenols] are shown to be inversely associated 
with CVD risk [70]. In contrast, foods such as meat, milk and butter tend to have an adverse 
association with CVD mortality. [71]. When the former foods are studied in combination as 
the Mediterranean diet, multiple studies report an inverse relationship with CVD mortality 
[72-75]. Results from MA [76] and SR [77] also support the former findings stated. In 
addition, evidence from RCTs was provided by the PREDIMED trial in Estruch et. al [78] and 
Estruch et. al [79], where diets supplemented with olive oil or nuts as compared to low-fat 
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diet, has beneficial effects for risk of CVD. However, the effects seen are not as prominent, 
as the trial was based on a population residing in the Mediterranean area to begin with, and 
therefore potentially following a Mediterranean diet. Alternatively, the Dietary Approaches 
to Stop Hypertension (DASH) diet, rich in fruits, vegetables and low-fat dairy products was 
successful at lowering CVD risk by lowering BP [70, 80]. In addition, a recent RCT reported 
reduced risk by a third in healthy middle-aged and older participants with adherence to the 
following recommendations promoted to lower or prevent CVD [81, 82]: 
 High intake of vegetables, fruits, whole grains, low- or non-fat dairy, seafood (oily 
fish), legumes and nuts 
 Moderate consumption of alcohol 
 Low intake of sodium, red and processed meat, sugar-sweetened foods, drinks, 
refined grains 
FVs are rich in a variety of nutrients which may be protective against CVD risk. 
Proposed components which may exert benefits within FVs in general include fibre, 
carotenoids, vitamin C, magnesium and potassium [70]. Multiple SR and MA have reported 
a significant, inverse association between greater intake of FVs and risk of CVD, CHD and 
stroke [83-85]. The EPIC-HEART study observed that every additional portion of FV (80 g) 
consumed per day leads to a 4% lower risk of CVD mortality [86]. In addition, Scarborough 
and colleagues estimated that 15,000 deaths could also be avoided in UK if adherence to 
five-a-day portions of FVs was achieved [87]. This is consistent with the study from the 
World Health Organisation (WHO), which reports an inadequacy of FV intake worldwide 
[88]. However, FVs are also (poly)phenol-rich foods, and there are few studies to support if 
specific fruits or fruit subgroups are more important than others, and associated with lower 
risk of CVD. 
In addition to FVs, coffee and tea are also rich in (poly)phenols, and play a significant 
role in the habitual diet within UK. Coffee was previously associated with an increased risk 
of CVD [89-91]. However, results overall are inconsistent. Recent MAs contradicts the 
former findings [92, 93]. The latter MAs included recent studies, and reported no positive 
relationship with greater consumption of coffee. There was also a non-linear response, 
where three cups of coffee was associated with the greatest risk reduction [93]. 
Furthermore, moderate coffee consumption (1 to 3 cups/day in US or 3 to 4 cups in Europe) 
significantly lowered CHD risk by 18% (95% CI 0.73 to 0.92) and 13% (95% CI 0.80 to 0.86) 
in men and women followed for more than ten years [92]. Wu and colleagues also did not 
observe a positive association with higher habitual coffee intake [92]. 
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As for evidence on tea consumption, green tea seems to only show a positive effect of 
lowering the risk of CVD in case-control studies and male subjects, but not for cohort studies 
or female subjects in case-control studies [94]. The evidence for beneficial health effects of 
consumption of black tea is inconclusive. A MA on RCTs reported that the consumption of 
black tea had no effects on BP and cholesterol levels, but it improved flow-mediated dilation 
[95]. However, another MA of cohort and case-control studies states that incidence of 
myocardial infarction reduced by 11% if consumption of tea was increased to 3 cups/day 
[89]. Despite multiple findings that act in either direction, a review of meta-analyses 
proposed that evidence for tea consumption (black and green) and stroke was the strongest 
out of all CVD outcomes [96]. Thus, further investigation is warranted for coffee and tea 
outcomes. 
1.2 (Poly)phenols overview 
(Poly)phenols represent a group of secondary plant metabolites that exists in plant 
based foods. Their functions within the plant includes assisting with growth, reproduction, 
defense and provision of colour characteristics [97]. They also play an important role in the 
prevention of diseases, such as cancer, stroke and CHD [98], through effects such as gene, 
enzyme and cell receptor modulations [99]. They are readily consumed in large quantities, 
from sources such as fruits, vegetables, red wine, tea, coffee and cocoa [100]. The estimated 
daily intake is known to be about 1 g/day [101].  
All (poly)phenols have an aromatic ring and a minimum of one hydroxyl group, and 
are divided into different classes according to their skeleton structures (Table 1.2). The 
largest groups of dietary (poly)phenols are phenolic acids and flavonoids. Flavonoids are 
further classified into subclasses: anthocyanidins, flavones, flavanols (catechins), flavonols, 
flavanones and isoflavones (Figure 1.3), which are found in large quantities at various 
concentrations within different plant-based foods [100]. Other classes include phenylacetic 
acids, napthoquinones, xanthones, lignans and condensed tannins (proanthocyanidin), 
which are present in limited food sources at various concentrations [102]. (Poly)phenols 
within each subclass are often metabolized in a similar manner, the general biological 
process is described in the following section. 
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Table 1.2 The classification and skeletal structure of (poly)phenols 
Classification Skeleton Structure 
Phenolics   
Hydroxybenzoic acid 
 
C6-C1 
  
 
Hydroxycinnamic acid 
 
C6-C3 
  
 
(Poly)phenolics   
Stillbenes C6-C2-C6 
 
Flavonoids C6-C3-C6 
 
Lignans (C6-C3)2 Not shown here as 
skeletal structure not 
consistent 
 
Figure 1.3 The skeletal structure of flavonoid subclasses 
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1.2.1 Absorption and bioavailability of (poly)phenols 
(Poly)phenols are present in large quantities within plant-based dietary sources, and 
extensively metabolized in the body, leading to the formation of various (poly)phenol 
metabolites. During ingestion, chewing releases (poly)phenols from the food matrix [103]. 
Some (poly)phenols are absorbed in the stomach and small intestine, where hydrolysis of 
the glycoside moiety to form aglycone is essential to facilitate absorption [104]. There are 
two proposed mechanisms concerning (poly)phenol absorption that have been reviewed. 
The first mechanism involves the enzyme lactase phloridizin hydrolase (LPH) which is 
capable of deglycolysation and hydrolysis of lactose. LPH is located in the brush-border of 
the small intestine epithelial cells. The specificity of this enzyme is very broad, and it readily 
converts flavonoid glucosides to aglycones. This increases the lipophilicity and proximity of 
(poly)phenols to the cellular membrane, resulting in passive diffusion into epithelial cells 
[105]. The alternative mechanism invovles an enzyme, cytosolic β-glucoside (CBG) located 
in epithelial cells. Polar glucosides are transported by active sodium-independent glucose 
transporter SGLT1 into the cell to be hydrolysed, catalysed by CBG [106]. Before passage 
into the bloodstream, the (poly)phenols now in the form of aglycones are conjugated via 
three possible mechanisms, including methylation, sulfation and glucuronidation, by action 
of catechol-O-methyltransferases (COMT), sulfotransferases and uridine-5’-diphosphate 
glucuronosyltransferases respectively [107]. These metabolites are carried via the portal 
bloodstream to the liver, where (poly)phenol metabolites are subjected to phase II 
metabolism and further conversions [107]. (Poly)phenols which are not metabolised and 
absorbed in the small intestine move on to the colon, where the microflora cleaves the 
remaining (poly)phenols glucosides into aglycones, possibly leading to the production of 
phenolic acids and hydroxycinnamic acids. [107]. (Poly)phenols in the colon could be 
absorbed to reach the liver, and undergo phase II metabolism before being excreted in the 
urine [107]. 
Bioavailability refers to the the quantity and effectiveness of (poly)phenols 
absorption from the gut into the bloodstream via the two possible mechanisms as explained 
above, and its metabolites are quantified in blood plasma and urine in human studies. The 
chemical structure of the (poly)phenol affects the rate of absorption into the blood, where 
levels in plasma rarely exceed 1µM when the ingested doses are in line with amounts 
normally consumed in the diet [98] (Table 1.3). Examples of relatively well-absorbed 
(poly)phenols include gallic acid and isoflavones [108] (Table 1.4). This is followed by 
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catechins (flavan-3-ols), flavanones and quercetin glucosides. Proanthocyanidins, 
galloylated tea catechins and anthocyanins are the least well absorbed [108]. 
Table 1.3 Pharmacokinetics on major (poly)phenol classes summarised from Manach et. al [108] 
(Poly)phenol 
subclass 
Range of 
dosage1 
Tmax in 
plasma2 (hr) 
Plasma 
concentration 
Elimination 
half-life (hr) 
Urinary 
excretion (% 
of intake) 
Anthocyanins 150 mg to 2 g 0.75 – 4 10 – 50 nmol/L - 0.004 – 0.1 
Flavonols 1.6 mg to 4 g 0.5 – 7.5 0.15 – 7.6 µmol/L 10.9 – 28.1 1 – 6.4 
Flavanones 7.2 to 500 mg 2 – 5.8 0.06 – 5.99 µmol/L 1.3 – 2.9 1.1 – 30.2 
Flavan-3-ols 32 mg to 1.6 g 0.5 – 2.9 0.21 – 7.4 µmol/L 1 – 8.6 0.1 – 55 
Isoflavones 12.5 to 389 mg 2 – 9.5 0.17 – 3.7 µmol/L 3.4 – 10.8 4 – 63 
1From various sources, including pure compound, supplements and foods 
2Time to maximum concentration (Cmax) in plasma 
Table 1.4 Summary of the biological activities of (poly)phenol subclasses from Manach et. al [108] and 
Del Rio et. al [109] 
(Poly)phenol 
subclass 
Metabolism Absorption 
Anthocyanins Limited – Often found as unchanged 
glycosides, sometimes as glucuronidated 
and/or sulfated derivatives. The gut 
microflora also converts limited amounts of 
anthocyanins to phenolic acid derivatives 
and aldehyde constituents. Anthocyanins are 
highly unstable, subjected to degradation 
through physiological changes (pH). 
Rapidly absorbed and eliminated, but with 
poor efficiency (low bioavailability) - 
Mostly absorbed in the stomach and small 
intestine, partially in the large intestine. 
Flavonols Extensively metabolised and conjugated in 
small and large intestine, not present as an 
aglycone, and undergoes substantial phase II 
metabolism. 
Efficiently absorbed as conjugates, where the 
bioavailability is dependent on the type of 
glycoside and food source. Relatively high 
urinary excretion and elimination half-life, 
indicating good chemical stability (see Table 
1.3) 
Flavanones Extensively metabolised and conjugated 
especially in the large intestine, undergoing 
substantial phase II metabolism. 
Rapidly absorbed in the large intestine as 
glucoronidated forms and phenolic acid 
derivatives, and especially in the form of an 
aglycone after deglycosylation through gut 
microflora. 
Flavan-3-ols Catechins are metabolised and conjugated 
as methylated forms (epigallocatechin) or 
glucoronidated and/or sulfated forms (other 
catechins). 
Theaflavins and thearubigins are not 
expected to be metabolised differently to 
catechins. 
Catechins are well absorbed in the small and 
large intestine, but rapidly eliminated. Rarely 
absorbed as unmetabolised forms. 
Theaflavins and thearubigins are absorbed in 
the large intestine after microflora catabolism. 
Their mode of absorption is not expected to be 
largely different to catechins. 
Isoflavones Rapidly metabolised into deglycosylated 
glucoronides and sulfates from glycosides. 
Absorption occurs simultaneously in both 
the small and large intestine over a long 
period of time (see half-life in Table 1.3), 
where the bioavailability is relatively highest 
in comparison to other flavonoid subclasses. 
1.2.2 Measuring (poly)phenol intake 
There are currently two leading (poly)phenol databases: the United States 
Department of Agriculture (USDA) flavonoid database [110] and the Phenol Explorer [111]. 
The USDA flavonoid database contain values for 506 foods on flavones, flavonols, flavan-3-
nols, flavanones and anthocyanidins. A wide range of analytical procedures that separate 
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flavonoid compounds effectively were accepted for the development of this database, such 
as (and not limited to) high-performance liquid chromatography (HPLC) and capillary zone 
electrophoresis (CE). However, spectrophotometric and pH differential methods were not 
accepted due to the lack of specificity. This database only reports values in aglycone form, 
conversion factors were applied to glycosylated forms (except for catechins and 
epicatechins). On the other hand, Phenol Explorer reports nine classes and 67 subclasses of 
(poly)phenols in 458 foods, including metabolites from intervention studies. In addition, 
retention factors for food processing were also recently published on 35 processes and 155 
foods [112]. Phenol Explorer also accepts values from a wider range of analytical methods 
for various purposes. Spectrophotometric methods such as Folin-Ciocalteu method and pH 
differential method are accepted as a global assay to estimate total phenolic content (TPC) 
and total anthocyanin content respectively, while HPLC, gas chromatography and CE before 
and after hydrolysis are accepted as main procedures for quantification of (poly)phenol 
glycosides and aglycones. Most studies derive their (poly)phenol intake estimates by 
incorporating either one of the two databases above, or a combination of both, sometimes 
in addition to supplementary data from literature, and are currently limited to US or 
European cohorts using food records or 24-hour recalls, with no standalone UK cohorts 
estimating (poly)phenol intake [113-115]. Unlike the previous studies, no total polyphenol 
score or intake is generated in this thesis, due to the following reasons. Firstly, (poly)phenol 
contents reported in databases are often the average of multiple samples. Natural variations 
exist within food samples, dependent on cultivar, species, growing, processing and storage 
conditions. Therefore, importing values from (poly)phenol databases and estimating 
(poly)phenol intake within individuals is subject to a large measurement error. 
Furthermore, as (poly)phenol databases are still under development, (poly)phenol content 
within less commonly consumed or processed foods, as well as foods with complex food 
matrices are limited, thus potentially under- or over-estimating (poly)phenol intake. 
1.2.3 Major (poly)phenol profiles in foods 
(Poly)phenol profiles in foods are hugely complex, and mostly contain multiple 
classes of (poly)phenols in a single plant. Few studies have examined the association of 
classes of (poly)phenols in relation to chronic disease outcomes [116-118], however, 
(poly)phenols are not consumed by class or sub-class. Estimation is also subject to 
limitations described above. (Poly)phenols are consumed as a mixture in different types of 
plant-based foods by culinary or botanical categories instead. Thus, before investigating the 
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association between (poly)phenols and CVD risk, the relationship between (poly)phenol-
rich foods and CVD risk itself should be investigated first. 
There are multiple methods to classify FVs, demonstrated within Pennington et. al 
[119], where groupings are available by botanic family, colour, plant part and total 
antioxidant capacity. However, in order to study the association of (poly)phenol rich foods 
and CVD in an applicable manner, the botanical, culinary and (poly)phenol systems must be 
taken into account altogether. In the interest of taking the (poly)phenol classes into account, 
as well as to address the lack of existing research on for FV subgroups and CVD risk in this 
thesis, FV subgroups were loosely based on the Phenol Explorer categorisation. Thus, fruits 
were divided into five subgroups: berries, citrus, drupes, pomes and tropical fruits, while 
vegetables were divided into: Allium, Brassicaceae, fruit vegetables, pod vegetables and 
‘stalk and root’ vegetables. 
1.2.3.1 Fruits 
The definition of fruit in botany refers to “the pericarp which derives from the ovary 
(or ovaries) of the flower, usually containing seeds for dispersal”. In common parlance and 
by culinary definitions, fruits are edible fleshy structures of plants which are usually sweet 
or sour, often consumed raw, which includes apples, bananas, oranges, strawberries, 
melons and grapes. The thesis follows the latter definition of fruits. 
1.2.3.1.1 Berries 
In botanical terms, the definition of a ‘true berry’ is “a fleshy fruit without a stone, 
consisting of a potentially edible pericarp, formed from a ripened simple or compound 
ovary”. This definition includes bananas and tomatoes, but excludes fruits commonly 
recognised as ‘berries’, such as blackberries, raspberries, blueberries and strawberries. The 
special term ‘hesperidium’ is also given to citrus fruits such as oranges and lemons which 
are botanically similar to ‘true berries’, while the term ‘pepo’ includes plants from the 
pumpkin family, such as pumpkin, melons and watermelon. 
Berries defined in this thesis is based on the term ‘berry’ in common parlance, 
associating more closely with the culinary applications, as well as in accordance with Phenol 
Explorer definitions [111]. Thus, consisting of fruits that are brightly coloured, juicy, sweet 
or sour without a stone or pit, but may contain pips or seeds, such as (but not limited to) the 
more commonly consumed blackberries (Rubus fruticosus), blackcurrants (Ribes nigrum), 
blueberries (Vaccinium cyanococcus), cranberry (Vaccinium oxycoccus), grapes (Vitis 
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vinifera), raspberries (Rubus idaeus), redcurrants (Ribes rubrum) and strawberries 
(Fragaria × ananassa). 
Berries are naturally rich in moisture, fibre, vitamin C and E, folic acid, calcium, selenium, 
and carotenoids such as α-, β-carotene and lutein [120]. They also contain high proportions 
of anthocyanins. Anthocyanins are the glycoside form (i.e. bonded to a sugar moiety) of 
anthocyanidins (Figure 1.4), and are pre-dominantly responsible for the bright colours (e.g. 
purple, blue, red, orange, pink) within berries. Cyanidin is the most widely distributed 
anthocyanidin within foods, followed by delphinidin, pelargonidin, peonidin, petunidin and 
malvidin [121] (Table 1.5). Berries also contain other (poly)phenols such as phenolic acids, 
flavanols and flavonols, but their contribution towards total anthocyanin intake is the 
greatest [122, 123]. The distribution of anthocyanins varies greatly across different fruits, 
where some fruits contain high levels of a particular anthocyanin, and others contain 
moderate levels of few (Table 1.6). 
 
Figure 1.4 The skeletal structure of anthocyanidin and substitution sites 
Table 1.5 Substitution pattern and approximate distribution of major anthocyanidins across food 
sources [121] 
Name R1 R2 Distribution (%) 
Cyanidin OH H 50 
Delphinidin OH OH 12 
Pelargonidin H H 12 
Peonidin OMe H 12 
Petunidin OMe OH 7 
Malvidin OMe OMe 7 
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Table 1.6 Distribution of major anthocyanins across commonly consumed berries, and estimated total 
phenolic content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 
g fresh weight [111] 
Name Major anthocyanins 
Total (poly)phenol 
content mg/100g 
FW 
Blackberry Cyanidin-3-O-glucoside 569 (226) 
Blackcurrant Delphinidin-3-O-rutinoside, cyanidin-3-O-
rutinoside, delphinidin-3-O-glucoside 
821 (230) 
Blueberries 
(Highbush) 
Delphinidin-3-O-galactoside, malvidin-3-O-
galactoside, delphinidin-3-O-arabinoside, 
malvidin-3-O-arabinoside, petunidin-3-O-
galactoside, malvidin-3-O-glucoside 
223 (173) 
Blueberries 
(Lowbush) 
Malvidin-3-O-glucoside, malvidin-3-O-galactoside, 
delphinidin-3-O-galactoside, delphinidin-3-O-
glucoside, malvidin-3-O-(6''-acetyl-glucoside), 
petunidin-3-O-glucoside 
- 
Cranberry 
(American) 
Peonidin-3-O-galactoside, cyanidin-3-O-
galactoside 
315 (0) 
Grapes (Black) Malvidin-3-O-glucoside, cyanidin-3-O-glucoside, 
delphinidin-3-O-glucoside 
185 (18) 
Raspberry Cyanidin-3-O-glucoside 155 (91) 
Redcurrant Cyanidin-3-O-xylosyl-rutinoside, cyanidin-3-O-
sambubioside 
448 (85) 
Strawberry Pelargonidin-3-O-glucoside, pelargonidin-3-O-
(6''-succinyl-glucoside) 
289 (95) 
The estimated consumption of anthocyanins vary greatly across regions, influenced 
by methodological differences and variation in diet composition. Previous estimation of 
mean anthocyanin intake in the US was 12.5 mg/day, where the consumption of berries 
contributed approximately 56% of total anthocyanin intake [122]. Within the NHANES 
2007-2010 study, mean estimated anthocyanin intake was 11.7 mg/day, where berry fruits 
contributed ~39% towards total anthocyanin intake [115]. Within the EPIC-cohort, berries 
were estimated to provide ~25% (~50%, inclusive of wine) of all anthocyanidins within the 
European region, with Italian men and French women having the highest anthocyanidin 
intake of 44 to 64 mg/day and 32 to 40 mg/day respectively. Estimated anthocyanidin 
intake in a UK general population was between 22-24 mg/day, and 28 to 31 mg/day within 
a health-conscious cohort [123]. More recently, estimates performed on the European 
region using dietary data collected from 1997 onwards reported a lower estimate of 19 
mg/day overall. Finland and Italy consumed the highest amount of anthocyanidins (28 
mg/day), while the UK estimate was 16 mg/day [113]. 
Berries are often processed into food products, such as jams and juices. During the 
production of these foods, anthocyanins are subjected to temperature and pH changes, 
which may affect the stability of the compounds. Thermal treatment is known to reduce 
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anthocyanin content in jams by up to 80%, and long storage periods (60 days) could also 
result in at least ~50% loss from blueberry puree and juice [124]. 
1.2.3.1.2 Citrus 
As mentioned above, hesperidia are botanically similar to ‘true berries’ with a tough, 
leathery rind, fluid-filled sacs known as carpels, and varying number of seeds, consisting of 
fruits from the Rutaceae family, Citrus genus. The same term is also consistent with culinary 
definitions. Commonly consumed citrus fruits include sweet orange (Citrus × sinensis), 
bitter/sour orange, (Citrus × aurantium), grapefruit (Citrus × paradisi), lemon (Citrus × 
limon), lime (Citrus aurantifolia), mandarin (Citrus reticulata), clementines (Citrus × 
clementina), tangerines (Citrus tangerina) and pomelos (Citrus maxima). Citrus fruit are 
naturally rich in moisture, fibre, vitamin C, sugars (sucrose, glucose and fructose), 
potassium, carotenes, vitamin B and E, and low in sodium. 
Citrus fruits are especially rich in flavanones (Figure 1.5) and were reported to 
contribute at least 90% towards total flavanone intake in the US [115]. The dominant form 
exists as hesperidin (hesperitin-7-O-rutinoside), present pre-dominantly in sweet orange, 
lemon, lime and mandarin. Bitter/sour orange is rich in neohesperidin (hesperitin-7-O-
neohesperidoside) and grapefruit contains a high concentration of naringin (naringin-7-O-
neohesperidoside) (Table 1.7), both known to be bitter flavoured compounds [100]. 
Flavanones are present in both the tissue and juice of the fruit, but are not evenly 
distributed. Citrus peel has the highest concentration of flavanones, while the juice, albedo 
and segment/sac membranes contain significantly less in comparison [125]. Citrus fruits 
are also consumed as juices, however, the amount of flavanones present in juices is lower 
in comparison (~50%), as the albedo and segments (which contain a higher concentration 
of flavanones) are not present [125, 126]. The stability of flavanones is high in comparison 
to anthocyanins, as temperature and storage result in minimal losses [127]. Quantification 
of flavanones is subjected to variation, dependent on the amount of albedo tissue remaining 
on the segment after peeling the fruit [100]. In addition, the natural variation of flavanones 
produced within different cultivars of the same species also introduces quantification issues 
[128, 129]. 
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Figure 1.5 The skeletal structure of flavanone and respective substitution sites 
Table 1.7 The substitution pattern of major flavanones and its glycosides 
Name R1 R2 R3 
Hesperitin OH OH OCH3 
Naringenin OH H OH 
Hesperidin rutinoside OH OCH3 
Narirutin rutinoside H OH 
Neohesperidin neohesperidose OH OCH3 
Naringin neohesperidose H OH 
 
An earlier assessment on average flavanone intake within Europe was conducted 
using the EPIC-cohort [130]. Within men, highest consumers were from Spain and health-
conscious UK, with an intake of ~69 mg/day, while women from Netherlands had an 
average intake of ~49 mg/day. Women from UK consumed between 40 to 43 mg/day of 
flavanones. However, estimates from US, NHANES were much lower at ~14 mg/day [131], 
in agreement with Vogiatzoglou et. al [113]. Intakes for UK population from Vogiatzoglou 
et. al [113] was 9 mg/day, where the highest flavanone consuming country was Finland (30 
mg/day). 
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1.2.3.1.3 Drupes 
By botanical definition, drupes (or stone fruits) are fruits with a fleshy mesocarp, 
surrounding a single seed, known as the pit, including fruits from the Prunus genus, 
mangoes and olives. However, the term ‘drupes’ here refer to only fruits from the Prunus 
genus, such as (and not limited to) apricots (Prunus armeniaca), sour cherries (Prunus 
cerasus) and sweet cherries (Prunus avium), nectarines (Prunus persica var. nucipersica), 
peaches (Prunus persica), plums (Prunus domestica) and prunes (Prunus domestica). Drupes 
are rich in potassium, sugars and contain some vitamin C and malic acid. 
The (poly)phenol profile of drupes is complex, and not dominantly rich in any 
particular flavonoid class like berries and citrus. Instead, they contain varying levels of 
hydroxycinnamic acids, flavanols and anthocyanins (Table 1.8). For this reason, estimation 
intakes are not available. Distribution of (poly)phenols also seem to be uneven, due to 
differences between peeled and whole nectarines and peaches, suggesting at least half of 
the total (poly)phenols are located within the skin. Thus, it is important to make note of the 
way drupes are consumed to accurately estimate (poly)phenol intakes.  
Table 1.8 Distribution of major (poly)phenol classes across commonly consumed drupes, and estimated 
total phenolic content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in 
mg/100 g fresh weight [100, 111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Apricots Hydroxycinnamic acids (3-caffeoylquinic acid), flava-
3-nols [(-)-epicatechin] 
133 (0) 
Cherries Anthocyanins (cyanidin-3-O-rutinoside), 
hydroxycinnamic acids (3-caffeoylquinic acid) 
Sweet: 174 (77) 
Sour: 352 (62) 
Nectarines Hydroxycinnamic acids (5-caffeoylquinic acid), flava-
3-nols (proanthocyanidins), anthocyanins (cyanidin-
3-O-glucoside) 
Peeled: 47 (13) 
Whole: 55 (12) 
Peaches Hydroxycinnamic acids (5-caffeoylquinic acid), 
flavanols [(-)-epicatechin], anthocyanins (cyanidin-3-
O-glucoside) 
Peeled: 107 (69) 
Whole: 279 (196) 
Plums Hydroxycinnamic acids (3-caffeoylquinic acid), 
anthocyanins (cyanidin-3-O-rutinoside), flava-3-nols 
(proanthocyanidins) 
410 (276) 
1.2.3.1.4 Pomes 
Pomes in botany are accessory fruits with a fleshy receptacle, and a core consisting of 
a few seeds surrounded by a shell. It also specifically refers to fruits from the Rosaceae 
family and Malinae subtribe. Apples (Malus domestica) and pears (Pyrus communis) belong 
in this subgroup, and are widely consumed. Pomes are a rich source of fibre, potassium, 
sugars, and contain varying amounts of vitamin C (3 to 14 mg/100 g) [132]. Apples are one 
of the main sources of proanthocyanidins (polymers of flavan-3-ols) after tea, 
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hydroxycinnamic acids and flavonols [100, 113, 115]. The (poly)phenol profile for pear is 
also very similar to apples (Table 1.9). Apples and pears also contribute 3.9 to 11.2% 
towards total (poly)phenol intake within Europe, and provide between 24.6% to 45.3% of 
selected proanthocyanidins in the diet [114]. Apples are often consumed fresh, or as apple 
juice, but in contrast to the stability of flavanones in orange juice, (poly)phenol content in 
apple juice is significantly lower in comparison to the unprocessed counterpart [133]. 
Table 1.9 Distribution of major (poly)phenol classes for apples and pears, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean and standard deviation in mg/100 g fresh 
weight [100, 111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Apple (Dessert) Flavan-3-nols (procyanidin dimer B2), 
Hydroxycinnamic acid (5-caffeoylquinic acid), 
Flavonols (quercetin-3-O-glucoside) 
Peeled: 132 (119) 
Whole: 201 (105) 
Apple (Cider) Hydroxycinnamic acid (5-caffeoylquinic acid),  
Flavan-3-ols [(-)-epicatechin, procyanidin dimer B2] 
Peeled: 251 (126) 
Whole: - 
Pear Hydroxycinnamic acid (5-caffeoylquinic acid),  
Flavan-3-ols [(-)-epicatechin] 
Peeled: 126 (102) 
Whole: 108 (47) 
1.2.3.1.5 Tropical fruits 
Tropical fruits consist of fruits from multiple botanical families, commonly consumed 
examples include bananas (Musa acuminta, Musa balbisiana), kiwifruit (Actinidia deliciosa), 
mango (Mangifera indica), passion fruit (Passiflora edulis), papaya (Carica papaya) and 
pineapple (Ananas comosus). These fruits are mostly cultivated in the tropics and 
subtropics, and are thus more widely consumed there. Data on (poly)phenol content within 
these fruits are limited, but current evidence suggest that tropical fruits do not seem to 
contribute greatly towards (poly)phenol intake in general, with the exception of bananas 
(Table 1.10). However, they do provide nutrients such as vitamin C, and are often 
particularly rich in both starch and sugars. 
Table 1.10 Distribution of major (poly)phenol classes across commonly consumed tropical fruits, and 
estimated total phenolic content using Folin-Ciocalteu assay, expressed as mean (standard 
deviation) in mg/100 g fresh weight [111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Banana1 Flava-3-nols [(+)-catechin] 155 (79) 
Kiwifruit1 Flavones (luteolin), flavan-3-ols [(-)-epicatechin] 180 (112) 
Mango1 Flava-3-nols [(+)-catechin] 145 (109) 
Passion fruit Data not available 57 (0) 
Papaya2 Flavonols (myricetin), flavones (luteolin) 58 (0) 
Pineapple2 Flavonols (quercetin) 148 (61) 
1Major flavonols from Phenol Explorer, 2major flavonol aglycone from USDA flavonoid database 
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1.2.3.2 Vegetables 
The definition of vegetables is largely driven by culinary tradition, referring to plant 
parts (usually not sweet) commonly consumed with various meats in savoury dishes. 
Vegetables could also be consumed raw as a salad. With the exception of the Allium genus, 
(poly)phenol profiles of vegetables are largely similar, consisting of mostly lignans. Thus, 
vegetables were firstly grouped by taking into account the genus, followed by plant parts 
and usual methods of consumption. 
1.2.3.2.1 Allium 
Allium vegetables here literally refer to vegetables from the Allium genus, such as 
onion (Allium cepa), shallot (Allium cepa var. aggregatum), chive (Allium schoenoprasum), 
garlic (Allium sativum) and leek (Allium ampeloprasum). These vegetables are more 
commonly consumed after cooking, although onion, garlic and chives can also be consumed 
raw. Allium vegetables pre-dominantly consist of flavonols (Figure 1.6), where the most 
abundant form is quercetin (Table 1.11) and its glycosides. Red onions are rich in quercetin-
3,4’-O-diglucoside and quercetin-4’-O-glucoside. They also contain some anthocyanins 
which contribute to the red pigment. White onions in contrast have a lower (poly)phenol 
content. The (poly)phenol composition of shallots is similar to red onions, while data on 
other Allium vegetables are limited due to lack of evidence (Table 1.12). Cooking methods 
such as frying, boiling or microwaving may decrease flavonol content within onions by 21%, 
75% and 64% in comparison to uncooked onions, though some (poly)phenols are leached 
into cooking water [134]. Even so, failure to account for retention factors may lead to bias 
in estimation of flavonol intakes. In addition to (poly)phenols, Allium vegetables are also 
rich in potassium and vitamin C. 
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Figure 1.6 The skeletal structure of flavonol and respective substitution sites 
Table 1.11 The substitution pattern of major flavonols 
Name R1 R2 
Quercetin OH H 
Myricetin OH OH 
Kaempferol H H 
Isorhamnetin OCH3 H 
Table 1.12 Distribution of major flavonols in Allium vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] 
Name Major flavonols 
Total (poly)phenols 
mg/100g FW 
Onions1 Quercetin-3,4’-O-diglucoside, quercetin-4’-O-glucoside 
Red: 45 
White: 103 (22) 
Shallot1 Quercetin-3,4’-O-diglucoside, quercetin-4’-O-glucoside Pink shallot: 115 
Garlic2 Quercetin, myricetin 87 (52) 
Leek2 Kaempferol - 
Chives2 Kaempferol, quercetin 81 (21) 
1Major flavonols from Phenol Explorer, 2major flavonol aglycone from USDA flavonoid database 
Flavonols are also present in a wide range of other foods, such as tea, alcoholic 
beverages, dark green vegetables and apples [115]. Sources of flavonols within the UK 
health-conscious EPIC cohort originate from tea (45.5%), soups (15.0%), pomes (6.0%), 
onions and garlic (6.0%), and is among the highest in the European region (42 to 54 
mg/day) [130]. Ireland and the UK were also reported to have the highest intake of flavonols 
reported by Vogiatzoglou et. al [113], at 38 and 28 mg/day respectively. In contrast, flavonol 
intake in United States was estimated to be lower (16 mg/day) [115]. 
1.2.3.2.2 Brassicaceae 
As above, Brassicaceae refers to vegetables belonging to the Brassicaceae family by 
classification. This includes commonly consumed examples, broccoli (Brassica oleracea 
Italica Group), Brussel sprouts (Brassica oleracea Gemmifera Group), cabbage (Brassica 
oleracea Capitata Group), cauliflower (Brassica oleracea Botrytis Group), radish (Raphanus 
sativus), swede (Brassica napus Napobrassica Group), turnip (Brassica rapa Rapifera Group) 
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and watercress (Nasturtium officinale). Brassicaceae vegetables are rich in fibre, carotenes, 
as well as glucosinolates. Table 1.13 provides the overview of major (poly)phenols in 
Brassicaceae vegetables. Unlike Allium vegetables, Brassicaceae vegetables do not 
specifically provide any particular class of (poly)phenols in abundance, with the exception 
of lignans. Lignans are polymers of hydroxycinnamic acids present in most vegetables. They 
are not to be confused with lignins (classed as insoluble fibre), though they share similar 
chemical characteristics. 
Table 1.13 Distribution of major flavonols in Brassicaceae vegetables, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh 
weight [111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Broccoli 
Flavonols (kaempferol-3-O-sophoroside), 
hydroxycinnamic acid (3-caffeoylquinic acid) 
199 (120) 
Brussel sprouts Flavonols (kaempferol), lignans (lariciresinol) 221 (183) 
Cabbage 
Flavonols (quercetin), lignans (pinoresinol, 
lariciresinol) 
White: 15 (0) 
Green: 89 (89) 
Red: 451 (173) 
Savoy: 120 (52) 
Cauliflower 
Hydroxycinnamic acid (sinapic acid), 
hydroxybenzoic acid (syringic acid) 
82 (106) 
Radish Flavonols (kaempferol) 44 (15) 
Swede Flavones (apigenin), flavonols (myricetin) - 
Turnip Lignans (lariciresinol) 55 (0) 
Watercress Flavonols (quercetin), lignans (lariciresinol) - 
1.2.3.2.3 Fruit vegetables 
Fruit vegetables consist of vegetables from multiple botanical families, including 
those previously identified as ‘pepo’. They are also botanically identified as fruits. 
Commonly consumed examples are aubergine (Solanum melongena), butternut squash 
(Cucurbita moschata), courgette (Cucurbita pepo), cucumber (Cucumis sativus), marrow 
(Cucurbita pepo), tomatoes (Solanum lycopersicum), olives (Olea europaea), sweet pepper 
(Capsicum annuum Longum Group) and pumpkin (Cucurbita pepo). These vegetables as a 
whole are rich in potassium, vitamin C and carotenes. In terms of (poly)phenol profile, fruit 
vegetables mostly contain low to moderate levels of hydroxybenzoic acids, 
hydroxycinnamic acids and lignans (Table 1.14). Olives and tomatoes are the most well 
quantified, while (poly)phenol data on butternut squash, marrow and sweet peppers are 
lacking. Processing can alter the levels of (poly)phenol within vegetables, such as tomatoes, 
leading it to decrease by mechanical or thermal treatment, or to increase by ‘reconstitution’ 
(addition of a sauce rich in tomato seeds and peels) [135]. Cooking processes such as frying, 
boiling and microwaving could also decrease the level of (poly)phenols by 35%, 82% and 
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65% [134], reinforcing the importance of retention factors in the estimation of (poly)phenol 
intake. 
Table 1.14 Distribution of major (poly)phenols in fruit vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Aubergine Hydroxybenzoic acid (protocatechuic acid) 61 (5) 
Butternut 
squash 
Data not available - 
Courgette Flavonols (quercetin-3-O-rutinoside), lignans 
(lariciresinol) 
30 (6) 
Cucumber Lignans (lariciresinol) 20 (4) 
Marrow Data not available - 
Tomato Hydroxycinnamic acid (5-caffeoylquinic acid), 
flavonols (quercetin-3-O-rutinoside) 
45 (16) 
Olive Green: Tyrosols (oleuropein), hydroxycinnamic 
acid (sinapic acid) 
Black: Tyrosols (oleuropein), anthocyanins 
(cyanidin-3-O-rutinoside), hydroxycinnamic acid 
(verbascoside), flavonols (quercetin-3-O-
rutinoside) 
Green: 161 (187) 
Black: 117 (64) 
Sweet pepper Lignans (lariciresinol) Red: 229 (206) 
Yellow: 214 (218) 
Green: 181 (118) 
Pumpkin Flavones (luteolin) 110 (81) 
1.2.3.2.4 Pod vegetables 
Pod vegetables grouped here include legumes which are usually consumed fresh with 
the pod. Examples include (and are not limited to) French beans (Phaseolus vulgaris), green 
beans (Phaseolus vulgaris), peas (Pisum sativum) and runner beans (Phaseolus coccineus). 
As described below (Table 1.15), there is a lack of data for the quantification of 
(poly)phenols in pod vegetables, but current evidence suggests low amounts of 
(poly)phenols in general. 
Table 1.15 Distribution of major (poly)phenols in pod vegetables, and estimated total phenolic content 
using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh weight 
[111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Green beans Flavonols (quercetin-3-O-rutinoside), flavanols [(-
)-epicatechin], lignans (lariciresinol) 
32 (23) 
Peas Lignans (pinoresinol) - 
Runner beans Data not available - 
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1.2.3.2.5 Stalk and root vegetables 
Lastly, stalk and root vegetables as the name suggests, consist of plant stalks and roots 
consumed as vegetables. Common examples include beetroot (Beta vulgaris), carrot 
(Daucus carota), celery (Apium graveolens), parsnip (Pastinaca sativa) and sweet potato 
(Ipomoea batatas). Stalk and root vegetables are rich in fibre, sodium and potassium, along 
with a modest amount of nutrients and minerals. Carrots in particular are rich in β-carotene, 
which provides the characteristic orange colour. Stalk and root vegetables are not major 
sources of (poly)phenols (Table 1.16). 
Table 1.16 Distribution of major (poly)phenols in stalk and root vegetables, and estimated total phenolic 
content using Folin-Ciocalteu assay, expressed as mean (standard deviation) in mg/100 g fresh 
weight [111] 
Name Major (poly)phenol class (dominant compound) 
Total (poly)phenols 
mg/100g FW 
Beetroot Flavones (luteolin), flavonols (quercetin) 164 (0) 
Carrot Hydroxycinnamic acid (5-caffeoylquinic acid) 58 (52) 
Celery Flavones (apigenin) 14 (1) 
Parsnip Flavonols (quercetin) - 
Sweet potato Lignans (matairesinol) 74 (0) 
 
1.2.3.3 Coffee 
Coffee is one of the most widely consumed beverages globally, processed from coffee 
cherry seeds. There are two varieties of coffee dominating the commercial market, known 
as Arabica coffee (Coffea Arabica), originally from Ethopia, and robusta coffee (Coffea 
canephora) which is cultivated in Africa. Coffee contains caffeine (1% to 2.5% of fresh 
weight) [132], but can also be consumed as decaffeinated coffee after caffeine removal using 
supercritical carbon dioxide or solvents [136]. Green coffee beans are rich in chlorogenic 
acids (between 6% to 10% by dry weight) [100], which are conjugates of hydroxycinnamic 
acids (Figure 1.7, Table 1.17) with tartaric or quinic acid. However, coffee beans undergo 
roasting, which destroys between 8 to 10% of chlorogenic acids for every 1% of dry weight 
lost [100]. Nonetheless, substantial amounts remain in the coffee beverage, where the most 
abundant compounds are 5-caffeoylquinic acid, 4- caffeoylquinic acid and 3-caffeoylquinic 
acid [111]. Regular coffee drinkers could consume up to 1 g/day of phenolic acids [100]. 
Coffee also contains other bioactive components such as caffeine (30 to 300 mg/cup 
depending on type of brew) and diterpenes (cafestol, kahweol) [137], where the latter is 
known to exhibit cholesterol-raising effects. Likewise, caffeine is also reported to cause an 
acute pressor effect. However, it has been recently reported that caffeine does not cause 
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adverse effects when caffeine from coffee or tea is consumed ad libitum [138]. Coffee may 
be consumed black, or with the addition of milk and sugar. The addition of milk does not 
seem to affect the absorption of chlorogenic acids [139]. 
 
Figure 1.7 The skeletal structure of hydroxycinnamic acid and respective substitution sites 
Table 1.17 The substitution pattern of major hydroxycinnamic acids 
Name R1 R2 
Caffeic acid H OH 
Ferulic acid H OCH3 
p-Coumaric acid H H 
Sinapic acid OCH3 OCH3 
1.2.3.4 Tea 
Tea is also a globally popular beverage produced from the leaves of the plant Camellia 
spp.. The leaves of the plant may contain between 3% to 4% of caffeine, and up to 30% 
(poly)phenols by dry weight, thus it is an extremely rich source of flavan-3-ols [100]. Tea is 
consumed as green, oolong or black, where black tea is subjected to the most processing. In 
the preparation of green tea, the leaves are steamed or subjected to firing (dry heat) to 
inhibit enzymes such as (poly)phenol oxidase. Black tea undergoes mechanical processes to 
disrupt the cell structure, releasing and activating enzymes. During the fermentation stage, 
(poly)phenols are transformed, before the leaves are dried, graded and sorted. Oolong tea 
is partly fermented, while other minor teas such as Pu-erh tea is additionally fermented by 
microorganisms [140]. 
Green tea is rich in flavan-3-ols, specifically (-)-epigallocatechin-3-O-gallate, (-)-
epigallocatechin, (-)-epicatechin and (-)-epicatechin-3-O-gallate. It also contains minor 
amounts of (poly)phenols such as hydroxycinnamic acids and flavonols [111]. The major 
(poly)phenol composition in black tea is also flavan-3-ols, but up to 90% of flavan-3-ols are 
destroyed during fermentation, and what remains are partly transformed into theaflavins 
[141], such as theaflavin-3’-O-gallate [111]. There are also still some uncharacterised 
(poly)phenols after transformation. 
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Black tea is habitually consumed with milk in UK, and multiple studies have 
investigated the antioxidant activity of flavan-3-ols with and without milk [142]. However, 
the evidence presented consists of mostly in vitro experiments using antioxidant assays, 
that do not reflect conditions in vivo. Where in vivo evidence is available, an increase in total 
catechins within plasma is not significantly affected by the addition of milk within a human 
study [143]. An in vitro digestion experiment was also supportive of the former conclusions, 
presenting no significant changes that would suggest impairment for catechin 
bioaccessibility when green or black tea was digested together with skimmed, semi-
skimmed and whole milk [144]. Thus the current evidence suggest that (poly)phenol 
bioavailability is not affected by the addition of milk in tea. 
Flavan-3-ol (monomers) intake varies greatly in the European region, where Ireland 
and UK have the highest intake at 156 and 110 mg/day, in comparison to Spain and Italy (5 
and 12 mg/day) [113]. Average daily flavan-3-ol (monomers) intake in United States (158 
mg/day) and UK health-conscious cohort from EPIC study (148 to 156 mg/day) was also 
similar to the estimation above [115, 145]. Daily consumption of theaflavins and 
thearubigins were also higher for countries with high consumption of flavan-3-ol 
monomers [113, 145], as the main contributor to flavan-3-ol intake is tea (95%) [115]. 
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Figure 1.8 Flavan-3-ol monomers [(+)-catechin and (-)-epicatechin], where * are rare forms of flavan-3-
ol monomers, its hydroxylated forms [(+)-gallocatechin and (-)-epigallocatechin] and subsequent 
forms after esterification [(-)-epicatechin-3-O-gallate and (-)-epigallocatechin-3-O-gallate] [100] 
 
1.2.4 (Poly)phenol mechanisms and its impact on CVD risk factors 
(Poly)phenols were believed to exhibit non-specific mechanisms, such as anti-oxidant 
activity [146]. However, this is now considered to be a quantity measurement rather than 
in vivo mechanistic function. More specifically, (poly)phenols can modulate metabolic 
enzymes, nuclear receptors, multiple signalling pathways and alter gene expression [104]. 
The potential mechanisms for each CVD risk factor and function is summarised briefly 
below. The literature surrounding each dietary source of (poly)phenols will be summarised 
and discussed within relevant results chapters. 
1.2.4.1 Endothelial function and blood pressure 
Endothelial function is the functional capacity of the monolayer of endothelial cells in 
the blood vessel lumen, known as the endothelium. Adequate nitric oxide (NO) output is an 
important feature of a healthy endothelium, as well as regulating vasodilation. The enzyme 
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endothelial nitric oxide synthase (eNOS) is responsible for its production. Simply put, 
endothelial dysfunction occurs when endothelium-dependent vasodilation decreases, 
causing an imbalance between vasodilation and vasoconstriction [147]. Endothelial 
dysfunction is also one of the main contributors to hypertension [57]. 
Red wine (poly)phenols have been demonstrated in cell culture studies to increase 
production of endothelial NO by inducing eNOS protein expression [147]. Animal studies 
also proposed that ferulic acid enhances bioavailability of nitric oxide (NO), improving 
endothelial-dependent vasodilation [148], and 5-caffeoylquinic acid improved endothelial 
function in hypertensive rats [147]. In human trials, a decrease in BP has been observed 
after consumption of cranberry juice and berry supplementation [120], and also an increase 
in NO production, as well as endothelium-dependent vasodilation [147]. Tea intake, 
specifically epigallocatechin gallate, improved endothelial function and flow-mediated 
dilation within CHD patients. However, this effect was not observed within healthy 
participants [147]. In particular, hesperidin (previously identified as vitamin P) is known to 
reduce permeability and fragility of capillary walls, a symptom which manifests in 
hypertension [149]. Its anti-hypertensive effect was also demonstrated in human studies, 
where BP was lowered in healthy subjects after consumption of orange juice [150, 151]. SRs 
and MAs of RCTs have reported favourable effects of chlorogenic acids, green tea catechins 
and black tea on BP [152-154]. 
1.2.4.2 Blood lipid profile 
Human intervention studies using various berries (blackcurrants, blueberries, 
cranberries, raspberries, strawberries, and the less commonly consumed acai berries, 
bilberries, boysenberries, chokeberries, lingonberries and wolfberries) which are rich in 
anthocyanins, revealed a decrease in total cholesterol, LDL-oxidation, lipid peroxidation, 
increase in HDL-C, as well as increased urinary or plasma antioxidant capacity after 
intervention [120]. The evidence for grape (poly)phenols from red wine is also fairly well 
established. It was proposed that anthocyanins could either reduce cholesterol absorption 
by increasing fecal bile acids, or by up-regulating the expression of LDL receptor [155]. 
Within animal and cell culture studies, catechins from green tea exhibit cholesterol-
lowering effects in animal plasma, and favourable cholesterol metabolism in cells [155]. 
Mechanisms are not fully understood, however, it was suggested that catechins could 
increase LDL-receptor activity, leading to lower plasma cholesterol [155]. There is mixed 
evidence from human interventions for the cholesterol-lowering effect, where some studies 
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report reduced levels of total cholesterol and LDL-C. However, other studies reported no 
significant change after administration of green or black tea to healthy volunteers [155]. 
1.2.4.3 Type 2 Diabetes 
From in vitro studies [104, 156], it is suggested that (poly)phenols may exert multiple 
anti-diabetic effects by: 
1) Reducing the absorption of simple sugars through: 
a) Inhibition of α-amylase and α-glucosidase within the intestinal lumen – 
Most (poly)phenols such as flavones, flavonols, catechins, anthocyanins, 
isoflavones, flavanones, phenolic acids have demonstrated this effect. 
b) Inibition of glucose transporters, sodium dependent glucose transporter, 
SGLT1 – chlorogenic acid, ferulic acid, caffeic acid, and sodium-independent 
glucose transporter, GLUT2 – quercetin, myricetin, apigenin and catechins. 
2) Improving uptake of glucose in muscle, skeletal and adipose tissues – 
Epigallocatechin gallate, quercetin, kaempferol, ferulic acid. 
3) Promote storage of glucose as glycogen by increasing activity of hepatic 
glucokinase – Epigallocatechin gallate, naringin, hesperidin, ferulic acid. 
4) Suppressing hepatic gluconeogenesis – Epigallocatechin gallate, naringin, 
hesperidin, genistein, daidzein. 
5) Protecting integrity of β-cells (preventing glucotoxicity) and increasing insulin 
production – catechins and flavonols. 
Evidence from human intervention trials also indicate a reduction in postprandial 
glucose after consumption of red wine, coffee, berries and apple juice, supporting 
mechanisms related to the reduction of glucose absorption [156]. 
1.2.4.4 Obesity 
Studies in vitro have demonstrated that (poly)phenols may exert various mechanistic 
functions which may impact on body weight control. Catechins, especially epigallocatechin 
gallate from green tea is suggested to have several mechanisms, such as supressing 
adipocyte differentiation and proliferation, inducing apoptosis in mature adipocytes, 
inhibiting fat absorption in the gut, and inhibiting COMT, which inhibits oxidation of fatty 
acids in brown adipose tissue [157]. However, studies performed in vivo for the 
consumption of green tea catechins were inconclusive, possibly due to the heterogeneity of 
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study design parameters [158]. Blueberries, rich in anthocyanins were able to attenuate 
parameters which affects obesity [157]. In vitro, other (poly)phenols such as resveratrol 
from grapes and red wine, also exhibited effects to induce apoptosis in mature adipocytes 
and decrease adipocyte proliferation, with limited supporting evidence in vivo [158]. 
1.2.4.5 Inflammation 
Inflammation is a highly complex process the body employs as an immune defence 
mechanism. Specific to CVD, multiple in vitro studies have been reviewed to demonstrate 
the anti-inflammatory action of flavonoids by modulating signal transduction pathways and 
gene expression, such as the downregulation of inducible NO synthase (iNOS) (produced 
during when immune defence is activated) and cyclo-oxygenase (COX-2) expression [159]. 
Luteolin and apigenin were also reported to inhibit pro-inflammatory cytokine expression, 
while epigallocatechin-3-gallate, epigallocatechin and epicatechin-3-gallate from tea 
enhanced anti-inflammatory cytokines [159]. (Poly)phenols were also demonstrated in 
vitro to attenuate the expression of adhesion molecules (apigenin, kaempferol, quercetin), 
inhibit monocyte-endothelial cell adhesion (isoflavones) and stabilizing atheroma plaques 
(quercetin) [160]. In vivo, the adherence and consumption of a high flavonoid FV diet (>four 
portions/day) lowered C-reactive.protein levels and vascular cell adhesion molecules 
within men at risk of CVD [161]. A seven-day supplementation of red orange juice (500 mL) 
within nondiabetic subjects with high risk of CVD significantly lowered C-reactive protein 
level, an inflammatory marker [162]. Berries supplied in various forms (fresh or extracts) 
can also reduce inflammatory stress by inhibiting pro-inflammatory markers or increasing 
anti-inflammatory molecules. Evidence for commonly consumed berries such as 
blueberries, cranberries and strawberries require further research to verify current 
findings. The evidence for less commonly consumed berries (bilberries, chokeberries etc.) 
in comparison, are overall more consistent [163].  
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1.3 Aims and objectives 
1.3.1 Thesis aims 
Based on the evidence presented above on (poly)phenol mechanisms and CVD risk 
factors, the primary aim of the thesis is to investigate the association between (poly)phenol-
rich foods in the UK and CVD risk, in particular: 
1. The direct association between (poly)phenol-rich foods and CVD risk. 
2. The indirect association between (poly)phenol-rich foods and CVD through 
the major CVD risk factor, HBP. 
3. To identify individual relationships between four groups of (poly)phenol-rich 
foods (FVs, tea and coffee) and CVD risk and BP. 
4. To explore if associations exist between FV subgroups by (poly)phenol 
content and CVD risk or BP to provide supporting evidence for hypotheses 
reported in literature, or generate further hypotheses for future investigation. 
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1.3.2 Thesis objectives 
Table 1.18 summarises the objectives of the current thesis. 
Table 1.18 Objectives of the thesis matching the aims met in the stated chapters 
 Objective Chapter Aim 
1 Explore and describe the study population and dietary assessment 
methods in two UK cohorts, the United Kingdom Women’s Cohort 
Study (UKWCS) (1995 – 1998) and the National Diet and Nutrition 
Survey Rolling Programme (NDNS RP) (2008 – 2012). 
2 - 
2 Explore and report consumption levels of (poly)phenol-rich foods in 
both study populations 
2 - 
3 Sub-categorise (poly)phenol-rich foods into groups which can be 
representative of major flavonoid subclasses, taking into account 
methods and habit of consumption, as proposed in the introduction 
2 - 
4 Define appropriate statistical methods to be used to analyse the 
relationship between (poly)phenol rich-foods and CVD 
2 - 
5 Assess if a direct association exists between four groups of 
(poly)phenol-rich foods (FVs, tea and coffee) and CVD mortality in the 
UKWCS 
3, 5 1, 3, 4 
6 Explore associations between fruit and CVD incidence in the UKWCS 4 1, 3, 4 
7 Investigate associations between the incidence of HBP (self-reported) 
in the UKWCS and (poly)phenol-rich foods 
6, 7 2, 3, 4 
8 Validate strength, weakness and agreement of dietary assessment 
tools used in the UKWCS to assess accuracy and precision of diet 
captured at baseline 
8 - 
9 Undertake (poly)phenol analysis of selected fruit beverages for where 
current evidence is limited, and explore variation in (poly)phenol 
content with selected fruit beverages 
9 - 
10 Explore associations between BP and FV intakes in the NDNS 10 2, 3, 4 
11 Discuss and conclude evidence generated by the research, and 
propose recommendations for further investigations 
11 4 
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1.3.3 Thesis overview 
The overview of the thesis is illustrated below in Figure 1.9: 
 
 
Figure 1.9 Thesis flowchart 
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Chapter 2  
General methodology 
2.1 Abstract 
This chapter contains three sections, detailing the description of the UK Women’s 
Cohort Study (UKWCS) and the National Diet and Nutrition Survey Rolling Programme 
(NDNS RP), followed by model building strategies undertaken throughout the thesis. In the 
following sections, the methodology for data collection in the UKWCS and the NDNS RP was 
described. Justification was provided for each potential confounder for inclusion, and 
statistical models were proposed for adaptation in each results chapter. In order to 
correctly assess the association between (poly)phenol-rich foods and CVD, directed acyclic 
graphs (DAG) were additionally applied to help visualise the relationships between 
potential confounders, exposure, and outcome. The exploration of dietary variables (fruit, 
vegetable, coffee and tea) and the corresponding baseline characteristics prior to exclusions 
were then provided and discussed. 
2.2 UK Women’s Cohort Study: Study design 
2.2.1 Sample design 
The UK Women’s cohort study was initially funded by the World Cancer Research 
Fund. Participants living in England, Wales and Scotland were recruited by direct mail 
survey in 1995 to 1998. There were half a million respondents (17% response rate), of 
which 16,000 were self-reported vegetarians and non-red meat eaters (aged 35 – 69 years). 
Women who expressed interest for further contact were eligible for inclusion [164]. Self-
reported vegetarians and non-red meat eaters from the respondents were matched with a 
non-vegetarian by age (no larger than 10 years). This recruitment design maximises power 
to detect statistically significant associations between diet and disease outcome through 
generating a cohort with high degree of dietary heterogeneity [165]. Further recruitment 
was also accomplished by inviting friends and relatives of initial respondents from a similar 
age group [164]. 
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2.2.2 Survey design 
Baseline information from participants of the UKWCS was initially collected between 
1995 and 1998, using a food frequency questionnaire (FFQ). A subsequent phase of data 
collection included a questionnaire, four-day food diary and physical activity diary (Figure 
2.1). However, only the baseline FFQ, phase 2 questionnaire and four-day food diary are 
explained in detail as data from the physical activity diary were not used in this thesis. 
 
Figure 2.1 Study design for the UKWCS 
2.2.2.1 Food frequency questionnaire 
The 217-item FFQ was adapted and modified from the EPIC-Oxford Cohort [166], 
after a pilot study with a subsample of vegetarian women [164]. Additional vegetable 
composite dish items and portion sizes were also added into the FFQ from the same pilot 
study. The FFQ was designed to capture yearlong dietary intake, health and lifestyle habits. 
Participants were required to report the frequency of consumption of listed foods by 
answering the question, “How often have you eaten those foods in the last 12 months?” 
using one of ten response categories ranging from “Never” to “More than 6+ portions a day” 
(Figure 2.2). Foods were presented as individual items in categories, but could also 
represent multiple types of the same food. For example, “Apples” could include a variety of 
types including cooking apples, dessert apples, and could be consumed raw or stewed with 
sugar. This ensures all variations were accounted for. Nine of 17 fruit items were classed 
under ‘seasonal’, and participants had to report the frequency of consumption when it was 
Recruitment
•Half a million respondents from the WCRF direct mail survey.
•16,000 women were self-reported vegetarians.
•Also included participants to match with vegetarians, relatives and friends of 
participants from the WCRF database.
Phase 1:
1995-1998
•Baseline FFQ sent to 61,000 selected participants, 35,372 responded.
Phase 2:
1999 - 2002
•Food diaries completed by 12,453 participants.
• Phase 2 questionnaire completed by 14,172 participants.
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seasonally available. The number of months the fruits were in season was taken into 
account when calculating daily intakes [167]. 
 
Figure 2.2 An extract from the FFQ showing the categories on the frequency of consumption 
Each food has nutrient composition data derived from McCance & Widdowson’s The 
Composition of Foods (5th Edition) [168]. Average nutrient intakes such as energy, 
macronutrient and micronutrient intakes are calculated by multiplying the frequency of 
consumption for each food with an estimated portion size. Portion sizes were an estimated 
average based on three sources [167], 1) a pilot study on food diaries [169], 2) women’s 
food portion sizes from the National Diet and Nutrition Survey [170], and 3) other published 
values [171]. The FFQ was also validated using a semi-weighed four-day food diary [172], 
where all correlation co-efficients between nutrient intakes from the FFQ and the food diary 
were highly significant (p <0.01). With regard to health, lifestyle habits and personal 
information, participants had to answer questions relating to age (as date of birth), 
anthropometrics (height, weight, waist circumference), smoking habits, physical activity 
levels, self-reported illnesses (including treatments and past surgeries, if applicable), 
education, employment, parity, as well as dietary habits (including portion size, cooking 
methods, alcohol consumption, the usage of milk, salt, fats, supplements, vegetarian/special 
diet status). 
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2.2.2.2 Four-day food diary 
There were 12,453 four-day semi-weighed food diaries collected in total during Phase 
2 of the study between 1999 to 2002. Participants were requested to list all the drinks and 
foods, as well as estimate the portion size or weigh foods consumed, following the example 
in Figure 2.3. They were also requested to start on a particular day (Friday, Saturday or 
Sunday). However, this meant that Thursday was never represented, and weekends were 
over-represented. 
 
Figure 2.3 An example from the UKWCS four-day food diary on recording food items and portion sizes 
 
Participants were also asked to include homemade recipes of foods made at home, 
consumed away from home or from takeaways, as well as supplement intake, following the 
example given in Figure 2.4. 
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Figure 2.4 An example from the UKWCS four-day food diary entry on recording homemade recipes and 
supplements 
 
In addition, participants had to fill in a short questionnaire on eating habits within the 
food diary during the period of food recording, shown in Figure 2.5 & Figure 2.6. The 
questions aided coders in the decision-making process when participants did not provide 
adequate information in their records, e.g. recording consumption of ‘milk’ but not 
specifying whether it is whole, semi-skimmed or skimmed milk. 
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Figure 2.5 Questions from the UKWCS four-day food diary on dietary preferences 
 
Figure 2.6 Questions from the UKWCS four-day food diary on dietary preferences (continued) 
Lastly, participants were also able to record dietary information from food labels if 
they consumed ready-made or packaged foods. A prompt was provided at the end of the 
recording day for any foods that the participants might have left out (Figure 2.7). 
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Figure 2.7 A table in the UKWCS food diary for ready-made/packaged foods 
An in-house tool developed in the University of Leeds using Microsoft Access known 
as ‘DANTE’ contained standard nutrient intakes from McCance & Widdowson’s The 
Composition of Foods (5th Edition) [168], supplementary information from food 
manufacturers, food labels and homemade recipes. DANTE also contained typical portion 
sizes for each food derived from Food Portion Sizes [171]. Typical portion sizes would be 
chosen when a portion size was not reported in the food diary for an entry. If no match was 
found for the reported food item, coders substituted the reported item with another item 
by matching nutrient information. When homemade recipes were provided, exact serving 
proportions were calculated by coders, and foods were coded by appropriate cooking 
methods. 
As food diary coding can be labour intensive, there were only 2136 food diaries which 
were coded and available for further study applications. However, since there were too few 
cases within this subpopulation to conduct a sensible statistical analysis on dietary 
exposure and outcome, the information was applied to validate the FFQ instead, which 
would be evaluated in Chapter 8. 
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2.2.2.3 Phase two questionnaire 
All women were invited to partake in the second FFQ approximately five years after 
the completion of the baseline FFQ. There were 14,245 women who responded to the phase 
2 questionnaire. This questionnaire contained similar health, lifestyle habits and personal 
information questions from the baseline FFQ in Section 2.2.2.1, but was structured 
differently. Some questions also provided more detail compared to the baseline FFQ, e.g. on 
self-reported illnesses (Figure 2.8). The questionnaire also provided additional information 
relative to the baseline FFQ on cooking methods and preferences. 
 
Figure 2.8 An extract from the phase 2 questionnaire on self-reported illnesses 
 
2.2.3 Ethical Approval 
Ethical approval was granted by 174 local research ethics committees, which 
represented all participants at the time of cohort establishment in 1993 [173]. Study ethical 
approval is now overseen by the National Research Ethics Committee-Yorkshire and the 
Humber, Leeds East. Approval concerning follow-up work for the cohort was granted in 
December 2011. 
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2.3 National Diet and Nutrition Survey Rolling Programme: Study 
design 
2.3.1 Study background and design 
The National Diet and Nutrition Survey Rolling Programme (NDNS RP) is a nation-
wide research collaboration between NatCen Social Research, Medical Research Council 
(MRC) Human Nutrition Research (HNR) and the University College London Medical School, 
funded by Public Health England (Department of Health) and the UK Food Standards Agency 
(FSA). The project focuses on the dietary assessment of food, nutrient intakes and 
nutritional status of people aged 1.5 years and above from private households. The survey 
is also designed to be representative of the UK population, and has collected data from 6,828 
participants in the past four years. In brief, the methods of assessment include a four-day 
food diary, background interview using computer assisted personal interview (CAPI) 
programme, anthropometric and BP measurements, self-completion questionnaires on 
smoking, drinking and physical activity, as well as the collection of information on 
prescribed medicines, 24-hour urine collection and blood sample. A detailed description of 
the full methodology is reported elsewhere [174]. The sections below will provide a brief 
summary of the study procedures. 
2.3.2 Sample design 
The NDNS RP survey aims to collect information from at least 1,000 participants (500 
adults, 500 children) who are representative of the general UK population. The study 
sample was drawn from the Postcode Address File (PAF), which contained all the addresses 
in UK. From April 2008 to March 2011, a random sample of 21,573 addresses from 799 
postcode sectors were drawn. These addresses were clustered into Primary Sampling Units 
(PSU) to improve cost effectiveness. There were 27 random addresses in each PSU, and 
selected addresses were subsequently allocated into two groups known as ‘adult (19 
years+) and child (1.5 to 18 years)’, or ‘child only’, also known as child boost. On average 
each year, 10 to 11 addresses were allocated into the ‘adult and child’ group, while 16 to 17 
addresses were in the child boost group to ensure the target goal of 500 children was 
achieved. The interviewer would select one household at random for each address, and 
either one adult and child, or one child were randomly selected for participation. 
Information describing the purpose of the study was posted to selected addresses, followed 
by a face-to-face visit to recruit eligible participants [174]. 
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In Years 1 to 4 combined, 46% of 21,573 addresses were eligible for household 
selection. The remaining 54% consist of vacant and derelict properties and institutions, 
which were ineligible. If addresses selected for child boost did not contain any children in 
the eligible age range, they were also excluded. [174]. 91% of selected addresses were 
eligible for household selection, while 9% refused before household selection was 
conducted. 58% of eligible households were productive, indicating at least one participant 
completed three or four food diary recording days [174]. 
2.3.3 Survey design 
The survey was conducted in two stages, with a total of five visits from the interviewer 
or nurse. Types of dietary and lifestyle information collected at each stage are listed in 
Figure 2.9. Stages which collect relevant data for the current study are elaborated in 
sections below. 
 
Figure 2.9 Main survey design framework for the NDNS RP 
 
Stage 1: 
Interviewer 
Visit (1)
•CAPI questionnaire (part 1)
•Recent Physical Activity Questionnaire (RPAQ) (19 years+) or ActiGraph for seven 
consecutive days (4 to 18 years)
•Self-completion questionnaire on smoking, drinking habits
•Height and weight measurements
•Four-day food diary explained and left for participants to fill in.
Stage 1: 
Interviewer 
Visit (2)
•Four-day food diary review
Stage 1: 
Interviewer 
Visit (3)
•Collection of four-day food diary
•RPAQ self-completion questionnaire
•CAPI questionnaire (part 2)
•Introduction to nurse visit
Stage 2: 
Nurse Visit 
(1)
•CAPI interview on prescribed medications
• Anthropometry and blood pressure measurements
•Explained 24-hour urine and blood sample procedures, obtaining consent if 
participant agrees to participate.
Stage 2: 
Nurse Visit 
(2)
•Collect 24-hour urine sample
•Collect fasting blood sample from participants aged 4+ years, or non-fasting blood 
sample from participants aged 1.5 to 3 years after consent.
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2.3.3.1 Computer Assisted Personal Interview (CAPI) programme 
The CAPI interview required the interviewer to read out questions from the laptop 
screen, followed by entering the participant’s answers in designated fields. There were 
three main sections in the CAPI questionnaire, (1) household composition/structure 
interview, (2) Main Food Provider (MFP) interview and (3) individual interview (which was 
divided into two parts). The household composition/structure section contained questions 
about housing tenure and employment to aid determination of the socio-economic 
classification, and was answered by the ‘Household Reference Person’ in each household. 
Information on food shopping, preparation practices and facilities in the MFP interview was 
answered by the MFP who was not a selected participant. Lastly, the selected participant 
answered the individual interview in two parts during the first and third interviewer visit. 
2.3.3.2 Four-day food diary 
Selected participants were required to complete a four-day food diary on four 
consecutive days, beginning on the day selected at random by the interviewer’s laptop 
program. Participants could also request to start on an alternative date of their choice if they 
found the CAPI program’s assigned date unsuitable for them. This was because previously 
in Year 1, food diary records always started on Thursday, Friday or Saturday. Thus, both 
weekend days were always included, and Wednesdays were never included. To address this 
issue of over-representing weekend days, food diary records could start during any day of 
the week from Year 2, so that all days were equally represented [174].  
Participants had to keep a detailed record of everything they ate and drunk, both in 
and outside home (Figure 2.11), and declare whether they ate or drank more food and drink 
than usual, stating the reasons why. Similarly to the UKWCS food diary reported in Section 
2.2.2.2, intake of supplements were asked to be recorded in detail (Figure 2.10), and 
prompts were provided to include leftovers and snacks. Participants were also asked to 
provide recipes for made-up dishes and takeaway (Figure 2.12). The interviewer would 
contact the participant on either the second or third day face-to-face, or over the telephone 
to conduct a food diary check. The purpose of this visit/call was to collect any missing details 
for food records, and to improve recording for the remaining days. Interviewers would also 
provide encouragement to participants to complete their food diary. The food diary was 
subsequently collected no later than three days after completion date during the third 
interviewer visit. 
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Figure 2.10 An example of recording supplement intake from the NDNS RP [174] 
 
Figure 2.11 An example of the four-day food diary entry from the NDNS RP [174] 
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Figure 2.12 An example of recording a homemade dish recipe from the NDNS RP [174] 
As the diary was not weighed, participants estimated food portion sizes using 
household measures (e.g. a glass of orange juice or a slice of bread) or food product labels 
(330 ml can of coke or 400 g tin of soup) (Figure 2.13 & Figure 2.14). Photographs of ten 
frequently consumed foods were also included in the diary to help those aged 16 and over 
to describe their portion size (Figure 2.15). 
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Figure 2.13 A portion size estimation guide provided in the four-day food diary in the NDNS RP 
 
Figure 2.14 ‘Life size’ glass, spoon and typical drink sizes in mL within the four-day food diary in the 
NDNS RP (not life-sized here) 
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Figure 2.15 Photographs of typical portion sizes of commonly consumed foods within the NDNS RP food 
diary [174] 
Parents were asked to help with keeping the food diary on behalf of participants aged 
11 years and younger. Carers were also able to contribute information where possible in 
addition to the child’s own contribution. In addition, three age-appropriate versions of 
‘Young person’s food photograph atlas’ [175] were used during the food diary check. The 
atlases contained 44 commonly consumed foods with a range of served and leftover portion 
sizes which were difficult to estimate. During the food diary check, the interviewer would 
use the atlases to ask the participant to select the appropriate portion size for all food 
entries in the diary. Overall response rate for fully productive participants (completing 
three or four food diary days) was between 53% to 57% for four years, providing a total of 
6,828 participants [174]. 
Food diaries were coded by trained coders and editors, using an in-house tool known 
as Diet In Nutrients Out (DINO), which was developed at MRC HNR using Microsoft Access. 
The food composition data used was from the Department of Health’s NDNS Nutrient 
Databank, which was based on McCance and Widdowson’s Composition of Foods [168], FSA 
Food Portion Sizes [176] and manufacturer labels when applicable. The Nutrient Databank 
was also updated regularly with new food products and relevant nutrient outputs every 
year, old food items that were outdated or unavailable were also removed [177]. In order 
to capture dietary data more accurately from composite dishes made of two or more 
ingredients, they were systematically disaggregated into various components and added 
into the Nutrient Databank. The main components that were disaggregated include fruits, 
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vegetables, meats, fish and cheese. These components were further divided into subgroups. 
Detailed description of method for disaggregation can be found elsewhere [178]. 
2.3.3.3 Blood pressure measurements 
BP measurements were taken according to a standard protocol [174]. In brief, the 
nurse gathered information on whether participants had exercised, ate, smoke or drunk 
alcohol in the past half an hour, indicating if the BP measurement was valid. Participants 
were required to sit still for five minutes, before BP measurements were taken thrice using 
an Omron HEM 907 BP monitor and an appropriate cuff size, with a minute interval in 
between each measurement. An average of the three measurements was also calculated and 
reported. 
24-hour urine and blood sample procedures were reported in detail elsewhere [174], 
and would not be discussed in the chapter as the data was not used. 
2.3.4 Ethical approval 
The current study was conducted according to guidelines laid down in the Declaration 
of Helsinki. Ethical approval was obtained from the Oxfordshire A Research Ethics 
Committee, and written informed consent was also obtained from all participants [174]. 
2.4 Statistical methodology 
2.4.1 Confounding 
When examining the association between any dietary exposure (e.g. fruit intake) and 
disease outcome (e.g. CVD risk), it is important to note that in addition to covariates which 
are fitted into the model, there may be other extraneous variables which associate with both 
the exposure and outcome, known as confounders. Failure to adjust for confounding would 
usually lead to confounding bias, or misinterpretation of the association between the 
exposure and outcome, which may distort relative risk estimates in different directions, 
either towards or away from the null [179]. 
In this thesis, the selection of potential confounding variables for inclusion in models 
was determined using directed acyclic graphs (DAGs) [180, 181]. DAGs are diagrams 
designed to aid in the determination of causal relationships between variables in 
epidemiological studies using a graphical approach. They may be combined with traditional 
methods such as stratification, univariate and multivariate analysis [182]. A DAG consist of 
a series of arrows depicting causal relationships between variables along a timeline. Since 
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time cannot go backwards, the arrows must not form a cycle, therefore termed acyclic [181]. 
When a variable has an arrow pointing towards the exposure and outcome as illustrated in 
Figure 2.16 through pathways ‘fruit intakeAFCVD’ and ‘fruit intakeBCCVD’, it 
is identified as an unblocked backdoor path. Thus any association discovered may be due to 
the independent effects of the confounder on the exposure and outcome, and may not 
directly reflect the true association between them. If the confounder is adjusted, the true 
association may then be defined [180, 181]. However, bias might also be introduced when 
adjustments are made for ‘confounders’. Causal relationships may exist between ‘fruit 
intakeAD’, as well as ‘DECVD’. If the collider (D) were adjusted for, it would 
introduce a bias, since there is no true relationship between variables ‘A’ and ‘E’ [181]. 
 
Figure 2.16 Example of a direct acyclic graph containing confounders (blue) and a collider (grey) 
Variables that populate the DAG can be defined a priori according to the information 
from previous studies which investigate specific variables as predictors of a disease 
outcome. Some variables modify the effect of an exposure on the outcome, causing different 
subpopulations (strata) to have different relative risk estimates. This is known as effect 
modification. A DAG was generated to guide the selection of several potential confounders 
or effect modifiers with the potential relationship between exposure and outcome. 
2.4.2 Testing for statistical assumptions 
Throughout the thesis, various statistical methods have been applied to explore 
associations between diet and health. Namely, multivariate regression, logistic regression 
and survival analysis. Correct application of these methods relies on fulfilling certain 
statistical assumptions. The methods to check for these statistical assumptions are 
described below. 
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2.4.2.1 Multiple Linear Regression 
In a multivariate model, residuals are the differences between the observed value 
and the predicted value by the model [182]. One of the assumptions requires the 
assumption of normality to be fulfilled for residuals of exposure variables. To check the 
residuals fulfil this assumption, a histogram of residuals was plotted for every model 
throughout the analysis. An inverse normal plot, commonly known as a Q-Q plot was also 
applied as an alternative graphical method to assess normality. This plot compares values 
from the observed distribution and compares it with points on the normal distribution. 
Observations are ranked and assigned a quantile via the formula n/(n+1), a probit (value of 
standard normal distribution corresponding to the quantile) was then calculated for each 
observed value. The inverse normal plot points are then calculated by the formula, 
mean+probit*S.D. [182]. The original observations are then compared to the inverse normal 
plot points. If the plot is linear, it fulfils the assumption of normality.  
In addition, Shapiro-Wilk test could also be performed to assess the normality of 
residuals by looking at the p-value outcome, this provides an objective test in addition to the 
graphical approach. However, the Shapiro-Wilk test can be extremely sensitive to large 
datasets, such as the current study, so generating a graphical representation would be more 
useful to double-check results from Shapiro-Wilk test [182]. This method was therefore not 
used. Scatter plots of residuals v.s. fitted or predicted values are also used to assess 
normality. If patterns exist in the scatter plot, it indicates the violation of assumptions. In 
other words, a scatter plot with no strong patterns (shaped like a cloud), would fulfil the 
model assumptions. The histogram of residuals, inverse normal plot, scatter plot of 
residuals v.s. fitted and predicted values were applied in Chapter 10. 
2.4.2.2 Logistic Regression 
Logistic regression was applied in Chapter 6, Chapter 7 and Chapter 10. This method 
does not have the model assumptions that are required in multiple regression. However, 
the model needs to be fitted correctly. The Hosmer-Lemeshow goodness of fit test was 
chosen to assess whether the model was fitted well. This test ranks participants by 
computed predicted risks and ranks them from largest to smallest values. It then divides the 
ordered predicted risks into percentile groupings, usually into deciles. This is followed by 
computing the observed, expected cases, as well as non-cases. The Hosmer-Lemeshow 
statistic is calculated by summing the percentile grouping values of cases and non-cases, 
followed by testing for significance against the percentage point of chi-square with the 
number of percentile groupings minus 2 degrees of freedom [183]. 
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2.4.2.3 Survival Analysis 
The survival analysis was applied in Chapter 3, Chapter 4 and Chapter 5. To use the 
Cox proportional hazards model correctly, the assumption that the HR is constant over time 
needs to be met. This meant that the survivor function has to be constant over time, and the 
hazard function needs to be proportional between different quintiles. To check that the 
model fulfils this assumption, proportional hazards were assessed using graphical 
approaches, such as the log-minus-log plot [184]. The log-minus-log plot expresses the 
survival probability (-ln[-ln](S)) against (ln)time. Exposure quantiles were plotted to assess 
whether survival probability for total CVD mortality was parallel between different intake 
quintiles over time. The roughly parallel lines in the graph indicate that the assumptions of 
proportional hazards have been met. Fulfilling the assumption meant that one HR could be 
generated for the whole duration of the study, as the hazards are proportional throughout 
time. The same method was also used for assessing if hazards are proportional for all 
exposures with CHD, stroke and CVD outcomes. Schoenfeld residuals test were used as an 
objective approach to validate the goodness of fit of the model, in addition to graphical 
approaches. If the assumption of proportional hazards is true, Schoenfeld residuals for the 
covariates in the model would not be correlated with survival time. For example, physical 
activity assessed as a binary variable reported a borderline significant p-value in Chapter 3, 
which suggests a degree of violation of assumption, indicating that the variable residuals 
may be correlated with survival time. However, none of the other covariates nor the global 
result rejected the null hypothesis, so the model is said to have fulfilled the assumption 
objectively. 
2.5 Model building 
2.5.1 Selection of variables for adjustment 
To provide evidence for the inclusion of potential confounders objectively, analysis of 
variance (ANOVA), chi-squared tests and correlation tests were performed to prevent over-
inclusion of variables in the model. Table 2.1 reports no correlation between the variables, 
suggesting minimal likelihood of multicollinearity. Likelihood ratio tests were also 
implemented to provide objective statistical evidence for the inclusion or exclusion of 
variables for effect modification and multicollinearity in the model. Energy intake was 
explored as one of the variables considered for inclusion or exclusion. Univariate analysis 
was also conducted to explore associations between potential confounders and CVD risk 
(Table 2.2). Results show a statistically significant elevated CVD risk with higher age, no 
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moderate physical activity, SES classification as intermediate and smoking, while a small 
increment of alcohol intake (g/day) was associated with lower CVD risk. 
Table 2.1 Correlation between variables included in the model 
Correlation Age BMI Physical 
Activity 
SES Smoking Alcohol Total 
Vegetables 
Age 1.00       
BMI 0.13 1.00      
Physical Activity 0.16 0.10 1.00     
SES 0.09 0.04 0.07 1.00    
Smoking 0.07 0.03 0.04 0.02 1.00   
Alcohol 0.11 0.06 0.06 0.07 0.11 1.00  
Total Vegetables <0.01 0.02 0.11 0.04 0.03 0.03 1.00 
Table 2.2 Univariate analyses of potential confounders and CHD, stroke and cardiovascular disease 
outcome [HR (95% CI)] 
Variable of Interest CHD Stroke Total CVD 
Age (years) 1.17 (1.15, 1.19) 1.18 (1.60, 1.21) 1.18 (1.16, 1.19) 
BMI (kg/m2) 1.04 (1.03, 1.06) 1.01 (0.98, 1.05) 1.03 (1.02, 1.05) 
Moderate Physical Activity    
Moderate Physical Activity -Yes 1 1 1 
Moderate Physical Activity -No 2.42 (1.75, 3.34) 2.44 (1.78, 3.33) 2.43 (1.94, 3.04) 
Socioeconomic Status (SES)    
Professional/Managerial 1 1 1 
Intermediate 1.58 (1.14, 2.20) 1.32 (0.94, 1.84) 1.44 (1.14, 1.82) 
Routine/Manual 0.98 (0.53, 1.79) 1.43 (0.88, 2.35) 1.21 (0.83, 1.78) 
Smoking Status    
Smoking Status - No 1 1 1 
Smoking Status - Yes 1.88 (1.27, 2.79) 1.71 (1.15, 2.54) 1.79 (1.35, 2.37) 
Alcohol Intake (g/day) 0.95 (0.93, 0.97) 0.98 (0.97, 1.00) 0.97 (0.96, 0.98) 
Total fruit (80g portion) 0.94 (0.89, 1.00) 0.94 (0.89, 1.00) 0.94 (0.91, 0.98) 
Total vegetables (80g portion) 0.95 (0.88, 1.02) 0.89 (0.82, 0.96) 0.92 (0.87, 0.97) 
Total coffee (250g portion) 0.96 (0.86, 1.07) 0.89 (0.79, 0.99) 0.92 (0.85, 1.00) 
Total tea (250g portion) 1.03 (0.96, 1.11) 1.02 (0.95, 1.09) 1.02 (0.97, 1.08) 
Rationale for adjustment and effect modification for listed potential confounders 
above are provided in the following sections. 
2.5.1.1 BMI, physical activity and total energy intake 
The implications of adjustment for total energy intake in epidemiological analysis had 
been well documented by Willett [185]. In general, three factors are known to cause 
variation in energy intake, namely body size (height, weight, BMI etc.), physical activity and 
metabolic efficiency (thermogenesis). The latter has the least amount of evidence for 
application in nutritional epidemiology. In addition, thermogenesis is only known to 
contribute ≈10% of individual energy expenditure, whereas ≈60% originates from resting 
metabolic rate. This is in turn dependent on body mass and composition, thus BMI is usually 
the primary determinant of energy intake. Physical activity can vary between individuals, it 
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contributes ≈30% to total energy expenditure, and is considered to be a major determinant 
of energy intake [185]. 
In this case, it is possible to adjust for all three variants, but this would lead to over-
adjustment. Therefore, likelihood ratio tests were conducted to give an objective reasoning 
if energy intake should be adjusted additionally. High BMI, or obesity is an independent and 
major risk factor for CVD [186], while high physical activity is also independently associated 
with a lower risk of CVD (and vice versa) [187], as elaborated in Chapter 1 Section 1.1.1.5. 
Furthermore, participants in the cohort with a higher fruit intake tend to have a statistically 
significant lower BMI and higher physical activity. Therefore, adjustments are warranted 
for BMI and physical activity. As described previously, BMI and physical activity also 
account for the majority of energy intake, thus it is likely that adjustment for energy intake 
is not necessary. However, a higher fruit intake may be accompanied by higher energy 
intake. This is because high fruit consumers might be eating more of everything in general 
by proportion. To objectively support the additional adjustment of energy after adjustment 
for BMI and physical activity, likelihood ratio tests were applied. Results show no significant 
differences between the fully adjusted model with energy and a fully adjusted model 
without energy adjustment. Thus, energy intake was only adjusted for with a fully adjusted 
model as part of the sensitivity analysis. 
In the cohort, there were various variables that describes body size. BMI (consisting 
of height and weight) was highly correlated with waist circumference and weight. It was 
chosen to be adjusted as this variable had the smallest amount of missing data. Physical 
activity was adjusted as a binary variable, where participants were required to answer if 
they were moderately active or not. A continuous variable using physical activity level 
would seem more ideal, however, there was a proportion of missing data (5.4%), and thus 
the binary variable was favoured instead to include the maximum number of cases. 
2.5.1.2 Smoking 
Smoking was described as a major CVD risk factor in Chapter 1 Section 1.1.1.5. There 
were multiple variables describing smoking habits in the cohort, however, smoking was 
chosen to be adjusted for as a binary variable (smokers vs. non-smokers) as there were 
fewer missing cases within this variable. It was also investigated as a potential effect 
modifier, due to the elevated CVD risk in smokers compared to non-smokers when 
conducting univariate analysis reported in Table 2.2. 
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2.5.1.3 Socio-economic status 
Chapter 1 Section 1.1.1.5 reported SES as one of the modifiable CVD risk factors. SES 
was chosen to be adjusted for in favour of education status, because there were fewer 
missing cases. SES was also able to represent a multitude of variables, such as income and 
occupation in addition to education which may influence the consumption levels of various 
dietary intakes or lifestyle behaviours. In addition, SES was also correlated with education, 
thus education was not adjusted for to prevent multicollinearity. Alternatively, deprivation 
scores could also be used to represent socio-economic status, however, this is not available 
within the cohort. 
2.5.1.4 Alcohol 
Excessive alcohol consumption is known to increase CVD risk. However, moderate 
alcohol intake was reported in Chapter 1 Section 1.1.1.5 to be associated with lower CVD 
risk, and this also applies to small amounts of alcohol consumption [188]. This is shown in 
Table 2.2. and is therefore adjusted for in the model. 
2.5.1.5 High blood pressure 
HBP was explored as an effect modifier in analysis that investigate CVD risk, as it is a 
major risk factor for CVD [189], described in Chapter 1 Section 1.1.1.5. Participants with 
HBP have a higher risk of fatal CVD than participants without HBP. The relationship 
between HBP and (poly)phenol-rich foods was also specifically explored in Chapter 6, 
Chapter 7 and Chapter 10. 
2.5.1.6 Menopausal status 
Menopausal status is strongly correlated with age. As age is included in all models. It 
was investigated as an effect modifier only. 
Variables that were not adjusted or considered to be included as part of the model 
included ethnicity. Ethnicity of the cohort is 99% white, and consist of only women, thus the 
proportion of non-white ethnic group was too small to warrant inclusion of ethnicity as a 
variable in the model. 
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With reference to the justifications above, unless stated otherwise, models employed 
in the analysis were: 
1. Age (years) 
2. Age (years), BMI (kg/m2), moderate physical activity (Yes/No), smoking status 
(smoker v.s. non-smoker), alcohol intake (ethanol g/day) and socio-economic status 
(professional/managerial, intermediate or routine/manual). 
3. In addition to model 2, energy intake (kcal/day) was also included for the reasons 
stated above. 
In general, models that investigated subgroup fruit or vegetable intakes were further 
adjusted for fruit intake not in that subgroup, for example citrus fruits were adjusted for the 
total amount of non-citrus fruit consumed (g/day). To maximise power in the model, 
variables with some missing data for body mass index (BMI) and smoking were updated 
using data collected via a questionnaire in a later stage of the study. This second phase of 
data collection has been previously reported in the current chapter as well as in published 
literature [190]. 
2.5.2 Directed acyclic graph 
A DAG was generated for the variables which are associated with fruit, vegetable, 
coffee and tea intake and CVD mortality risk in Figure 2.17, HBP in Figure 2.18. According 
to the diagram based on the analyses above, the possible confounders are SES, physical 
activity, BMI, alcohol intake and smoking, as they are the variables that lie within the 
unblocked backdoor paths. However, adjusting only for the possible confounders as 
mentioned above would over-simplify the relationship between the dietary intakes and 
CVD. Thus, it is also important to adjust for variables which are known to influence risk of 
CVD from established literature evidence. 
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2.6 UK Women’s Cohort Study: Dietary intakes of (poly)phenol-
rich foods and participant characteristics 
2.6.1 Dietary exposures 
Four main (poly)phenol-rich sources were explored in the thesis, namely fruit, 
vegetables, coffee and tea as they are the main sources of (poly)phenols in the UK diet. 
Alcoholic beverages such as wine, and chocolate were not explored in this thesis due to time 
constraint, but should also be noted as a rich source of dietary (poly)phenols. Total fruit 
intake was derived by combining multiple variables from the FFQ, including intakes of fresh 
fruits, dried fruits, pure fruit juices and processed fruits (Table 2.3). Cooking and food 
processing techniques (heating, freezing, canning etc.) are thought to affect stability of 
(poly)phenols by increasing or decreasing levels of (poly)phenols within fruits or 
vegetables [191, 192]. Therefore, fruit subgroups were also investigated individually, 
except for processed fruits, due to low intake levels. Fresh fruits were divided into 
subgroups by culinary/botanical family on Phenol Explorer to characterise fruit types 
according to their similarities in (poly)phenol profiles. These subgroups were berries, 
citrus, drupes, pomes and tropical fruits, with the exception of grapes [111]. Grapes was 
categorised under ‘berries’ within Phenol Explorer. However, due to differences in botanical 
families, (poly)phenol content [111] and the frequency of consumption, it was defined as an 
individual category. Likewise, total vegetable intake, total coffee and total tea was also 
derived from multiple FFQ variables in a similar manner described above. However, starchy 
vegetables such as potatoes, as well as pulses, grains, nuts and seeds were excluded from 
this variable, as they have a different (poly)phenol profile, and for public health 
implications, are also not included as a part of ‘five-a-day’ in the UK. 
The range of reported intakes shown in Table 2.3 tend to be very wide. The most 
consumed fruit on average is apples, followed by orange juice, bananas, citrus fruits, other 
forms of pure juices and grapes. The remaining types of fruit are consumed less frequently 
compared to the fruits listed formerly. As for vegetables, tomatoes were the most commonly 
consumed fruits, followed by ‘broccoli, spring greens and kale’, carrots, cauliflower and 
‘green beans, runner beans’. Cabbage and Brussel sprouts are also consumed in decent 
amounts compared to other fresh vegetables, while stir-fry vegetables is the most popularly 
consumed item within the vegetable dish group. 
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Consumption of tea is almost two-fold higher than coffee in general. In comparison to 
black tea, average intake of herbal tea is nearly six times less, while intake of decaffeinated 
coffee is three times less than regular coffee. 
Major composition of flavonoid subgroups are reported in Table 2.3 and Table 2.4. 
Table 2.3 Baseline total fruit, fruit subgroups, coffee, tea and respective subgroups from the FFQ grouped 
according to suggested categorisation in the Phenol Explorer prior to the application of exclusion 
criteria 
Investigated 
variables 
FFQ variables Mean (SD) 
(g/day) 
Median 
(g/day) 
Intake range 
(g/day) 
Major Flavonoid 
Composition 
T
o
ta
l 
fr
u
it
 i
n
ta
k
e
 (
T
F
),
 n
 =
 3
4
,6
7
7
 
Total fruit juice 
(FJ), n = 35,372 
Orange Juice (Pure Fruit) 66 (89) 20 0 – 870 Flavanones (orange 
juice); dependent on 
type of fruit juice for 
other fruit juices 
Other (100%) Pure Fruit 
Juices 
34 (67) 10 0 – 870 
Total dried 
fruits (DF), 
n = 35,372 
Dates 2 (6) 0.5 0 – 150 
Varied depending on 
fruit type 
Figs 2 (10) 0 0 – 330 
Prunes 1 (5) 0.4 0 – 120 
Mixed Dried Fruit e.g. 
Apricots, Apples, Pears, 
Mangoes 
2 (6) 0.5 0 – 150 
Currants, Raisins, 
Sultanas 
2 (5) 1.1 0 – 90 
Processed Fruits* 
Fruit Tarts, Pies, 
Crumbles 
8 (14) 2.2 0 – 500 
Dependent on 
fruit(s) within the 
dish 
T
o
ta
l 
fr
e
sh
 f
ru
it
 (
F
F
),
 n
 =
 3
4
, 6
7
7
 
Total 
citrus, 
n = 35,372 
Oranges, Satsumas, 
Grapefruits etc. 
40 (54) 13 0 – 552 
Flavanones 
Orange Juice (Pure Fruit) 65 (89) 20 0 – 870 
Total 
berries, 
n = 34,878 
Raspberries 4 (10) 1.2 0 – 102 Anthocyanins, 
Flavonols, 
Hydroxybenzoic 
acids 
Red currants/Black 
currants 
4 (14) 0.7 0 – 210 
Strawberries 3 (6) 1.2 0 – 53 
Total 
pomes, 
n = 35,372 
Apples 75 (80) 47 0 – 702 Flavanols, 
Hydroxycinnamic 
acids Pears 24 (42) 8 0 – 690 
Total 
drupes, 
n = 34,792 
Apricots 1 (2) 0.1 0 – 39 
Flavanols, Flavonols, 
Hydroxycinnamic 
acids 
Nectarines 3 (5) 1.5 0 – 64 
Peaches 2 (3) 1 0 – 42 
Plums 1 (2) 0.5 0 – 20 
Total 
tropical 
fruits,  
n = 35,372 
Bananas 55 (56) 40 0 – 600 
Flavanols, Lignans 
Kiwi Fruit 7 ( 15) 1.2 0 – 360 
Mangoes 4 (14) 2.6 0 – 780 
Papaya 2 (12) 0 0 – 840 
Pineapple 4 ( 9) 1.3 0 – 384 
Grapes,  
n = 35,372 
Grapes 27 (51) 14 0 – 600 
Anthocyanins, 
Flavanols, 
Hydroxycinnamic 
acids 
Total Coffee,  
n = 35,372 
Coffee 281 (316) 190 0 – 1140 Hydroxycinnamic 
acids Decaffeinated Coffee 98 (212) 0 0 – 1140 
 
Black Tea 679 (511) 650 0 – 1560 Flavanols, 
Hydroxybenzoic 
acids  
Herbal Tea* 100 (231) 5 0 – 1560 Dependent on 
herb(s) within the 
dish 
*Not investigated individually  
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Table 2.4 Baseline total vegetable and vegetable subgroups from the FFQ grouped according to 
suggested categorisation in the Phenol Explorer prior to the application of exclusion criteria 
Investigated variables FFQ variables Mean (SD) 
(g/day) 
Median 
(g/day) 
Intake range 
(g/day) 
Major Flavonoid 
Composition 
T
o
ta
l 
v
e
g
e
ta
b
le
 i
n
ta
k
e
, n
 =
 3
5
,3
7
2
 
Vegetable Dishes* 
Quorn 1.1 (3.4) 0 0 – 37.7 
Dependent on 
vegetable(s) within 
the dish 
Textured vegetable 
protein/Sosmix/burger 
mix/soya sausages 
0 0 0 
Vegetarian chilli 
/Vegetable curry 
3 (7) 0 0 – 380 
Mixed bean casserole 
/Ratatouille 
4 (7) 2 0 – 459 
Stir-fry vegetables 22 (35) 19 0 – 1600 
Vegetable – 
Lasagne/Moussaka/Ravioli/ 
filled pasta with sauce 
7 (12) 3 0 – 641 
Vegetable pizza 2 (4) 1 0 – 260 
T
o
ta
l 
fr
e
sh
 v
e
g
e
ta
b
le
 i
n
ta
k
e
, n
 =
 3
5
,3
7
2
 
Allium, 
n = 35,372 
Garlic 1 (1) 0.4 0 – 18 
Flavonols, Lignans 
Leeks 10 (13) 5 0 – 337 
Brassicaceae, 
n = 35,372 
Broccoli, Spring greens, Kale 25 (26) 13 0 – 540 
Flavones, 
Flavonols, Lignans 
Brussel sprouts 13 (19) 6 0 – 540 
Cabbage 17 (22) 13 0 – 570 
Cauliflower 19 921) 13 0 – 540 
Swede 7 (11) 5 0 – 342 
Turnip 4 (8) 1 0 – 456 
Watercress, Mustard & Cress 1 (2) 0.2 0 – 60 
Fruit 
vegetables, 
n = 35,372 
Courgettes, Marrow, Squash 9 (13) 6 0 – 382 
Hydroxybenzoic 
acids, 
Hydroxycinnamic 
acids, Lignans 
Cucumber 6 (7) 3 0 – 138 
Aubergine 2 (4) 1 0 – 175 
Olives 1 (3) 0 0 – 120 
Peppers (Red, green, yellow, 
black etc.) 
10 (12) 6 0 – 270 
Tomatoes 
(raw/canned/sauce) 
46 (43) 33 0 – 498 
Pod 
vegetables, 
n = 35,372 
Green beans, Runner beans 19 (22) 12 0 – 528 
Lignans Okra/Lady’s Fingers 1 (2) 0.5 0 – 117 
Peas, Mushy peas, Mange-tout 12 (13) 9 0 – 372 
Stalk/Root 
vegetables, 
n = 35,372 
Beetroot 3 (6) 1 0 – 240 
Flavones, 
Hydroxycinnamic 
acids, Lignans 
Carrot 24 (23) 25 0 – 372 
Celery 7 (10) 3 0 – 240 
Parsnip 7 (11) 5 0 – 456 
*Not investigated individually 
 
Figure 2.19 demonstrates the distribution of total fruit, vegetable, coffee and tea 
which were investigated. Most distributions here do not conform to normality, and were 
positively skewed with a long tail. Distributions of total coffee and tea were not normal at 
all. This may be due to the application of fixed portion sizes of typical cups (190 g) and mugs 
(250 g) when translating frequency into g/day. 
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Figure 2.19 Distribution of total fruit, vegetable, coffee and tea intakes in histograms prior to the 
application of exclusion criteria 
 
Correlations between fruit and fruit subgroup variables are presented in Table 2.5. 
Total fruit, fresh fruit, ‘fresh fruit & juice’ and ‘fresh and dried fruit’ were all highly 
correlated with each other (0.90 to 0.99). Total citrus was also highly correlated with citrus 
fruit (0.60, 95% CI 0.59 to 0.60) and orange juice (0.87, 95% CI 0.87 to 0.88). However, 
citrus fruit and orange juice were weakly correlated (0.13, 95% CI 0.12 to 0.14). In general, 
fruit subgroups were moderately correlated with total fruit, fresh fruit, ‘fresh fruit & juice’ 
and ‘fresh and dried fruit’ groups. Correlation between fruit subgroups tend to be weak, 
ranging between 0.05 to 0.49. With regard to vegetable and vegetable subgroups, total 
vegetables are highly correlated with fresh vegetables, while the correlation of vegetable 
subgroups ranged from weak to moderate (0.25 to 0.61). 
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Table 2.5 Correlations between total fruit and fruit subgroups intake assessed from the baseline FFQ 
prior to the application of exclusion criteria 
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Total fruit 1             
Fresh fruit 0.90 1            
Fresh fruit and juice 0.99 0.90 1           
Fresh and dried fruit 0.91 0.99 0.90 1          
Total fruit juice 0.58 0.18 0.58 0.19 1         
Dried fruits 0.33 0.26 0.26 0.34 0.10 1        
Berries 0.43 0.46 0.42 0.47 0.10 0.19 1       
Total citrus 0.64 0.39 0.65 0.39 0.75 0.10 0.14 1      
Citrus fruit 0.53 0.57 0.53 0.57 0.14 0.11 0.18 0.60 1     
Orange juice 0.48 0.14 0.48 0.14 0.85 0.05 0.06 0.87 0.13 1    
Drupes 0.52 0.57 0.52 0.57 0.12 0.21 0.49 0.23 0.31 0.09 1   
Pomes 0.65 0.4 0.65 0.74 0.08 0.16 0.18 0.20 0.33 0.05 0.32 1  
Tropical fruit 0.63 0.69 0.63 0.69 0.14 0.17 0.18 0.21 0.27 0.10 0.29 0.37 1 
 
Table 2.6 Correlations between vegetable and vegetable subgroups intake assessed from the baseline 
FFQ prior to the application of exclusion criteria 
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Total vegetables 1       
Fresh vegetables 0.97 1      
Allium 0.54 0.54 1     
Brassicaceae 0.77 0.81 0.36 1    
Fruit vegetables 0.68 0.69 0.31 0.25 1   
Pod vegetables 0.63 0.65 0.44 0.42 0.36 1  
Stalk/Root vegetables 0.73 0.76 0.37 0.61 0.37 0.39 1 
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2.6.2 Baseline characteristics of participants 
Table 2.7 to Table 2.10 report the baseline characteristics of all participants by dietary 
intakes prior to the application of exclusion criteria. When possible, participants were 
divided into approximately five equal groups for each dietary intake. Participants who 
consumed more total fruit tend to be older and slightly slimmer with a lower BMI (Table 
2.7). Energy intake, total vegetable consumption, portions of FV tend to be higher across the 
quintiles as intake of total fruit increases. However, ethanol intake tends to be lower with 
increasing total fruit intake. Participants who consumed more total fruit also tended to 
consume supplements, be moderately active, report being vegetarian or vegan, and not 
smoke. In terms of socioeconomic status, they tend to be well educated, and were more 
likely to hold a professional/managerial job as consumption of total fruit increases. There 
were no significant differences in the history of parental heart disease, heart attack, high BP 
and diabetes when compared across quintiles. However, there was a significant difference 
between percentage of participants with parental history of cancer/heart disease, high 
cholesterol/hyperlipidaemia by total fruit quintiles, though the trend may not necessarily 
be linear. Participants were also more likely to have had a stroke or angina by increasing 
total fruit quintiles, where participants consuming 202 to 306 g of fruits reporting the least 
angina. 
The baseline characteristics of participants by total vegetable intake was largely 
similar to what was reported above, except for a few differences (Table 2.8). Contrary to 
ethanol intake levels by total fruit quintile, the consumption of ethanol increased with 
increasing vegetable intake. In terms of medical history, participants who consumed 
moderate amount of vegetables tend to have the lowest history of heart attack, stroke and 
angina compared to lowest and highest consumers. There were no obvious trends by 
history of parental cancer/heart disease and heart disease alone. In addition, participants 
who consumed more total vegetables were less likely to have history of diabetes. 
When participants were divided by coffee consumption quintiles (Table 2.9), the 
fourth quintile contained the least number of participants, while the third quintile had the 
highest number. On average, participants from the second quintile were the oldest with the 
largest waist circumference, while the highest coffee consumers were the youngest. Lowest 
coffee consumers also had the smallest waist circumference. BMI remained stable by 
increasing coffee intake, but increased sharply in the fifth quintile. Energy and ethanol 
intake tend to be higher across coffee intake quintiles, while total tea intake tend to be lower 
when coffee consumption is higher. Portions of FV did not differ between coffee quintiles. 
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High coffee consumers were also less likely to be supplement users, non-smokers, 
moderately active or vegetarian/vegan. Participants in the fourth quintile tend to be more 
well-educated, and more likely to hold a professional/managerial job compared to other 
quintiles. Trends do not follow a linear pattern in terms of medical history, however, lower 
coffee consumers tend to have higher proportion of participants who had history of 
cardiovascular diseases and cancer, and vice versa for higher coffee consumers. 
Baseline characteristics by black tea intake quartiles are shown in Table 2.10. General 
characteristics of participants were similar across quartiles. Higher tea consumers had a 
higher energy intake, but lower intakes of ethanol, coffee and portions of FV. They were also 
less likely to be supplement users, non-smokers, moderately active, be well-educated and 
hold a professional/managerial status. With regard to medical history, higher tea 
consumers were more likely to hold a history of parental cancer/heart disease, had a heart 
attack, stroke, angina, HBP, diabetes, high cholesterol and cancer. 
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Table 2.11 reported the baseline characteristics of all participants, and by completion 
of phase 2 questionnaire. There was approximately one third of all participants who 
completed the phase 2 questionnaire. Overall, phase 2 participants displayed more health-
conscious behaviours than non-participants. By age and waist circumference, there were no 
significant differences between the two groups. However, participants who completed 
phase 2 questionnaire tend to have a slightly lower BMI than those who did not. In general, 
participants who completed the phase 2 questionnaire were more likely to be supplement 
users, non-smokers, moderately active and vegetarian/vegan. They were also more likely 
to hold professional/managerial status, more educated. In terms of medical history, 
participants who completed phase 2 questionnaire were more likely to have parents who 
had a history of cancer and/or heart disease and a personal history of high cholesterol. 
However, they were less likely to have a history of heart attack, stroke, angina, HBP, diabetes 
and cancer compared to participant who did not complete the phase 2 questionnaire. With 
regard to dietary intakes, participants who completed the phase 2 questionnaire were more 
likely to have a higher energy, total fruit, vegetable and tea intake, while participants who 
did not complete the phase 2 questionnaire tend to consume more alcohol. There were no 
significant differences between coffee consumption by completion of phase 2 questionnaire. 
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2.7 National Diet and Nutrition Survey: Dietary intakes of 
(poly)phenol rich foods and participant characteristics 
2.7.1 Dietary exposures 
Two main (poly)phenol-rich sources were explored in this study, namely FVs. Total 
fruit intake (excluding juice) was derived by NatCen, by combining all food diary entries 
relating to fruit, including intakes of fresh fruits, dried fruits, and processed fruits. Mean 
fruit intake (excluding juice) is 108 g/day, while mean fruit juice intake is 61 g/day. Total 
vegetable was also derived by the NDNS RP, and the mean intake is 184 g/day. 
Food items coded in the Nutrient Databank main food groups “Salads and other raw 
vegetables”, “Vegetables (not raw), “Fruit” and “Fruit Juice” were listed for inclusion. Fruit 
subgroups by processing methods (juice, dried fruits) and (poly)phenol profiles were also 
investigated for similar reasons stated in Section 2.6.1. Likewise, total vegetable intake was 
also derived in a similar manner described above. A flowchart was subsequently used to 
decide whether food items were eligible for inclusion (Figure 2.20). 
 
Figure 2.20 Decision flowchart for the inclusion of food items from the NDNS Nutrient Databank for 
division into FV subgroups 
 
The intake range of fruits tend to be varied (Table 2.12). The most popularly 
consumed fruits were apple, pears, oranges and bananas, while the remaining fruits were 
consumed in small or insignificant amounts. Citrus and pomes fruits were the most popular 
groups with the highest total number of consumers, while tropical, drupes and berries were 
less frequently consumed. Bananas, apples and oranges were the most frequently 
consumed, followed by grapes, pears, tangerine, clementine and strawberries. By intake 
levels, apples were consumed the most, 114 g/day equivalent to a small apple a day. With 
regard to vegetables, in terms of quantity, tomatoes, carrots and onions were the most 
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abundantly consumed, followed by peas, broccoli, cucumber and peppers. Tomatoes, 
carrots and onions were also the most frequently consumed, followed by lettuce, cucumber, 
peas and peppers. The major (poly)phenol composition for each subgroup was previously 
reported in Table 2.3 and Table 2.4. 
Table 2.12 Fruit subgroup intakes within adults (aged >19 years) in the NDNS RP grouped according to 
derived categories of fruit prior to the application of exclusion criteria (n = 2073) 
Fruit subgroups Individual Fruit Mean (SD) 
(g/day) 
Median 
(g/day) 
Intake range 
(g/day) 
Consumers (n) 
Berries 
Bilberries 1.0 (6.5) 0 0 – 100 93 
Blackberries 0.3 (4.3) 0 0 – 142 28 
Blackcurrants 0.04 (1.0) 0 0 – 33 8 
Cranberries 0.04 (1.0) 0 0 – 33.5 6 
Goji berries/Wolfberries 0.008 (0.23) 0 0 – 8.2 3 
Gooseberries 0.1 (2.0) 0 0 – 70 10 
Grapes 6.0 (24) 0 0 – 515 386 
Mulberries 0.007 (0.3) 0 0 – 15 1 
Physalis 0.004 (0.2) 0 0 – 7.5 1 
Pomegranate 0.9 (11.6) 0 0 – 284 22 
Raspberries 1.3 (7.1) 0 0 – 106 123 
Redcurrants 0.02 (0.6) 0 0 – 25 3 
Sharonfruit 0.04 (1.3) 0 0 – 55 2 
Strawberries 4.3 (15) 0 0 – 232 266 
Citrus 
Orange 38.8 (88.9) 0 0 – 1420 703 
Grapefruit 2.7 (24) 0 0 – 800 76 
Lemon 0.5 (3.8) 0 0 – 98 205 
Lime 0.03 (0.32) 0 0 – 5.7 29 
Mandarin 0.4 (5.5) 0 0 – 200 22 
Tangerines, Clementines 5.7 (18.7) 0 0 – 227 285 
Drupes 
Apricots 0.65 (5.0) 0 0 – 94 58 
Cherries 0.6 (6.1) 0 0 – 147 55 
Dates 0.10 (1.8) 0 0 – 50 8 
Greengages 0.03 (1.13) 0 0 – 50 2 
Nectarines 1.6 (8.9) 0 0 – 135 83 
Peaches 1.5 (9.4) 0 0 – 165 86 
Plums 1.9 (11) 0 0 – 246 117 
Prunes 0.77 (8.3) 0 0 – 187 40 
Pomes 
Apples 114 (198) 0 0 – 1750 978 
Pears 39.6 (124) 0 0 – 2074 307 
Quinces 0.001 (0.05) 0 0 – 2.3 1 
Tropical 
Bananas (Green, yellow) 25.3 (35.5) 0 0 – 250 986 
Kiwi 1.2 (6.1) 0 0 – 120 125 
Mango 1.1 (7.9) 0 0 – 187 77 
Passion fruit 0.01 (0.4) 0 0 – 15 5 
Paw-paw, Papaya 0.16 (2.7) 0 0 – 75 10 
Pineapple 3.1 (15.5) 0 0 – 212 157 
Total fruit 108 (109) 81.1 0 – 1022 2073 
Total fruit juice 61 (110) 9.1 0 – 1529 2073 
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Table 2.13 Vegetable subgroups within adults (aged >19 years) in the NDNS RP grouped according to 
derived categories of vegetables prior to the application of exclusion criteria (n = 2073) 
Vegetable 
subgroups 
Individual Vegetables Mean (SD) 
(g/day) 
Median 
(g/day) 
Intake range 
(g/day) 
Consumers (n) 
Allium 
Chives 0.008 (0.1) 0 0 – 3.7 20 
Garlic 0.3 (0.9) 0 0 – 17.5 457 
Leeks 1.7 (7.4) 0 0 – 80 187 
Onion 14.7 (19.0) 8.1 0 – 176 1367 
Brassicaceae 
and leaves 
Broccoli/Broccoli Spears 7.4 (14.5) 0 0 – 110 596 
Brussel Sprouts 1.6 (6.5) 0 0 – 75 161 
Cabbage (Red, Savoy, Spring, 
Summer, White, Winter Kale) 
4.1 (11.0) 0 0 – 135 385 
Cauliflower 3.9 (11.3) 0 0 – 112 331 
Chinese Leaves 0.1 (2.1) 0 0 – 66 10 
Lettuce (Butterhead, Cos, 
Iceberg, Webb) 
4.8 (8.7) 0 0 – 94 927 
Mustard Cress 0.02 (0.3) 0 0 – 10 26 
Raddiccio 0.02 (0.6) 0 0 – 25 3 
Radish (Red, white) 0.23 (1.5) 0 0 – 28 67 
Sauerkraut 0.03 (0.8) 0 0 – 31 4 
Swede 1.3 (6.1) 0 0 – 80 137 
Turnip 0.46 (3.1) 0 0 – 45 80 
Watercress 0.2 (1.7) 0 0 – 30 64 
Fruit 
vegetables 
Aubergine 0.28 (2.9) 0 0 – 65 31 
Avocado 0.9 (5.9) 0 0 – 109 71 
Butternut squash 0.9 (8.5) 0 0 – 250 54 
Cho cho 0.02 (0.6) 0 0 – 27 2 
Courgette 1.3 (6.6) 0 0 – 145 154 
Cucumber 5.9 (12.3) 0 0 – 120 800 
Gherkins 0.09 (1.12) 0 0 – 31 24 
Gourd, bitter 0.01 (0.5) 0 0 – 15 2 
Gourd, bottle 0.005 (0.2) 0 0 – 7.5 2 
Marrow 0.08 (1.5) 0 0 – 51 9 
Tomatoes 31 (41) 20 0 – 623 1449 
Peppers (Red, Yellow, Green) 5.8 (13.4) 0 0 – 122 674 
Pumpkin 0.05 (1.7) 0 0 – 65 3 
Olives 0.5 (2.5) 0 0 – 35 122 
Pod 
vegetables 
Beansprouts 0.4 (2.6) 0 0 – 32 54 
Capers 0.01 (0.2) 0 0 – 8 13 
Cluster guar beans 0.006 (0.29) 0 0 – 13 1 
French beans 2.1 (7.8) 0 0 – 112 213 
Green beans 0.007 (0.3) 0 0 – 15 1 
Mange Tout 0.44 (3.0) 0 0 – 42.5 68 
Okra 0.07 (1.2) 0 0 – 34.5 9 
Peas 8.1 (15.2) 0 0 – 201 775 
Petit Pois 0.4 (3.4) 0 0 – 67 47 
Runner beans 1.5 (6.9) 0 0 – 105 152 
Root 
vegetables 
Beetroot 1.5 (5.9) 0 0 – 104 192 
Carrot 16.2 (22.1) 10 0 – 180 1210 
Cassava 0.07 (1.75) 0 0 – 72 5 
Celery  1.3 (5.3) 0 0 – 86 221 
Celeriac 0.06 (1.5) 0 0 – 64 8 
Fennel 0.1 (1.9) 0 0 – 62 15 
Ginger root 0.09 (0.6) 0 0 – 14 99 
Parsnip 2.1 (8.2) 0 0 – 100 204 
Sweet potato 0.6 (3.9) 0 0 – 50 64 
Water chestnut 0.02 (0.4) 0 0 – 11 9 
Yam 0.08 (1.6) 0 0 – 52 8 
Total vegetables 184 (106) 168 0 – 1168 2073 
Correlations between fruit and fruit subgroup variables are presented in Table 2.14. 
‘Total fruit and juice’ was strongly correlated with total fruit intake and ‘fruit juice & 
smoothies’ (0.74 and 0.75 respectively). The two latter categories were also strongly 
correlated with citrus intake. The intake of pomes were moderately correlated with total 
fruit and ‘total fruit and juice’, while tropical fruit was moderately correlated with total fruit. 
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In general, correlation between the remaining fruit subgroups tend to be weak, ranging 
between 0.03 to 0.39. With regard to vegetable and vegetable subgroups, total vegetables 
were highly correlated with fruit vegetables, and moderately correlated with Allium, 
Brassicaceae and ‘stalk and root vegetables’. Total vegetables were the least correlated with 
pod vegetables, while the correlation of vegetable subgroups ranged from weak to 
moderate (0.02 to 0.38). 
Table 2.14 Correlations between total fruit and fruit subgroups intake assessed from the food diary 
prior to the application of exclusion criteria 
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Total fruit 1         
Fruit juice & smoothies 0.12 1        
Total fruit and juice 0.74 0.75 1       
Dried fruit 0.32 0.03 0.23 1      
Berries 0.39 0.18 0.38 0.12 1     
Citrus 0.25 0.80 0.70 0.05 0.05 1    
Drupes 0.36 0.07 0.29 0.17 0.12 0.04 1   
Pomes 0.55 0.28 0.56 0.13 0.08 0.12 0.09 1  
Tropical fruit 0.63 0.07 0.47 0.12 0.13 0.09 0.10 0.25 1 
Table 2.15 Correlations between total vegetables and vegetable subgroups intake assessed from the 
food diary prior to the application of exclusion criteria 
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Total vegetables 1      
Allium 0.51 1     
Brassicaceae and leaves 0.46 0.12 1    
Fruit vegetables 0.70 0.33 0.17 1   
Pod vegetables 0.25 0.02 0.10 0.02 1  
Stalk/Root vegetables 0.51 0.23 0.38 0.19 0.17 1 
Table 2.16 Correlation between total fruit and total vegetable intake assessed from the food diary prior 
to the application of exclusion criteria 
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Total fruit 1  
Total vegetables  0.29 1 
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2.7.2 Baseline characteristics of participants 
Adults (aged 19 and above) within the NDNS RP study were divided into 
approximately equal tertiles by intakes of FV prior to the application of exclusion criteria 
(Table 2.17). Mean age increased with higher FV intakes, with a greater proportion of adults 
aged 65 years and above. There was no particular trend by BMI, and no significant 
differences between the proportion of obese and non-obese participants by tertiles. Waist 
circumference was also not significantly different with higher FV intake. However, there 
was a higher proportion of hypertensive participants with increasing FV intake. In terms of 
lifestyle habits, participants in the third tertile were more likely to be vegetarian or vegan, 
non-smokers and supplement users. There were no significant trend for the usage of statins 
(without prescription) and moderate/vigorous physical activity levels. Participants were 
also more likely to hold a professional/managerial job in comparison with intermediate or 
manual job with increasing FV intake. With regard to dietary intakes, energy intake 
increased across the tertiles, while intake of alcohol remained stable. Higher intake of 
carbohydrates, fats and proteins, as well as the percentage of energy from these nutrients 
were also greater with a higher intake of FVs, with the exception of percentage of energy 
from total fat. Consumption of sodium, total fruit, total vegetables and portions of FVs was 
also increased across the tertiles. 
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Table 2.17 Baseline characteristics of participants by tertiles of total FV intakes prior to the application 
of exclusion criteria, expressed as mean and standard deviation for continuous variables, 
percentage and 95% CI for categorical variables 
  
 Total fruit and vegetable intake (g/day) 
ANOVA/Chi-
Squared Test 
 0 - 201 202 - 339 339 – 1554 p-value 
General     
Participants (n) 695 694 694  
Age (years) (SD) 45.2 (17.9) 49.4 (16.7) 52.9 (16.0) <0.001 
      19 – 64 years (%, 95% CI) 83.4 (80.5, 86.0) 79.7 (76.5, 82.5) 75.2 (71.9, 78.3) 
0.001 
      65 + years (%, 95% CI) 16.5 (14.0, 19.5) 20.3 (17.5, 23.5) 24.8 (21.7, 28.1) 
BMI (kg/m2) (SD) 27.6 (5.5) 28.1 (5.5) 27.3 (5.1) 0.047 
      <29.9 kg/m2 (%, 95% CI) 71.4 (67.8, 74.9) 68.5 (64.8, 72.0) 74.4 (70.9, 77.6) 
0.063 
      30+ kg/m2 (%, 95% CI) 28.5 (25.1, 32.2) 31.5 (28.0, 35.2) 25.6 (22.3, 29.1) 
Waist Circumference (cm) (SD) 93.5 (14.8) 94.6 (14.7) 93.0 (14.6) 0.211 
Systolic Blood Pressure (mmHg) (SD) 127 (16) 127 (17) 127 (17) <0.001 
Diastolic Blood Pressure (mmHg) (SD) 75 (11) 75 (11) 73 (10) <0.001 
Hypertensive (140/90 mmHg) (%, 95% CI) 14.7 (12.2, 17.5) 18.7 (16.0, 21.8) 19.0 (16.3, 22.1) <0.001 
     
Dietary Intake     
Total Energy (kcal/d) (SD) 1680 (571) 1804 (571) 1924 (558) <0.001 
Total Energy –no alcohol (kcal/d) (SD) 1586 (514) 1709 (517) 1829 (519) <0.001 
Alcohol (g/d) (SD) 13.5 (25.1) 13.5 (24.2) 13.6 (19.6) 0.992 
Carbohydrates (g/d) (SD) 200 (72) 215 (66) 235 (71) <0.001 
% Energy from Carbohydrates (%) (SD) 47.4 (6.9) 47.5 (6.6) 48.3 (6.7) 0.014 
Protein (g/d) (SD) 64.3 (21.3) 74.1 (27.4) 80.2 (23.7) <0.001 
% Energy from Protein (%) (SD) 16.5 (3.8) 17.6 (3.8) 17.9 (4.0) <0.001 
Total Fat (g/d) (SD) 64.3 (24.8) 67.5 (26.4) 69.7 (26.5) <0.001 
% Energy from Total Fat (%) (SD) 36.1 (6.1) 34.9 (6.0) 33.7 (6.6) <0.001 
Sodium (mg/d) (SD) 2092 (802) 2241 (807) 2306 (867) <0.001 
Portions of Fruits & Vegetables (no./d) (SD) 2.0 (0.8) 3.9 (0.8) 6.8 (1.9) <0.001 
Total fruit (excluding juice) (g/day) (SD) 28.4 (31.3) 87.5 (55.0) 209 (121) <0.001 
Total vegetables (g/day) (SD) 95.7 (46.7) 176 (55) 280 (108) <0.001 
     
Lifestyle Habits     
Vegetarian/Vegan Status (%, 95% CI) 0.7 (0.3, 1.7) 2.4 (1.5, 3.9) 3.4 (2.2, 5.9) 0.009 
Non-smokers (%, 95% CI) 42.3 (38.7, 46.0) 55.2 (51.5, 58.8) 65.6 (61.9, 69.0) 
<0.001 Ex-regular smoker (%, 95% CI) 19.3 (16.5, 22.4) 26.4 (23.2, 29.8) 25.8 (22.7, 29.2) 
Current smokers (%, 95% CI) 38.4 (34.9, 42.1) 18.4 (15.7, 21.5) 8.6 (6.8, 11.0) 
      Cigarettes smoked (if smokers) (no./d) (SD) 5.1 (8.4) 2.1 (5.5) 1.0 (4.1) <0.001 
Supplement users (%, 95% CI) 25.2 (22.1, 28.5) 34.9 (31.4, 38.5) 41.9 (38.3, 45.6) <0.001 
Statin users (%, 95% CI) 4.3 (3.0, 6.1) 3.4 (2.3, 5.1) 5.5 (4.0, 7.4) 0.065 
Moderately/Vigorously Active (hr/d) (SD) 1.4 (2.3) 1.5 (2.2) 1.7 (2.2) 0.221 
     
Socio Economic Status     
      Professional & Managerial (%, 95% CI) 30.8 (27.5, 34.3) 43.4 (39.7, 47.1) 50.0 (46.3, 53.7) 
<0.001 
      Intermediate (%, 95% CI) 19.3 (16.5, 22.4) 18.7 (16.0, 21.8) 21.5 (18.6, 24.7) 
      Routine/Manual (%, 95% CI) 45.7 (42.1, 49.5) 34.6 (31.1, 38.2) 24.3 (21.3, 27.7) 
      Unemployed (%, 95% CI) 2.7 (1.7, 4.2) 1.4 (0.8, 2.6) 2.0 (1.2, 3.4) 
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2.8 Discussion 
2.8.1 Comparison of FV intakes in the UKWCS and other studies 
The mean intake of fruits (excluding juice) and vegetables (including composite 
dishes) assessed by the baseline FFQ in UKWCS was 302 g/day and 317 g/day respectively, 
while the median intake was 252 g/day and 282 g/day respectively. These intakes were 
higher compared to other studies, elaborated as follows. The European Prospective 
Investigation into Cancer and Nutrition (EPIC) cohort reported a median consumption of 
205 g/day of fruit and 244 g/day of vegetables within the UK [193], while the EPIC-Heart 
study reported a mean intake of 328 g/day and 384 g/day of FVs for men and women 
respectively in the UK [86]. Within cohorts from other countries, the Nurses’ Health Study 
observed a median intake of 186 g/day of fruit, 230 g/day of vegetables, and participants in 
the Health Professionals’ Study consumed a median intake of 170 g/day of fruits and 235 
g/day of vegetables [194]. Intakes from the Women’s Health Study were nearly half for 
fruits at 176 g/day, but similar for vegetables at 312 g/day, while a Swedish cohort reported 
mean intakes of 216 g/day for fruits and 376 g/day for vegetables. 
The consumption of FV in the UKWCS is relatively high in comparison to other 
cohorts. This could be explained by the higher proportion of vegetarians in the study, or 
because they were relatively more health-conscious, consisting of women only. In addition, 
there are also methodological limitations to account for. For example, higher consumption 
of FVs could be attributed to a higher number of FFQ items [195]. The current study has 17 
fruit items and 22 vegetable items. This is less than the number of FFQ items in the Nurses’ 
Health Study, Health Professionals’ Follow-up Study and the Women’s Health Study from US 
with lower FV intakes [194, 196], while the Swedish cohort, [197] reports a higher 
consumption of FV intakes compared to UKWCS, with a lower number of FFQ items. 
However, these studies measure diet from different countries, thus it would not be fair to 
compare across studies. An objective way to assess if over-reporting exist is through the 
assessment of biochemical markers (biomarkers), as well as relative validity using 24-hour 
recalls (single or multiple) and food diaries. Mean β-carotene intakes derived from FFQ 
were higher than β-carotene intakes derived from a seven-day food diary within the UK arm 
of the EPIC-study, due to the higher vegetable intake in FFQ by 120 g/day, attributed to the 
higher number of FFQ vegetable items [198]. Similarly, the FFQ also overestimated vitamin 
C, α-, β-carotene and folate when compared to a 7-day food diary in the Whitehall II Study 
for the same reason [199]. In terms of fruit intake, overestimation also occurred within the 
Shanghai Women’s Health Study, due to severe overestimation of watermelon consumption 
Chapter 2 
102 
 
despite adjustments for seasonality. In addition, the authors partly attributed this to 
participants with a social desirability bias, who may report food consumption based on 
social desirability, e.g. underreporting fat and energy intake [200]. This is most likely a 
possible limitation of the UKWCS due to the large proportion of ‘health-conscious’ women 
within the study. To address whether the UKWCS FFQ is relatively valid, a comparison must 
be made against the food diary from the UKWCS instead of other studies. This will be 
assessed in Chapter 8, along with strengths and limitations of both dietary assessments. 
2.8.2 Comparison of FV intakes in the NDNS RP and other studies 
With regard to intakes from food diaries in the NDNS RP [174, 201], mean intakes 
reported from publications (with weighting factors applied) for FVs were 108 g/day (104 
g/day for men, 112 g/day for women) and 184 g/day (187 g/day for men, 181 g/day for 
women) respectively, while median intakes were 81 g/day (75 g/day for men, 86 g/day for 
women) and 167 g/day (167 g/day for both men and women) respectively. In the NDNS 
conducted in 2001 before NDNS RP which used a seven-day weighed food diary, the 
consumption of fruits had remained relatively similar, and even decreased a little for 
women (104 g/day for men, 120 g/day for women). However, intakes of vegetables had 
improved from 112 g/day for men and women [202]. When intakes were compared with 
other studies, the North/South Ireland Consumption Survey reported a slightly higher 
intake at 136 g/day for fruits (133 g/day in men, 140 g/day in women) and a slightly lower 
intake for vegetables at 140 g/day (149 g/day in men, 132 g/day in women) [203]. Within 
the EPIC-Norfolk cohort, mean total fruit intake was higher than NDNS (158 g/day in men, 
183 g/day in women) while vegetable intakes were lower (151 g/day in men, 150 g/day in 
women) [204]. In summary, intakes of FVs do not vary as much between studies as the 
observed intakes measured by FFQ, possibly due to nature of the participants. However, 
there are also other methodological concerns within the food diary which may affect 
reported intakes. Firstly, the definition of ‘total fruits’ and ‘total vegetables’ may vary 
between studies [204]. For example, fruits are more likely consumed fresh, thus less likely 
to be part of a composite dish, while vegetables are vice versa. An Irish cohort demonstrated 
that only 5% of fruit intake was from composite dishes, while the proportion of vegetables 
from composite dishes were 26% [203]. Thus the exclusion of vegetables from composite 
dishes could introduce bias in intake estimates or misclassification when ranking 
individuals by consumption. Within the NDNS RP, FV intakes were disaggregated to 
minimize bias in this manner. It was also reported in the EPIC-Norfolk cohort that 
differences between crude and disaggregated intakes ranged from 0.5 to 1 portion of fruit 
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or vegetable, which could affect which category participants belonged to, thus affecting the 
outcome estimates [204]. 
2.8.3 Comparison of FV intakes between the UKWCS and NDNS RP 
In terms of which foods are consumed most frequently, dietary intakes captured by 
the FFQ in the late 1990s within the UKWCS and by the food diary in the NDNS RP a decade 
later do not show substantial differences in patterns of intakes for FV intakes. In both 
studies, apples, bananas and citrus fruits (both fruit and juice) were reported to be 
consumed in the largest quantities relative to the other fruits, while tomatoes, carrots and 
broccoli were consumed in the largest quantities relative to other vegetables within these 
two studies. Onion consumption was also very high (14.7 g/day) in the NDNS RP study, 
however, intake of onions was not available in the UKWCS baseline FFQ. An Irish study, 
O'Brien et. al [203] reports similar preferences for FV intakes, where apples, bananas and 
citrus fruits (including juice) were the most frequently consumed, while tomatoes, carrots 
and onions had the highest mean intakes. 
2.9 Summary 
This chapter provided the relevant methodology for the UKWCS and the NDNS RP to 
support the following result chapters. The study design of both studies were described, 
along with the descriptive statistics and exploration of FV intakes from both studies, coffee 
and tea intakes from the UKWCS, using correlations and histograms. Participant 
characteristics were also presented by FV, coffee and tea intake quantiles when appropriate. 
Consumption of these foods were discussed and compared with other studies. Further 
investigation on the relative validity of the FFQ and the food diary within the UKWCS will 
be addressed in Chapter 8 including the strengths and limitations of both dietary 
assessment methods. The following chapters will be using the dietary data and the methods 
of analyses presented here to examine the risk between CVD, HBP and fruit, vegetable, 
coffee and tea intake. 
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Chapter 3  
Fruit and vegetable intake and cardiovascular disease 
mortality in the UK Women’s Cohort Study 
3.1 Abstract 
FV intake is associated with a reduced risk of cardiovascular disease (CVD) in 
observational studies, though fruit or vegetable type has been less frequently explored. The 
aim of the current study was to explore the association between total fruit, total vegetable 
and respective FV subgroup intake according to (poly)phenol content and CVD mortality in 
the UK Women’s Cohort Study. Total FV intake (g/day) derived from a 217-item food 
frequency questionnaire, was obtained from 30,458 women (aged 35 to 69 years) at 
baseline from 1995 to 1998. FV intakes were sub-categorised according to similarities in 
(poly)phenol profile from Phenol Explorer, including berries, citrus, drupes, pomes and 
tropical fruits, as well as Allium, Brassicaceae, fruit vegetables, pod vegetables and stalk & 
root vegetables. Mortality events were derived from the NHS Central Register. During the 
mean follow-up period of 16.7 years, 286 fatal CVD deaths (138 coronary heart disease 
(CHD), 148 stroke) were observed. Survival analysis was conducted using participants free 
from history of CVD at baseline. Total fruit intake was associated with a lower risk of CVD 
and CHD mortality, with a 6-7% reduction in risk for each 80 g/day portion consumed (99% 
CI 0.89, 1.00 and 0.85, 1.01 respectively). The direction of the associations tended to be 
inverse for some fruit subgroups, but point estimates and tests for trend were not generally 
statistically significant. However, women in the highest intake group of grapes and citrus 
experienced a significant reduction in risk of CVD and stroke respectively compared with 
non-consumers [HR 0.56 (99% CI 0.32, 0.98) and 0.34 (0.14, 0.82) respectively]. Total 
vegetable intake was associated with a lower risk of stroke mortality, with a 9% reduction 
in risk for each 80 g/day portion consumed (95% CI 0.82 to 1.00). Fresh vegetables and 
vegetable subgroups were not associated with a lower risk of CVD. Overall, the findings of 
this study do not provide strong evidence to suggest that FV type is important. Until further 
knowledge is obtained from intervention studies, consumption of a wide variety of different 
types of fruit is recommended. 
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3.2 Background 
CVD is a major cause of death in Europe [10] and the UK, being accountable for a third 
of all-cause mortality [15]. Observational epidemiological studies in older adults have 
indicated that higher FV intake may lower risk of CVD [86, 196, 205-209]. Evidence in the 
literature that demonstrates high total FV intakes individually have beneficial effects on 
CHD [205, 210-212] and stroke [197, 213, 214], but null findings for CHD have also been 
previously reported for fruit intake [212], as well as vegetable intake [86, 194, 196, 215, 
216]. 
There are also protective associations observed for CHD risk when investigating fruit 
intakes by subgroups (e.g. citrus fruits) and individual fruits (i.e. blueberries and 
strawberries) [117, 210], as well as for stroke risk with increased consumption of citrus 
fruits [205, 213]. However, evidence is limited for berries [197], and pomes [117], with no 
published evidence for drupes and tropical fruits to our knowledge. In studies which 
investigated types of vegetables, a high consumption of green leafy vegetables was 
associated with a lower risk of CVD [194], CHD [205] and total stroke [197], while higher 
intakes of cruciferous vegetables (Brassicaceae) was associated with lower CHD risk [205]. 
Higher intake of carrots was also associated with a lower risk of CVD and stroke mortality, 
while greater intake of peas was associated with a lower risk of CHD mortality [217]. 
Similarly, studies also reported null associations with higher intakes of vegetable subgroups 
and CVD risk [197, 214, 216, 218], leading to inconclusive findings, thus further research in 
this area is warranted. 
Dietary fibre [219-221], potassium [222-224], folate [225] and “antioxidants”, such 
as carotenoids [226] and (poly)phenols are suggested properties of FV which may be 
protective against CVD. However, (poly)phenol profiles differ for each type of FV. Citrus 
fruits are rich in flavanones specifically, and berries are rich in anthocyanins. In terms of 
(poly)phenol content, drupes are more complex than citrus as they are rich in flavanols and 
hydroxycinnamic acids, while pomes contain different proportions of flavonols, flavanols 
and hydroxycinnamic acids. On the other hand, all vegetables contain various concentration 
of lignans in general, onions (especially red) from the Allium genus are rich in flavonols, 
especially quercetin. Other vegetables contain complex (poly)phenol profiles. The 
Brassicaceae family pre-dominantly consist of flavones and flavonols. Fruit vegetables are 
rich in phenolic acids such as hydroxybenzoic and hydroxycinnamic acids, while stalk and 
root vegetables contain different proportions of hydroxycinnamic acids and flavones. 
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Some observational studies have reported lower CVD mortality risk in individuals 
with a higher consumption of flavonoids (a subgroup of (poly)phenols) [116, 117, 227]. The 
main flavonoid in oranges is hesperidin, which is bioavailable [228], and exhibits favourable 
effects on hypertension [126, 150, 151]. Anthocyanins from berries have been associated 
with ‘healthy’ blood lipid profiles, [120] and are also anti-inflammatory [163]. High 
quercetin consumption was also associated with lower ischemic heart disease risk [116]. 
Quercetin is known to exhibit in vitro various protective effects on endothelial function, as 
well as anti-hypertensive and anti-atherogenic functions [229]. However, there are limited 
evidence in vivo within human trials [229]. Evidence from intervention studies are also 
lacking to directly support the effect of flavonoids from pomes, drupes, tropical fruit and 
various vegetable subgroups on CVD risk or CVD risk factors. Furthermore, very few studies 
have thoroughly and specifically investigated CVD risk and the relationship between 
consumption of FV subgroups. 
The aim of the current study was to explore the association between total FV intake 
and subgroups of FV intake according to similarities in (poly)phenol profile with reference 
to Phenol Explorer [111] and the risk of CVD mortality using data from the UK Women’s 
Cohort Study (UKWCS). 
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3.3 Method 
3.3.1 Dietary exposure 
Total FV intake was individually generated by combining multiple variables from the 
FFQ which recorded intakes of fresh fruits, dried fruits, pure fruit juices, processed fruits, 
fresh vegetables and vegetables from composite dishes reported in Chapter 2 Section 2.6.1. 
Non-response was taken to indicate non consumption for the small amount of missing data 
on fruit intake. There were no missing data in vegetable intakes. Consumption was 
expressed as grams of fruit per day (g/day). 
3.3.2 Mortality outcomes 
Mortality data were available for participants who had provided information at 
baseline to allow tracing of their records through the UK’s NHS Central Register (98% of 
participants provided this). Deaths of participants were classified using codes provided by 
the International Classification of Disease (ICD) 9th edition and 10th editions. Deaths from 
CVD were classified as either fatal cerebrovascular cases (codes 430-438 or I60-I69.8) or 
fatal heart disease cases (codes 410-4149 or I20-I25.9). There were no important 
differences in the characteristics of those who were traced versus those untraced (data not 
shown). 
3.3.3 Statistical method and design 
3.3.3.1 Outliers and exclusions 
Prior to analysis, various methods were applied to detect outliers within the 
distribution. Normality of the distribution was evaluated by histograms, while boxplots 
were used to detect outliers in continuous variables. Scatter graphs and correlations were 
useful for identifying patterns and interactions between variables, demonstrated in Chapter 
2. It is important to detect for outliers as they would lead to estimation bias. Outliers can 
occur due to over or misreporting in the case of FFQs, such as values outside of expected 
normal variation within the population. Analyses for FV intakes were conducted separately. 
Participants who met the following criteria were excluded from the analysis: 
1. No, or incorrect NHS number provided at baseline FFQ, (n = 695) 
 Without the appropriate follow-up data, participants are unable to be traced 
for cancer or mortality outcomes, and are therefore excluded from the 
analysis. 
2. Extreme energy intakes (<500 kcal/day & >6000 kcal/day) (n = 86) 
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 Implausible intakes of energy could be generated due to under, or over 
reporting within the FFQ or recall bias, and were excluded. 
3. Extreme total fruit  and juice intakes (> 1500 g/day) (n = 970) or extreme total 
vegetable intake (>1500 g/day) (n = 59) 
 Implausible intakes of FV could be generated due to participant error, over 
reporting within the FFQ or recall bias, and were excluded. The cut-off point 
was decided by plotting a boxplot shown below, where most outliers are 
excluded (Figure 3.1). The cut-off point for total vegetables was also based 
on Figure 3.1. 
4. Previous self-reported heart attacks, angina, cancer, diabetes and stroke at baseline 
(n = 4,014). 
 Participants with self-reported diseases mentioned above were likely to be 
subjected to post-diagnosis changes in dietary behaviour. The current analysis 
also intended to study a healthy population. Where information was missing for 
prior history of disease, participants were assumed to have no prior history. 
There were 30,643 participants eligible for inclusion after the application of the 
exclusion criteria above. 
 
Figure 3.1 Boxplot of total fruit intake, including dried fruits and fruit juice, prior to exclusion criteria 
application 
3.3.3.2 Confounding 
The current analysis is based on the DAG from Chapter 2, Section 2.5.2 to provide 
evidence for inclusion of previously identified risk factors for CVD within the scientific 
literature. Exclusively statistical approaches such as stepwise procedures were avoided, but 
likelihood ratio tests were implemented as objective evidence to indicate whether there 
were major changes in point estimates after adjusting for potential confounders. These 
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confounders were also previously explored as a correlation matrix in Chapter 2. Results 
show that none of the potential confounders are correlated to each other, thus 
multicollinearity is unlikely. Univariate analysis was also conducted to explore the 
relationship between the variable of interest and outcome. Models for the presented results 
in this chapter were adjusted for: 
1. Age (years) 
2. Age (years), BMI (kg/m2), moderate physical activity (Yes/No), smoking status 
(smoker v.s. non-smoker), alcohol intake (ethanol g/day) and socio-economic status 
(professional/managerial, intermediate or routine/manual), additionally fruit 
intake when investigating vegetable intake 
3. In addition to model 2, energy intake (kcal/day) was also included for the reasons 
stated above (data not shown). 
Models that investigated subgroup fruit or vegetable intakes were further adjusted 
for fruit or vegetables not in that subgroup. For example, citrus fruits were adjusted for the 
total amount of non-citrus fruit consumed (g/day). To maximise power in the model, 
variables with some missing data for BMI and smoking were updated using data collected 
via a questionnaire in a later stage of the study. This second phase of data collection has 
been previously reported [190] and elaborated in Chapter 2 Section 2.2.2.3. 
3.3.3.3 Descriptive statistics 
Age, waist circumference, height, weight, medical history and smoking habits, were 
self-reported. Physical activity was recorded using a binary question in the FFQ which 
questioned if participants spent time on activities vigorous enough to cause sweating or a 
faster heartbeat, which indicated moderate physical activity. Supplement usage was 
identified by asking whether participants took any vitamins, minerals, fish oils, fibre or 
other food supplements. Participants also self-reported their status regarding the adoption 
of vegetarian or vegan diets. Classification of socio-economic status was undertaken based 
on occupation, according to the UK National Statistics-Socio-Economic Classification (NS-
SEC), where women are divided into three categories, 1) Managerial/professional, 2) 
Intermediate, or 3) Routine/manual [230]. Additional socio-demographic information such 
as marital status and high school education was determined by self-report questions asking 
for marital status (married or living as married, divorced, single, widowed, separated) and 
achieved qualifications (CSE, GCE ‘O’ Level, City & Guilds, ‘A’ Levels or Highers, Teaching 
diploma or HNC, Degree, None of these) respectively. 
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3.3.3.4 Survival analysis 
Survival analysis was conducted using the Cox proportional hazards models to 
calculate a hazard ratio (HR) and 99% CI [231]. Time of survival was determined by the date 
the questionnaire was received until death or censor date. The censor date applied to 
patients who had died of a different disease, or for surviving patients. The last censor date 
in the current analysis for surviving patients was at 18th December 2013. Risk of CVD 
mortality was determined by comparing each intake group with the reference group which 
included the lowest consumers, (non-consumers in the case of citrus fruit). Linear 
association was tested by calculating increments of FV intake according to a typical portion 
size of 80 g, with the exception of 250 g for orange juice and 125 g for other fruit juices, since 
these represent more commonly consumed portion sizes [176].  
Sensitivity analysis was performed by including adjustment for energy intake 
(kcal/day) in the models stated above. Effect modification was explored by stratification of 
subgroups of participants selected a priori. Variables investigated included BMI (obese v. 
non-obese), smoking (smoking v. non-smoking), menopausal status (pre-menopausal v. 
post-menopausal) and self-reported HBP. However, due to inadequate numbers of fatal 
cases (<50), these analyses were ultimately restricted to postmenopausal women, women 
with and without self-reported HBP, non-smokers and non-obese women. A summary of 
exclusion criteria and analysis plan is provided in Figure 3.2 and Figure 3.3. 
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Figure 3.2 Summary flowchart of the current study exclusion criteria and analysis plan 
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Figure 3.3 Summary flowchart of the current study exclusion criteria and analysis plan 
 
3.3.3.5 Testing for statistical assumptions 
Statistical assumptions were tested according to the procedure reported in Chapter 2 
Section 2.4.2. Table 3.1 lists the Schoenfeld residuals for fully-adjusted model on total fruit 
intake. Most p-values were not significant, indicating covariates in the model were not 
correlated with survival time. Although physical activity was borderline significant, the 
overall global test is not. Figure 3.4 displays the log-minus-lot plot for total fruit analysis. 
The lines in the graph are roughly parallel to each other, thus statistical assumptions were 
fulfilled. Statistical significance was determined by 2-sided p-value of ≤0.01 for 99% CI. Stata 
version 12.0 [232] was used for all statistical analysis. 
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Table 3.1 Schoenfeld residuals of covariates in the full-adjusted model for total fruit intake on total CVD 
mortality. 
Covariates p-value 
1st Quintile (Total fruit) - 
2nd Quintile 0.97 
3rd Quintile 0.46 
4th Quintile 0.86 
5th Quintile 0.40 
Age 0.12 
BMI 0.34 
Moderate physical activity 0.05 
Socio-economic Status  
Professional/Managerial - 
Intermediate 0.29 
Routine/Manual 0.94 
Smoking Status  
Non-smoker - 
Smoker 0.13 
Alcohol 0.84 
Total vegetables 0.12 
Global Test 0.26 
  
Figure 3.4 Survival probability for quintiles of total fruit intake on total CVD mortality plotted over time 
Chapter 3 
114 
 
3.4 Results 
3.4.1 Baseline Characteristics 
After the exclusion criteria was applied, 30,458 eligible participants were left for 
inclusion in the analysis. The baseline characteristics of participants by case status, are 
reported in Table 3.2 and Table 3.4. During the follow-up period from 1995 to 2013, there 
were 286 cases of CVD mortality, of which 138 were CHD deaths and 148 were stroke 
mortality cases. In summary, fatal CVD cases tend to be older, with a higher BMI and larger 
waist circumference than non-cases. Fatal CVD cases also report higher rates of ‘unhealthy 
lifestyle habits’, such as higher smoking rates, lower vitamin/mineral supplement 
consumption, lower physical activity, and a lower proportion of vegetarians. Fatal CVD 
cases also tend to be from a lower socio-economic class and are less likely to be married 
than non-cases. In addition, the percentage of self-reported medical conditions was twice 
as high in fatal CVD cases compared to non-cases. Minor differences between fatal CVD cases 
and non-cases were observed for energy intake, total FV consumption, where fatal cases 
were more likely to have lower intakes than non-cases. Participant characteristics reported 
here after the application of exclusion criteria by fruit or vegetable consumption quintile 
(Table 3.3 and Table 3.5) were not largely different from what was described in Chapter 2 
(Table 2.8).  
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3.4.2 Survival Analysis 
3.4.2.1 Full Cohort 
In the fully-adjusted model (Table 3.6), HR and 99% CI for increasing quintiles of fruit 
intake are presented with analysis of linear association addressing dose response. 
Participants from the highest TF intake quintile, consuming >7 portions/day had a 43% 
lower risk of death from CVD (95% CI 0.34 to 0.95) compared with women in the lowest 
quintile consuming <2.5 portions/day. When CVD outcomes were analysed separately, no 
association was found with fatal stroke. However, there was an association for fatal CHD in 
the highest quintile of TF intake, with risk lowered by 55% (95 % CI 0.21 to 0.97) compared 
to the lowest quintile. When total fruit intake was examined in fully-adjusted dose-response 
models, a lower risk of fatal CVD of between 6 to 8% was seen for every additional 80 g/day 
of FF, FFJ intake, as well as for FDF intake consumed (Table 3.6). Significant associations for 
TF intake were also found when analysing CHD individually. Risk of fatal CHD was halved in 
the highest TF intake quintile compared with the reference intake group, and reduced by 
7% with every additional 80g portion of fruit consumed (95 % CI 0.85 to 1.01). The risk of 
CHD was also 11% lower for every 80 g increase of FFJ intake (excluding dried fruits), and 
FDF intake (excluding fruit juice). TF intake was not statistically associated with the risk of 
fatal stroke, although point estimates tended to be lower with increasing consumption. 
Neither total DF intake nor FJ intake alone were associated with risk of fatal CVD, CHD or 
stroke. 
Total vegetable intake was not associated with CHD and stroke mortality by quintiles, 
however, the risk of fatal stroke was lowered by 9% (95% CI 0.82 to 1.00) for every 
additional 80 g portion of total vegetables in the dose response analysis (Table 3.7). The risk 
of fatal CVD was also significantly lowered by 38% (95% CI 0.42 to 0.92) when participants 
consumed between four to five portions of total vegetables (fourth quintile), compared with 
women from the first quintile. However, the association was no longer significant when 
participants consumed five or more portions. In the age-adjusted model for fresh vegetable 
intake and fatal stroke and CVD, there was a significant inverse association, but the 
association was attenuated in the fully-adjusted model. 
With regard to FV subgroups, the risk of fatal CVD in the highest quintile for total 
citrus intake (fruit and juice) was halved when compared to non-consumers [HR 0.49 (99 
% CI 0.25 to 0.96)], and was found to be even lower for risk of fatal stroke [HR 0.34 (99 % 
CI 0.14 to 0.82)]. However, neither association was seen to have a significant dose response. 
Similarly, an inverse association was seen with citrus fruits and fatal CVD [HR 0.54 (99 % CI 
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0.31 to 0.95)] and fatal stroke [HR 0.49 (99 % CI 0.23 to 1.07)] when comparing the highest 
consuming quintile and non-consumers, but significant dose responses were not observed. 
No association was found with citrus fruit intake and fatal CHD. Orange juice intake was also 
not associated with fatal CVD risk. Risk of fatal CVD is 34% lower with each 80 g/day greater 
grape intake (99 % CI 0.43 to 1.02). Intake of grapes was not associated with fatal CHD or 
stroke. Participants who consumed between 11 to 13 g of Allium vegetables had a 71% (99% 
CI 0.12 to 0.70) lower risk of fatal CHD and 54% (99% CI 0.26 to 0.80) lower risk of fatal 
CVD compared to the lowest consumers. However, the linear association was not significant. 
No association or dose response for fatal CVD was found in the analysis of subgroups of 
berries, pomes, drupes, tropical fruit, Brassicaceae species, fruit vegetables, pod vegetables 
and stalk & root vegetable. 
3.4.2.2 Sensitivity Analysis 
Further analysis addressed dose response through establishing linear associations for 
age-adjusted and fully adjusted models restricted to certain participants (separate analyses 
on the non-obese, non-smokers, post-menopausal women, women with or without HBP, 
and women with or without parental history of CVD). These are subsequently reported in 
Appendix A. Due to the limited number of CVD cases, analysis by increasing quintiles were 
not investigated in subgroups as meaningful conclusions cannot be drawn. 
No significant associations were found for stratified populations of non-smoking 
women, non-obese women, and in women with or without parental history of fruit and CVD 
(Table A.1). There was an 8 to 14% lower fatal CVD risk with every additional portion of TF, 
FF, FFJ and FDF intakes within women with no self-reported HBP (Table A.1). Similar 
associations were detected between fatal risk of CHD and FF, FDF intakes, where every 80 
g/day portion lowered risk by 16%. However, these associations were not seen in women 
with self-reported HBP (Table A.1). In addition, there is double the risk of fatal CHD for 
every additional portion of berries consumed among women with self-reported HBP. 
Within postmenopausal women, previous associations between TF, FF, FFJ, FDF intakes and 
CVD were not significant, however, every 80 g portion of grapes lowered CVD risk by 38% 
(Table A.1). No significant associations for vegetable intake and CVD were found for the 
stratified subpopulations of non-obese, non-smokers, self-reported HBP, postmenopausal 
and parental history of CVD (Table A.2). 
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3.5 Discussion 
3.5.1 Summary of Results 
The objective of this study was to investigate the association between different 
subgroups of FV and fatal CVD risk. Results from the present study indicated a lower risk of 
fatal CVD with higher intake of TF and grape, and lower fatal CHD with higher intake of FF. 
A lower risk of fatal stroke for every 80 g portion of total vegetables was also present, but 
not with risk of fatal CVD or CHD. In terms of FV subgroups, greater intake of total citrus 
and grapes were associated with a lower risk of fatal stroke, however, due to the absence of 
a significant linear trend, the association for lower fatal stroke risk and increasing citrus 
intake could not be confirmed. Point estimates also indicate a lower risk of fatal CHD and 
CVD for participants consuming between 11 to 13 g/day of Allium species, but a significant 
linear trend was absent. No evidence of association was determined for FJ, orange juice, 
dried fruit, and the remaining FV subgroups in the full cohort. 
Within subgroup analyses, significant associations reported above were restricted to 
women with no self-reported HBP for fruit intake, while no associations were significant for 
vegetable intakes. These findings require further verification with larger sample sizes. 
Consumption of berries were also associated with two-fold increase in fatal CHD. However, 
CI were particularly wide, thus this finding also need to be further verified and carefully 
interpreted. 
3.5.2 General comparison with literature 
Previous MAs of observational studies have indicated a significant, inverse 
association with risk of total CVD [83], CHD and greater consumption of FVs [84]. This 
exposure also had a similar association with risk of stroke [85]. In addition, evidence from 
studies conducted on the effects of total fruit intake on CVD risk in different countries is 
generally consistent with the current study [215, 218, 233], as well as for CHD [86, 205, 
210] and stroke. Findings for total vegetables are also consistent with other studies based 
in Northern Europe [197, 214]. However, the association between total vegetable and fatal 
CVD or CHD was not significant, contrary to the conclusions from the EPIC-Diabetic cohort, 
US and Japan [205, 208, 209, 212]. Northern European studies also tend to report an inverse 
association between stroke and total vegetable intake in comparison to other countries, 
where the Nordic diet [234] recently demonstrated to improve blood lipid profile and lower 
BP in hypercholesterolaemic participants [235]. 
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Studies rarely investigate both CHD and stroke outcomes in the same cohort [215]. 
Stroke and CHD share some common aetiology, being mainly driven by the process of 
atherosclerosis, and were thus examined together to explore total CVD. However, there are 
distinct differences between these two conditions which warrant separate examination. For 
example, stroke manifests in the brain, while CHD occurs in the heart. These conditions 
could also be caused by different biological mechanisms (high blood cholesterol, weak 
endothelial function, capillary permeability, and occlusion or rupturing arteries) involving 
different risk factors [3, 5]. This approach was therefore adopted in the current study. There 
was also a lack of association between fruit juices and CVD risk in this study, and there are 
a number of potential explanations. In the UKWCS, citrus juice consumption was higher than 
the broad fruit juice category. Citrus fruits also retain more flavanones after processing, 
although some studies report a higher content of flavanones in fruit, than in juice [125]. 
However, apple juice, as included in the broad fruit juice category, does not [133]. In 
addition, a RCT indicated that whole fruit had a more potent impact on reducing CVD risk 
factors than apple juice, suggesting that the fibre content might potentially be more 
important than the (poly)phenols delivered, or that disaggregation of the (poly)phenols 
may render them less biologically potent [236]. However, possibly and more importantly, 
juice consumption levels are low in the cohort overall, and there are fewer consumers 
compared to whole fruit. 
3.5.3 Relevance with (poly)phenol mechanisms 
The vegetable subgroups proposed within this chapter have been studied similarly 
within other observational studies [194, 197, 205, 214, 216, 218, 237]. Furthermore, these 
proposed categories were also loosely based on a botanical and culinary criteria proposed 
by the American Institute for Cancer Research [238]. While the intention was to divide 
groups according to (poly)phenol profiles, vegetable subgroups, unlike fruits tend to 
contain a broad spectrum of different (poly)phenols, rather than being a concentrated 
source of one particular type. Therefore the best approach was to group them using a 
botanical and culinary criteria, and then hypothesise if (poly)phenols could possibly play a 
role in any significant associations detected within the study. 
Observational studies exploring fruit subgroups and CVD risk, have tended to focus 
on grape consumption, or wine and the (poly)phenols contained within, stemming from the 
so-called ‘French Paradox’ [239]. Evidence for (poly)phenols in grapes consumed fresh or 
as products that support health benefits has been fairly consistent, and reported attributes 
such as total antioxidant capacity [which is effectively a general estimate of total 
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(poly)phenol content] [240] and vasoprotective effects [241] support the findings of the 
current study. There is also evidence relating to increased total citrus intake and lowered 
risk of CHD [205, 210]. Evidence from cohort studies of a protective association between 
citrus consumption and risk of CVD is suggestive of a lowering of risk [213], although there 
is some inconsistency between studies, possibly due to variation in consumption pattern 
between countries [213, 242]. In the analyses reported here, no dose response with 
increasing citrus consumption was observed, although, non-citrus consumers were found 
to be at greater risk of fatal CVD in comparison to citrus consumers overall (data not 
shown). This suggests a possible protective effect of citrus fruits independent of a dose 
response or may indicate the presence of residual confounding. High levels of vitamin C in 
citrus fruits were previously suggested as a possible mechanism for lowering risk of CVD 
through its biological activities including antioxidant action, but results from RCTs of 
vitamin C intake (not fruit) do not support this hypothesis [243, 244]. However, 
epidemiological studies have found significant associations between flavanone intake and 
CVD risk [116, 117], and hesperidin [a (poly)phenol in citrus fruit] was seen to significantly 
lower DBP in two human studies after a single dose of 500 mL commercial orange juice 
[150, 151]. Hesperidin also improved endothelial function [126], and reduced permeability 
and fragility of capillary walls [149], which were symptoms that manifests in hypertension, 
a major risk factor for stroke. Therefore, the current evidence is indicative of a potentially 
beneficial effect deriving from (poly)phenols rather than specifically from vitamin C intake. 
Allium vegetables, especially onions, are good sources of flavonols (quercetin), 
previously known as ‘Vitamin P’ from one of the earliest studies [245]. Like hesperidin, 
quercetin also decreased permeability and fragility of capillary walls. However, there are 
limited evidence on the effects of isolated flavonols on the development of atherosclerosis 
[229]. Lignans exist in all vegetable subgroups, and common examples include lariciresinol, 
pinoresinol and secoisolariciresinol. The evidence for intake of lignans and its effects on 
improving CVD risk factors (BP, lipid profile and lipoproteins) in RCTs are lacking [246]. In 
addition, estimating lignan intake is also analytically challenging [247], which possibly led 
to inconclusive results on the association between lignans and CVD. Furthermore, rich 
sources of lignans consist of flaxseed and sesame, while other sources of vegetables contain 
significantly less lignan content [246]. 
Considering all the evidence given above, if beneficial effects of all (poly)phenols are 
responsible for lowered fatal CVD risk, then associations should also be seen for other FV 
subgroup intakes. However, no association was found between intakes of Brassicaceae, fruit 
vegetables, pod vegetables, stalk & root vegetables, or pomes and CVD risk in UKWCS, 
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despite high levels of consumption, in contrast to other studies [116, 117, 197, 217, 242]. 
Further investigations into other FV subgroups in this cohort revealed relatively low intakes 
and this limited variation in consumption may somewhat explain the lack of association 
here, as the concentration of active compounds may not be high enough in vivo to have any 
mechanistic effects. Moreover, the UKWCS contains a higher proportion of vegetarians and 
well educated participants who tend to eat more healthily than the general population, thus 
results need to be carefully interpreted. In addition, fruit subgroups tend to contain a broad 
spectrum of different (poly)phenols, rather than being a concentrated source of one 
particular type (such as flavanones in citrus fruits), and so it is possible that in isolation, 
none of these fruit types provided sufficient amounts of the most potent types of 
(poly)phenol. Additionally, variance in dietary assessment methods may also cause 
variation through different portion sizes or design of the FFQ itself. Moreover, some studies 
did not include vegetables from composite dishes [194, 197, 214, 218]. As the proportion of 
vegetables consumed within composite dishes are higher than fruits, failure of inclusion 
could lead to error in estimation of total vegetable intakes, and further possible errors in 
point estimates. 
It is also important to note that other components in fruits, such as dietary fibre, 
nitrates, carotenoids and glucosinolates in Brassicaceae may also play a role in CVD 
prevention besides (poly)phenols. For example, one recent MA of cohort studies reported 
an inverse association between FV fibre and CHD risk, although numbers of included studies 
were low and heterogeneity between studies was high [221]. Fibre from FV may impact on 
CVD risk factors through multiple suggested mechanisms, including, but not restricted to, 
lowering blood cholesterol via alteration of bile acid synthesis and excretion [248]. 
Observational studies have also suggested that carotenoids (single and total) are associated 
with a lower CHD risk [249]. Suggested mechanisms include free radial scavenging and 
protecting low-density lipoproteins against oxidation, however, RCTs have failed to show a 
reduction in CVD events with β-carotene supplementation [226]. With regard to 
glucosinolates, high intakes within animals studies reported improvements in endothelial 
function [250], while an observational study reported a linear association between 
cruciferous vegetable intake and CVD mortality [251]. However, there is limited evidence 
for the effects of glucosinolates in human RCTs. 
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3.5.4 Strengths and limitations 
In interpreting the results of these analyses, certain limitations of the study should be 
considered. The relatively low numbers of cases of CVD, incomplete follow-up of 
participants and missing information on certain covariates may have lowered our ability to 
detect associations. Other limitations of the study include the fact that dietary intakes from 
one time point only were utilised in these analyses, which meant any changes in dietary 
pattern over time could not be taken into account. Self-reported fruit intakes in the UKWCS 
(400 g/day) are well above the national average value [201, 252] and other studies [194, 
197], possibly due to over-reporting on FFQ in general [253], as observed in other cohort 
studies employing this method of dietary assessment [199]. In addition, results are more 
difficult to generalise to current diets, as assessment of diet was conducted more than two 
decades ago, and so the dietary patterns for the cohort then compared to the population 
now could be different. In the past two decades the variety and availability of previously 
seasonal fruit has expanded, and the range of processed foods containing exotic fruits with 
unquantified (poly)phenol content has also increased [191, 192]. Whilst inverse 
associations between FV intake and the risk of CVD have been observed, interpretation of 
the extent of causality should be undertaken with caution since with any observational 
study, there is a substantial potential for biases caused by incomplete adjustment for 
confounding, measurement error in the exposure estimate, and other biases in participant 
selection or data collection. The bias could be large in size, and act in either direction, either 
towards or away from the null. In particular, results are not necessarily transferrable to 
men, as FV intake [201] and CVD risks [15] differ between sex, although we do not have 
reason to suppose that the mechanism of action of FV on CVD risk may differ by sex. Further 
intervention studies on subgroups of FV divided by (poly)phenol profiles would be 
recommended to establish causal relationships. The current study also only investigated 
mortality data, which meant that any non-fatal events were unknown and misclassified as 
non-cases. This would reduce the number of fatal events available, especially for sensitivity 
analyses where case numbers were lower. 
However, the analysis has certain strengths: the UKWCS is a large prospective cohort 
which has been followed up for a long period of time, and a wide diversity in dietary intakes 
and patterns in this health-conscious cohort facilitates the elucidation of associations 
between chronic disease and dietary intake. Furthermore, to our knowledge, this is the first 
study that has extensively investigated the effects of subgroups of fruit according to 
(poly)phenol profiles on risk of CVD. The estimation of FV intake is also strengthened by the 
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inclusion of other fruit sources such as dried fruit, juices or processed fruits and composite 
vegetable dishes. In addition, using Phenol Explorer as a reference database for sub-dividing 
fruit intake has certain advantages, due to the extensive method implemented to collect 
high-quality literature articles on (poly)phenol composition, the impacts of food processing 
on (poly)phenols and metabolite composition in the body, ensuring that the fruit groupings 
applied here were sensible with regard to the variety of (poly)phenols in each fruit group. 
3.6 Summary 
In conclusion, greater consumption of total fruit, total vegetable, fresh fruit, fresh 
grapes were seen to be protectively associated with fatal CVD risk in the UKWCS. This 
finding is aligned with widely promoted guidelines promoting FV consumption for health. 
Further investigations are recommended for consumption of citrus fruits to assess its 
relationship with CVD risk in the population. Overall, the findings of this study do not 
provide strong evidence to suggest that FV type is important. Until further knowledge is 
obtained from intervention studies, consumption of a wide variety of different types of FV 
are recommended. 
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Chapter 4  
Fruit intake and incidence of cardiovascular disease in the UK 
Women’s Cohort Study 
4.1 Abstract 
In Chapter 3, it was concluded that high total fruit intake was negatively associated 
with risk of CVD mortality, however, there was no particular fruit type that was more 
important than others. The current chapter aims to improve the quality of outcome 
measure, by investigating the association between total fruit, fruit subgroup intake 
according to (poly)phenol content and CVD incidence in the UKWCS. Total fruit intake 
(g/day) derived from a 217-item food frequency questionnaire, was obtained from 26,794 
women (aged 35 to 69 years) at baseline from 1995 to 1998. Fruit intakes were sub-
categorised according to similarities in (poly)phenol profile from Phenol Explorer, 
including berries, citrus, drupes, pomes and tropical fruits. CVD incidence events were 
derived from data linkage to Hospital Episode Statistics (HES) and Myocardial Ischaemia 
National Audit Project (MINAP) databases. During a mean follow-up period of 16.4 years, 
291 CVD incident events (152 CHD, 142 stroke) were observed. Survival analysis was 
conducted using participants free from history of CVD at baseline. Moderate consumption 
of total fruit (302 – 571 g/day), fresh fruit and juice (291 – 554 g/day) and orange juice (116 
– 145 g/day) was associated with a lower risk total stroke incidence, however, not 
statistically significant for dose response. Increasing intake of berries by 80 g portions were 
protective against risk of chronic coronary events, especially within non-smoking and non-
obese women, while greater intakes of citrus fruit was inversely associated with risk of total 
CVD in postmenopausal women. Overall, the findings of this study provide further evidence, 
in addition to those in Chapter 3 to suggest that the consumption of berries and citrus fruits 
should be promoted for cardiovascular health. It is also important to note that this 
particular study is constrained by the low number of incident cases, thus results should be 
interpreted cautiously. 
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4.2 Background 
The association between total fruit intake and CVD mortality was investigated in 
Chapter 3, where higher total fruit intake, especially fresh fruit and grapes were found to be 
protective against risk of fatal CVD. Several studies on the association between fruit intake 
and fatal CVD [83, 215, 218, 233], fatal CHD [84, 86, 205, 210] and fatal stroke [85] are in 
agreement with the study findings. However, Chapter 3 only investigated mortality data, 
which meant that any non-fatal events were unknown and misclassified as non-cases. Re-
investigating using incidence data could possibly improve the quality of analysis as non-
cases and incident cases would be correctly classified. In addition, the current study also 
intends to subcategorise CHD and stroke further, thus investigating the relationship 
between fruit intake and the incidence of myocardial infarction (MI), acute coronary 
syndrome (ACS), chronic coronary events (CCE), haemorrhagic stroke (HS), ischaemic 
stroke (IS) and unclassified stroke (USt). As discussed in Chapter 3 Section 3.5.2, although 
CHD and stroke share some common aetiology, such as the process of atherosclerosis, 
distinct differences exist between these two conditions. Stroke manifests in the brain, while 
CHD occurs in the heart. In addition, these conditions could also be caused by different 
biological mechanisms (high blood cholesterol, weak endothelial function, capillary 
permeability, and occlusion or rupturing arteries) involving different risk factors [3, 5]. For 
example, ischaemic stroke is mostly driven by atherosclerosis, while haemorrhagic stroke 
is the rupturing of blood vessels, causing bleeding into the brain (Chapter 1 Section 1.1.1). 
Therefore, further insights into the association between these separate conditions and total 
fruit, fruit subgroup intake could potentially help generate more, or reconfirm hypotheses 
with regard to the mechanism of (poly)phenols, should there be any significant associations. 
Therefore, the aim of this chapter is to further explore the association between total 
fruit, fruit subgroup intake according to similarities in (poly)phenol profile [111] and risk 
of CVD incidence using data from the UKWCS. 
4.3 Methods 
4.3.1 Dietary exposure 
Intakes of fresh fruits, dried fruits, pure fruit juices and processed fruits from the FFQ 
were combined to generate total fruit intake, as reported in Chapter 2, Section 2.6.1. 
Consumption was expressed as grams of fruit per day (g/day). 
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4.3.2 Incidence outcomes 
Incidence data was available for participants who had provided information at 
baseline to allow tracing of their records through HES and MINAP. The types of CVD events 
explored include total CVD, total CHD and total stroke, as well as subcategories of CHD and 
stroke incidence. CHD incidence was divided into three broad categories: MI, ACS and CCE, 
while stroke was divided into HS (consisting of subarachnoid, intracerebral, intracranial 
haemorrhage), IS (consisting of cerebral infarction) and unclassified stroke (USt) (Table 
4.1). Since access to the HES and MINAP was restricted due to ethical reasons, the linkage 
of the HES, MINAP and UKWCS was conducted by Dr. Diane Threapleton, who also ran the 
statistical analysis detailed in the following sections. 
Table 4.1 The classification of coronary heart disease and stroke categories by ICD10 codes 
  Incidence outcomes Corresponding disease (ICD10 codes) 
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Myocardial infarction Acute myocardial infarction (I21.0 – I21.4, I21.9) 
Subsequent myocardial infarction (I22.0 – I22.1, I22.8 – I22.9) 
Acute coronary syndrome Unstable angina (I20.0) 
Acute myocardial infarction (I21.0 – I21.4, I21.9) 
Subsequent myocardial infarction (I22.0 – I22.1, I22.8 – I22.9) 
Other forms and unspecified acute ischaemic heart disease (I24.8 – I24.9) 
Chronic coronary events Angina pectoris (I20.1, I20.8 – I20.9) 
Atherosclerotic heart disease (I25.0 – I25.1) 
Old myocardial infarction (I25.2) 
Aneurysm of heart (I25.3) 
Ischaemic cardiomyopathy (I25.5) 
Silent myocardial ischaemia (I25.6) 
Other forms and unspecified chronic ischaemic disease (I25.8 – I25.9) 
Others Cardiac arrest (I46.0 – I46.1, I46.9) 
Re-entry ventricular arrhythmia (I47.0) 
Ventricular tachycardia (I47.2) 
Ventricular fibrillation and flutter (I49.0) 
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Subarachnoid haemorrhage Subarachnoid haemorrhage in various locations (I600-I609) 
Intracerebral haemorrhage Intracerebral haemorrhage in various locations (I610 – I616, I618 – I619) 
Intracranial haemorrhage Intracranial haemorrhage in various locations (I620 – I621, I629) 
Cerebral infarction Cerebral infarction in various locations (I630 – I636, I638 – I639) 
Unclassified stroke Unclassified stroke (I64X) 
4.3.3 Statistical method and design 
4.3.3.1 Outliers and exclusions 
The procedure for omitting outliers and implementing exclusions is documented in 
Chapter 2, Section 2.5.1. Additional criteria were also implemented. In brief, participants 
who met the following criteria were excluded: 
1. Non-English participants (n = 3872) 
 Northern Ireland and Scottish residents were not covered by HES 
2. No, or incorrect NHS number provided at baseline FFQ, (n = 1013) 
3. Requested drop out from participant (n = 1) 
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4. Extreme energy intakes (<500 kcal/day & >6000 kcal/day) (n = 488) 
5. Previous self-reported heart attacks, angina, cancer, diabetes and stroke at 
baseline (n = 4,011). 
6. Participants who died of CVD or any other disease within one year of baseline 
(n = 129) 
7. Participants without survival outcomes (n = 5) 
8. Extreme fruit intakes (n = 578) 
There were 26,794 participants eligible for inclusion after the application of the 
exclusion criteria above. 
4.3.3.2 Confounding 
The current analysis was based on the DAG from Chapter 2, Section 2.5.1 to provide 
evidence for inclusion of potential confounders. These confounders were previously 
explored as a correlation matrix. Results showed that none of the potential confounders 
were correlated to each other, thus multicollinearity was unlikely. Univariate analysis was 
also conducted to explore the relationship between the variable of interest and outcome. 
The models used in these analyses were: 
1. Age (years) 
2. Age (years), BMI (kg/m2), moderate physical activity (Yes/No), smoking 
status (smoker v.s. non-smoker), alcohol intake (ethanol g/day) and socio-
economic status (professional/managerial, intermediate or routine/manual). 
3. In addition to model 2, energy intake (kcal/day) (data not shown). 
Intakes of total vegetable would be adjusted for when modelling the association 
between total fruit and CVD. When investigating subgroups of fruit, mutual adjustments 
would be made. 
4.3.3.3 Descriptive statistics 
Descriptive statistics were explored as part of the Chapter 2 Section 2.6.2 by dividing 
according total fruit quintiles before exclusions listed in Section 4.3.3.1. Baseline 
characteristics by fruit quintiles after exclusions and by disease status, into CHD, stroke and 
non-cases, were previously explored (Chapter 3). It should be noted that due to access 
restrictions to datasets, there were 19 (0.07%) additional participants within the dataset 
when exposure intakes were generated. However, as the figure is negligible in comparison 
to the total sample, reported intake values should still be sufficiently accurate. 
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4.3.3.4 Survival analysis 
Survival analysis was conducted using the Cox proportional hazards models to 
calculate a HR and 95% CI [231]. Time of survival was determined by the date the 
questionnaire was received until death or censor date. The censor date applied to patients 
who had died of a different disease, or for surviving patients. The last censor date in the 
current analysis for surviving patients was at 3rd October 2012. The risk of CVD incidence 
was determined by comparing each intake group with the reference group which included 
the lowest consumers, non-consumers in the case of citrus fruit. Linear trend, sensitivity 
analysis and effect modifications were also conducted in a similar manner to Chapter 3 
Section 3.3.3.4, with the exception of not exploring parental history of CVD. A summary of 
exclusion criteria and analysis plan is provided in Figure 4.1. 
 
Figure 4.1 Summary flowchart of the current study exclusion criteria and analysis plan 
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4.3.3.5 Testing for statistical assumptions 
Statistical assumptions were not tested in this chapter. However, because the 
statistical model applied here was highly similar to Chapter 3, in addition to the fulfilment 
of statistical assumptions proven in Chapter 3, statistical assumptions here were most likely 
fulfilled. Statistical significance was determined by 2-sided p-value of ≤0.05 for 95% CI. 
Stata version 12.0 [232] was used for all statistical analysis. 
4.4 Results 
4.4.1 Baseline characteristics 
The baseline characteristics of participants were previously reported in Chapter 3 
Section 3.4.1. 
4.4.2 Survival Analysis 
4.4.2.1 Full Cohort 
After an average follow-up of 16.4. years, 291 CVD incidences were observed, where 
152 were CHD related, and 142 were of stroke. In particular, there were 78 MI, 133 ACS and 
193 CCS cases, and 58 HS, 63 IS and 48 USt cases. In summary, age-adjusted HR tended to 
be less than 1 in consumers versus non-consumers, with little evidence of dose response. 
Further adjustment for confounders attenuated relationships, and were all non-significant. 
Table 4.4 provides the results for total CHD, total stroke and total CVD incidence. 
Previously significant associations found in Chapter 3 are mostly attenuated here, where 
the odd category of TF (302 – 571 g/day), FFJ (291 – 554 g/day) was associated with 42% 
to 56% lower total stroke incidence. Likewise, the second quintile of orange juice intake 
(116 – 145 g/day) was associated with 61% (95% CI 0.18 to 0.86) lower incidence of total 
CHD. In addition, incidence of total CVD was also 51% (95% CI 0.29 to 0.82) and 32% (95% 
CI 0.48 to 0.96) lower for second (~20 g/day) and fourth quintile (116 – 145 g/day) for the 
intake of orange juice. Interestingly, intake of pomes was associated with a higher risk of 
total CVD incidence (HR 1.10, 95% CI 1.00 to 1.20). By subtypes of CHD, every 80 g portion 
of berries was associated with 66% (95% CI 0.13 to 0.87) lower risk of CCE incidence (Table 
4.2). This association was not found within Chapter 3 (as CHD mortality). Within subtypes 
of stroke, although moderate consumption of FDF (222 – 306 g/day) was significantly 
associated with a 60% (95% CI 0.17 to 0.94) lower risk of IS, and risk of USt incidence was 
67% to 79% lower for participants consuming moderate amounts of TF (302 – 411 g/day) 
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and FFJ (291 – 554 g/day), results should be interpreted cautiously due to small case 
numbers (Table 4.3). This association was also not found within Chapter 3 (as stroke 
mortality) Moderate total citrus consumption was associated with a 71% to 72% (95% CI 
0.08 to 1.00, 0.09 to 0.94 respectively) lower risk of USt. The intake of approximately 20 g 
of orange juice was also associated with 88% (95% CI 0.01 to 0.91) lower risk of HS, 
however, there was only one HS incidence case within that quantile. Every portion of pomes 
was also associated with 29% (95% CI 1.00 to 1.65) higher risk of USt.  
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4.4.2.2 Sensitivity Analysis 
4.4.2.2.1 Postmenopausal women 
In a subpopulation of postmenopausal women (Table B.1), total CVD was 25% (95% 
CI 0.57 to 0.99) lower for every portion of citrus fruit. The adverse association previously 
found in the full cohort also remained significant here, where every 80 g of pomes was 
associated with a 24% (95% CI 1.09 to 1.40) higher risk of total stroke and a 16% (95% CI 
1.05, 1.27) higher risk of total CVD. 
4.4.2.2.2 Non-smokers 
Every additional portion of berries was associated with 69% (95% CI 0.11 to 0.86) 
lower risk of CCE incidence in non-smoking women. The risk of total stroke and total CVD 
was higher by 15% (95% CI 1.02 to 1.30) and 11% (95% CI 1.01 to 1.21) respectively with 
every portion of pomes, similar to associations reported above (Table B.2). 
4.4.2.2.3 Normotensive and hypertensive women 
Within a subpopulation of hypertensive women (Table B.3), consumption of tropical 
fruit was not protective against CCE incidence, and risk was 39% (95% CI 1.04 to 1.87) 
higher with every portion consumed. Similarly, every portion of FDF was associated with 
25% (95% CI 1.06 to 1.48) higher risk of total CVD. The intake of pomes was also associated 
with a higher risk of total stroke and total CVD by 21% (95% CI 1.04 to 1.42) and 15% (95% 
CI 1.00 to 1.31) respectively. Interestingly, no adverse association for the intake of pomes 
was reported within normotensive women (Table B.4), however, there was also no 
significant protective associations. 
4.4.2.2.4 Non-obese 
Similar to the subpopulation of non-smokers, within non-obese participants (Table 
B.5), every 80 g of berries was protectively associated with risk of CCE incidence, where risk 
was lower by 72% (95% CI 0.10 to 0.79). The adverse association between intake of pomes 
and total stroke, total CVD was also observed here. Risk of these outcomes were 14% (95% 
CI 1.00 to 1.30) and 12% (95% CI 1.02 to 1.23) higher respectively. 
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4.5 Discussion 
4.5.1 Summary of results 
The objective of this study was to investigate the association between different 
subgroups of fruit and the risk of CVD incidence. Incidence of total stroke was lower in 
participants who consumed moderate amounts of TF, FFJ and orange juice, however, due to 
the absence of a significant linear trend, the association for lower stroke risk and increasing 
TF, FFJ and orange juice could not be confirmed. In terms of fruit subgroups, the intake of 
total pomes was associated with a higher incidence of total CVD. However, increasing intake 
of berries by portions was protective against risk of CCE. No evidence of association was 
determined for intake of FF, total dried fruit, total fruit juice, citrus fruit, drupes, grapes and 
tropical fruit in the full cohort. 
Within sensitivity analyses, consumption of pomes was associated with 11% to 16% 
increase in risk of total CVD within subpopulations of postmenopausal, non-smoking, 
hypertensive and non-obese women, but not within normotensive women. The intake of 
pomes was also associated with higher total stroke risk in non-smoking women. In addition, 
hypertensive women also had a higher risk of total CVD with increasing intakes of total 
dried fruit. However, the intake of citrus fruit was inversely associated with the risk of CVD 
within postmenopausal women, and consumption of berries lowered risk of CCE within 
non-obese and non-smoking women. However, the CI for some associations was 
particularly wide, in addition to the small number of cases, findings should be carefully 
interpreted. 
4.5.2 General comparison to literature 
As explained earlier in Section 4.2, several studies have found an inverse association 
between higher fruit intake and lower risk of CVD mortality. Within studies that include 
incidence as an outcome, results appear to be less agreeable with the former finding among 
other studies. Results from the current study for total CVD are in agreement with the 
Women’s Health Study [196], where the risk of CVD incidence was not significantly lower 
with higher intakes of fruit by serving/day [HR 0.96 (95% CI 0.70 to 1.33)] in comparison 
to the lowest consumers. Similarly, higher fruit intake was also not associated with a lower 
risk of MI in the multivariate adjusted model in comparison to the lowest consumers [HR 
0.66 (95% CI 0.36 to 1.22)]. With regard to CHD incidence, pooled results for Nurses’ Health 
Study (NHS) and Health Professional’s Follow-Up Study (HPFS), as well as the PRIME study 
report a significant association between higher fruit intake and lower risk of CHD [205, 
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210]. However, associations were inconclusive in recent studies conducted in Denmark and 
China [216, 237], in agreement with the current study findings. On the other hand, the Diet, 
Cancer and Health study reported a protective association between fruit intake and 
ischemic stroke [214], which was not detected in the current study. Contradictory results 
to the present findings were also reported in the MORGEN study, where white coloured FVs 
(55% consists of pomes) were associated with lower incidence of stroke [242]. A Japanese 
cohort also reported lower risk of ischemic stroke with higher consumption of citrus fruits 
[213]. 
As discussed in Chapter 3 Section 3.5.2, CHD and stroke were studied in combination 
because these conditions share some common aetiology. However, separate exploration is 
warranted due to the effects of different biological mechanisms and the involvement of 
different risk factors [3, 5]. In addition, the current study had further divided CHD as a 
collection of coronary diseases down to specific conditions such as MI, or acute and chronic 
events. Theoretically speaking, the inclusion of both CHD and stroke outcomes (and 
additionally by subcategories) within the current cohort would provide a broader overview 
in comparison to other studies, allowing the formation of more specific hypotheses 
surrounding the mechanisms of the CVD event if significant associations were detected. 
However, from the evidence given above, heterogeneity may exist due to inconsistent 
conclusions deriving from different studies (though no formal statistics test was 
conducted), and may be attributed to the variation in consumption pattern between 
countries [205, 210, 213, 242], characteristics of participants, or simply due to the limited 
number of cases within the current study which may result in false positives or null 
associations because of wide CIs. 
4.5.3 Relevance with (poly)phenol mechanisms 
As mentioned in Chapter 3 Section 3.5.3, there are multiple studies in vitro and in vivo 
that support the association between hesperidin from citrus fruits and risk of stroke. 
However, a significant dose response was not found in the current study when investigating 
the same relationship using incidence data. This could be due to residual confounding, as 
similar results were reported in Chapter 3 Section 3.5.3. A possible explanation relates to 
the definition of mortality and incidence, where the former is associated with likelihood of 
death from the disease, and the latter is associated with prevention of the disease 
occurrence. So far, evidence from observational studies points towards a lower risk of CVD 
mortality with greater fruit intake [83], indicating that derived benefits may help prevent 
death. It is also not certain if greater fruit intake improves survival against CVD events. 
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However, there are few observational studies which address if higher fruit and fruit 
subgroup intakes can prevent the manifestation of CVD, with the exception of the Jichi 
Medical School Cohort Study from Japan [213]. Thus more evidence from studies are 
required to ascertain if fruit and fruit subgroup intakes are associated with the prevention 
or survival odds of CVD. 
Contrary to the adverse association found in this study between pomes and CVD risk, 
significant inverse associations had been reported between intakes of apples and pears and 
CVD risk in observational studies [117, 254]. However, there is limited evidence to support 
the beneficial effect of (poly)phenols from apples on markers of CVD and BP. Apple and 
apple juices were reported to improve lipid profiles in some intervention studies [236, 255, 
256], but contrasting results were also reported elsewhere [257]. From the sensitivity 
analysis, women who were normotensive did not present with a higher risk of CVD with 
increasing intake of pomes, thus the adverse association could be due to effect modification 
of hypertension. An alternative explanation may be related to reverse causality, however, 
participants who died within a year were excluded to minimize this effect. 
On the association between berries and risk of CCE, there were no associations 
reported in other cohort studies that are in agreement with the current findings. 
Surprisingly, a higher risk of stroke, especially cerebral infarction and subarachnoid 
haemorrhage with greater intakes of berries was observed in a Swedish cohort [197]. 
However, anthocyanins from berries have been associated with ‘healthy’ blood lipid 
profiles, [120] and are also anti-inflammatory [163]. A recent human study reported an 
improvement in plasma lipid profile, specifically lower levels of LDL-C, as well as improved 
platelet function after supplementation of 500 g of fresh strawberries for 30 days [258]. 
High levels of LDL and platelet activity are known to play a role in the development of CCE 
related mechanisms, such as atherosclerosis [259], thus a reduction could lower risk of CCE. 
Within hypertensive individuals, increasing portions of dried fruits (25 g) were 
adversely associated with total CVD risk. Dried fruit here consist mostly of raisins, sultanas 
and currants, which are rich in dietary fibre, phytochemicals (such as quercetin, kaempferol, 
caftaric acid and coutaric acid) and potassium [260]. In contrast to evidence from literature, 
higher consumption of raisins are associated with lower BP and LDL-C [261]. Intake of 
raisins (160 g/day) over six weeks in a human intervention trial also lowered levels of 
cytokine and cellular adhesion molecules, which may potentially decelerate or prevent the 
development of atherosclerosis by reducing the adhesion of monocytes on the vascular 
endothelium, which in turn affects the production of foam cells [262]. Thus, the results 
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observed here could also be partly due to residual confounding, or effect modification of 
hypertension itself, as the intake of dried fruits within normotensive participants were not 
associated with risk of total CVD. 
Possible explanations in relation to null associations have been previously elaborated 
in Chapter 3 Section 3.5.3. In summary, low case numbers, low intakes (in addition to the 
application of quintiles), and a low concentration of (poly)phenols in vivo could be the 
reason why no associations were observed. Other than (poly)phenols, possible mechanisms 
of other components within fruits such as dietary fibre and carotenoids are also reported in 
Chapter 3 Section 3.5.3, and may serve as an alternative explanation for associations 
observed, or act synergistically with (poly)phenols. 
4.5.4 Strengths and limitations 
The strengths and limitations documented in Chapter 3 Section 3.5.4 apply directly to 
the current analysis. In addition, the case numbers are relatively less in comparison to other 
studies, so results should be interpreted cautiously. However, the limitation relating to 
misclassifying non-fatal cases mentioned previously no longer apply due to the application 
of incidence data. The current analysis could also be subjected to a higher chance of type 1 
error as 95% CI is reported instead of 99% CI. 
4.6 Summary 
To conclude, a greater consumption of berries was seen to be protectively associated 
with risk of CCE especially within non-obese, non-smoking women, and a higher intake of 
citrus fruit was beneficial in lowering total CVD within postmenopausal women. Further 
investigations from intervention studies or RCTs are recommended for the consumption of 
berries and citrus fruits to assess its relationship with CVD risk in the population. Overall, 
the findings of this study provided further evidence in addition to Chapter 3 to suggest that 
the consumption of berries and citrus fruits should be promoted for cardiovascular health. 
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Chapter 5  
Coffee and tea intake and cardiovascular disease mortality in 
the UK Women’s Cohort Study 
5.1 Abstract 
Coffee and tea are widely consumed beverages and known to exhibit various effects 
on health. Coffee has been reported to have significant adverse association with CVD risk, 
possibly due to ingestion of diterpenes. However, recent meta-analyses now suggest that 
the previously reported adverse association between coffee and CVD is no longer 
significant. Most observational studies found a significant inverse association between 
increased coffee intake and CVD risk. On the other hand, there is an increasing amount of 
evidence that higher black and green tea intake is associated with lower stroke risk. The 
aim of the study is to investigate whether there are adverse associations for coffee with CVD 
risk and an inverse association for tea with CVD risk in the UKWCS. Total coffee and tea 
intake (g/day) was derived from a 217-item FFQ, was obtained from 30,458 women (aged 
35 to 69 years) at baseline from 1995–1998. Coffee and tea intakes were also further 
divided into regular coffee, decaffeinated coffee and black tea. Mortality events were 
derived from the NHS Central Register. During the mean follow-up period of 16.7 years, 296 
fatal CVD deaths (143 coronary heart disease (CHD), 153 stroke) were observed. Survival 
analysis was conducted using participants free from history of CVD at baseline. There was 
no significant adverse association between coffee and CVD risk. There was also no 
significant inverse association between tea and CVD risk. These findings are partially 
supported by studies in the literature, but is contradictory with recent meta-analyses. 
Findings from the current study add to the evidence pool in literature, and further 
investigations are required by optimising methodology. 
5.2 Background 
Coffee and tea are the most commonly consumed non-alcoholic beverages in the 
world after water [263]. Coffee contains bioactive components such as caffeine (30 to 300 
mg/cup depending on type of brew), chlorogenic acids and diterpenes (cafestol, kahweol) 
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[137], while bioactive components in tea are mostly caffeine, and flavanols, consisting of 
catechin, and its isomers and derivatives [264]. Diterpenes in unfiltered coffee are known 
to exhibit cholesterol-raising effects, potentially leading to an increased risk of 
cardiovascular disease (CVD) [265]. Caffeine also increases heart rate and BP which could 
affect the risk of CVD. However, it is recently reported that caffeine do not cause adverse 
effects when caffeine from coffee or tea is consumed ad libitum [138]. In addition, 
(poly)phenols in both beverages are suggested to counter negative aspects from diterpenes 
and caffeine [266], while association between long-term tea consumption and CVD risk is 
uncertain [141]. 
The current pool of evidence for the association between coffee consumption and CVD 
risk is inconsistent. Previous MAs suggested a higher risk of coronary heart disease (CHD) 
mortality with a higher intake of coffee [90, 91]. However, results from a recent meta-
analyses contradict the former findings [92, 93]. The risk of stroke had been studied in some 
detail, but results are inconsistent. A weak to moderate protective association was observed 
for risk of stroke by coffee consumption in two MAs [267, 268]. However, the Nurses’ Health 
Study did not find a significant association with higher coffee consumption and the risk of 
stroke. An inverse association was found for decaffeinated coffee and risk of stroke instead 
[269], suggesting that caffeine may be the culprit for the former null finding. On the other 
hand, evidence in the literature for tea intake and CVD risk was also inconsistent over the 
last decade. Despite multiple findings that act in either directions, a review of meta-analyses 
proposed that evidence for tea consumption (black and green) and stroke was the strongest 
out of all CVD outcomes [96]. A more recent MA also reported a lower cardiac death, CHD 
and stroke incidence with increasing tea intake [270]. 
As findings are inconclusive, and coffee and tea intakes were not studied in the 
current cohort, the aim of the current study was to explore the association between coffee, 
tea intake and risk of CVD mortality using data from the UKWCS. 
5.3 Method 
5.3.1 Dietary exposure 
Total coffee intake was generated by combining regular coffee and decaffeinated 
coffee from the FFQ. Both types of coffee were studied as a single variable due to the minor 
differences in (poly)phenol profile (chlorogenic acids), however, the degree of roasting may 
affect the quantity of chlorogenic acids within different brews [271]. Caffeine was also 
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previously associated with increased CVD risk, especially BP, though evidence had been 
inconsistent [272]. Therefore, regular coffee was investigated separately from 
decaffeinated coffee. Likewise, black tea was investigated separately from herbal tea 
because its (poly)phenol profile is different. Herbal tea represents a general term for a 
collection of less commonly drunk tea in the UK. Depending on the variety of herbs used, 
each specific type of herbal tea would contain a different (poly)phenol profile, thus it would 
be difficult to investigate unless information on specific herbal tea intake was available. In 
addition, due to the wide variety of herbal tea, consumption levels for each particular tea 
might too small for analysis. Herbal tea was therefore not investigated as an individual 
variable. Consumption was expressed as g/day. 
5.3.2 Mortality outcomes 
Mortality outcomes for the current analysis are described in Chapter 3 Section 3.3.2. 
5.3.3 Statistical method and design 
5.3.3.1 Outliers and exclusions 
The procedure for omitting outliers and implementing exclusions is documented in 
Chapter 2 Section 2.5. In brief, participants who met the following criteria were excluded: 
1. No, or incorrect NHS number provided at baseline FFQ, (n = 695) 
2. Extreme energy intakes (<500 kcal/day & >6000 kcal/day) (n = 86) 
3. Extreme total coffee (> 2000 g/day, equivalent to 8 cups) or tea (> 3000 g/day, 
equivalent to 12 cups) intakes (n = 21 & 0 respectively) 
4. Previous self-reported heart attacks, angina, cancer, diabetes and stroke at 
baseline (n = 4014). 
In total, 4780 participants were excluded for the analysis of coffee, and 4778 participants 
were excluded for the analysis of tea. 
5.3.3.2 Confounding 
The current analysis is based on the DAG from Chapter 2 Section 2.5.2 to provide 
evidence for inclusion of potential confounders. These confounders are previously explored 
as a correlation matrix. Results show that none of the potential confounders are correlated 
to each other, thus multicollinearity is unlikely. Univariate analyses were also conducted to 
explore the relationship between the variable of interest and outcome. The models used in 
the current analyses are: 
1. Age (years) 
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2. Age (years), BMI (kg/m2), moderate physical activity (Yes/No), smoking 
status (smoker v.s. non-smoker), alcohol intake (ethanol g/day) and socio-
economic status (professional/managerial, intermediate or routine/manual). 
3. In addition to model 2, energy intake (kcal/day) (data not shown). 
Models that investigated coffee would adjust for tea intake, and vice versa. 
5.3.3.3 Descriptive statistics 
Characteristics of participants prior to the application of exclusion criteria were 
explored as part of the Chapter 2 Section 2.6 (Table 2.8). Baseline characteristics by coffee 
or tea quintiles after the application of listed exclusions (Section 5.3.3.1) and by disease 
status, into CHD, stroke and non-cases, was explored and reported here. 
5.3.3.4 Survival analysis 
Survival analysis was conducted using the Cox proportional hazards models to 
calculate a HR and 95% CI (or 99% CI for sensitivity analysis) [231]. Details of the survival 
analysis parameters were reported in Chapter 3 Section 3.3.3.4. Linear trend was tested by 
calculating increments of coffee or tea intake according to a typical portion size of 250 g, 
which is representative of a typical cup or mug [176]. Sensitivity analysis and effect 
modifications were also conducted in a similar manner to Chapter 3 Section 3.3.3.4. A 
summary of exclusion criteria and analysis plan is provided in Figure 5.1 & Figure 5.2. 
5.3.3.5 Testing for statistical assumptions 
Statistical assumptions were tested according to procedure reported in Chapter 2 
Section 2.4.2. Schoenfeld residuals and log-minus-lot plot for both total coffee and total tea 
fully-adjusted models suggested that statistical assumptions were fulfilled. Statistical 
significance was determined by 2-sided p-value of ≤0.05 for 95% CI, or ≤0.01 for 99% CI. 
Stata version 13.0 [273] was used for all statistical analysis. 
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Figure 5.1 Summary flowchart of the current study exclusion criteria and analysis plan for coffee 
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Figure 5.2 Summary flowchart of the current study exclusion criteria and analysis plan for tea 
5.4 Results 
5.4.1 Baseline characteristics 
Baseline characteristics by case status are reported in Table 5.1 and Table 5.2. During 
the follow-up period from 1995 to 2013, there were 296 cases of CVD mortality (143 CHD 
cases, 153 stroke cases) in the coffee and tea analysis. The proportion of participants 
between cases and non-cases are similar in both analyses, and consistent with previous 
results investigating fruit intake and CVD mortality (Chapter 3). Fatal CVD cases tend to be 
older, with a higher BMI and larger waist circumference than non-cases. Fatal CVD cases 
also tend to be smokers and non-vegetarians, have lower physical activity levels, and are 
less likely to be supplement users. In general, fatal CVD cases tend to be from a lower socio-
economic class. Non-cases have the highest proportion of participants in the 
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professional/managerial class, fatal CHD cases have the highest proportion within the 
intermediate class while fatal stroke cases have the highest proportion within the 
routine/manual class when compared across all three classes. Fatal CVD cases are also less 
likely to be married than non-cases and more likely to be well-educated. In addition, fatal 
CVD cases are twice as likely to report medical conditions compared to non-cases. FV 
intakes were lower in fatal CVD cases compared to non-cases. This is also reflected in 
portions of FV consumed. Coffee consumption was highest in fatal CHD cases, while non-
cases consumed the most tea. 
Baseline characteristics for participants by quintiles of coffee and tea intake are 
reported in Table 5.3 & Table 5.4. In general, participants who consume higher amounts of 
coffee tend to consume lower amounts of tea across the quintiles. This association is also 
observed vice versa. High coffee consumers are also more likely to be supplement users and 
consume more alcohol, with a slightly higher energy intake across the quintiles. However, 
participants who have higher intakes of tea are more likely to consume lower amounts of 
alcohol and have a higher energy intake across the quintiles. Trends across other variables 
in relation to tea or coffee are varied with no clear direction, though there are significant 
differences between quintiles. In addition, participants consume similar amounts of FVs 
regardless of the amount of coffee or tea intake. 
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5.4.2 Survival Analysis 
5.4.2.1 Full cohort 
In the fully adjusted model (Table 5.5), HR and 95% CI for increasing quintiles of 
coffee and tea intake are presented with analysis of linear association addressing dose 
response. When coffee and tea were examined, there were no significant associations with 
CVD outcome in age-only or fully-adjusted models. There were also no significant 
associations between coffee, decaffeinated coffee and CVD outcomes in both models. 
5.4.2.2 Sensitivity analysis 
In the sensitivity analysis for coffee, tea and coffee subgroups (Table C.1), there were 
no significant associations with CVD outcome both the age-only or fully-adjusted models. 
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5.5 Discussion 
5.5.1 Summary of results 
The objective of this study was to study the association between coffee, tea intake and 
risk of CVD. The present results indicate no association between coffee intake and the risk 
of CVD, and no association for higher tea intake and the risk of CVD. Although directions of 
associations for coffee tend to be inverse, point estimates and tests for linear association 
were not statistically significant. In contrast, risk estimates for tea tend to be positive, but 
also not statistically significant. When participants were stratified into subgroups, there 
were no significant associations between coffee, tea intake and CVD. 
5.5.2 General comparison with literature 
Findings for coffee intake here are in agreement with a few studies which investigated 
CVD mortality [274, 275], CHD and stroke mortality [276], and MI incidence [277] recently. 
No positive association with increasing coffee intake and the risk of CVD were reported in 
the studies above. Recent MAs report a significant non-linear inverse associations between 
CVD risk and higher coffee intake [93, 278]. Specifically, an 18% lower significant relative 
risk (RR) (95% CI 0.73 to 0.92) of CHD with moderate coffee consumption (1 to 3 cups in 
US, 3 to 4 cups in Europe) in women alone, or 13% lower RR (95% CI 0.80 to 0.96) of CHD 
in men and women followed-up for less than 10 years [92]. The direction of association is 
similar to the current study, which observed a 24% (95% CI 0.49 to 1.18) lower risk in CVD 
in women with the highest coffee consumption (855 to 1140 g/day, or 3.5 to 4.5 cups), but 
the association was not statistically significant. Other cohort studies also reported an 
inverse association between greater intake of coffee and fatal CHD or fatal stroke risk. The 
risk of fatal heart disease and stroke was 28% (95% CI 0.59 to 0.88) and 16% (95% CI 0.56 
to 1.25) lower respectively in women who consumed six cups of coffee or more per day, 
compared to non-consumers. This association is also observed in men at the same coffee 
consumption levels [279]. However, a Japanese cohort only reported a significant negative 
association in women for higher intake of coffee and CVD, especially CHD, but not in men 
[280]. Women from the Nurses’ Health Study also had a lower risk of stroke with increasing 
coffee intake. In summary, though studies conducted recently do not suggest an adverse 
association with higher coffee intake and CVD risk in general, results are still inconsistent. 
With regard to tea intake and CVD risk, the evidence had been reviewed extensively. 
An earlier MA on tea and CVD risk suggested a borderline statistically significant lower 
incidence of MI by 11% (95% CI 0.79 to 1.01) with three cups of tea [281]. However, the 
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authors stated that heterogeneity was very high amongst studies for reliable conclusions to 
be drawn. Heterogeneity resulted from several factors. Firstly, publication bias for studies 
reporting an inverse association between greater tea intake and lower CVD risk. Secondly, 
the direction of association for UK and Australia were also positive for CHD and stroke 
respectively with greater tea intake, in contrast to a negative association reported in 
continental Europe. Thirdly, all but one Japanese study were ambiguous when assessing tea 
intake. Details to variety of tea (green, black or others), and preparation methods were 
unavailable in dietary assessments. As (poly)phenol profile and levels vary according to 
these factors, failure to account for the type of tea and brewing methods may contribute to 
large error estimates when attributing the mechanisms to (poly)phenols [281]. 
Within the latest SR and MA of prospective cohort studies, higher tea intake was 
associated with a lower cardiac death, CHD incidence and stroke mortality, specifically, a 
lower risk of cerebral infarction [270]. In addition, dose response meta-analysis reported a 
significantly reduced risk in cardiac death, CHD and stroke incidence, specifically cerebral 
infarction and intracerebral haemorrhage, but not stroke mortality with increments of three 
cups of tea. Sensitivity analyses revealed attenuated associations with risk of CHD, unless 
participants were European, or consumed black tea. Associations for all sensitivity analyses 
in Zhang et. al [270] by sex, country and type of tea were also attenuated for stroke 
mortality, in agreement with findings here. In another recent review of five MAs, a lower 
risk of stroke (mortality and incidence) was associated with greater tea (black and green), 
or greater flavonoid consumption in general [96]. These results are in contrast to Zhang et. 
al [270]. However, evidence of bias were found or not addressed in flavonoid meta-analyses. 
Case control studies were also included in three out of five these meta-analyses, which have 
a higher likelihood of recall and selection bias, and reverse causality. Thus in comparison to 
Zhang et. al [270], the quality of evidence presented here is relatively inferior and less 
reliable [96]. 
No association for tea consumption and CHD [282] or vascular death [275] was also 
reported in other studies, but a significant linear association between high consumption of 
tea and lower CHD risk was reported in the Dutch EPIC-NL cohort [276]. Interestingly, 
studies conducted within the UK, including the UKWCS all report a positive association with 
increasing black tea intake, although risk estimates tend to be attenuated adjusting for 
confounders [283, 284]. In summary, results in literature generally report an inverse 
association with higher tea consumption, with a minority number of studies reporting null 
significance. 
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5.5.3 Relevance with (poly)phenol mechanisms 
Coffee intake was associated with an increase in CVD risk. MAs in the past have 
reported a positive association between CVD risk and high coffee consumption [90, 91]. 
Inconsistent conclusions from recent studies in contrast to these MAs could be due to 
various reasons. The three major components within coffee are caffeine, chlorogenic acids 
and diterpenes. Previous studies have revealed high levels of diterpenes (6 to 12 mg/cup) 
in boiled coffee prior to the popularization of instant or filtered coffee (0.6 mg/cup) [266]. 
This may have contributed to the positive association, due to cholesterol raising effects of 
diterpenes [265, 285], by decreasing bile acid formation and regulation of cholesterol 
biosynthesis [286]. Adverse effects of caffeine on cardiovascular factors were also 
previously suggested, however, further investigation revealed no adverse association with 
high caffeine intake in observational studies and RCTs [138]. The proposed protective 
component suggested to be chlorogenic acids, reported to improve endothelial and vascular 
function, producing an anti-hypertensive effect by mechanisms such as reducing free radical 
production, scavenging free radicals and stimulating NO production [148]. A SR and MA of 
RCTs on the supplementation effect of chlorogenic acids also reported a significant 
reduction in BP following an increase in the consumption of chlorogenic acids [152]. 
However, heterogeneity for methodology and study designs are high. In summary, the 
current study acknowledges the proposed evidence in literature on caffeine, and 
investigated caffeinated and decaffeinated coffee separately. However, no significant 
associations were detected. Levels of consumption were likely too low and varied to 
produce a reliable risk estimate. 
On the other hand, the results of the investigation between tea consumption and risk 
of CVD were also inconsistent prior to recent findings. Green tea is more popularly 
consumed in Asian countries, where significant findings were previously reported [141]. 
Zhang et. al [270] also observed statistically significant findings in Asian populations with 
greater tea consumption and a lower risk of cardiac death. Caffeine levels in tea is 
approximately half of reported levels in coffee [287], and is unlikely to cause any adverse 
association for the reasons stated above. Tea flavonoids such as catechins (green tea) and 
theaflavins (black tea) inhibited the development of atherosclerotic lesions in animal 
models by lowering aortic cholesterol and triglyceride content [288] and improved 
endothelial function by improving NO-dependent vasodilation in animals and humans 
[141]. However, no significant association between higher tea intake and lower CVD 
mortality was found in the current study, despite the evidence from literature. 
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Inconsistent methodology between studies might have led to inconsistent results, in 
this case, non-significant associations. The UKWCS used FFQs to collect dietary data, as it is 
a better representation of yearlong dietary habits. However, information on brewing 
methods, composition or variety of coffee beans were ambiguous, for example, instant and 
ground coffee were combined as a single variable. These factors could affect the levels of 
diterpenes, caffeine and chlorogenic acids [266]. Likewise, multiple factors could also affect 
the levels of catechins and theaflavins within tea, such as variety, growth conditions, 
processing and brewing methods [289]. Cup sizes also varied across studies. Associations 
with CVD risk are then harder to detect if the quality of data on coffee, tea and its 
components are not precise enough. This is a limitation the current study also faced. In 
addition, heterogeneity could also exist by geographical location, as suggested by the 
positive associations found in UK cohorts [283, 284], including the current study, and may 
suggest differences in habit of tea preparation and consumption between UK and 
continental Europe. 
The likelihood of detecting an association also increases if disease outcomes were 
more specific. The current study is limited to mortality, however, there were enough cases 
to investigate CHD and stroke separately, as the aetiology of those two diseases are different 
[3, 5]. CVD, CHD and stroke incidence was not studied here, thus it was not possible to 
suggest if higher tea consumption prevent stroke events in comparison to preventing death 
from stroke. For example, within Zhang et. al [270] all point estimates were attenuated for 
stroke mortality sensitivity analyses, but not for stroke incidence in men, Asian populations 
and for green tea. Thus future studies examining both mortality and incidence are preferred 
to investigate if differences exist. 
Heavy consumption of coffee was associated with ‘unhealthy’ lifestyle factors, such as 
cigarette smoking, and was previously suggested as a reason why coffee drinkers appeared 
to have a higher risk of MI [91, 290]. However, the current study did adjust for smoking in 
acknowledgement to this and stratified the analysis by smoking status (non-smokers), with 
no significant associations found. It was also suggested that studies are more likely to report 
a significant positive association if follow-up time is shorter, as effects of coffee tend to be 
acute rather than chronic on CHD [291]. In addition, although social class was adjusted for 
using SES, there could be residual confounding SES could not account for, which may be why 
no protective associations were detected. 
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5.5.4 Strength and limitations 
In addition to the discussion above, strengths for this study have been previously 
elaborated in Chapter 3, in relation to the ‘health-conscious’ study design and wide diversity 
of dietary intakes and patterns. However, the following limitations should be considered. 
Limitations in relation to considering only mortality data, few case numbers, incomplete 
follow-up, missing information on some covariates, as well as collection of dietary data at 
only one time point were also elaborated in the Chapter 3. More specific dietary intakes 
relating to coffee and tea components or disease outcomes, such as risk factors are 
recommended to improve the analysis. 
5.6 Summary 
In conclusion, the study did not find an association with coffee consumption and fatal 
CVD risk, nor a significant association with consumption of tea with fatal CVD in the UKWCS. 
Findings for coffee, although not significant are in agreement with literature, but findings 
for tea contrast with other non-UK studies. Further optimisation of methodology is required 
before conclusions can be drawn. 
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Chapter 6  
Fruit, vegetable intake and the incidence of self-reported 
blood pressure in the UK Women’s Cohort Study 
6.1 Abstract 
High blood pressure (HBP) is currently the leading risk factor for global disease 
burden. High FV intake is associated with a lower risk of hypertension in intervention and 
observational studies, however, FV types have been less frequently explored. This study 
aimed to explore the association between FV and respective subgroups and self-reported 
HBP in the UKWCS within a sub-cohort with follow-up. Total FV intake (g/day) derived from 
a 217-item FFQ, was obtained from 9,402 women (aged 35 to 69 years) at baseline from 
1995 to 1998. FV intakes were sub-categorised according to similarities in (poly)phenol 
profile from Phenol Explorer, including berries, citrus, drupes, pomes, tropical fruits, Allium 
species, Brassicaceae species, fruit vegetables, pod vegetables and stalk & root vegetables. 
Incidence of self-reported HBP was reported through the phase 2 questionnaire. After a 
follow-up period of approximately five years, 716 incident self-reported HBP cases were 
observed. Logistic regression was conducted using participants free from history of CVD at 
baseline. Total FV intake, and especially total vegetable intake was associated with lower 
odds of self-reported HBP, with a 2% (95% CI 0.95 to 1.00) and 5% (95% CI 0.90 to 0.99) 
reduction in odds for each 80 g/day portion consumed respectively. With regard to 
subgroups, the intake of pomes and fruit vegetables significantly reduced odds of self-
reported HBP by 11% (99% CI 0.80 to 0.99) and 18% (99% CI 0.67 to 1.00) respectively 
with each additional portion. In conclusion, the findings from this study provide strong 
evidence that total FV intake, especially vegetables are protective against odds of self-
reported HBP. In particular, higher intakes of pomes and fruit vegetables may be 
particularly beneficial in terms of lowering odds of self-reported HBP, offering potential as 
a primary prevention to lower CVD. 
  
Chapter 6 
176 
 
6.2 Background 
High blood pressure (HBP), previously defined in Chapter 1 Section 1.1.1.5.1, is the 
leading risk factor for global disease burden [292]. It is also a major risk factor for CVD, 
prevalent in 31% men and 26% women in the UK [293]. Diet is one of the modifiable factors 
known to play a prominent role in the development of HBP [294]. Increased FV intake have 
been reported to decrease BP in hypertensive and normotensive individuals [80]. 
Observational studies investigating FV intake and BP are also consistent with findings from 
the former study [295-300]. However, limited evidence exists for specific fruit or vegetable 
subgroups [301]. On the other hand, higher potassium [302] and lower sodium [303] 
consumption were also recommended to lower BP. Beneficial effects for potassium 
supplements had been previously reported in a MA of RCTs, causing an average reduction 
of -3.1 mmHg and -2.0 mmHg in systolic (SBP) and diastolic blood pressure (DBP) [302]. 
However, a recent RCT failed to replicate BP lowering effects of increased potassium intake 
from the diet and supplementation [304]. Furthermore, the Dietary Approaches to Stop 
Hypertension (DASH) trial [80] caused a greater reduction in SBP and DBP by -3.5 mmHg 
and -2.1 mmHg within normotensive subjects compared to a MA of RCTs investigating 
potassium [302]. Thus the BP lowering effect may not be fully accounted for by high 
potassium content, and warrants further investigation using whole foods instead of single 
nutrients. 
As emphasized in previous chapters, FVs contain various nutrients and (poly)phenols, 
which are known to exhibit favourable effects on hypertension. Specifically, the incidence 
of hypertension was 8% lower in relation to higher habitual anthocyanin intake, 
predominantly from strawberries and blueberries [305]. Intervention studies on 
hesperidin, the main bioavailable flavonoid in citrus fruit, also reported favourable effects 
on HBP [126, 150, 151]. However, there are few studies to support the effect of other FV 
subgroups on incidence of HBP. In addition, very few studies have also examined incident 
HBP and the relationship between fruit or vegetable subgroups. 
The aim of the current study was to explore the association between total FV intake 
and subgroups of FV intake according to similarities in (poly)phenol profile with reference 
to Phenol Explorer [111] and incidence of self-reported HBP within the UK Women’s Cohort 
Study. 
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6.3 Methods 
6.3.1 Dietary exposure 
As described in Chapter 2 Section 2.6.1, total FV intakes were generated by combining 
multiple variables from the FFQ which recorded intakes of fresh fruits, dried fruits, pure 
fruit juices and processed fruits for fruits, and intakes of fresh vegetables and vegetables 
from composite dishes for vegetables. 
6.3.2 Incidence outcomes 
Data on self-reported HBP were available for participants who had answered the 
question ‘Have your doctor ever told you that you have, or have had, any of the following 
conditions?’ at baseline and at the follow-up phase 2 questionnaire (64% of participants 
provided this). The definition of BP statuses are reported in Table 6.1. 
Table 6.1 Matrix to define BP status for participants with follow-up 
 Response at baseline 
Response at phase 2 Yes No 
Yes Prevalent Incidence 
No Recovered Non-cases 
 
6.3.3 Statistical method and design 
6.3.3.1 Outliers and exclusions 
The procedure for omitting outliers and implementing exclusions is documented in 
Chapter 2 Section 2.5. In brief, participants who met the following criteria were excluded: 
1. No, or incorrect NHS number provided at baseline FFQ, (n = 695) 
2. Extreme energy intakes (<500 kcal/day & >6000 kcal/day) (n = 86) 
3. Previous self-reported heart attacks, angina, cancer, diabetes and stroke at 
baseline (n = 4,014). 
4. Outliers/Missing data for BMI (n = 1361) 
5. Outliers for alcohol intake (n = 9) 
6. No self-reported HBP data in Phase 2 (n = 22646) 
7. Prevalent cases (n = 1663) 
8. Recovered cases (n = 399) 
9. Extreme total fruit intake (n = 284) 
10. Extreme total vegetable intake (n = 59) 
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There were 9,402 participants eligible for inclusion after the application of the 
exclusion criteria above. 
6.3.3.2 Confounding 
The current analysis is based on the DAG from Chapter 2, Section 2.5.1 which was 
used to guide the selection of potential confounders. These confounders were previously 
explored as a correlation matrix (see Chapter 2). The results show that none of the potential 
confounders are correlated with each other, thus multicollinearity is unlikely. Univariate 
analyses were also conducted to explore the relationship between the variable of interest 
and outcome. The models used in the current analyses are: 
1. Age (years, categorical) 
2. Age (years, categorical), BMI (kg/m2), moderate physical activity (Yes/No), 
smoking status (smoker v.s. non-smoker), alcohol intake (alcohol g/day), 
socio-economic status (professional/managerial, intermediate or 
routine/manual), family history of HBP (Yes/No), self-reported history of 
hypercholesterolaemia (Yes/No) (data not shown) 
3. Model 2 and in addition, energy intake (kcal/day) 
Total vegetable intake was adjusted for when modelling the association between total 
fruit and self-reported HBP. When investigating subgroups of fruits, mutual adjustments 
were also made. Salt and sodium intake was not adjusted for, as likelihood ratio tests 
suggest no significant difference between inclusion and exclusion of these variables in the 
model. 
6.3.3.3 Descriptive statistics 
Descriptive statistics were explored as part of the Chapter 2, Section 2.6.2 . These 
baseline characteristics were explored by dividing participants into total FV quintiles before 
exclusions listed in Section 6.3.3.1. Baseline characteristics by FV quintiles after exclusions 
and by disease status, into incident cases, recovered cases, prevalent cases and non-cases, 
were also explored and reported here. 
6.3.3.4 Logistic Regression 
Logistic regression was conducted to calculate odds ratios (OR) and 95% or 99% CI 
of self-reported HBP incidence [182]. A binary variable was created to categorise 
participants as having developed HBP (coded as 1) or not (coded as 0). The odds of self-
reported HBP were determined by comparing each intake group with the reference group 
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which included the lowest consumers, (or non-consumers). Increments of fruit intake 
according to typical portion size (80g, or 125 g for fruit juice, 250 g for orange juice) [176] 
were also regressed to assess if there was a linear association with odds of self-reported 
HBP. 
Effect modification was explored by stratification of subgroups of participants 
selected a priori. Variables investigated included BMI (obese v. non-obese), smoking 
(smoking v. non-smoking), menopausal status (pre-menopausal v. post-menopausal) and 
parental history of CVD. However, due to inadequate cases of self-reported HBP (<50), these 
analyses were ultimately restricted to not include smokers. A summary of exclusion criteria 
and analysis plan is provided in Figure 6.1. 
6.3.3.5 Testing for statistical assumptions 
Statistical assumptions were tested according to procedure reported in Chapter 2, 
Section 2.4.2.2. Goodness of fit was assessed by Hosmer-Lemeshow test where predicted 
risks were compared to observed risks. An insignificant chi-squared p-value suggested that 
there is no evidence the model is ill-fitted. 
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Figure 6.1 Summary flowchart for the current study exclusion criteria and analysis plan 
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6.4 Results 
6.4.1 Baseline characteristics 
After exclusion criteria were applied, 9,402 eligible participants were left for 
inclusion in the analysis. The baseline characteristics of participants by case status, are 
reported in Table 6.2. Non-cases and recovered cases tended to be younger than incident 
and prevalent cases, with a lower BMI and smaller waist circumference. However, non-cases 
had the highest energy and total vegetable intake, while prevalent cases consumed the most 
fruits. Prevalent cases were least likely to be vegetarian/vegans, moderately active, and 
most likely to be smokers. Incident cases were most likely to consume supplements out of 
the four groups. Non-cases contained the highest proportion of participants with a 
professional/managerial job, and smallest proportion of intermediate and routine/manual 
job holders, while incident cases had the highest proportion of the latter profession. 
Interestingly, incident cases consisted of the highest proportion of degree holders, while 
recovered cases consist of the least. Across all self-reported medical conditions and history, 
non-cases had the lowest proportion of participants with history of parental cancer or heart 
disease, family history of HBP and self-reported high cholesterol, while prevalent cases had 
the highest proportion of participants with the listed medical conditions and history. 
When participants were divided according to FV intakes (Table 6.3), those who 
consumed more FVs tended to be older, with a lower BMI and smaller waist circumference. 
Participants who consumed more FVs tended to have a higher energy intake and lower 
alcohol intake. They were also more likely to be vegetarians/vegans, non-smokers, 
supplement users and moderately active. In addition, higher FV consumers also tended to 
be educated and hold a professional or managerial job. Despite the lower proportion of 
participants with family history of HBP, higher FV consumers were more likely to report a 
history of parental cancer or heart disease, as well as self-reported high cholesterol. 
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6.4.2 Logistic Regression 
6.4.2.1 Full cohort 
The odds of HBP and 95% or 99% CI are presented by increasing quantiles of FV 
intakes, as well as by portion to address linear association (Table 6.4). The odds of HBP 
incidence were 25% (95% CI 0.57 to 0.99) lower among participants who consumed >12 
portions of FV per day. With every additional 80 g portion, odds of HBP incidence decreased 
by 2% (95% CI 0.95 to 1.00). Participants who consumed >5.5 portions of fresh and dried 
fruit per day had a 25% (95% CI 0.57 to 0.99) lower odds of HBP incidence compared with 
lowest consumers. However, there is no significant linear association by portion was 
observed. Point estimates also did not appear to be linear. There were no other significant 
associations between total fruit intake and odds of HBP. With regard to fruit subgroups, 
participants who consumed >2 portions of pomes had a 42% (99% CI 0.40 to 0.86) lower 
odds of HBP compared to lowest consumers. This association was also significant for every 
additional portion of pomes consumed, where odds of HBP was 11% (99% CI 0.80 to 0.99) 
lower. The remaining subgroups of fruit were not associated with change in odds of HBP. 
When total vegetable intake was examined, there was an inverse association for the 
odds of HBP with higher intakes of total vegetables. Odds of HBP was a third lower (0.66, 
95% CI 0.50 to 0.87) among participants who consumed >5.5 portions of vegetables 
compared to the lowest consumers. For every additional portion consumed, odds of HBP 
was 5% lower (95% CI 0.90 to 0.99). A similar association was also reported for the intake 
of fruit vegetables, where odds of HBP was 38% (99% CI 0.43 to 0.91) lower in the highest 
consuming quantile compared to the lowest. Every 80 g portion of fruit vegetable was also 
significantly associated with 18% (99% CI 0.67 to 1.00) lower odds of HBP. No other 
significant associations were detected for other vegetable subgroups and odds of HBP. 
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Table 6.4 Total fruit, total vegetable, FV subgroup intake and odds of self-reported HBP incidence 
 
Intake (g/day) 
Odds of high blood pressure (95% or 99%* CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Total fruit & vegetable     
Q1 10 – 451 150 1 1 
Q2 451 – 604 136 0.84 (0.66, 1.07) 0.81 (0.63, 1.04) 
Q3 604 – 759 137 0.84 (0.66, 1.07) 0.81 (0.63, 1.05) 
Q4 759 – 974 124 0.75 (0.59, 0.96) 0.73 (0.56, 0.95) 
Q5 974 – 2704 137 0.83 (0.66, 1.06) 0.75 (0.57, 0.99) 
p trend   0.093 0.028 
OR per 80 g/day   0.98 (0.97, 1.00) 0.98 (0.95, 1.00) 
Total fruit     
Q1 0 – 216 145 1 1 
Q2 216 – 316 146 0.94 (0.74, 1.19) 0.95 (0.74, 1.22) 
Q3 316 – 419 125 0.77 (0.61, 0.99) 0.83 (0.64, 1.08) 
Q4 419 – 573 128 0.78 (0.61, 0.99) 0.82 (0.62, 1.06) 
Q5 574 – 1494 140 0.86 (0.68, 1.09) 0.93 (0.71, 1.23) 
p trend   0.231 0.620 
OR per 80 g/day   0.98 (0.96, 1.01) 0.99 (0.96, 1.02) 
Fresh fruit     
Q1 0 – 145 153 1 1 
Q2 145 – 221 129 0.80 (0.63, 1.01) 0.78 (0.60, 1.00) 
Q3 222 – 302 154 0.92 (0.73, 1.15) 0.90 (0.70, 1.16) 
Q4 302 – 420 118 0.64 (0.50, 0.82) 0.69 (0.53, 0.90) 
Q5 421 – 1477 130 0.73 (0.57, 0.93) 0.76 (0.57, 1.00) 
p trend   0.070 0.405 
OR per 80 g/day   0.97 (0.94, 1.00) 0.98 (0.95, 1.02) 
Fresh fruit & juice     
Q1 0 – 206 144 1 1 
Q2 206 – 303 146 0.95 (0.75, 1.21) 0.98 (0.76, 1.25) 
Q3 303 – 405 124 0.79 (0.62, 1.01) 0.84 (0.65, 1.10) 
Q4 405 – 557 132 0.81 (0.64, 1.03) 0.86 (0.66, 1.11) 
Q5 557 – 1488 138 0.87 (0.68, 1.10) 0.94 (0.71, 1.24) 
p trend   0.245 0.614 
OR per 80 g/day   0.98 (0.96, 1.01) 0.99 (0.96, 1.02) 
Fresh & dried fruit     
Q1 0 – 154 157 1 1 
Q2 154 – 234 124 0.73 (0.58, 0.94) 0.72 (0.56, 0.93) 
Q3 234 – 317 151 0.86 (0.69, 1.09) 0.85 (0.66, 1.09) 
Q4 317 – 440 119 0.62 (0.49, 0.80) 0.68 (0.52, 0.89) 
Q5 440 – 1480 133 0.73 (0.57, 0.93) 0.75 (0.57, 0.99) 
p trend   0.066 0.414 
OR per 80 g/day   0.97 (0.94, 1.00) 0.98 (0.95, 1.02) 
Dried fruit*     
Q1 0 – 1.5 138 1 1 
Q2 1.5 – 2.8 129 0.92 (0.66, 1.27) 0.91 (0.65, 1.27) 
Q3 3 – 6 133 0.85 (0.62, 1.18) 0.88 (0.62, 1.23) 
Q4 6 – 14 148 0.93 (0.68, 1.28) 1.03 (0.73, 1.44) 
Q5 14 – 436 136 0.86 (0.62, 1.18) 0.96 (0.68, 1.37) 
p trend   0.788 0.571 
OR per 25 g/day   0.98 (0.86, 1.13) 1.03 (0.89, 1.19) 
Fruit juice*     
Q1 0 – 10 149 1 1 
Q2 13 – 41 145 0.97 (0.71, 1.33) 0.97 (0.70, 1.34) 
Q3 58 – 116 158 1.19 (0.88, 1.61) 1.15 (0.84, 1.59) 
Q4 119 – 148 104 1.04 (0.74, 1.45) 1.00 (0.70, 1.43) 
Q5 155 – 1015 128 0.98 (0.71, 1.35) 0.97 (0.69, 1.36) 
p trend   0.493 0.723 
OR per 125 g/day   1.03 (0.92, 1.15) 1.02 (0.90, 1.14) 
Total citrus*     
Non-Consumers 0 23 1 1 
Q1 2 – 22 139 0.99 (0.56, 1.77) 0.90 (0.48, 1.68) 
Q2 23 – 60 116 0.86 (0.48, 1.54) 0.81 (0.43, 1.53) 
Q3 64 – 102 144 0.98 (0.55, 1.74) 0.98 (0.53, 1.84) 
Q4 112 – 182 169 1.04 (0.59, 1.84) 0.99 (0.53, 1.85) 
Q5 190 – 962 93 0.91 (0.50, 1.66) 0.94 (0.49, 1.80) 
p trend   0.743 0.351 
OR per 80g/day   1.01 (0.93, 1.09) 1.03 (0.95, 1.12) 
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(Table 6.4 continued) 
 
Intake (g/day) 
Odds of high blood pressure (95% or 99%* CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Citrus fruit*     
Non-Consumers 0 44 1 1 
Q1 2 – 6 208 1.03 (0.67, 1.59) 1.02 (0.65, 1.62) 
Q2 13 102 0.92 (0.57, 1.47) 0.93 (0.57, 1.54) 
Q3 37 145 0.86 (0.55, 1.34) 0.87 (0.54, 1.40) 
Q4 74 61 0.84 (0.50, 1.41) 0.95 (0.55, 1.65) 
Q5 92 – 552 124 0.89 (0.56, 1.40) 1.01 (0.62, 1.66) 
p trend   0.979 0.137 
OR per 80 g/day   1.00 (0.85, 1.17) 1.10 (0.93, 1.31) 
Orange juice*     
Non-Consumers 0 91 1 1 
Q1 3 – 10 181 0.77 (0.55, 1.08) 0.75 (0.52, 1.07) 
Q2 20 81 0.86 (0.55, 1.30) 0.91 (0.60, 1.40) 
Q3 58 136 1.04 (0.72, 1.49) 1.00 (0.68, 1.47) 
Q4 116 – 145 175 0.86 (0.61, 1.21) 0.84 (0.59, 1.21) 
Q5 362 – 870 20 0.83 (0.43, 1.59) 0.80 (0.40, 1.58) 
p trend   0.678 0.783 
OR per 250 g/day   1.05 (0.78, 1.41) 1.03 (0.75 ,1.41) 
Total berries*     
Q1 0 – 2 140 1 1 
Q2 2 – 4 133 1.04 (0.75, 1.44) 1.04 (0.75, 1.46) 
Q3 4 – 8 128 0.92 (0.67, 1.28) 0.92 (0.65, 1.29) 
Q4 8 – 16 141 1.00 (0.73, 1.37) 1.01 (0.72, 1.41) 
Q5 16 – 365 142 0.93 (0.68, 1.28) 0.98 (0.69, 1.40) 
p trend   0.447 0.355 
OR per 80 g/day   0.90 (0.64, 1.28) 0.87 (0.59, 1.28) 
Total grapes*     
Q1 0 – 2 144 1 1 
Q2 7 176 0.94 (0.70, 1.26) 0.94 (0.69, 1.28) 
Q3 14 134 1.00 (0.73, 1.37) 1.00 (0.72, 1.40) 
Q4 40 145 1.09 (0.80, 1.48) 1.12 (0.80, 1.55) 
Q5 80 – 600 85 1.04 (0.72, 1.50) 1.20 (0.80, 1.78) 
p trend   0.248 0.082 
OR per 80 g/day   1.07 (0.91, 1.26) 1.12 (0.95, 1.32) 
Total pomes*     
Q1 0 – 24 166 1 1 
Q2 24 – 55 127 0.68 (0.50, 0.93) 0.70 (0.50, 0.96) 
Q3 62 – 102 146 0.85 (0.63, 1.15) 0.90 (0.65, 1.24) 
Q4 108 – 140 152 0.76 (0.57, 1.03) 0.81 (0.59, 1.12) 
Q5 162 – 1044 93 0.56 (0.40, 0.79) 0.58 (0.40, 0.86) 
p trend   0.001 0.007 
OR per 80 g/day   0.88 (0.80, 0.97) 0.89 (0.80, 0.99) 
Total drupes*     
Q1 0 – 1 140 1 1 
Q2 1 – 3 152 1.04 (0.76, 1.43) 1.05 (0.76, 1.46) 
Q3 3 – 7 140 0.99 (0.72, 1.36) 1.02 (0.73, 1.43) 
Q4 7 – 11 123 0.91 (0.66, 1.26) 0.90 (0.63, 1.28) 
Q5 11 – 115 129 0.88 (0.64, 1.22) 0.96 (0.65, 1.40) 
p trend   0.481 0.988 
OR per 80 g/day   0.78 (0.31, 1.93) 1.00 (0.35, 2.85) 
Total tropical*     
Q1 0 – 18 141 1 1 
Q2 18 – 45 161 1.05 (0.77, 1.43) 1.05 (0.76, 1.44) 
Q3 45 – 80 116 0.78 (0.56, 1.09) 0.77 (0.54, 1.09) 
Q4 80 – 107 119 0.82 (0.59, 1.14) 0.80 (0.57, 1.14) 
Q5 108 – 666 147 0.95 (0.70, 1.30) 1.05 (0.74, 1.49) 
p trend   0.821 0.635 
OR per 80 g/day   0.99 (0.86, 1.13) 1.03 (0.88, 1.20) 
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(Table 6.4 continued) 
 
Intake (g/day) 
Odds of high blood pressure (95% or 99%* CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Total vegetable     
Q1 0.4 – 188 163 1 1 
Q2 188 – 257 140 0.81 (0.64, 1.03) 0.77 (0.60, 0.98) 
Q3 257 – 332 129 0.73 (0.58, 0.93) 0.70 (0.55, 0.91) 
Q4 332 – 436 123 0.71 (0.56, 0.90) 0.64 (0.49, 0.83) 
Q5 436 – 1460 129 0.77 (0.60, 0.97) 0.66 (0.50, 0.87) 
p trend   0.084 0.018 
OR per 80 g/day   0.97 (0.93, 1.00) 0.95 (0.90, 0.99) 
Fresh vegetable*     
Q1 0.4 – 159 147 1 1 
Q2 160 – 218 140 0.90 (0.66, 1.24) 0.89 (0.64, 1.23) 
Q3 218 – 284 129 0.79 (0.57, 1.09) 0.77 (0.55, 1.08) 
Q4 284 – 373 142 0.90 (0.66, 1.23) 0.86 (0.61, 1.21) 
Q5 373 – 1416 126 0.79 (0.58, 1.09) 0.72 (0.50, 1.05) 
p trend   0.138 0.072 
OR per 80 g/day   0.97 (0.91, 1.02) 0.95 (0.89, 1.02) 
Allium*     
Q1 0 – 3 179 1 1 
Q2 3 – 6 139 0.82 (0.61, 1.11) 0.88 (0.64, 1.20) 
Q3 6 – 11 123 0.72 (0.52, 0.98) 0.78 (0.56, 1.09) 
Q4 11 – 13 109 0.75 (0.55, 1.03) 0.78 (0.55, 1.11) 
Q5 13 – 82 134 0.81 (0.60, 1.09) 0.92 (0.64, 1.32) 
p trend   0.453 0.760 
OR per 80 g/day   0.83 (0.43, 1.59) 1.10 (0.50, 2.41) 
Brassicaceae*     
Q1 0 – 34 142 1 1 
Q2 34 – 55 127 0.86 (0.62, 1.20) 0.82 (0.59, 1.15) 
Q3 55 – 80 138 0.92 (0.67, 1.26) 0.89 (0.64, 1.24) 
Q4 81 – 125 142 0.91 (0.66, 1.26) 0.90 (0.64, 1.27) 
Q5 125 – 774 135 0.85 (0.62, 1.17) 0.78 (0.54, 1.13) 
p trend   0.540 0.540 
OR per 80 g/day   0.97 (0.85, 1.10) 0.96 (0.83, 1.12) 
Fruit vegetable*     
Q1 0 – 37 171 1 1 
Q2 37 – 55 146 0.85 (0.63, 1.15) 0.82 (0.60, 1.13) 
Q3 55 – 82 137 0.84(0.62 ,1.14) 0.78 (0.56, 1.07) 
Q4 82 – 110 117 0.66 (0.48, 0.91) 0.63 (0.45, 0.89) 
Q5 110 – 645 113 0.66 (0.48, 0.91) 0.62 (0.43, 0.91) 
p trend   0.003 0.010 
OR per 80 g/day   0.83 (0.70, 0.97) 0.82 (0.67, 1.00) 
Pod vegetable*     
Q1 0 – 12 140 1 1 
Q2 12 – 21 147 1.17 (0.85, 1.59) 1.10 (0.79, 1.52) 
Q3 21 – 37 114 1.07 (0.77, 1.50) 1.08 (0.76, 1.53) 
Q4 37 – 47 139 1.07 (0.78, 1.47) 1.11 (0.79, 1.55) 
Q5 50 – 375 144 1.21 (0.88, 1.65) 1.26 (0.88, 1.79) 
p trend   0.224 0.111 
OR per 80 g/day   1.16 (0.85, 1.58) 1.26 (0.87, 1.84) 
Stalk & root vegetable*     
Q1 0 – 17 150 1 1 
Q2 17 – 30 139 0.88 (0.64, 1.20) 0.88 (0.63, 1.22) 
Q3 30 – 42 121 0.79 (0.57, 1.09) 0.78 (0.56, 1.11) 
Q4 42 – 63 131 0.80 (0.59, 1.11) 0.83 (0.59, 1.18) 
Q5 63 – 404 143 0.87 (0.64, 1.19) 0.98 (0.67, 1.44) 
p trend   0.226 0.938 
OR per 80 g/day   0.88 (0.68, 1.15) 0.99 (0.71, 1.37) 
a Cases apply to fully-adjusted models 
b Adjusted for age (categorical), BMI, physical activity, energy intake, smoking status, socio-economic status, 
alcohol intake, family history of HBP, self-reported history of hypercholesterolaemia, mutual adjustment for 
total fruit or total vegetable intake and mutual adjustments for fruits/vegetables that are not in the exposure 
category 
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6.4.2.2 Sensitivity analysis 
6.4.2.2.1 Obese v.s. Non-obese 
Within women in both subpopulations, there were no significant associations 
between total FV, total fruit and total vegetable intakes and odds of HBP (Table D.1). Within 
obese women, every 80 g portion of grapes was adversely associated with 75% (99% CI 
1.03 to 2.99) higher odds of HBP. This association was not detected within non-obese, 
women, instead, every 80 g portion of fruit vegetables was inversely associated with 19% 
(99% CI 0.65 to 1.00) lower odds of HBP. The intake of pomes was also significantly 
associated with 10% lower odds of HBP when the model was age-adjusted, however, the 
association disappeared when the model was fully-adjusted. No significant associations 
were detected for FV subgroups. 
6.4.2.2.2 Menopausal status 
There were no significant associations between FV intake and odds of HBP when 
analyses were restricted to postmenopausal women (Table D.2). The odds of HBP were 
lower for every additional portion of pomes by 17% (99% CI 0.70 to 0.99) and by 28% (99% 
CI 0.54 to 0.96) for every portion of fruit vegetables when the model was age-adjusted. No 
significant associations were found for premenopausal women when models were fully-
adjusted. 
6.4.2.2.3 Parental history of CVD 
No significant associations were detected for FV intake and odds of HBP within 
women who had parental history of CVD (Table D.3). The odds of HBP were 4% (99% CI 
0.92 to 1.00) lower for every additional portion of total FV intake for participants without 
parental history of CVD. The odds of HBP were also lower for every additional portion of 
pomes by 16% (99% CI 0.73 to 0.97) and by 24% (99% CI 0.60 to 0.95) for every portion of 
fruit vegetables when the model was age-adjusted in participants without parental history 
of CVD. However, these associations were no longer significant when the model was fully-
adjusted. 
6.4.2.2.4 Non-smokers 
The odds of HBP was 3% (99% CI 0.95 to 1.00) lower for every portion of total FV 
within non-smokers (Table D.4). In addition, intake of pomes and fruit vegetables was 
associated with 11% (99% CI 0.79 to 0.99) and 19% (99% CI 0.66 to 0.99) lower odds of 
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HBP respectively within non-smokers for every additional portion. There were no other 
associations detected for subgroups of fruit or vegetables. 
6.5 Discussion 
6.5.1 Summary of results 
The objective of this study was to investigate the association between different 
subgroups of FV and the incidence of self-reported HBP. Findings from the current study 
observed a lower odds of self-reported HBP with higher intake of total FVs, as well as total 
vegetables. In terms of FV subgroups, greater intake of total pomes and fruit vegetables 
were associated with a lower odds of self-reported HBP. No evidence of association was 
determined for the remaining fruit or vegetable subgroups in the full cohort. 
With regard to subgroup analyses, significant associations reported above were 
restricted to non-smokers, and partially restricted to non-obese women and those with no 
parental history of CVD. Consumption of grapes were also associated with nearly two-fold 
increase in odds of self-reported HBP. However, there were few cases and CIs were 
particularly wide, thus this finding needs to be further verified and carefully interpreted. 
6.5.2 General comparison with literature 
In general, findings here support results from previous observational studies 
investigating the association between total FV intake and HBP from different countries [298, 
300], despite methodological differences with regard to the outcome. The latter studies 
utilised standard procedure involving a mercury sphygmomanometer to attain measured 
BP in mmHg, while the current study relied on self-reported general practitioner’s 
diagnosis. There are certain methodological limitations with regard to the reliability of self-
reported data, and is a potential limitation in this study. With regard to the exposure, an 
improvement was made in the current study where total FVs included food items which 
were part of a composite dish, which may or may not be the case in other cohorts. 
The results reported above are supported by findings from the DASH trial [80]. In 
addition, other studies also investigated dietary patterns rather than subgroups of FVs, 
where the results are also supportive for the current findings [306, 307]. Furthermore, 
dietary patterns, greater FV intake and lower sodium consumption has the strongest 
evidence for association with lower BP [294]. Findings from dietary patterns are also easily 
applied to public health recommendations specific to the habitual diet of the particular 
country. However, the concept of a dietary pattern may introduce challenges when trying 
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to investigate the actual properties within the fruit or vegetable which may be associated 
with lower BP. 
When examining FV intakes separately, findings tend to vary across cohorts. Two 
studies are in agreement with the current findings [295, 296], however, some studies also 
report lower BP incidence or risk of HBP with higher intake of fruits [295, 297, 299, 301], 
which was not found in the current study, despite the reported high intakes of total fruit in 
general. Kim et al. reported higher BP in association with higher consumption of Kimchi and 
salty vegetables native to Korea [300]. While these types of vegetables are not commonly 
consumed in UK, the finding prompts further investigation into differences between raw 
and cooked/processed vegetables, in particular, the addition of salt. In terms of FV 
subgroups, results from the Nurses’ Health Study are supportive of the findings on the 
intake of pomes and fruit vegetables in the current study, specifically, a higher intake of 
apples and aubergines were associated with lower BP [295]. However, favourable 
associations between lower BP and greater intake of oranges and grapes were also found in 
the Nurses’ Health Study, but not here. 
6.5.3 Relevance with (poly)phenol mechanisms 
In previous intervention studies which examined nutrients in FVs, such as 
potassium supplementation [224, 302], there was inconsistent evidence for effects of 
potassium on HBP for normotensive populations, while evidence suggests that lowering 
sodium intakes [116, 224, 308] are beneficial towards lowering BP. There are also other 
nutrients in FVs which have significant association with CVD risk including fibre [221, 248], 
glucosinolates [251] and “antioxidants” such as carotenoids [249] and (poly)phenols, which 
may also exhibit certain effects on HBP, either independent of or synergistically with 
potassium and sodium. As explained in Chapter 3, Section 3.5.3, pomes are rich in flavanols, 
especially catechin and proanthocyanidins [309, 310]. Significant associations were also 
found between intakes of apples and pears and CVD risk in observational studies [117, 254]. 
However, there is limited evidence to support the beneficial effect of (poly)phenols from 
apples on markers of CVD and BP. Apple and apple juices were reported to improve lipid 
profiles in some intervention studies [236, 255, 256], but contrasting results using freeze 
dried apples were also reported elsewhere [257]. Non-significance in the latter study could 
be due to a relatively smaller dose of apple, and differences in processing effects (freeze 
drying). Interestingly, despite evidence from RCTs to support the association between 
citrus fruits (or hesperidin) and effects on BP [150, 151], a significant association was not 
observed in the current study. Further inspection into intakes of berries, drupes and 
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tropical fruit also revealed relatively low intakes, which may somewhat explain the lack of 
association. 
On the other hand, fruit vegetables mainly consist of tomatoes and peppers. 
Tomatoes are rich in quercetin, lignans and caffeic acid, while peppers (red, yellow and 
green) are also rich in quercetin, as well as lignans and luteolin. It was previously elaborated 
that quercetin exhibited the ability to decrease permeability and fragility of capillary walls, 
which were symptoms that manifests in hypertension [245]. Limited evidence from a 
human clinical trial show promise of an anti-hypertensive effect for a high dose of quercetin 
within stage 1 hypertensive patients, however, this effect was not observed in pre-
hypertensive patients. In addition, the administered quercetin dosage was also much 
greater than the amount a normal diet could provide [311]. Evidence on the effects of 
isolated flavonols on the development of atherosclerosis are also limited [229]. 
The current study observed a null association between the Allium subgroup and 
incidence of self-reported BP, possibly because the subgroup does not contain onions, one 
of the richest sources of quercetin. Thus, supposing that the association is due to high 
intakes of quercetin within tomatoes and peppers, the concentration of quercetin overall 
may not be high enough in vivo within the Allium subgroup to have any mechanistic effects, 
which resulted in the lack of association. The intake of lignans, potential effects on 
improving CVD risk factors in RCTs [246], and the limitations of the current methodology 
surrounding literature [247] have been reviewed in Chapter 3. Despite its availability in all 
the remaining vegetable subgroups (Brassicaceae, pod and stalk & root vegetables), 
concentrations of lignans are relatively low, thus in isolation, none of these vegetable types 
provided sufficient amounts of the most potent types of (poly)phenols, resulting in non-
significant associations. 
6.5.4 Strengths and limitations 
The following limitations should be considered when interpreting the results of the 
current study. Limitations in relation to usage of the FFQ, missing information on some 
covariates, collection of dietary data at only one time point, variation in availability of foods 
from different time periods were elaborated in the Chapter 3. Furthermore, application of 
the study findings is also restricted to women only. 
Strengths for this study have been previously elaborated in Chapter 3, in relation to 
advantageous usage of Phenol Explorer, the larger sample size compared to other studies, 
the design of the ‘health-conscious’ cohort and a wide diversity in dietary intakes and 
patterns. This is also the first study which extensively investigated the effects of subgroups 
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of FVs according to (poly)phenol profiles on incidence of self-reported HBP. The estimation 
of total FV intake is also strengthened by the inclusion of other fruit sources such as dried 
fruit, juices or processed fruits, and vegetables from composite dishes. 
6.6 Summary 
In conclusion, a greater consumption of total FV intake, especially total vegetables, 
fruit vegetables, and pomes were associated with lower odds of self-reported HBP in the 
UKWCS. This finding is aligned with Chapter 3 and Chapter 4, as well as current literature 
promoting high FV dietary patterns, and guidelines promoting FVs consumption for health. 
Further investigations are recommended using measured BP instead of self-reported data 
(which will be explored in Chapter 10), and interventions are recommended for the 
consumption of pome fruits and fruit vegetables to assess its relationship with HBP 
development. 
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Chapter 7  
Coffee, tea intake and incidence of self-reported blood 
pressure in the UK Women’s Cohort Study 
7.1 Abstract 
Chapter 6 explored the association between FV intake, and the odds of self-reported 
HBP. This study aimed to explore the association between coffee, coffee subgroups and tea 
and self-reported HBP in the UKWCS. Total coffee and tea intake (g/day) derived from a 
217-item food frequency questionnaire, was obtained from 9,467 women (aged 35 to 69 
years) at baseline from 1995 to 1998. Coffee intakes were also further explored by type into 
regular coffee and decaffeinated coffee. Incidence of self-reported HBP was derived through 
the phase 2 follow up questionnaire. After a follow-up period of approximately five years, 
721 incident self-reported HBP cases were observed. Logistic regression was conducted 
using participants free from history of CVD at baseline. Total coffee and total tea intake were 
not found to be associated with odds of self-reported HBP. In conclusion, the lack of 
association with coffee is aligned with evidence current literature, but results for the null 
association between black tea intake and HBP were not. Until further methodological 
improvements are made in future cohort or RCTs, the association between coffee, tea and 
HBP remains controversial. 
7.2 Background 
The association between coffee, tea intake and CVD mortality was explored 
previously (Chapter 5) due to inconsistent evidence in literature. The findings reveal no 
associations between either beverage type and CVD mortality risk in the UKWCS. As 
explained earlier (Chapter 5) with regard to the limitations of mortality rates, this chapter 
intends to reinvestigate by improving specificity of the outcome. CVD was introduced in 
Chapter 1 as a collection of diseases, its development influenced by multiple biological, 
environmental and behavioural risk factors. The present chapter will place emphasis on 
HBP, as it is the leading risk factor for global disease burden [292] and currently prevalent 
in 31% men and 26% women in the United Kingdom (UK) [293]. By improving the 
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specificity of the outcome relative to CVD mortality, this chapter will explore and generate 
hypotheses based on mechanisms of (poly)phenols on BP. 
Chapter 5 Section 5.2 introduced coffee and tea as the most commonly consumed non-
alcoholic beverages in the world after water [263]. These beverages contain various 
bioactive components, such as caffeine in both coffee and tea, chlorogenic acids and 
diterpenes in coffee [137], catechins and derivatives in tea [264]. These bioactive 
components may impact or act on CVD risk factors. Previous research suggested that 
diterpenes in unfiltered coffee raised serum cholesterol [265]. Caffeine is known to exhibit 
an acute pressor effect up to three hours after administration as demonstrated in RCTs. This 
effect is known to vary by hypertensive status, mental or physical stress, by age, and 
especially in habitual consumers, where heavy coffee drinkers are more likely to build a 
tolerance to the acute pressor effect [312, 313]. Recent evidence from a SR and MAs did not 
suggest an adverse association between BP and habitual coffee consumption within 
hypertensive [314] and normotensive individuals [315]. More importantly, a scientific 
opinion based on SRs and MAs concluded no adverse effects when caffeine from coffee or 
tea is consumed ad libitum [138]. In addition, (poly)phenols in both beverages are 
suggested to counter negative aspects from diterpenes and caffeine [266]. Chlorogenic acids 
(from various sources, including coffee) were found to significantly reduce both SBP and 
DBP within a SR and MA of RCTs, but the majority of the trials were conducted in Japan 
[152]. A SR and MA of catechins from green tea and BP also reached a similar conclusion, 
however, heterogeneity was high in the analysis of DBP [153]. Findings from prospective 
cohort studies are also inconclusive, most likely due to methodological variances, such as 
ambiguous assessment of coffee and tea intakes. A U-shaped association for incident 
hypertension was observed across coffee intakes ranging from none to >5 cups/day [316], 
while a SR and MA analysing a highly similar set of cohort studies in comparison to the 
former study showed no association between coffee and HBP incidence [315]. 
As earlier research findings are inconclusive, the aim of the current study was to 
explore the association between coffee, tea intake and the risk of self-reported HBP 
incidence using data from the UKWCS. 
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7.3 Methods 
7.3.1 Dietary exposure 
Total coffee and black tea intakes were generated by combining multiple variables 
from the FFQ which recorded intakes of regular coffee and decaffeinated coffee documented 
in Chapter 2, Section 2.6.1. There were no missing data for coffee or tea intakes. 
Consumption was expressed as grams of coffee or tea intake per day (g/day). 
7.3.2 Incidence outcomes 
Incidence outcome for the current analysis is equivalent to the outcome reported in 
Chapter 6, Section 6.3.2. 
7.3.3 Statistical method and design 
7.3.3.1 Outliers and exclusions 
The procedure for omitting outliers and implementing exclusions is documented in 
Chapter 2, Section 2.5.1. In brief, participants who met the following criteria were excluded: 
1. No, or incorrect NHS number provided at baseline FFQ, (n = 695) 
2. Extreme energy intakes (<500 kcal/day & >6000 kcal/day) (n = 86) 
3. Previous self-reported heart attacks, angina, cancer, diabetes and stroke at 
baseline (n = 4,014). 
4. Outliers/Missing data for BMI (n = 1361) 
5. Outliers for alcohol intake (n = 9) 
6. No self-reported HBP data in Phase 2 (n = 22646) 
7. Prevalent cases (n = 1663) 
8. Recovered cases (n = 399) 
9. Extreme coffee intake (n = 21) 
There were 9,467 participants eligible for inclusion after the application of the 
exclusion criteria above. 
7.3.3.2 Confounding 
The current analysis is based on the DAG from Chapter 2, Section 2.5.1 to provide 
evidence for inclusion of potential confounders. These confounders were previously 
explored as a correlation matrix. Results showed that none of the potential confounders 
were correlated to each other, thus multicollinearity is unlikely. Univariate analysis was also 
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conducted to explore the relationship between the variable of interest and outcome. The 
models used in these analyses are: 
1. Age (years, categorical) 
2. Age (years, categorical), BMI (kg/m2), moderate physical activity (Yes/No), smoking 
status (smoker v.s. non-smoker), alcohol intake (alcohol g/day), socio-economic 
status (professional/managerial, intermediate or routine/manual), family history of 
HBP (Yes/No), self-reported history of hypercholesterolaemia (Yes/No) (data not 
shown) 
3. Model 2 and in addition, energy intake (kcal/day) 
Tea intake was adjusted for when modelling the association between total coffee and 
self-reported HBP, and vice versa. Salt and sodium intake was not adjusted for, as likelihood 
ratio tests suggest no significant difference between inclusion and exclusion of these 
variables in the model. 
7.3.3.3 Descriptive statistics 
Descriptive statistics were explored as part of the Chapter 2, Section 2.6.2. These 
baseline characteristics were explored by dividing according total coffee and tea quantiles 
before exclusions listed in Section 7.3.3.2. Baseline characteristics by coffee and tea 
quantiles after exclusions, as well as by disease status, into incident cases, recovered cases, 
prevalent cases and non-cases, was also explored and reported in the current chapter. 
7.3.3.4 Logistic Regression 
Logistic regression was conducted in a similar manner documented in Chapter 6, 
Section 6.3.3.4. OR was reported with 95% or 99% CI of self-reported HBP incidence [182]. 
The odds of self-reported HBP was determined by comparing each intake group with the 
reference group which included the lowest consumers, (or non-consumers). Increments of 
coffee or tea intake according to typical portion size (250 g) [176] were also regressed to 
assess if there is a linear association with odds of self-reported HBP. 
Stratification for types of coffee consumed was also assessed, where participants 
were divided into those who only consumed regular coffee and those who only consumed 
decaffeinated coffee. Effect modification was explored by stratification of subgroups of 
participants selected a priori. Variables investigated included BMI (obese v. non-obese), 
smoking (smoking v. non-smoking), menopausal status (pre-menopausal v. post-
menopausal) and parental history of CVD. However, these analyses were ultimately 
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restricted to not include smokers due to low case numbers. A summary of exclusion criteria 
and analysis plan is provided in Figure 7.1. 
 
Figure 7.1 Summary flowchart of the current study exclusion criteria and analysis plan 
 
7.3.3.5 Testing for statistical assumptions 
Statistical assumptions were tested according to procedure reported in Chapter 2, 
Section 2.4.2.2. Goodness of fit was assessed by Hosmer-Lemeshow test where predicted 
risks were compared to observed risks. An insignificant chi-squared p-value suggested that 
there is no evidence the model is ill-fitted. 
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7.4 Results 
7.4.1 Baseline characteristics 
A total of 9,467 eligible participants were included within the analysis after the 
application of exclusions. The baseline characteristics of participants by case status, were 
presented in Table 7.1. In general, recovered and non-cases were younger, and more likely 
to possess traits which were ‘health-conscious’, while incident and prevalent cases shared 
similar tendencies. Specifically, recovered and non-cases were younger in comparison to 
incident and prevalent cases, whereas prevalent cases tended to be the oldest on average. 
Non-cases tended to have the lowest BMI and waist circumference compared to other 
subpopulations. Non-cases were also more likely to have a lower energy intake, while 
incident cases had the highest energy intake. In terms of dietary preferences, salt and 
sodium intakes were highest within recovered cases, in contrast to non-cases with the 
lowest intakes. Prevalent cases were more likely to consume the least amount of alcohol, 
total vegetables, and coffee. While recovered cases tended to consume the least amount of 
fruits, they were more likely to consume the most tea. With regard to lifestyle habits, 
prevalent cases had the lowest proportion of vegetarians, but the highest proportion of non-
smokers. Incident cases were more likely to be supplement users. Prevalent cases were least 
likely to be moderately active participants, vice versa for non-cases. When participants were 
divided according to SES status, non-cases had the highest proportion of participants 
holding a professional/managerial job, and the lowest proportion of participants holding 
intermediate, routine and manual jobs when compared across the subgroups. Prevalent 
cases had the highest proportion of participants with no education, while non-cases had the 
highest proportion of participants who were degree holders. With regard to medical history, 
non-cases were less likely to have a history of parental cancer/heart disease, family history 
of HBP and high cholesterol, while prevalent cases had a greater tendency of reporting 
medical histories mentioned above . 
When participants were divided according to intakes of total coffee (Table 7.2), 
participants who consumed the least coffee tended to be the youngest, with the lowest BMI 
and smallest waist circumference, as well as lowest energy, total salt, sodium and alcohol 
intakes. This is consistent with the previous chapter (Chapter 6). Participants who 
consumed the least coffee tended to consume highest amount of FVs overall. The proportion 
of vegetarians were also highest among participants who consumed least amount of coffee. 
Percentages from Table 7.2 show no apparent trend for non-smokers, but highest coffee 
consumers had the lowest proportion of non-smokers compared to other quintiles, as well 
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as the lowest proportion of supplement users and moderately active participants. In terms 
of SES, participants from the fourth coffee quintile had the highest proportion of 
participants with high school education and above as well as professional & managerial jobs. 
There were no apparent trends for the history of parental cancer/heart disease and family 
history of HBP. Interestingly, lowest and highest coffee consumers have the smallest 
proportion of participants with high cholesterol, while the third quintile consuming 
between one to two cups of coffee had the highest proportion. 
Participants were also divided according to black tea consumption quartiles (Table 
7.3), and the patterns observed here are similar in comparison to above. Participants who 
consume less black tea were more likely to be younger, with a lower BMI, smaller waist 
circumference and lower energy, total salt and sodium intake. The lowest black tea 
consumers were also more likely to consume the greatest amount of FVs, as well as coffee. 
In terms of lifestyle habits, the proportion of vegetarians/vegans and supplement users 
decreased significantly across the quartiles. The proportion of non-smokers tend to be 
higher across the quartiles, but was lowest in the highest quartile. The proportion of 
participants who were moderately active was the lowest among consumers who consumed 
highest intake of tea. Low black tea consumers tended to have a higher proportion of 
participants who were well educated, with professional & managerial jobs compared to high 
black tea consumers. In terms of medical history, low black tea consumers had a smaller 
proportion of participants with a history of parental cancer/heart disease, family history of 
HBP and high cholesterol. 
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7.4.2 Logistic Regression 
7.4.2.1 Full cohort 
The table below presents the odds of self-reported HBP for total coffee and tea by 
quintiles of intake (Table 7.4). There were no significant associations found for total coffee, 
regular coffee, decaffeinated coffee and black tea with the odds of self-reported HBP in both 
the age-adjusted model and the fully-adjusted model. 
Table 7.4 Total black tea, coffee and coffee subgroup intake and odds of self-reported HBP incidence 
 
Intake (g/day) 
Odds of high blood pressure (95% CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Total coffee     
Q1 0 – 27 131 1 1 
Q2 30 – 190 145 1.13 (0.89, 1.44) 1.14 (0.88, 1.46) 
Q3 194 – 475 183 1.15 (0.91, 1.44) 1.11 (0.87, 1.41) 
Q4 479 – 665 103 1.15 (0.88, 1.50) 1.10 (0.84, 1.46) 
Q5 855 – 1995 127 1.17 (0.92, 1.51) 1.03 (0.79, 1.35) 
p trend   0.287 0.797 
OR per 250 g/day   1.03 (0.97, 1.09) 0.99 (0.93, 1.05) 
Regular coffee     
Q1 0 128 1 1 
Q2 4 – 76 149 1.03 (0.81, 1.31) 1.04 (0.81, 1.34) 
Q3 152 – 190 126 1.06 (0.82, 1.36) 1.08 (0.83, 1.41) 
Q4 475 201 1.19 (0.95, 1.49) 1.14 (0.90, 1.45) 
Q5 855 – 1140 85 1.01 (0.77, 1.34) 0.89 (0.66, 1.19) 
p trend   0.555 0.568 
OR per 250 g/day   1.02 (0.96, 1.08) 0.98 (0.92, 1.05) 
Decaffeinated coffee     
Q1 0 342 1 1 
Q2 4 102 1.04 (0.83, 1.31) 1.04 (0.82, 1.31) 
Q3 13 – 190 150 0.93 (0.77, 1.14) 0.96 (0.78, 1.17) 
Q4 475 – 1140 95 1.12 (0.88, 1.41) 1.08 (0.85, 1.38) 
p trend   0.386 0.669 
OR per 250 g/day   1.04 (0.95, 1.14) 1.02 (0.93, 1.12) 
Black tea     
Q1 0 – 36 131 1 1 
Q2 104 – 650 331 1.06 (0.86, 1.30) 1.07 (0.86, 1.33) 
Q3 1170 151 0.99 (0.78, 1.25) 0.97 (0.75, 1.25) 
Q4 1560 76 1.07 (0.80, 1.43) 1.02 (0.74, 1.39) 
p trend   0.951 0.761 
OR per 250 g/day   1.00 (0.96, 1.04) 0.99 (0.95, 1.03) 
a Cases apply to fully-adjusted models 
b Adjusted for age (categorical), BMI, energy intake, physical activity, smoking status, socio-economic status, 
alcohol intake, family history of HBP, self-reported history of hypercholesterolaemia, mutual adjustment for 
total coffee or black tea intake 
 
7.4.2.2 Sensitivity Analysis 
Results from the sensitivity analyses suggest that the odds of self-reported HBP were 
lower in regular coffee drinkers for the fully-adjusted model, however, not statistically 
significant. There were also no other significant associations found within obese, non-obese, 
non-smoking, postmenopausal, premenopausal subpopulations with and without parental 
history of CVD (Table E.1). 
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7.5 Discussion 
7.5.1 Summary of results 
The objective of this study was to explore the association between coffee, tea intake 
and the risk of self-reported incident HBP. Results show no association for higher coffee or 
tea intake and the risk of self-reported incident HBP in UKWCS. The direction of associations 
for total coffee tend to be inverse, but point estimates and tests for linear association were 
not significant. When participants were stratified into subgroups, associations between 
coffee, tea intake and incident outcomes were also not significant. 
7.5.2  General comparison to literature 
Findings from the current study are aligned with the recent MAs which reported no 
association between coffee consumption and the risk of incident hypertension when 
comparing between the highest and lowest consumers [315, 316]. Slightly elevated risk was 
reported for the risk of self-reported HBP within light to moderate consumers (1 to 3 
cups/day) [316]. Furthermore, SR and MA of ten recent RCTs also show no association 
between coffee intake and BP [315], thus more evidence is required for further investigation 
before conclusions can be drawn. With regard to the findings for black tea intake, it was not 
possible to make a direct comparison with other studies as there was a lack of studies which 
investigated black tea consumption and hypertension incidence. However, there is evidence 
from two SRs and MAs of RCTs to suggest a small but significant BP lowering effect with 
regular consumption of black tea [154, 317]. However, some RCTs had a relatively small 
sample size, and there was some evidence of heterogeneity for DBP results within Liu et. al 
[317], thus results should be interpreted carefully. 
Overall, there are some methodological concerns which exist in previous studies that 
could have led to inconsistent results. Firstly, coffee and tea consist of multiple components, 
of which may exert effects on BP. The concentrations of these compounds within are largely 
varied due to multiple factors, such as variety of beans, processing methods, such as 
roasting and brewing for coffee [266, 318, 319] and fermenting processes for tea [289, 320]. 
Variance in portion sizes and food composition databases used in different cohorts could 
also add to the observed heterogeneity. As the current study used a FFQ to estimate intake 
of coffee and tea, this would be a potential limitation the study faced. However, the FFQ, in 
comparison to single food diary records or 24-hour recalls, is a better measure of habitual 
diet, and more appropriate to survey large populations. Secondly, RCTs have demonstrated 
an acute pressor effect caused by ingestion of caffeine up to three hours. This effect is known 
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to vary in previous trials by hypertensive status, mental or physical stress, by age, and 
especially habitual consumers, where heavy coffee drinkers are more likely to build a 
tolerance to the acute pressor effect [312, 313]. This may cause additional variation within 
RCTs or cohort studies, leading to errors in measured BP. Thus in response, the current 
study attempted to explore associations by habitual consumption of regular and 
decaffeinated coffee, as well as by menopausal status (related to age), however, no 
associations were found. Within studies that investigate incident hypertension, despite the 
specificity in comparison to e.g. CVD mortality or incidence, the quality of outcome may also 
impact on the risk estimates. Self-reported HBP reported through a medical practitioner, is 
considered to be an inferior option in comparison to measured BP, although instances of 
‘white coat hypertension’ may be prevalent. Furthermore, genetic factors such as CYP1A2 
genotype, which influences caffeine intake and metabolism, may also modify the association 
between coffee consumption and BP [321]. As the cohort did not have data on this particular 
genotype, further sensitivity analysis could not be conducted. However, the study adjusted 
and conducted sensitivity analysis for smoking status, which is thought to induce CYP1A2 
activity [322], and its effects on non-smokers and smokers may vary [323]. 
7.5.3 Relevance with (poly)phenols 
Other than caffeine, chlorogenic acids also exist abundantly within coffee, where 
habitual drinkers may consume up to 2 g/day, exceeding the amount consumed from FVs in 
total [266]. High intakes of chlorogenic acids have been reported to lower SBP and DBP 
significantly by -4.31 mmHg (95% CI 5.60 to -3.01 mmHg) and -3.68 mmHg (95% CI -3.91 
to -3.45 mmHg) respectively within a SR and MA of RCTs [152]. There is a number of 
mechanisms linking chlorogenic acids and its metabolites to a BP lowering effect. One third 
of the chlorogenic acids are absorbed in the small intestine, the remaining two thirds are 
intensively metabolised in the colon by microflora, where its metabolites are reabsorbed 
back into the bloodstream [148]. NO is a vasodilator [324] and regulates the arterial wall 
tone. One of the suggested mechanisms include increasing NO bioavailability in aortic rings 
which were pre-contracted using phenylephrine (vasoconstrictor), which enhances 
endothelial-dependent vasodilation, a function directly related to BP. This effect is seen 
especially when ferulic acid was administered in vitro and in vivo. Urinary NO metabolites 
also increased when chlorogenic acids were consumed in vivo, indicating higher levels of 
NO bioavailability [148]. Other mechanisms include reduced radical production, as well as 
scavenging free radicals directly [148, 325]. Alternatively, chlorogenic acid metabolites may 
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also inhibit platelet activity, exerting anti-thrombotic effects, preventing formation of blood 
clots which may lead to the onset of CVD, such as MI [266]. 
On the other hand, various amounts of flavanols, such as catechin, epicatechin, 
epigallocatechin and epigallocatechin gallate are found in green tea [141]. These 
compounds may polymerise after fermentation to form theaflavins and thearubigins, which 
is abundant in black tea [320]. Flavanols exhibit similar functions to chlorogenic acids by 
improving endothelial function, demonstrated by significant improvements of flow-
mediated dilation in trials, as well as enhancing NO status [141]. Despite the evidence 
reported above from RCTs, limitations in methodology within cohort studies might 
introduce errors when calculating risk estimates. As emphasized throughout the thesis, 
UKWCS was designed to be a ‘health-conscious’ cohort to accommodate wide diversity of 
dietary intakes. In comparison to the general population, these women might be more likely 
to have a higher physical activity level, smoke less, more likely to be vegetarian etc.. Under 
these circumstances, perhaps this could be why no additional benefit from higher coffee or 
tea consumption could be detected, but it is more likely due to the broad exposure and 
outcome measures. 
7.5.4 Strengths and limitations 
The following limitations should be considered when interpreting the results of the 
current study. As reviewed previously, limitations surrounding missing information on 
some model covariates, the usage of the FFQ and methodological limitations of 
observational studies were elaborated in the previous chapters (Chapter 3 and Chapter 6). 
Furthermore, application of the study findings is also restricted to women only. 
This analysis also has certain strengths mentioned in previous chapters, attributed to 
the advantageous usage of Phenol Explorer, the larger sample size compared to other 
studies, the design of the ‘health-conscious’ cohort and a wide diversity in dietary intakes 
and patterns. These factors help to facilitate the elucidation of associations between chronic 
disease and dietary intake. 
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7.6 Summary 
In conclusion, coffee and tea intakes were not associated with odds of self-reported 
HBP in the UKWCS. Findings for coffee were consistent with results from Chapter 5 and 
current literature, but results for the association between black tea intake and HBP were 
not. The chapter raised some methodological concerns which may have led to the current 
conclusion, despite using the best available data and methods for this cohort. Overall, 
improvements with methodology in the future is required before further investigations are 
conducted in both prospective cohorts and RCTs. 
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Chapter 8  
Fruit, coffee and tea intake in the UK Women’s Cohort Study: 
Impact of dietary assessment methods 
8.1 Abstract 
The relationship between various (poly)phenol-rich dietary sources and CVD 
outcomes were investigated in previous chapters. However, there were no significant 
associations between some fruit subgroups, vegetables, coffee and tea and CVD outcomes. 
The current chapter attempts to investigate whether FFQ derived food groups are 
comparable with intakes derived using an alternative method of dietary assessment to form 
an opinion about the robustness of the four-day weighted food diaries as the reference 
method. Individual fruit intake from the FFQ was combined and analysed as total fruit 
intake, and sub-categorised into berries, citrus, drupes, pomes and tropical fruit intake 
(same as previous chapters). Coffee and tea intakes were also derived in a similar manner 
from the FFQ. Individual food items recorded in the food diaries were combined to form the 
same subgroups as a comparison to the FFQ. Statistical analyses used to assess relative 
validity included correlations, cross-tabulation and the Kappa statistic. 
Results from the study show a good correlation for coffee and tea intakes using 
different methods, but only a slight to fair correlation for fruit subgroup intakes. Using the 
Kappa’s statistic, there is also a slight to fair agreement across the fruit, where drupes had 
the lowest extent of agreement. Drupes were also the most grossly misclassified group 
compared to other dietary variables. The agreement for coffee and tea subgroups were both 
good, and tea had the highest extent of agreement. In the interpretation of these findings, 
an important limitation should be noted, where the administration of the FFQ and the food 
diary is five years apart. Thus the low extent of agreement between certain fruit subgroups 
could be due to dietary changes overtime instead. In conclusion, despite the limitations of 
the study design and findings here, the inclusion of this chapter provided a deeper 
understanding to the design of the FFQ and the food diary, which may be useful for further 
discussion and evaluation within this thesis. 
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8.2 Background 
The FFQ is the most widely used dietary assessment method for use within large 
prospective cohorts, and are often tailored to be food or nutrient specific [326]. Reviewing 
the relative validity of FFQs is important as low validity may affect the outcome of the diet-
disease relationship. In analyses such as logistic regression and survival analyses, the 
exposure of interest is often expressed in categories. Thus, the ability to rank participants 
correctly according to groups of intake is important, as misclassification may affect the risk 
estimate of the disease outcome [185]. However, there are advantages to using the FFQ to 
study diet-disease relationship. It is inexpensive, quick to administer, and easy to process 
after initial setup of database. The FFQ can also take into account mid- to long-term dietary 
habits spanning from weeks to a year, depending on the time frame of measurement in the 
study. The food diary is also capable of capturing dietary data over long periods of time if 
multiple diaries were completed over time at different time points. However, the 
application of this assessment is usually restricted to a limited number of days for practical 
purposes, due to the time required to process the collected data. Dietary assessment 
methods are vulnerable to some unavoidable errors. The FFQ relies on memory, question 
interpretation by participants and it is also dependent on a pre-defined food list [185]. On 
the other hand, the food diary is capable of recording diet in an open-ended manner with 
no restrictions to food lists or portion sizes. If completed prospectively, it is also less likely 
to be susceptible to memory errors. As the two methods are largely different in terms of 
possible errors, the food diary is recommended to be appropriate as a reference to study 
the relative validity of the FFQ [185, 253]. Furthermore, the relative validity of food groups 
such as fruit, coffee and tea had not been studied in this cohort. Therefore, the aim of this 
study is to evaluate the ability of the FFQ to rank individuals correctly into consumption 
groups. Findings from this chapter would help explain if associations (or the lack of) may 
be explained by the ability to quantify or rank women using the FFQ. Objectives of this 
chapter are as follows: 
 Compare measured intakes (g/day) of fruit, fruit subgroup, coffee and tea 
between food diaries and baseline FFQ to examine the relative validity of 
baseline FFQ. 
 To assess whether the baseline FFQ is capable of allocating women into 
similar categories as the food diaries based on total fruit, fruit subgroup, 
coffee and tea intake from both methods, thus addressing the extent of 
agreement between the two methods. 
Chapter 8 
210 
 
 To identify the percentage of women who were misclassified into extreme 
total fruit, fruit subgroup, coffee and tea intake categories. 
8.3 Method 
8.3.1 Study population 
Four-day weighed food diaries were collected between 1999 and 2002. These were 
mailed to all women who had previously consented for re-contact and with no notification 
of death. There were 12,453 women who responded, and 2136 completed food diaries that 
were fully coded at the time of analysis. Women who had missing baseline FFQ data were 
excluded (n = 15). A single participant who reported consuming >8000 g/day of total fresh 
fruit intake in the baseline FFQ was also excluded, because she was considered to be an 
extreme outlier. Therefore, the final sub-population for comparison of baseline FFQ with 
food diary consisted of 2120 women. 
8.3.2 Dietary data 
Dietary data for the current analysis was obtained from the baseline FFQ and four-
day weighed food diaries, previously introduced in Chapter 2 Section 2.2.2.2. 
8.3.2.1 Food frequency questionnaire 
Development and application of the baseline FFQ was previously explained in Chapter 
2 Section 2.2.2.1. Details for the creation of total fruit, fruit subgroup variables can be found 
in Chapter 2 Section 2.6.1, where the only exception is the inclusion of grapes in the berry 
subgroup. Coffee and tea variables used in this chapter were the same as reported variables 
in Chapter 5 Section 5.3.1. 
8.3.2.2 Four-day weighed food diary 
Four-day weighed food diaries were coded directly using McCance & Widdowson’s 
The Composition of Foods (5th Edition) [168], through ‘DANTE’ (Chapter 2 Section 2.2.2.2). 
The food items were combined using a similar method according to the FFQ. In the example 
of generating ‘pomes’, food codes which consist of single ingredients, such as ‘apples’ or 
‘pears’ were grouped as a category. Categories form include total fresh fruit, which consist 
of berries (including grapes), total citrus (including fresh orange juice), drupes, pomes and 
tropical fruit, total coffee, and black tea. These categories were applied through ‘DANTE’ to 
food diary intakes where mean intake in g/day for each category was then generated for 
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each individual, depending on how many days were completed for the food diary. These 
intakes were subsequently compared with the mean intakes derived from the FFQ. 
Table 8.1 shows the total number of food codes from McCance & Widdowson’s The 
Composition of Foods (5th Edition) that were used for each investigated food variable from 
the FFQ and food diaries. There is a significantly less amount of items that were used in the 
FFQ compared to the food diaries, especially for coffee. Basic nutrient intakes were also 
generated for comparison with the FFQ. 
Table 8.1 Total number of food codes within each investigated dietary variable from the food diary and 
baseline FFQ (% of food codes in FFQ over total number of food codes used in food diary) 
Dietary Variable 
Total no. of food codes 
Food Diary Baseline FFQ 
Total fresh fruit 153 53 (35%) 
Berries 43 14 (32%) 
Citrus 23 9(39%) 
Drupes 26 12 (46%) 
Pomes 41 10 (24%) 
Tropical fruit 20 8 (40%) 
Coffee 15 1 (6%) 
Black tea 6 1 (16%) 
8.3.3 Statistical analysis 
Baseline characteristics of women who completed the FFQ and food diaries were 
explored and tabulated. Normality of relevant variables were evaluated using histograms 
and descriptive statistics. If the data is normal, paired t-tests were conducted to assess 
significantly difference between mean intakes of fruit, coffee and tea intakes for FFQ and 
food diaries. If the dietary variables were not normally distributed, the non-parametric 
equivalent, Wilcoxon signed-rank test was used instead. 
The correlation coefficient was calculated for fruit, coffee and tea intakes to assess the 
relationship between the two dietary assessment methods. The Pearson correlation was 
applied to normally distributed variables, while variables that are not normally distributed 
used Spearman’s rank correlation. However, correlation only examines the degree of 
association instead of agreement between the two methods. It also ignores any systematic 
bias that maybe present [327]. The recommended approach would be the application of the 
Bland-Altman plot [328]. The Bland-Altman plot is a graphical approach to visualise the 
extent of agreement between two methods, by plotting the mean of the two measures, 
against the difference between the two measurements. Mean difference between the two 
measurements would be the estimated bias, and the 95% limits of agreement would be 
equivalent to the mean difference ±1.96 SD. Assumptions for the 95% limits of agreement 
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were also checked by plotting a histogram for the mean difference to assess whether they 
approximately follow a normal distribution. If the measurements are not normal, a log 
transformation was applied and the 95% limits of agreement were interpreted as ratios 
after back transformation (antilog) [329]. However, as the data was still not suitable for 
analysis after log transformation, this method was ultimately not applied. 
The remaining alternative was to assess the extent of agreement objectively between 
the two dietary assessments, and evaluate the ability for both methods to rank women into 
the same category. Thus, the Kappa statistic (K) was applied [330]. This approach is based 
on the difference between the expected agreement by chance and actual agreement that is 
present. Firstly, women from the FFQ and food diaries were classified into approximately 
equal intake quintiles. The first quintile contained women with the lowest dietary intake, 
while the fifth quintile consisted of women with the highest intake. Cross tabulation and 
percentages were then derived for women classified into the same, adjacent or extreme 
quintile. However, due to the narrow range of intakes derived from some dietary variables 
(e.g. drupes), or the artificial linearity from converting frequency to g/day (e.g. black tea), 
some categories were unable to be forced into five approximately equal quintiles. Therefore, 
dietary intakes were also divided into quartiles and tertiles. The weighted Kappa (Kw) was 
also calculated to minimize misclassification, as it assigns weight to adjacent categories. 
Thus, if a participant was placed in the lowest intake quintile on the food diary, but third 
quintile in the FFQ, it would be credited as partial agreement [331]. 
The interpretation of Kappa statistics is shown in Table 8.2, where 0 is equivalent to 
no agreement, and 1 is perfect agreement. For the purpose of application, this meant that 
when K = 0, the two methods are entirely different in measurement, and when K = 1, the 
measurements between the methods are exactly the same. In other words, the Kappa 
statistic reports whether women who are categorised into the highest intake quintile in the 
FFQ, are also categorised into the highest intake quintile in the food diary, reflecting the 
ability of FFQ to rank participants correctly into consumption groups. 
Table 8.2 Interpretation of Kappa statistics [330] 
Kappa Statistic Strength of Agreement 
<0.00 Poor 
0.00 – 0.20 Slight 
0.21 – 0.40 Fair 
0.41 – 0.60 Moderate 
0.61 – 0.80 Substantial 
0.81 – 1.00 Almost Perfect 
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8.4 Results 
8.4.1 Baseline characteristics 
The baseline characteristics of women with fully coded food diaries, were explored 
alongside the UKWCS cohort. Women with fully coded food diaries tend to be older, and 
were more likely to be moderately active, vegetarians/vegans, were non-smokers and 
supplement users. Women with fully coded food diaries were also more likely to be from a 
professional/managerial class, and a degree holder. Nutrient intakes do not differ greatly 
between women with fully coded diaries and the full cohort. This showed that the sub-
population of women who completed food diaries were generally a good representative of 
the full cohort (Table 8.3). 
Table 8.3 Baseline characteristics of women who completed the baseline FFQ and fully coded food 
diaries 
 Participants with 
completed food diary 
Full Cohort 
Participants (n) 2136 35372 
Age, years (SD) 54.5 (9.3) 52.3 (9.3) 
BMI, kg/m2 (SD) 24.2 (4.0) 24.5 (4.4) 
Supplement users (%, 95% CI) 61.4 (59.2, 63.5) 57.8 (57.3, 58.3) 
Non-smokers (%, 95% CI) 91.3 (90.1, 92.4) 89.2 (88.9, 89.5) 
Moderately active (%, 95% CI) 60.3 (58.2, 62.4) 58.3 (57.8, 58.9) 
Vegetarians/Vegans (%, 95% CI) 30.0 (28.4, 32.3) 27.7 (27.2, 28.1) 
Socio-Economic Status (%, 95% CI)   
          Professional/Managerial 65.1 (63.0, 67.1) 63.2 (62.7, 63.7) 
          Intermediate 27.0 (25.2, 29.0) 27.5 (27.0, 28.0) 
          Routine and manual 7.9 (6.8, 9.1) 9.3 (9.0, 9.6) 
Degree holder (%, 95% CI) 26.5 (24.7, 28.4) 24.9 (24.4, 25.3) 
Energy, kcal/day (SD) 2292 (828) 2291 (797) 
Carbohydrate, % of total energy (SD) 54.8 (6.4) 54.7 (6.5) 
Total fat, % of total energy (SD) 33.1 (6.0) 33.1 (5.9) 
Protein, % of total energy (SD) 15.8 (2.7) 15.9 (2.8) 
Total sugar, g/day (SD) 150 (63) 150 (65) 
Fibre, g/day (SD) 26.3 (11.7) 25.6 (11.0) 
Alcohol, g/day (SD) 8.0 (9.7) 8.7 (10.3) 
However, the baseline FFQ reported a significantly higher energy and nutrient intake 
(except for alcohol, percentage of energy from fat and protein) compared to the food diary. 
The baseline FFQ also significantly over-reported on all fruit groups, coffee and tea intakes 
except drupes (Table 8.4). SDs for consumption of fruit groups, coffee and black tea in the 
FFQ were generally wider than the reported values for food diaries, indicating there was a 
greater variation of consumption when dietary intakes were reported through the baseline 
FFQ, with the exception of drupe consumption. When percentage distributions of fruit 
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groups were compared, there was a relatively small difference between the two assessment 
methods. The baseline FFQ reported a lower percentage distribution of drupe intake (3% 
in baseline FFQ, 10% in food diary), and a slightly higher percentage distribution of berries 
(12% berries in baseline FFQ, 9% in food diary) when compared to the food diary. In both 
assessments, citrus (33% in baseline FFQ, 31% in food diary) and pomes (32% in baseline 
FFQ, 26% in food diary) were the most frequently consumed fruit type, followed by tropical 
fruits (26% for both assessment methods). 
Table 8.4 Differences between nutrient and dietary intakes of fruit, coffee and black tea variables 
derived using the FFQ and food diaries, by paired t-test† or Wilcoxon signed-rank test‡ (n = 2120) 
Dietary Variables FFQ Food Diary Difference 
Energy†, kcal/day (SD) 2292 (828) 1813 (424) 479* 
Carbohydrate†, % of total energy (SD) 54.8 (6.4) 50.9 (8.0) 3.9* 
Total fat†, % of total energy (SD) 33.1 (6.0) 33.1 (6.9) 0 
Protein†, % of total energy (SD) 15.8 (2.7) 15.9 (3.6) -0.1 
Total sugar†, g/day (SD) 150 (63) 108 (39) 42* 
Fibre†, g/day (SD) 26.3 (11.7) 17.4 (6.4) 8.9* 
Alcohol‡, g/day (SD) 8.1 (9.7) 9.0 (12.0) -0.9 
Total fresh fruit‡, g/day (SD) 318 (275) 201 (147) 117* 
Berries‡, g/day (SD) 41 (62) 23 (40) 18* 
Citrus‡, g/day (SD) 104 (108) 79 (95) 25* 
Drupes‡, g/day (SD) 7 (10) 23 (50) -16 
Pomes‡, g/day (SD) 107 (107) 62 (73) 45* 
Tropical‡, g/day (SD) 74 (90) 53 (53) 21* 
Coffee‡, g/day (SD) 391 (352) 342 (347) 49* 
Black tea‡, g/day (SD) 664 (514) 514 (453) 150* 
*p-value <0.001 
Correlations for all dietary intake categories were calculated using Spearman 
correlations, as the distributions for dietary intakes were not normal (Table 8.5). Intakes of 
coffee and black tea were the most strongly correlated between the two dietary assessment 
methods, while intake of drupes was weakly correlated, consistent with findings for the 
previous section. All the correlations were also statistically significant. 
Table 8.5 Correlations between the mean intake of total fresh fruit, fruit subgroup, coffee and black tea 
from the FFQ and food diary 
 Correlation p-value 
Total Fruit 0.41 (0.38, 0.45) 
<0.001 
Citrus 0.41 (0.38, 0.45) 
Berries 0.22 (0.18, 0.26) 
Drupes 0.15 (0.10, 0.19) 
Pomes 0.43 (0.39, 0.46) 
Tropical 0.43 (0.39, 0.46) 
Coffee 0.66 (0.63, 0.68) 
Black tea 0.72 (0.70, 0.74) 
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8.4.2 Degree of agreement between the FFQ and food diaries 
Bland-Altman plot measures the mean difference between two dietary assessment 
methods as consumption increases and is the preferred method to assess extent of 
agreement between two measures. As most of the data was not normally distributed, the 
Bland-Altman plot was not a suitable method to assess agreement. 
The Kappa statistic was used instead to assess the extent of agreement categorically. 
The degree of agreement for un-weighted Kappa between quintiles of dietary intake ranged 
from slight to fair, where intake of drupes had the lowest agreement (K = 0.050). As the 
number of quantiles decreased, the Kappa statistic for all dietary variables naturally 
increased [179]. However, the weighted Kappa statistics were less affected by the number 
of categories, and reports slight agreement was observed for total fresh fruit, citrus, berries 
and drupes, fair agreement for pomes and tropical fruits, and a moderate agreement for 
coffee and black tea consumption. 
Table 8.6 Degree of agreement between the mean intake of total fresh fruit, fruit subgroup, coffee and 
black tea from the FFQ and food diary 
 Five Quantiles Four Quantiles Three Quantiles 
 Kappa Weighted 
Kappa 
Kappa Weighted 
Kappa 
Kappa Weighted 
Kappa 
Total Fruit 0.132 0.272 0.175 0.281 0.217 0.288 
Citrus 0.140 0.283 0.189 0.305 0.222 0.289 
Berries 0.070 0.148 0.097 0.155 0.128 0.159 
Drupes 0.050 0.093 0.053 0.091 0.068 0.090 
Pomes 0.167 0.306 0.198 0.310 0.218 0.291 
Tropical 0.159 0.304 0.198 0.306 0.239 0.308 
Coffee 0.295 0.482 0.374 0.514 0.373 0.469 
Black tea 0.319 0.484 0.354 0.491 0.476 0.566 
 
The FFQ was also assessed for the ability to rank women into appropriate dietary 
intake groups, using food diary groups as the reference. This was assessed using quintiles 
initially, followed by quartiles and tertiles. Table 8.7 reports the percentage of agreement 
for each dietary variable divided by quintiles between the FFQ and food diary. Within 
dietary intakes that were successfully divided into quintiles, majority of participants with 
extreme consumption levels were classified within the same quintile, ranging from 6.1% to 
13.1%. Gross misclassification occurred from 0.5% to 2.5%. Proportion of women who were 
grossly misclassified are higher within intakes of berries, drupes and tea, of the unequal 
number of quantiles. 
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In summary, there were 0.6 to 15.2% of women who were grossly misclassified in 
general, that is when women who were classified in the lowest intake group within the 
baseline FFQ was classified in the highest intake group according to food diary, or vice versa 
(Table 8.8). Intake of berries and drupes had the largest proportion of women who were 
grossly misclassified (10% and 15.2% respectively) compared to other dietary variables, 
while coffee and tea had the least proportion women who were grossly misclassified (1.2% 
and 0.6% respectively). With regard to the consumption of citrus, pomes and tropical fruit, 
these categories had 4.2%, 3.9% and 3.4% of women who were grossly misclassified 
respectively. The proportion of grossly misclassified women were also considered to be low 
when investigating total fruit intake, at 2.7%. 
Majority of the women were classified within one adjacent quintile, except for coffee 
and black tea intake, where a larger proportion of the women (43.6% and 45.8% 
respectively) were correctly classified compared to fruit subgroups (Table 8.8). The 
distribution of intakes of some dietary variables meant it was not possible to equally divide 
into quintiles, e.g. berries, drupes and black tea consumption, as the reported consumption 
values were not linear. Further analyses were therefore conducted in quartiles and tertiles 
(Table 8.9, Table 8.10, Table 8.11, Table 8.12). 
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Table 8.7 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical fruit, 
coffee and tea quintiles by FFQ and food diary consumption quintiles 
  Baseline FFQ  
 Total fresh fruit Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 178 (8.4%) 103 (4.9%) 66 (3.1%) 45 (2.1%) 36 (1.7%) 428 
2th 114 (5.4%) 95 (4.5%) 81 (3.8%) 72 (3.4%) 58 (2.7%) 420 
3rd 70 (3.3%) 96 (4.5%) 101 (4.8%) 87 (4.1%) 71 (3.3%) 425 
4th 41 (1.9%) 83 (3.9%) 93 (4.4%) 111 (5.2%) 97 (4.6%) 425 
Highest intake 21 (1.0%) 47 (2.2%) 83 (3.9%) 109 (5.1%) 162 (7.6%) 422 
 Total 424 424 424 424 424 2120 
  Baseline FFQ  
 Total citrus fruit Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 286 (13.5%) 148 (7.0%) 121 (5.7%) 104 (4.9%) 54 (2.5%) 713 
2th 40 (1.9%) 34 (1.6%) 30 (1.4%) 24 (1.1%) 10 (0.5%) 138 
3rd 84 (4.0%) 102 (4.8%) 85 (4.0%) 113 (5.3%) 43 (2.0%) 427 
4th 41 (1.9%) 83 (3.9%) 77 (3.6%) 135 (6.4%) 82 (3.9%) 418 
Highest intake 36 (1.7%) 40 (1.9%) 66 (3.1%) 152 (7.2%) 130 (6.1%) 424 
 Total 487 407 379 528 319 2120 
  Baseline FFQ  
 Berries Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 278 (13.2%) 241 (11.4%) 221 (10.5%) 182 (8.6%) 149 (7.1%) 1071 
2th - - - - - - 
3rd 32 (1.5 %) 41 (1.9%) 49 (2.3%) 56 (2.7%) 43 (2.0%) 221 
4th 64 (3.0%) 71 (3.4%) 82 (3.9%) 84 (4.0%) 94 (4.5%) 395 
Highest intake 62 (2.9%) 55 (2.6%) 73 (3.5%) 94 (4.5%) 135 (6.4%) 419 
 Total 436 408 425 416 421 2106 
  Baseline FFQ  
 Pomes Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 278 (13.1%) 128 (6.0%) 109 (5.1%) 67 (3.2%) 53 (2.5%) 635 
2th 47 (2.2%) 62 (2.9%) 54 (2.5%) 37 (1.7%) 28 (1.3%) 228 
3rd 72 (3.4%) 84 (4.0%) 96 (4.5%) 98 (4.6%) 60 (2.8%) 410 
4th 47 (2.2%) 61 (2.9%) 105 (5.0%) 113 (5.3%) 97 (4.6%) 423 
Highest intake 29 (1.4%) 47 (2.2%) 79 (3.7%) 103 (4.9%) 166 (7.8%) 424 
 Total 473 382 443 418 404 2120 
  Baseline FFQ  
 Drupes Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 361 (17.3%) 299 (14.3%) 252 (12.0%) 261 (12.5%) 274 (13.1%) 1447 
2th - - - - - - 
3rd - - - - - - 
4th 35 (1.7%) 50 (2.4%) 57 (2.7%) 50 (2.4%) 39 (1.9%) 231 
Highest intake 44 (2.1%) 71 (3.4%) 88 (4.2%) 106 (5.1%) 105 (5.0%) 414 
 Total 440 420 397 417 418 2092 
  Baseline FFQ  
 Tropical Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 231 (10.9%) 131 (6.2%) 80 (3.8%) 56 (2.6%) 45 (2.1%) 543 
2th 73 (3.4%) 65 (3.1%) 86 (4.1%) 40 (1.9%) 43 (2.0%) 307 
3rd 58 (2.7%) 103 (4.9%) 120 (5.7%) 82 (3.9%) 66 (3.1%) 429 
4th 55 (2.6%) 60 (2.8%) 95 (4.5%) 115 (5.4%) 92 (4.3%) 417 
Highest intake 28 (1.3%) 45 (2.1%) 64 (3.0%) 122 (5.8%) 165 (7.8%) 424 
 Total 445 404 445 415 411 2120 
  Baseline FFQ  
 Coffee Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 270 (12.7%) 83 (3.9%) 47 (2.2%) 13 (0.6%) 11 (0.5%) 424 
2th 110 (5.2%) 158 (7.5%) 95 (4.5%) 45 (2.1%) 26 (1.2%) 434 
3rd 39 (1.8%) 115 (5.4%) 155 (7.3%) 65 (3.1%) 40 (1.9%) 414 
4th 31 (1.5%) 54 (2.5%) 158 (7.5%) 89 (4.2%) 93 (4.4%) 425 
Highest intake 14 (0.7%) 22 (1.0%) 77 (3.6%) 58 (2.7%) 252 (11.9%) 423 
 Total 464 432 532 270 422 2120 
  Baseline FFQ  
 Black tea Lowest intake 2th 3rd 4th Highest intake Total 
F
o
o
d
 d
ia
ry
 Lowest intake 345 (16.3%) 64 (3.0%) - 17 (0.8%) 6 (0.3%) 432 
2th 71 (3.3%) 299 (14.1%) - 35 (1.7%) 11 (0.5%) 416 
3rd 21 (1.0%) 306 (14.4%) - 82 (3.9%) 18 (0.8%) 427 
4th 9 (0.4%) 212 (10.0%) - 167 (7.9%) 43 (2.0%) 431 
Highest intake 7 (0.3%) 93 (4.4%) - 161 (7.6%) 153 (7.2%) 414 
 Total 453 974 - 462 231 2120 
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Table 8.8 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from 
the baseline FFQ and food diary 
Extent of Agreement (%) Total Fruits Berries Citrus Drupes Pomes Tropical Coffee Black tea 
Exact 30.5 25.9 31.6 24.7 33.7 32.8 43.6 45.8 
Within 1 adjacent quantile 36.8 28.9 35.1 23.9 33.8 37.0 36.7 34.3 
Within 2 adjacent quantile 21.0 20.9 19.9 18.6 19.7 17.4 14.2 13.5 
Within 3 adjacent quantile 9.0 14.2 9.2 17.5 8.9 9.4 4.3 6.1 
Grossly misclassified 2.7 10.0 4.2 15.2 3.9 3.4 1.2 0.6 
When variables were divided into quartiles and cross tabulated, the extent of 
agreement improved. Women were mostly classified in the exact quartile, except for total 
fruit intake (Table 8.9). However, the percentage of grossly misclassified participants had 
also increased, ranging between 1.3 to 18.8%. This pattern naturally reoccurred when 
dietary variables were divided into tertiles, and almost half of all women were classified in 
the exact tertile. Therefore, as the number of quantiles decreased, women were more likely 
to be classified in the exact quantile. 
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Table 8.9 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical fruit, 
coffee and tea quintiles by FFQ and food diary consumption quartiles 
  Baseline FFQ  
 Total fresh fruit Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 257 (12.1%) 126 (5.9%) 82 (3.9%) 72 (3.4%) 537 
2th 149 (7.0%) 154 (7.3%) 125 (5.9%) 95 (4.5%) 523 
3rd 79 (3.7%) 144 (6.8%) 171 (8.1%) 136 (6.4%) 530 
Highest intake 45 (2.1%) 106 (5.0%) 152 (7.2%) 227 (10.7%) 530 
 Total 530 530 530 530 2120 
  Baseline FFQ  
 Total citrus fruit Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 329 (15.5%) 167 (7.9%) 127 (6.0%) 90 (4.2%) 713 
2th 105 (5.0%) 106 (5.0%) 89 (4.2%) 48 (2.3%) 348 
3rd 86 (4.1%) 147 (6.9%) 169 (8.0%) 130 (6.1%) 532 
Highest intake 49 (2.3%) 79 (3.7%) 167 (7.9%) 232 (10.9%) 527 
 Total 569 499 552 500 2120 
  Baseline FFQ  
 Berries Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 340 (16.1%) 288 (13.7%) 247 (11.7%) 196 (9.3%) 1071 
2th - - - - - 
3rd 99 (4.7%) 129 (6.1%) 149 (7.1%) 133 (6.3%) 510 
Highest intake 95 (4.5%) 102 (4.8%) 133 (6.3%) 195 (9.3%) 525 
 Total 534 519 529 524 2106 
  Baseline FFQ  
 Pomes Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 318 (15.0%) 163 (7.7%) 84 (4.0%) 70 (3.3%) 635 
2th 111 (5.2%) 133 (6.3%) 116 (5.5%) 66 (3.1%) 426 
3rd 87 (4.1%) 138 (6.5%) 178 (8.4%) 129 (6.1%) 532 
Highest intake 57 (2.7%) 96 (4.5%) 156 (7.4%) 218 (10.3%) 527 
 Total 573 530 534 483 2120 
  Baseline FFQ  
 Drupes Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 429 (20.5%) 352 (16.8%) 341 (16.3%) 325 (15.5%) 1447 
2th - - - - - 
3rd 30 (1.4%) 41 (2.0%) 39 (1.9%) 30 (1.4%) 140 
Highest intake 68 (3.3%) 126 (6.0%) 175 (8.4%) 136 (6.5%) 505 
 Total 527 519 555 491 2092 
  Baseline FFQ  
 Tropical Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 262 (12.4%) 143 (6.7%) 80 (3.8%) 58 (2.7%) 543 
2th 126 (5.9%) 181 (8.5%) 123 (5.8%) 87 (4.1%) 517 
3rd 89 (4.2%) 126 (5.9%) 170 (8.0%) 148 (7.0%) 533 
Highest intake 53 (2.5%) 87 (4.1%) 155 (7.3%) 232 (10.9%) 527 
 Total 530 537 528 525 2120 
  Baseline FFQ  
 Coffee Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 367 (17.3%) 105 (5.0%) 48 (2.3%) 23 (1.1%) 543 
2th 125 (5.9%) 218 (10.3%) 119 (5.6%) 56 (2.6%) 518 
3rd 59 (2.8%) 137 (6.5%) 220 (10.4%) 113 (5.3%) 529 
Highest intake 24 (1.1%) 44 (2.1%) 142 (6.7%) 320 (15.1%) 530 
 Total 575 504 529 512 2120 
  Baseline FFQ  
 Black tea Lowest intake 2th 3rd Highest intake Total 
F
o
o
d
 d
ia
ry
 
Lowest intake 416 (19.6%) 84 (4.0%) 23 (1.1%) 9 (0.4%) 532 
2th 101 (4.8%) 363 (17.1%) 68 (3.2%) 15 (0.7%) 547 
3rd 27 (1.3%) 285 (13.4%) 154 (7.3%) 45 (2.1%) 511 
Highest intake 18 (0.8%) 133 (6.3%) 217 (10.2%) 162 (7.6%) 530 
 Total 562 865 462 231 2120 
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Table 8.10 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from 
the baseline FFQ and food diary 
Extent of Agreement (%) Total Fruits Berries Citrus Drupes Pomes Tropical Coffee Black tea 
Exact 38.2 32.5 39.4 28.9 40.0 39.9 53.1 51.7 
Within 1 adjacent quantile 39.2 32.4 38.0 28.6 38.3 38.7 35.0 37.7 
Within 2 adjacent quantile 17.1 21.3 16.0 23.8 15.7 16.2 9.8 9.3 
Grossly misclassified 5.5 13.8 6.6 18.8 6.0 5.2 2.2 1.3 
Table 8.11 Percentage of participants in total fresh fruit, citrus fruit, berries, pomes, drupes, tropical 
fruit, coffee and tea quintiles by FFQ and food diary consumption tertiles 
  Baseline FFQ  
 Total fresh fruit Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 383 (18.1%) 189 (8.9%) 136 (6.4%) 708 
2th 224 (10.6%) 272 (12.8%) 211 (10.0%) 707 
Highest intake 100 (4.7%) 246 (11.6%) 359 (16.9%) 705 
 Total 707 707 706 2120 
  Baseline FFQ  
 Total citrus fruit Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 395 (18.6%) 194 (9.2%) 124 (5.8%) 713 
2th 248 (11.7%) 281 (13.3%) 203 (9.6%) 732 
Highest intake 114 (5.4%) 216 (10.2%) 345 (16.3%) 675 
 Total 757 691 672 2120 
  Baseline FFQ  
 Berries Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 441 (20.9%) 354 (16.8%) 276 (13.1%) 1071 
2th 88 (4.2%) 135 (6.4%) 118 (5.6%) 341 
Highest intake 176 (8.4%) 211 (10.0%) 307 (14.6%) 694 
 Total 705 700 701 2106 
  Baseline FFQ  
 Pomes Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 390 (18.4%) 212 (10.0%) 111 (5.2%) 713 
2th 225 (10.6%) 290 (13.7%) 222 (10.5%) 737 
Highest intake 107 (5.0%) 227 (10.7%) 336 (15.8%) 670 
 Total 722 729 669 2120 
  Baseline FFQ  
 Drupes Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 551 (26.3%) 442 (21.1%) 454 (21.7%) 1447 
2th - - - - 
Highest intake 149 (7.1%) 254 (12.1%) 242 (11.6%) 645 
 Total 700 696 696 2092 
  Baseline FFQ  
 Tropical Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 390 (18.4%) 205 (9.7%) 115 (5.4%) 710 
2th 212 (10.0%) 279 (13.2%) 215 (10.1%) 706 
Highest intake 117 (5.5%) 211 (10.0%) 376 (17.7%) 704 
 Total 719 695 706 2120 
  Baseline FFQ  
 Coffee Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 547 (25.8%) 102 (4.8%) 63 (3.0%) 712 
2th 266 (12.5%) 247 (11.7%) 189 (8.9%) 702 
Highest intake 83 (3.9%) 183 (8.6%) 440 (20.8%) 706 
 Total 896 532 692 2120 
  Baseline FFQ  
 Black tea Lowest intake 2th Highest intake Total 
F
o
o
d
 
d
ia
ry
 Lowest intake 560 (26.4%) 110 (5.2%) 42 (2.0%) 712 
2th 157 (7.4%) 362 (17.1%) 193 (9.1%) 712 
Highest intake 40 (1.9%) 198 (9.3%) 458 (21.6%) 696 
 Total 757 670 693 2120 
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Table 8.12 Cumulative percentage of total fresh fruit, fruit subgroup, coffee and black tea derived from 
the baseline FFQ and food diary 
Extent of Agreement (%) Total Fruits Berries Citrus Drupes Pomes Tropical Coffee Black tea 
Exact 47.8 41.9 48.2 37.9 47.9 49.3 58.2 65.1 
Within 1 adjacent quantile 41.0 36.6 40.6 33.3 41.8 39.8 34.9 31.0 
Grossly misclassified 11.1 21.5 11.2 28.8 10.3 10.9 6.9 3.9 
8.5 Discussion 
8.5.1  Summary of results 
The aim of the study was to evaluate the ability of the baseline FFQ to rank individuals 
correctly into consumption groups, by application of the Kappa statistic and cross-
tabulation. Descriptive statistics suggested that the subpopulation of women with fully 
coded food diary was a good representative of the full cohort. In general, most mean intakes 
of fruit, coffee and tea were significantly higher in the baseline FFQ compared to food diary. 
Based on the results of the weighted Kappa, the extent of agreement between both dietary 
methods ranged from slight to fair for intakes of fruit and fruit subgroups, while there was 
a moderate agreement for the intakes of coffee and tea. When quintiles of dietary intakes 
were cross-tabulated, 0.6 to 15.2% of women were grossly misclassified in general. 
However, both assessments were able to classify 80% of women at least within one adjacent 
coffee and tea quantile, while 48.6% to 69.8% of women were classified in within at least 
one adjacent quintile for the intakes of fruit and fruit subgroups. 
8.5.2 General comparison of dietary intakes between the FFQ and food 
diaries 
Characteristics of nutrient and dietary intakes indicated that there might be some 
form of estimation bias, either over-estimation within the baseline FFQ or under-estimation 
within the food diary. A study is also in agreement with the findings of the current study 
[332]. There are two factors which may influence estimates of reported intake. It was 
previously suggested that the increased number of food items may be associated with 
higher total intake [195]. The median frequency of fruits consumed per week (8.4, 15.0, 
15.4) appeared to increase with the number of fruit variables in the questionnaire 
respectively (6, 14, 15), but there were also contradictory findings from another study 
[332]. The Oxford FFQ which listed 11 fruit variables had a lower intake (219 g/day) 
compared to the Cambridge FFQ which lists 9 fruit variables (231 g/day). Portions sizes 
could also affect the translation to amounts within FFQ-derived items. In the current study, 
the intake of drupes in the baseline FFQ was much lower than the reported food diary intake 
Chapter 8 
222 
 
as a smaller portion size was applied when compared to other types of fruit (data not 
shown). This led to a discrepancy between FFQ and food diaries for the intake of drupes. In 
spite of this, the FFQ tend to consistently report higher absolute intakes overall compared 
to food diary intakes in the current study, which may be due to the presence of an 
underlying, and possibly unavoidable systematic bias. However, if both methods are able to 
rank the majority of women within one adjacent or in the exact quantile, it demonstrates 
that the FFQ is able to rank women correctly according to their dietary intake quantiles 
relative to the food diary. 
In addition, the FFQ is structured in a different format from the food diary. FFQ food 
variables often contain one or more food code (e.g. apples, stewed apples, cooked apples 
classed as ‘apples’), and may also include additional FFQ food variables that asks for the 
frequency of consumption for composite or homemade dishes (e.g. apple pie, apple 
crumble). Participants would potentially over report or double report their intakes [326]. 
However, it may be more likely that there is a tendency to report more socially acceptable 
foods (fruits), especially in a health-conscious cohort [333].  
Application of the FFQ is usually the preferred approach when studying the 
relationship between diet and disease in large prospective cohorts [164]. In general, FFQs 
are quick, cheap and easy to process when compared to administering food diaries, which 
can be more time-consuming and difficult to process. The FFQ also have the advantage of 
recording long-term habitual diet in addition to the advantages above, and take seasonal 
variability into account. Food diaries on the other hand, are more suitable for recording high 
quality ‘snapshots’ of dietary data, which may or may not reflect usual habitual diet, 
depending on the length of the record (e.g. three, four, seven or two week food diary). Since 
all dietary assessments have their own limitations, the method of dietary assessment needs 
to be tailored for the appropriate research question. 
8.5.3 Correlation and extent of agreement between the FFQ and food 
diaries 
In terms of correlations, results showed that the correlation between FFQ and food 
diaries varied, ranging from 0.15 to 0.72, where coffee and tea (0.66 and 0.72 respectively) 
have a higher correlation between the two methods than fruit and fruit subgroup intakes 
(0.15 to 0.43). Coffee and tea are often consumed in standard portion sizes. As habitual 
consumption of coffee and tea are usually consistent, it is less likely to under- or over-report 
intakes. It is also less likely for participants to misreport intakes of coffee and tea due to 
social acceptability. In terms of total fruit and fruit subgroups, berries (0.22) and drupes 
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(0.15) were poorly correlated between the baseline FFQ and food diaries. Similar results 
were reported in Andersen et. al [334], where the correlation for ‘other fruits and berries’ 
(excluding apples, pears and citrus fruits) between 14-day weighted food record and a short 
FFQ was also 0.22 within Norwegian men. However, the correlation for ‘apples, pears’ (0.58) 
and ‘citrus fruits’ (0.45) were higher than the current study. The higher correlation co-
efficient may be attributed to the shorter time period (1.5 – 2 months) between the 
administration of two dietary assessments, compared to approximately five years for the 
current study. Berries and drupes may also be less frequently consumed, in addition to 
seasonality and the food diaries’ inability to capture long-term habitual diet, intakes of these 
fruits may not reflect usual intake depending on the time the diet was captured. 
Validation studies on FFQ and food diaries in the literature generally report 
reasonable correlations between the two dietary assessments for macronutrient and 
micronutrient intakes [172, 335-337]. However, when dietary variables are classed into 
food groups, some studies report that the FFQ performs less well for FV intakes [335, 338]. 
There is also variation in the methodology between studies. Some included multiple 24-
hour recalls [339], or single 24-hour recalls and other types of FFQ as the method of 
comparison [332]. 24-hour recalls may potentially share the same sources of error, relating 
to memory and the perception of portion sizes. It is also more representative to record data 
over a longer period of time, as single 24-hour recalls only provide a snapshot of dietary 
habits on a particular day. Food diaries are generally less susceptible to memory or portion 
size errors, as they are recorded by meals on the same day [185], although it is recognised 
that food diaries are filled in at the end of the day, rather than prospectively. An alternative 
method to validate intakes of FVs from the FFQ include the analysis of biomarkers, such as 
flavonoids and carotenoids from urine [340] or plasma [341]. In the study by Brantsæter et. 
al [340], flavonoids (phloretin, hesperidin and kaempferol were shown to correlate strongly 
with total fruits, citrus fruits/juice and tea intake respectively, and thus are interpreted as 
suitable biomarkers for validation. Similarly, β-cryptoxanthin, α-carotene and lycopene 
were strong predictors for intake of fruits, ‘carrots and vegetables’ and tomatoes 
respectively [341]. There are obvious advantages to using biomarkers as a form of 
validation for dietary assessments, due to the differences in sources of possible errors. 
Assessment of biomarkers are not hindered by recall or memory error, and may not 
necessarily rely on the integrity of the food composition database as a FFQ or food diary 
would rely on. However, it can be susceptible to biological or technical errors, as well as 
inter-individual variation. It is important to note that biomarkers can also be potentially 
affected by other factors such as metabolism and rate of utilisation within the body. Pollard 
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et. al [342] had previously investigated the validity of plasma-based biomarkers in a sub-
sample of women from UKWCS, and found no association between plasma biomarkers and 
FV intakes. While certain biomarkers can be good indicators of specific nutrient intake from 
food in general, physiological processes can also influence levels of biomarkers within the 
body, thus it is not recommended to act as a proxy measure of any specific nutrient or food 
intake [342]. However, it is a good alternative in terms of methodology for relative validity 
studies. 
In terms of the extent of agreement between the FFQ and food diary, the extent of 
exact agreement between the two dietary assessment methods when dietary variables were 
divided into quintiles was slight to fair (Kw = 0.093 to 0.484), and was similar whether it 
was divided into quartiles (Kw = 0.091 to 0.514) or tertiles (Kw = 0.090 to 0.566). The 
percentage of exact agreement in fruit and fruit subgroup variables was between 24.7% to 
33.7%, while for coffee and tea, it was between 43.6% to 45.8%. Only 0.6% to 1.2% of 
participants were grossly misclassified for tea and coffee respectively. 2.7% to 15.2% of 
participants were grossly misclassified for total fruit and fruit subgroup intakes. Decreasing 
the number of quantiles naturally increased extent of agreement as well as misclassification. 
Wong et. al [338] supports the current study findings for total fruit intake, where 10% of 
New Zealand adolescent participants between 14 to 18 years were grossly misclassified, 
which was similar to 11.1% in the current study. Bonifacj et. al [335] reported 11% grossly 
misclassified participants for citrus fruits in quartiles, which is higher than the current study 
(6.6%) in a French Mediterranean region. Additional direct comparisons with other studies 
are difficult as there are few studies that validated fruit subgroup intakes in the way 
undertaken by the current study. In particular, there is also a gap of approximately five 
years between the administration of the baseline FFQ and food diary in the current study. 
Diet changes are highly likely to have occurred between this time period. Therefore, results 
here should be interpreted cautiously, as the low extent of agreement could be due to 
dietary changes over time instead. Despite the FFQ showing reasonable ability to broadly 
classify women correctly into exact quantiles, misclassification is high for fruit subgroups 
such as berries and drupes, thus the risk estimates produced are less likely to be relatively 
valid when studying the relationship between these fruit groups and disease outcome. 
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8.6 Summary 
The current study reviewed the strengths and weaknesses of the FFQ and food diary, 
and provided a deeper understanding to the design of both dietary assessment methods. 
Results from the current study indicated a fair extent of agreement for FFQ-derived intakes 
of consumption of total fruit, citrus, pomes, tropical fruits, coffee and tea, but not for berries 
and drupe consumption in the FFQ when compared to the food diaries. However, results 
from cross-tabulation suggest that the FFQ is broadly able to classify women in correct 
quantiles of intake However, an important limitation should be noted, where the 
administration of the FFQ and food diary is five years apart. Thus the low extent of 
agreement between certain fruit subgroups could be due to dietary changes overtime 
instead. Nonetheless, as no dietary assessment measures diet without error, it is important 
to consider the possible measurement errors in the FFQ, which may have led to some of the 
null association findings in the previous chapters addressing the relationship between FV, 
coffee and tea intake and CVD related outcomes. In conclusion, findings here are useful for 
further discussion and evaluation within the scope of this thesis, bearing in the mind the 
limitation of the study design. In terms of future work, investigating more specific disease 
outcomes (such as BP) using food diary data instead of the FFQ would be recommended. 
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Chapter 9  
(Poly)phenols in processed fruit beverages in UK: Evaluation 
of its importance in dietary collection methods 
9.1 Abstract 
This chapter reports the total (poly)phenol content in selected fruit beverages, 
including juices, fruit drinks and concentrates, for where existing information on 
(poly)phenol content was lacking or inadequate. The Folin-Ciocalteu assay was applied as a 
screening test to include or eliminate samples for quantification of specific major 
(poly)phenols by HPLC. Fruit smoothies and cranberry juice had the highest total phenolic 
content (TPC) in comparison to mixed fruit juices and fruit concentrates. Blackcurrant 
concentrates were analysed further to quantify major anthocyanins, where reported values 
were similar to other studies [343, 344]. In conclusion, both methods were suitable to 
generate TPC and quantify (poly)phenols efficiently. Findings also supported analyses 
conducted in previous chapters to include fruit juices and smoothies as part of ‘total fruit 
intake’. In addition, limitations with estimation errors should be considered in dietary 
assessments and food databases when generating total (poly)phenol intakes. The chapter 
also highlights the importance of analysing processed foods to update (poly)phenol 
databases to estimate (poly)phenol intake more accurately in the future. 
9.2 Background 
Fruits in general are known to be a good source of (poly)phenols. In previous 
chapters, fruit subgroups such as berries and citrus were reported to lower risk of CVD in 
the UKWCS (Chapter 3 and Chapter 4), and hypotheses based on (poly)phenol mechanisms 
were generated to explain the observations. Dietary assessments for the UKWCS and NDNS 
RP were conducted nearly two decades apart. Between this period, fruit based processed 
products, such as fruit beverages, became more commonly consumed. Little is known about 
the (poly)phenol content of these beverages, and few studies have investigated them [192, 
345, 346]. There was also little or no relevant data on these foods in the (poly)phenol 
database, Phenol Explorer [111]. Before (poly)phenol intakes could be estimated in these 
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populations to explore the hypotheses, limitations in the (poly)phenol database should be 
addressed. 
The Folin-Ciocalteu assay is one of the most commonly used methods to estimate total 
phenolic content (TPC), and is based on an oxidation/reduction reaction [347]. Singleton et. 
al [348] developed this from the Folin-Dennis reagent. The assay is based on the reduction 
of tungstates and molybdates in an alkaline condition to form a blue coloured compound, 
which can be measured using a spectrophotometer. In the context of this chapter, this assay 
functions as a screening test to eliminate samples with low TPC. Further analysis using 
HPLC was applied to allow quantification of (poly)phenols for food samples which have a 
high TPC content, ensuring that the compounds quantified would most likely to play a role 
in vivo. 
The aim of the study was to determine the TPC of selected fruit beverages, quantify 
major (poly)phenols in fruit samples with a high TPC. Firstly, to provide novel data which 
could potentially be included in (poly)phenol databases. Secondly, to address the 
significance of fruit based beverages if (poly)phenol intakes were to be estimated in the 
general population or cohort. 
9.3 Materials and methods 
9.3.1 Materials 
9.3.1.1 Reagents and standards 
Folin-Ciocalteu reagent, sodium carbonate, caffeic acid, catechin, gallic acid, glucose, 
sucrose, fructose, and formic acid (HPLC grade) were purchased from Sigma Aldrich 
(Dorset, UK). Methanol, ethanol and acetonitrile was obtained from Fisher Scientific 
(Loughborough, UK). Cyanidin-3-O-rutinoside (CY3RUT), delphinidin-3-O-rutinoside 
(DP3RUT), myricetin-3-O-rhamnoside (also known as myricitrin) (MY3RNS) nicotinic acid 
and ascorbic acid were provided by Extrasynthese (Genay, France). A Millipore Milli-Q 
water purifying system (Millipore, Hertfordshire, UK) was used to provide deionised and 
ultrapure water (≥ 18.2 MΩ cm at 25 °C) for all assays, reagent preparation and HPLC 
analyses. 
9.3.1.2 Samples 
All beverages analysed in this study were purchased in local supermarkets based in 
Leeds, UK, between November 2011 and March 2012. Orange concentrates were acquired 
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from Sainsbury’s and Waitrose outlets, Leeds, UK. Pineapple juices, Oceanspray cranberry 
juices, Britvic J2O juices, Sun Exotic Tropical fruit juice were purchased from Morrisons, 
Leeds, UK. Ribena concentrate and squashes, Robinsons fruit concentrate and Innocent fruit 
smoothies were purchased from ASDA, Leeds, UK. The Co-operative cranberry, blackberry 
and raspberry smoothie was acquired from the Leeds University Union convenience store. 
Other supermarket branded juices, concentrates or squashes were purchased in their 
respective supermarket outlets, such as ASDA, Sainsbury’s, Morrison’s, Marks & Spencer 
and Tesco, Leeds, UK. Samples were opened, aliquoted (2 mL) and stored at -20°C on the 
day of purchase. Analyses were carried out within one month of storage. 
9.3.2 Methods 
The following section determines the approach to conduct the Folin-Ciocalteu assay. 
The analysis performed in this chapter was done in collaboration with Dr. Hanis Matsura 
Yahya, who published part of the results in her thesis, Chapter 3 [349]. 
9.3.2.1 Standard & reagent preparation for Folin-Ciocalteu assay 
Samples mentioned in the previous section were extracted and diluted differently 
according to the type of food matrix, resulting in various centrifugation and homogenisation 
times (Table 9.1) for Folin-Ciocalteu assay. A standard curve for gallic acid at 0, 25, 50, 75, 
100, 125, 150, 175 and 200 µg/mL was prepared for each Folin-Ciocalteu assay using a 1 
mg/mL stock solution. Folin-Ciocalteu reagent (1:10, v/v) was also freshly prepared for 
each experiment as it degraded under the light. 1M sodium carbonate and 80% methanol 
was stored at ambient temperatures for a period of no longer than six months. 
9.3.2.2 Folin-Ciocalteu assay 
For analysis, 5 mL of diluted Folin-Ciocalteu reagent (1:10, v/v) was added to 1 mL of 
diluted sample (Table 9.1), followed by the addition of 4 mL of 1M sodium carbonate within 
3 – 8 min. The mixtures were vortexed for 5 sec between the additions of each solution. The 
mixtures were then incubated in a water bath at 26°C for 2 hours in Grant GLS Aqua 12 Plus 
water bath (26 °C) (Grant Instruments, Cambridgeshire, UK). Absorbance was measured in 
Cecil Aquarius CE 7200 Double Beam Spectrophotometer (Cecil Instruments Ltd, 
Cambridgeshire, UK) at 765 nm, using 2.5 mL plastic disposable cuvettes (Fisher Scientific, 
Loughborough, UK), and distilled water as the blank reference sample. TPC were expressed 
in the units of gallic acid equivalents (GAE) per serving size after substituting absorbance 
values into the gallic acid standard curve (R2 < 0.995), where the standard curve for gallic 
acid was also produced according to the steps above. The majority of samples were tested 
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in double duplicate format: 1) Duplicate extractions and 2) duplicates for each extraction, 
equating to four replicates per sample, unless stated otherwise. This method of replication 
allows the identification of errors within single extraction and between multiple 
extractions. For samples which did not undergo the double duplicate format, a triplicate 
format was applied. 
Table 9.1 Detailed extraction methods for different categories of fresh and commercial samples from 
supermarkets (Leeds, UK). 
Sample Category Extraction Method 
Fruit Juice 
Concentrate or Juice 
without bits 
1:1 dilution with 80% methanol, followed by vortex for at least 30 sec. Left in room 
temperature to extract for a few minutes before further dilution if required, usually 
1:10. 
Fruit Juice with bits Requires 1:2 dilution with 80% methanol, followed by vortex for at least 30 sec. The 
mixture is then centrifuged at 3000 g, 4˚C for 15 min in Eppendorf 5810R centrifuge 
for larger volumes (>2 mL) (Eppendorf UK Limited, Stevenage, UK) or IEC MicroCL 
17 centrifuge for smaller volumes (< 2 mL) (Thermo Electron Corporation, 
Massachusetts, US). The supernatant is extracted and stored separately. This process 
is repeated for another two times to ensure maximum extraction from the solids. The 
supernatants are combined together for centrifugation at 3000 g, 4˚C for 5 min. 
Thick Fruit Juices & 
Fruit Smoothies 
The food sample is homogenised in POLYTRON™ PT 1600E Benchtop Homogenizer 
(Kinematica, Schweiz, Switzerland) for 1 min 30 sec to 2 min. The remainder of the 
procedure is same as ‘fruit juice with bits’. 
9.3.2.3 Validation of the Folin-Ciocalteu assay 
Two trials were conducted to validate the standards and interferences within the 
Folin-Ciocalteu assay. Gallic acid as the reference for the current analysis was compared 
with caffeic acid, catechin (of which both were commonly used as standards in other 
studies), CY3RUT and DP3RUT which are major anthocyanins in blackcurrant concentrates. 
The Folin-Ciocalteu assay is also known to be subject to chemical interference by other 
compounds [350], including glucose, sucrose, fructose, ascorbic acid and sodium 
metabisulphite which are common in fruit beverages. Standard curves were calculated to 
see how much interference these compounds could cause. Both trials followed the standard 
procedure for extraction in Table 9.1 where applicable, and the preparation of a standard 
curve and Folin-Ciocalteu assay was described in Section 9.3.2.1, with the exception of 
increasing the concentration range for including fructose, ascorbic acid and sodium 
metabisulphite up to 300 µg/mL, and up to 450 µg/mL for glucose and sucrose. 
Correction of ascorbic acid interference was conducted by modifying the Folin-
Ciocalteu assay according to Perla et. al [351]. Sodium carbonate was replaced with an equal 
amount of distilled water in the assay to identify any reducing interference in the samples. 
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In addition, a trial was established by conducting the Folin-Ciocalteu assay described 
in Section 9.3.2.2 on two pineapple juice samples (Morrison’s and Tropicana Pineapple 
Juice). The results from this trial were compared to values from the Phenol Explorer [111]. 
A spiking trial was also conducted to determine whether changes in absorbance 
originate from either the sample, ascorbic acid or standard, using Tesco’s Blackcurrant High 
Juice 50% concentrate (BHJ) as an example. The sample was spiked with a) 200 µg/mL of 
gallic acid, and b) 200 µg/mL of ascorbic acid separately and compared with the absorbance 
of the original sample, 200 µg/mL of gallic acid and 200 µg/mL of ascorbic acid (Table 9.2). 
Both the Folin-Ciocalteu assay (Section 9.3.2.2), and the correction assay [351] conducted 
for this trial in duplicate. Standard curves for gallic acid and ascorbic acid were also 
prepared according to Section 9.3.2.1. 
Table 9.2 The format of the spiking trial 
Folin-Ciocalteu assay Ascorbic acid correction assay [351] 
BHJ BHJ 
Gallic acid (GA) (200 µg/mL) GA (200 µg/mL) 
Ascorbic acid (AA) (200 µg/mL) AA (200 µg/mL) 
BHJ + GA (200 µg/mL)a BHJ + GA (200 µg/mL)a 
BHJ + AA (200 µg/mL)b BHJ + AA (200 µg/mL)b 
a72 µL of undiluted BHJ, 160 µL of gallic acid stock solution at 1 mg/mL and 1368 µL of 80% methanol 
b72 µL of undiluted BHJ, 160 µL of ascorbic acid stock solution at 1 mg/mL and 1368 µL of 80% methanol 
9.3.2.4 High performance liquid chromatography analysis 
Blackcurrant concentrate samples that yielded GAE >100 mg/serving size of 250 mL 
were selected for HPLC analysis. Samples that yielded a lower GAE were not analysed as 1) 
the amount detected within the sample might be insignificant or 2) HPLC is not sensitive 
enough to detect compounds in minute amounts. 
Standard curves for CY3RUT and DP3RUT were prepared using 50% ethanol (v/v) for 
concentrations 10, 50, 100, 200, 250, 300, 350, 400 µM, in triplicates. These standards were 
chosen as they are known to be present in juices after processing, and are major 
anthocyanins present within blackcurrants [352, 353]. Standard curves were prepared in a 
darkened fume cupboard, as anthocyanins are sensitive to light [121], and analysed in 
triplicate. MY3RNS was chosen as the internal standard, due to the similarity in chemical 
structure with CY3RUT and DP3RUT. Its retention time was also similar to both standards. 
A standard curve for MY3RNS was also made according to the description above, and added 
to CY3RUT and DP3RUT standards in amber vials (to prevent degradation by light), with a 
proportion of 30 µl to 20 µl for standard to internal standard respectively, at the same 
concentration for each standard. 
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Extraction methods for samples used were similar to those described for the Folin-
Ciocalteu assay (Table 9.1), with some minor changes. In brief, a 1:10 dilution was made 
with the sample using 80% methanol (HPLC grade) in a 10 mL volumetric flask, followed by 
vortexing for at least 30 seconds. The sample was then left at room temperature to extract 
for a few minutes. This was followed by filtration through a 0.2 µM PTFE filter into a 2 mL 
eppendorf tube, discarding the first few drops. 30 µl was then pipetted into an amber vial 
(to prevent degradation by light), followed by the addition of 20 µl of 50 µM MY3RNS to 
check for consistency of retention time. Samples were prepared and analysed in triplicate. 
High performance liquid chromatography (HPLC) for quantification of major 
anthocyanins was performed on an Agilent 1200 SL system (Agilent technologies, Dorset, 
UK) fitted with a degasser, column oven (30 °C), binary pump, auto-sampler (4 °C) and a 
diode array detector measuring at 350 nm (MY3RNS) and 520 nm (CY3RUT and DP3RUT). 
The stationary phase used for the current analysis was a Zorbax Eclipse XDB-C18 Rapid 
Resolution HT column, at 4.6 x 50 mm, 1.8 µM particle size (Agilent technologies, Dorset, 
UK). The mobile phase consist of 0.5% formic acid in deionised water as solvent A, 0.5% 
formic acid in acetonitrile as solvent B. Solvents were sonicated for at least 30 minutes to 
remove air prior to analysis. The flow rate was 0.5 mL/min. The gradient was as follows for 
solvent B: at 0 – 5 min, 5%; 5 – 20 min, 10 – 40%; 20 – 25 min, 40 – 90%; 25 – 29 min, 90%; 
29 – 30 min, back to 5%; 30 – 33 min, 5%. 
The same HPLC system was used to quantify ascorbic acid levels within blackcurrant 
concentrates, using nicotinic acid as the internal standard. Samples were prepared as above, 
but spiked with nicotinic acid instead of MY3RNS as the internal standard. Standard curves 
for ascorbic acid and nicotinic acid were prepared using 50% ethanol for concentrations 10, 
50, 100, 200, 250, 300, 350, 500, 750, 1000 µM, in triplicates. These compounds were 
measured at 260 nm and 245 nm respectively. The stationary phase used for the current 
analysis was a Waters µBondapak C-18 column, at 3.9 x 300 mm (Waters, UK). The mobile 
phase consisted of 0.2% formic acid in deionised water as solvent A, 0.2% formic acid in 
acetonitrile as solvent B. The flow rate was 1 mL/min. The gradient was as follows for 
solvent B: at 0 – 6 min, 5 – 95%; 6 – 12 min, 95%; 12 – 18 min, 95% – 5%; 18 – 24 min, 5%; 
24 – 44 min, 5%. 
9.3.2.5 Statistical analyses 
The Shapiro-Wilk’s test was applied to assess normality of data distribution as a pre-
requisite for the one-way analysis of variance (ANOVA) to determine whether TPC in 
samples is statistically different. For normally distributed data, one-way ANOVA 
Chapter 9 
232 
 
determined if differences overall are statistically significant. This was followed by a 
Bonferroni post-hoc test to report statistical difference by p-value between each sample. For 
data which are not normally distributed, the non-parametric Kruskal-Wallis one-way 
ANOVA was applied to report if samples overall are statistically different. Statistical 
significance was determined by 2-sided p-value of ≤0.05 for GAE in mg/serving size before 
correction for ascorbic acid content. Stata version 13.0 was used for all statistical analysis 
[273]. 
9.4 Results and Discussion 
9.4.1 Validation of the Folin-Ciocalteu assay 
The parameters for the Folin-Ciocalteu assay was validated in the current study 
because research studies in literature had varied parameters, such as 1) Duration of 
incubation; 2) Temperature of incubation; 3) Timing of acid and alkaline solution; 4) 
Proportion of acid and alkaline solution, 5) Type of standard to use and 6) Interferences. 
As the potential intention was to obtain data in a suitable form for Phenol Explorer, it 
was important that the method used was as similar as possible to the references within the 
database. Data from US [354] and UK [355] added by researchers from Phenol Explorer 
referenced the original method of Singleton et. al [348]. In addition, in the early trials of the 
assay, leaving the samples at room temperature, such as in a Chinese study Xu et. al [129] 
and the PREDIMED trial [356], resulted in a polynomial standard curve, when it was 
supposed to be linear, due to the fluctuating temperature in the laboratory. Thus, a water 
bath at 26°C was implemented into the method. 
In the original paper by Singleton et. al [348], it was suggested that temperature could 
be increased in proportion to decrease incubation time, if samples were left on the bench at 
a low room temperature. In addition, some references from Phenol Explorer did use a higher 
temperature at 40°C [357-359], but the amount of sodium carbonate had to be altered, 
otherwise there would be possibilities of colour fading [348]. This phenomenon was also 
reported in another study [359]. To ensure the stability and repeatability of the assay, 26°C 
was used to reflect a stable room temperature. 
The proportion and timing of adding Folin-Ciocalteu reagent (acidic solution) and 
sodium carbonate (alkaline solution) also affected the repeatability of the assay. Trials 
showed that if the timing for addition of acid was not followed strictly, erratic results would 
be obtained. For this reason, the original parameters from Singleton et. al [348] were used 
in this study. 
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9.4.1.1 Comparison of different standards 
Figure 9.1 illustrates the standard curves for gallic acid, caffeic acid, catechin, CY3RUT 
and DP3RUT. Gallic acid was the standard used in the current study, where the range of 
concentration and absorbance was the highest in comparison to all other compounds. 
Caffeic acid had a lower sensitivity, thus was not advantageous over gallic acid. The curve 
for catechin was comparable to gallic acid, but the compound was more expensive, and 
sensitive towards light [360], and thus may be less reproducible if a standard curve was 
required to be made for every experiment. However, caffeic acid [127] and catechin [146, 
356] were used within other studies. CY3RUT and DP3RUT were also similar to gallic acid, 
however, these compounds were very expensive and light sensitive. After consideration of 
these factors, and bearing in mind practices reported in Phenol Explorer, gallic acid was 
selected as the best choice of standard. In addition, standardising the procedure would 
allow better comparisons with other sources from Phenol Explorer. 
 
Figure 9.1 Standard curves for gallic acid, caffeic acid, catechin, cyanidin-3-O-rutinoside and 
delphinidin-3-O-rutinoside using the Folin-Ciocalteu assay expressed as absorbance measured at 
765 nm. 
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9.4.1.2 Influence of interferences 
Sodium metabisulphite, fructose, glucose and sucrose, commonly found in fruit based 
beverages, were investigated for their interference in the Folin-Ciocalteu assay (Figure 9.2). 
From the figure below, it was possible to conclude that none of these compounds had a 
significant effect on the assay, as they did not react across the concentration range, based 
on negligible absorbance. Therefore, no corrections were made for the presence of these 
compounds. 
 
Figure 9.2 Response of various concentrations of sodium metabisulphite, fructose, glucose and sucrose 
using Folin-Ciocalteu assay expressed as absorbance measured at 765 nm. 
 
9.4.1.3 Preliminary trial using pineapple juice 
Two brands of pineapple juice were tested and compared with Phenol Explorer to 
assess the validity of the assay (Table 9.3). In comparison to Phenol Explorer, the TPC of 
Tropicana Pineapple Juice was higher than the results from Phenol Explorer. In comparison 
to other studies, the TPC of pineapple juice was 40 mg/100 g [146]; 48 mg/100 g [361] and 
94 mg/ 100g [358]; where the highest value of 174 mg/100 g is from a study conducted in 
US by Wu et. al [362]. A study from UK by Mullen et. al [346] conducted the Folin-Ciocalteu 
assay on a commercial product, Tesco Pure Pineapple juice, where the GAE is 2 mmol/L, 
equivalent to 34 mg/ 100 mL, similar to the results obtained. Differences observed between 
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studies could be due to various factors, such as the variety of pineapples used, recipe and 
processing differences. Variation in parameters of the Folin-Ciocalteu assay within different 
studies could also affect the estimation of TPC. Nevertheless, Morrison’s Pineapple Juice had 
a similar TPC in comparison to the Phenol Explorer, confirming the validity of the assay. 
Table 9.3 Total phenolic content of pineapple juices from Phenol Explorer and the current study 
measured by the Folin-Ciocalteu assay expressed as mean (standard deviation) 
 
Phenol Explorer 
Tropicana Pineapple 
Juice (n=3) 
Morrison’s Pineapple 
Juice (n = 3) 
Total phenolic 
content 
(GAE mg/100 mL) 
35.8 68.8 (2.1) 39.9 (1.8) 
9.4.1.4 Spiking trial 
Results of the spiking trial are presented in Table 9.4. TPC of gallic acid and ascorbic 
acid is 70.2 µg/mL and 125.7 µg/mL respectively according to the Folin-Ciocalteu assay, and 
22.2 µg/mL and 50.8 µg/mL according to the correction assay. When assays were conducted 
on samples containing either gallic acid or ascorbic acid, and blackcurrant concentrate in 
combination, measured TPC was 190.6 µg/mL and 240.5 µg/mL respectively for Folin-
Ciocalteu assay and 45.6 µg/mL and 71.5 µg/mL respectively for the correction assay. These 
results were similar in comparison to results in the right column in Table 9.4, derived by 
adding TPC of each component tested separately. Deviance from measured TPC was 
between 7.2 to 15.2% for the Folin-Ciocalteu assay, and 11.1 to 30.1% for the correction 
assay. This trial therefore confirmed that the increased TPC did come from the addition of a 
known concentration of gallic acid or ascorbic acid. 
Table 9.4 Total phenolic content of a blackcurrant concentrate (BHJ), gallic acid, ascorbic acid, and 
spiked BHJ samples with gallic acid and ascorbic acid measured using the Folin-Ciocalteu assay, 
expressed as mean and standard deviation 
Folin-Ciocalteu assay 
Samples 
Total phenolic content 
(µg/mL) (n = 2) 
Total phenolic content after 
addition/subtraction of 
standards (µg/mL) (n = 2) 
Tesco’s Blackcurrant High Juice 50% 
(BHJ)a 
135.3 (2.9) 
d-bBHJ without GA: 120.4 (-11.2%) 
e-cBHJ without AA: 114.8 (-15.2%) 
Gallic acid (GA) (200 µg/mL)b 70.2 (0.2)  
Ascorbic acid (AA) (200 µg/mL)c 125.7 (6.7)  
BHJ + GA (200 µg/mL)d 190.6 (1.3) a+bBHJ with GA: 205.5 (+7.2%) 
BHJ + AA (200 µg/mL)e 240.5 (18.4) a+cBHJ with AA: (+7.8%) 
Ascorbic acid correction assay 
Samples 
Total phenolic content 
(µg/mL) (n = 2) 
Total phenolic content after 
addition/subtraction of 
standards (µg/mL) (n = 2) 
BHJf 29.6 (0.4) 
i-gBHJ without GA: 23.4 (-20.9%) 
j-hBHJ without AA: 20.7 (-30.1%) 
GA (200 µg/mL)g 22.2 (1.0)  
AA (200 µg/mL)h 50.8 (1.6)  
BHJ + GA (200 µg/mL)i 45.6 (0.4) f+gBHJ with GA: 51.8 (+12.0%) 
BHJ + AA (200 µg/mL)j 71.5 (0.6) f+hBHJ with AA: 80.4 (+11.1%) 
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9.4.2 Total phenolic content in fruit based beverages 
9.4.2.1 Fruit juices and smoothies 
TPC of five cranberry juices are reported in Figure 9.3, where TPC overall was 
statistically different, determined by one-way ANOVA. Juices containing additives such as 
sweeteners, or named ‘juice drink’, had a significantly lower TPC in contrast to cranberry 
‘juices’. Oceanspray Cranberry Classic Light with Sweetener had the lowest TPC at 115.8 ± 
20.3 GAE mg/serving size, while a serving of Oceanspray 100% Juice Cranberry Blend 
(OJCB) provided 271.3 ± 13.7 GAE mg of phenolic content. As compared to Phenol Explorer, 
OJCB had the closest value to the citied reference of cranberry fruit (data for juice was 
unavailable) with a TPC of 337 – 360 mg/serving [363]. However, OJCB consist of a blend of 
cranberries and grapes, and which the latter is known to contribute to high phenolic 
content, consisting mainly of anthocyanins. In comparison to the literature outside Phenol 
Explorer, the results obtained were similar for the same commercial product, Oceanspray 
Cranberry Classic (OCC) (230 mg/serving size), at a TPC of 195 mg/serving size from a 
different study [346], once again suggesting that the method used in the current study is 
valid. 
Figure 9.4 provides the TPC of various mixed fruit juices. Results here were 
incomparable to other studies, due to differences in methods and samples. The range of 
measured TPC was very wide, ranging from ASDA’s Apple & Blackberry Juice Drink with 
59.4 ± 1.8 GAE mg/serving size to Tropicana Pomegranate, Grape and Apple juice containing 
224.5 ± 3.0 GAE mg/serving size. The Kruskal-Wallis ANOVA determined that the TPC here 
was significantly different overall (p-value <0.001). Judging by the name of the product, 
‘juice drinks’ tended to have a lower TPC in comparison to ‘juices’. Among the five samples 
with the highest TPC, fruits included were citrus fruits, cranberry, pomegranate, grape, 
apple, peach, mango and papaya within the beverages. According to Phenol Explorer, these 
fruits all yield a high TPC value in Folin-Ciocalteu assay [146, 361-364]. However, some of 
these fruits also contained a high amount of ascorbic acid, which could cause an 
overestimation of TPC. As for mixed fruit juices with lower TPC, several reasons were 
proposed: 1) The fresh fruit juices could be diluted with water, with flavourings and sugar 
added instead; 2) The juices were sieved, hence the (poly)phenols that remained in the bits 
could have been removed; or 3) Other sources of interference were present in large 
amounts within the juices. This figure illustrates that the term ‘mixed fruit juices’ was very 
broad in terms of estimating TPC. 
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The TPC for fruit smoothies are reported in Figure 9.5. Fruit smoothies had a higher 
overall TPC than cranberry and mixed fruit juices, which ranged from 145.4 ± 1.9 to 247.2 
± 19.2 GAE mg/250 mL. The Kruskal-Wallis ANOVA also determined that the overall TPC 
content here are statistically different (p-value = 0.006). From the names of the smoothies, 
those containing berries were more likely to have a higher TPC, as agreed in a study 
analysing from German smoothies [365]. Smoothies which only consist of fruits such as 
mango, orange and pineapple also had the lowest TPC in that particular study, similar to the 
findings here. The TPC of German commercial smoothies ranged from 127.5 to 532.5 GAE 
mg/250 g [365]. The study suggested that fruit smoothies with high TPC contained fruit 
purees, in comparison to fruit smoothies without fruit purees, indicating differences in 
ingredient composition and processing could affect the outcome of TPC greatly. Varying 
processing effects and duration of storage could have also caused the differences in TPC 
[366]. Fruit smoothies in this study were frozen at -20°C instead of storage at 4°C, it is 
unclear if different storage temperatures may impact on the stability of (poly)phenols. In 
comparison to mixed fruit juices, the significance in the removal of pulp and bits was 
observed here. According to the label on the beverage, smoothies were not diluted and do 
not contain additives, which meant that it is possible that the higher the percentage of real 
fruit or fruit juices could be associated with a higher TPC. The same observation was also 
reported in Müller et. al [365]. 
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Figure 9.3 Total phenolic content in gallic acid equivalents for cranberry juices measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3). Samples that share a 
different alphabet expressed as significantly different using one-way ANOVA and Bonferroni post-
hoc test (p<0.05). 
Serving size: 250 mL; Full sample name in the order of presentation: OCCL (Oceanspray Cranberry Classic Light 
with Sweetener), ACJN (ASDA’s Cranberry Juice Drink with No Added Sugar), ACJ (ASDA’s Cranberry Juice 
Drink), OCC (Oceanspray Cranberry Classic), OJCB (Oceanspray 100% Juice Cranberry Blend) 
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Figure 9.4 Total phenolic content in gallic acid equivalents for mixed fruit juices measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3, *replicates = 4) 
Serving size: 250 mL; Full sample name: ABJD (ASDA's Apple & Blackberry Juice Drink), JOAM (J2O Apple and 
Mango), JOAR (J2O Apple and Raspberry), SETF (Sun Exotic Tropical Fruit), JOOP (J2O Orange and Passionfruit), 
GARJ (ASDA's Grape, Apple & Raspberry Juice Drink), ACJD (ASDA's Citrus Juice Drink), JOAB (J2O Apple and 
Blackberry), FFJD (ASDA's Forest Fruits Juice Drink), ITJ (Innocent Tropical Juice), TRB (Tropicana Ruby 
Breakfast), MTJ (Morrison's Tropical Juice), MOC (Morrison's Orange and Cranberry), IARJ (Innocent Apple & 
Raspberry Juice), TMPP (Tropicana Mango, Peach and Papaya), TPGA (Tropicana Pomegranate, Grape and 
Apple) 
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Figure 9.5 Total phenolic content in gallic acid equivalents for fruit smoothies measured by the Folin-
Ciocalteu assay, expressed as mean and standard deviation (replicates = 3) 
Serving size: 250 mL; Full sample name: IPBC (Innocent Pineapple, Banana and Coconut), IOMP (Innocent for 
Kids: Orange, Mangoes and Pineapple), IMP (Innocent Mango and Passionfruit), IKAL (Innocent Kiwi, Apples 
and Limes), CSBR (Co-operative Cranberry, Blackberry and Raspberry), ISB (Innocent Strawberries and 
Bananas), IAB (Innocent for Kids: Apples and Blackcurrants), ISBR (Innocent for Kids: Strawberries, 
Blackberries and Raspberries) 
 
9.4.2.2 Concentrates 
The Folin-Ciocalteu assay results for five different orange concentrates, both with and 
without ascorbic acid correction are presented in Figure 9.6. In general, the content of TPC 
were statistically different, determined by the Kruskal-Wallis ANOVA (p-value <0.001). The 
concentrates with the term ‘high juice’ tended to have a higher phenolic content compared 
to ‘squash’. Sainsbury’s Basics Double Strength Orange Squash had the lowest phenolic 
content (7.9 ± 0.1 GAE mg/serving size), while Waitrose High Juice Orange Squash had the 
highest phenolic content (82.2 ± 1.4 GAE mg/serving size). In terms of estimated ascorbic 
acid content, this seemed to increase with increasing TPC (Figure 9.6). 
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Figure 9.6 Total phenolic content in gallic acid equivalents and estimated vitamin C content for orange 
concentrates measured by the Folin-Ciocalteu assay, expressed as mean and standard deviation 
(replicates = 4) 
Serving size: 250 mL after dilution; Full sample name: DSON (Sainsbury's Basics Double Strength Orange 
Squash), SOSN (Orange Squash by Sainsbury's), SOC (Orange Cordial by Sainsbury's), SOHJ (High Juice Orange 
by Sainsbury's), WOSH (Waitrose High Juice Orange Squash) 
 
With regard to blackcurrant concentrates within 30 different types tested, a large 
variation of phenolic content was observed (Figure 9.7), ranging from 0 to 135.9 ± 8.7 GAE 
mg/serving size, with a mean of 43.2 ± 3.0 GAE mg/serving size after correcting for ascorbic 
acid content. The Kruskal-Wallis ANOVA also confirmed that TPC here are statistically 
different in general (p-value <0.001). With the exception of two blackcurrant concentrates 
with the lowest phenolic content, the estimated ascorbic acid levels generally follow a 
similar pattern described above. Samples which consisted of both ‘apple and blackcurrant’ 
or ‘double strength’ were more likely to have a lower phenolic content, compared to 
blackcurrant only concentrates, as well as ‘cordials’ or ‘high juice’. The figure illustrates 
clearly the wide extent of variation in phenolic content within a specific type of product. 
There have not been many reported analyses of fruit juice concentrates, but there 
were a few studies that the results may be compared with. A Spanish study by Bermúdez-
Soto et. al [352] used the same reference method for Folin-Ciocalteu assay and reported the 
TPC of blackcurrant concentrate to be 117 mg/serving size. This is similar to the TPC of 
commercial blackcurrant concentrates on the high end of the graph, such as High Juice 
Blackcurrant by Sainsbury’s (SBHJ). Other samples had extremely low GAE, which might be 
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due to processing effects, such as the extent of dilution and proportion of blackcurrant fruit. 
Even so, the concentrates contained considerably less TPC when compared to the data on 
Phenol Explorer on fresh blackcurrant fruits, where the average was 821 mg/ 100g [354, 
357, 367]. The difference in phenolic content was reasonable as they were mostly 
anthocyanins, which were likely to degrade up to >90% during processing that involving 
exposure to heat, pH change and light [368]. However, a study also suggested that there 
were no significant losses of anthocyanins in commercial processing [345]. Enzyme 
treatments were also suggested to increase phenolic content within blackcurrant juice to 
650 – 665 mg/ 100 mL GAE [369]. 
Overall by sample groups, fruit juices and smoothies had a higher TPC in comparison 
to made-up concentrates. (Table 9.5). Of the juice based drinks, mixed fruit juices had the 
lowest TPC, followed by fruit smoothies and cranberry juice, while blackcurrant 
concentrates had a slightly higher TPC than orange concentrates. In conclusion for this 
section, the Folin-Ciocalteu assay was able to effectively act as a screening assay to 
differentiate fruit beverages according to TPC. Parameters in the Folin-Ciocalteu assay here 
had also been tested, thus it would also be possible to apply this method directly to future 
studies. In addition, the correction for ascorbic acid was also important as it was 
demonstrated to interfere with the assay. 
Alternative methods are also available to measure antioxidant activity [347], but 
these methods were not adopted here because the study was only interested in separating 
‘low’ TPC and ‘high’ TPC samples. Antioxidant activity is not one of the possible mechanisms 
of (poly)phenols in vivo, where these compounds also exhibit various other effects. 
Therefore, application of other antioxidant assays suggested in Prior et. al [347] is not 
reflective of the mechanistic effects occurring in vivo, and does not account for 
bioavailability. 
Table 9.5 Total phenolic measured by Folin-Ciocalteu assay by sample group, expressed as mg/serving 
size (250 mL) without ascorbic acid correction 
Sample group Total phenolic content,  
(GAE mg/serving size) 
(mean ± SD) 
Total phenolic content, 
(GAE mg/serving size) 
(min – max) 
Kruskal-Wallis 
one-way ANOVA, 
(p-value) 
Cranberry juice 200.9 ± 20.9 116 – 271 
<0.001 
Mixed fruit juice 136.1 ± 5.2 59.4 – 212 
Fruit smoothies 198.8 ± 8.0 145 – 247 
Orange concentrates 42.8 ± 0.8 8 – 63 
Blackcurrant concentrates 54.4 ±2.9 5 – 153 
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Figure 9.7 Total phenolic content in gallic acid equivalents and estimated vitamin C content for 
blackcurrant concentrates measured by the Folin-Ciocalteu assay, expressed as mean and 
standard deviation (replicates = 4, *replicates = 3) 
Serving size: 250 mL after dilution; Full sample name: MABD (Morrisons Double Strength Apple & Blackcurrant 
Squash No Added Sugar), MABN (Morrisons Apple & Blackcurrant Squash No Added Sugar), SPAB (ASDA Smart 
Price Apple & Blackcurrant Double Strength Squash No Added Sugar), DSSA (Sainsbury's Basics Double Strength 
Apple and Blackcurrant Squash), DSAB (Tesco's Value Double Strength Apple and Blackcurrant Squash No 
Added Sugar), SBFC (Schweppes Blackcurrant Flavour Cordial), SABN (Apple and Blackcurrant Squash by 
Sainsbury's), ABSD (Tesco's Apple and Blackcurrant Squash Double Strength), MSAB (Simply M&S Apple & 
Blackcurrant Squash No Added Sugar), ABDN (ASDA Apple & Blackcurrant Double Strength Squash No Added 
Sugar), RABN (Robinson's Apple and Blackcurrant No Added Sugar), ABDS (ASDA Apple & Blackcurrant Double 
Strength Squash), RABS (Robinson's Apple and Blackcurrant), SBCN (Blackcurrant Squash by Sainsbury's), 
ABHN (ASDA 50% Fruit High Juice Apple & Blackcurrant No Added Sugar), BS (Tesco's Blackcurrant Squash 
Double Strength), ABSN (Tesco's Apple and Blackcurrant Squash Double Strength No Added Sugar), BCDN 
(ASDA Blackcurrant Double Strength Squash No Added Sugar), MBHN (Marks & Spencer Blackcurrant High Juice 
No Added Sugar), MSBJ (Marks & Spencer Blackcurrant High Juice), BCJD (ASDA Blackcurrant Juice Drink), BCJN 
(ASDA Blackcurrant Juice Drink No Added Sugar), MSBC (Marks & Spencer British Blackcurrant Cordial), MBHJ 
(Morrisons Blackcurrant High Juice 45% Fruit Juice), SBHJ (High Juice Blackcurrant by Sainsbury's), RC (Ribena 
Concentrate), RPIS (Ribena Plus Immunity Support), BHJ (Tesco's Blackcurrant High Juice 50%), BC (Tesco's 
Blackcurrant Cordial (25% Fruit Juice)), RNAS (Ribena No Added Sugar) 
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9.4.3 Quantification of major anthocyanins in blackcurrant 
concentrates using HPLC 
9.4.3.1 Method development 
Prior to HPLC analysis, the method had to be validated. Compounds in blackcurrant 
juice, which were mostly anthocyanins, could not be separated using the original 
parameters (Figure 9.8). In addition, the chemical structures of CY3RUT and DP3RUT were 
very similar, which made separation even more difficult (Chapter 1 Section 1.2.3.1.1). The 
initial solvents used contained 0.1% of formic acid, equivalent to pH 2.9. Anthocyanins are 
largely affected by pH, capable of existing in different chemical forms under different pH 
conditions [121, 370]. The most stable form is at pH 1, where the red flavylium cation is 
dominant, contributing to produce red and purple colour within the food matrix. As the pH 
increases, the predominant form of anthocyanin changes. At pH 2 – 4, the blue quinoidal 
species dominates, and at pH 5 – 6 the colourless carbinol pseudo-base dominates. At pH 7 
and above, the anthocyanin will degrade. If the acidity of the solvent is increased, separation 
might improve as there would be more of the red flavylium cation, improving sensitivity of 
the anthocyanin detected. Therefore, the concentration of formic acid was increased to 
lower the pH to 2, which should allow better separation of peaks for CY3RUT and DP3RUT 
(Figure 9.9). 
 
Figure 9.8 A section of the chromatogram of compounds delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside using 0.1% formic acid solvents (both A and B). 
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Figure 9.9 A section of the chromatogram of compounds delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside using 0.5% formic acid solvents (both A and B). 
9.4.3.2 Standard curves and chromatograms 
Levels of CY3RUT, DP3RUT and ascorbic acid in blackcurrant concentrates with over 
100 GAE mg/serving size measured from the Folin-Ciocalteu assay were further quantified 
using HPLC.  
Figure 9.10 and Figure 9.11 report the typical standard curve for the three 
compounds of interest, as well as for the internal standard nicotinic acid. 
 
Figure 9.10 Standard curves for cyanidin-3-O-rutinoside and delphinidin-3-O-rutinoside quantified by 
HPLC, expressed in mean and standard deviation in nmol (replicates = 3) 
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Figure 9.11 Standard curves for ascorbic acid and nicotinic acid quantified by HPLC, expressed in mean 
and standard deviation in nmol (replicates = 3) 
 
9.4.3.3 Content of ascorbic acid and anthocyanins in blackcurrant 
concentrates 
Figure 9.12 illustrates the typical chromatograms obtained from HPLC analysis for a 
blackcurrant concentrate, while Figure 9.13 provides an overview of CY3RUT and DP3RUT 
content within the beverages. The proportion of CY3RUT to DP3RUT was consistent 
throughout all samples and compared to Phenol Explorer. The range of total anthocyanins 
was between 4.5 to 35.3 mg/50 mL of undiluted concentrate, while the average amount was 
12.6 mg/50 mL. Ribena Plus Immunity Support had the lowest levels of total anthocyanins 
within 50 mL of undiluted concentrate (4.51 mg/50 mL), while Marks & Spencer British 
Blackcurrant Cordial had the highest total anthocyanin content (35.3 mg/50 mL). The latter 
cordial was able to provide major anthocyanins equivalent 6 to 8 g of blackcurrants (≈15% 
of reported values in Phenol Explorer). 
In terms of specific anthocyanins, the levels of CY3RUT and DP3RUT within 
blackcurrant concentrates ranged between 1.5 to 10.5 mg/50 mL and 3.0 to 11.6 mg/50 mL 
of undiluted concentrate, and the mean was 3.9 ± 2.6 mg/50 mL and 8.6 ± 6.1 mg/50 mL 
respectively. The Kruskal-Wallis ANOVA determined statistically different levels of CY3RUT 
and DP3RUT between these samples overall (p-value <0.001). In comparison to other 
studies, the findings from this experiment were similar to a study on European fruit juices 
by Mattila et. al [343], where the range reported was 4.3 – 58 mg/250 mL on a ready-to-
drink basis (directly comparable to 50 mL of undiluted concentrate). UK commercial 
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blackcurrant concentrates tested within that study had an average anthocyanin content of 
7.5 mg/250 mL on a ready-to-drink basis. The authors were also able to identify 
delphinidin-3-O-glucoside and cyanidin-3-O-glucoside as a different method to the current 
study was used. In a Spanish study by Bermúdez-Soto et. al [352], the reported values for 
total phenolics in HPLC and Folin-Ciocalteu assay were extremely high, as compared to the 
results from this study. Total phenolics detected by HPLC were 1480 mg/100 mL and for 
Folin-Ciocalteu were 2340 mg/100 mL, which was ten times greater than the amount 
detected here. However, the amount of total anthocyanins (7.8 mg/100 mL) was lower than 
all the samples in this study. Total anthocyanin content for RC, BHJ and BC were also similar 
to the results from Hollands et. al [344] (UK), which ranged from 4.1 to 32.2 mg/50 mL of 
undiluted blackcurrant squashes and cordials. However, the current method was unable to 
detect other anthocyanins in comparison to Hollands et. al [344]. To conclude, total 
anthocyanin levels quantified from the current analysis are similar to other studies, with 
the exception of Bermúdez-Soto et. al [352]. 
When findings from the current study were compared to HPLC analysis of fresh 
blackcurrant in Phenol Explorer, the average amount of CY3RUT is 80.4 mg/50 g, which was 
about ten times greater than blackcurrant concentrates. This was also consistent for 
DP3RUT [354, 371]. From the evaluation above, it is possible to conclude that processing 
fresh blackcurrants into cordials, squash and concentrates reduces the amount of 
anthocyanins greatly. This is reasonable as anthocyanins are known to be unstable at higher 
temperatures [121, 372], through hydrolysis of sugars attached. The aglycones generated 
would also breakdown further as they are also unstable [372]. The yield of anthocyanins in 
blackcurrant juice could be increased by using pectinolytic enzymatic treatments, [369, 
373]. 
Quantified anthocyanin levels here were also significantly less than estimates using 
the Folin-Ciocalteu assay (though no statistical tests were conducted). This was expected as 
Folin-Ciocalteu assay was likely to be interfered by components such as ascorbic acid, thus 
it was also quantified in the next section. 
Data produced from HPLC provided a better estimation on the amount of 
anthocyanins are consumed via blackcurrant concentrate drinks. From the findings of this 
study, it was possible to conclude that blackcurrant concentrates are unlikely to contribute 
greatly to total (poly)phenol intakes, unless it was consumed in high quantities. 
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Figure 9.12 Example HPLC chromatograms of myricitrin, delphinidin-3-O-rutinoside and cyanidin-3-O-
rutinoside, and their respective UV absorption spectras from Ribena No Added Sugar sample 
 
Figure 9.13 Amount of cyanidin-3-O-rutinoside and delphinidin-3-O-rutinoside quantified using HPLC 
in blackcurrant concentrates in comparison to blackcurrant fruit from Phenol Explorer, 
expressed as mean and standard deviation (replicates = 9) 
Full sample name: RPIS (Ribena Plus Immunity Support), BCJN (ASDA Blackcurrant Juice Drink No Added 
Sugar), BCJD (ASDA Blackcurrant Juice Drink), BC (Tesco's Blackcurrant Cordial (25% Fruit Juice), MSBJ (Marks 
& Spencer Blackcurrant High Juice), RC (Ribena Concentrate), BHJ (Tesco's Blackcurrant High Juice 50%), 
MBHN (Marks & Spencer Blackcurrant High Juice No Added Sugar), RNAS (Ribena No Added Sugar), MBHJ 
(Morrisons Blackcurrant High Juice 45% Fruit Juice), MSBC (Marks & Spencer British Blackcurrant Cordial) 
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In terms of ascorbic acid content, a typical chromatogram is presented in Figure 9.14, 
while Figure 9.16 shows the levels of ascorbic acid content within blackcurrant 
concentrates by serving size. The beverages provided between 11 to 144 mg/50 mL of 
ascorbic acid in an undiluted form, where the average level is 76.9 ± 48.3 mg/50 mL, 
adequate to achieve the reference nutrient intake for both male and females (40 mg/day) 
[374]. The Kruskal-Wallis ANOVA also confirmed that ascorbic acid content in blackcurrant 
concentrates are statistically different from each other (p-value <0.001). 
When ascorbic acid content was plotted against levels of anthocyanin within 
blackcurrant concentrates (Figure 9.15), graphically, no distinct patterns observed were 
observed. Moreover, the correlation between the two was -0.40, suggesting that there was 
only a weak negative correlation between ascorbic acid and anthocyanin content. 
 
 
Figure 9.14 Example HPLC chromatograms of ascorbic acid and nicotinic acid, and their respective UV 
absorption spectras from Ribena No Added Sugar sample 
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Figure 9.15 Scatter graph showing the association and correlation between ascorbic acid and total 
anthocyanin content quantified by HPLC in blackcurrant concentrates 
 
Figure 9.16 Amount of ascorbic acid quantified using HPLC in blackcurrant concentrates, expressed as 
mean and standard deviation (replicates = 9) 
Full sample name: MSBC (Marks & Spencer British Blackcurrant Cordial), MBHN (Marks & Spencer Blackcurrant 
High Juice No Added Sugar), MSBJ (Marks & Spencer Blackcurrant High Juice), MBHJ (Morrisons Blackcurrant 
High Juice 45% Fruit Juice), BHJ (Tesco's Blackcurrant High Juice 50%), RNAS (Ribena No Added Sugar), RPIS 
(Ribena Plus Immunity Support), RC (Ribena Concentrate), BCJN (ASDA Blackcurrant Juice Drink No Added 
Sugar), BCJD (ASDA Blackcurrant Juice Drink), BC (Tesco's Blackcurrant Cordial (25% Fruit Juice))  
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The HPLC method applied here is a suitable method to quantify major (poly)phenols 
within fruit beverages, as exhibited above. Minor components were not quantified because 
the HPLC method was not sensitive enough. It was also unlikely for these components to 
have concentration high enough in vivo to exhibit mechanistic effects after considering the 
variation in bioavailability as well. Alternative methods such as mass spectrometry could 
quantify minor components to complete the (poly)phenol profile of blackcurrant 
concentrates. 
9.4.4 Importance in the assessment of total dietary (poly)phenol 
intakes 
The data obtained in this study revealed the importance of including pure fruit juices 
and smoothies when collecting dietary data, whether to estimate total fruit intake, or to 
estimate TPC and specific (poly)phenol intake. This implication was based on the higher 
TPC in fruit smoothies and some fruit juices in comparison to concentrates. Assuming that 
the percentage of real fruit would be higher in smoothies than concentrates, it would 
contribute more to (poly)phenol intakes. In addition for the same reason mentioned above, 
concentrates, juice with or without bits and fruit smoothies should not be included in the 
same category in dietary assessment methods where possible, to avoid or minimise 
estimation error. 
This estimation error could result from a number of factors. Firstly, the variation in 
TPC observed within blackcurrant concentrates revealed a limitation in taking an average 
value to represent a particular food item within dietary assessments. This could be due to 
processing effects, which had been elaborated above, or because of the natural variation in 
(poly)phenol content that exists within cultivars of the same fruit, and their growing 
conditions. In relation to FFQs, variables from the FFQ usually represent multiple food items 
categorised together. For example, if fruit based beverages were all grouped under ‘fruit 
juice’, the limitation mentioned in the previous paragraph would apply. Similarly, grouping 
all citrus related food items under ‘citrus’ fruit could also result in the same problem, if the 
intention of the study was to estimate dietary (poly)phenol intake. A food diary could 
possibly minimise this type of error by asking for further details on fruit beverages drunk 
by matching items to the exact, or closest items on the food database. However, both the 
FFQ and food diary are reliant on food databases to translate food items into nutrient, 
mineral and phytochemical intakes. Food databases usually store average values of food 
items, instead of having an entry for each item. Thus, this is a limitation which should be 
recognised when estimating TPC or (poly)phenol intakes. To overcome this limitation, food 
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analyses on items which are not in (poly)phenol databases (USDA, Phenol Explorer) should 
be conducted to fill in gaps, in order to estimate TPC and specific (poly)phenol intake more 
accurately. 
In reflection to the analysis completed in previous chapters using the UKWCS 
(Chapter 3, Chapter 4 and Chapter 6), the results from this study support the methodology 
where fruit juices were included as part of the estimated total fruit intake. The current 
results also support the methodology adapted in Chapter 10, however, due to the low 
variation in consumption, smoothies and fruit juices were categorised together. If 
(poly)phenol intakes were to be estimated in the future, it would be ideal if the two 
categories were investigated separately. 
9.5 Summary 
In conclusion, fruit smoothies and cranberry juice have the highest TPC, and would 
most likely make a potential contribution to the estimation of total (poly)phenol intakes, 
but further analyses using HPLC would be required for verification. CY3RUT and DP3RUT 
in blackcurrant concentrates were successfully quantified. A substantial consumption of 
blackcurrant concentrates containing high amounts of anthocyanins would also contribute 
to anthocyanin intake in general populations. Results from this chapter also supported 
methodology adopted in previous chapters (Chapter 3, Chapter 4, Chapter 6 and Chapter 
10). 
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Chapter 10  
Fruit, vegetable intake and blood pressure measurements 
within adults in the National Diet and Nutrition Survey Rolling 
Programme (2008 – 2012) 
10.1 Abstract 
Chapter 6 explored the association between FV intake, and the odds of self-reported 
HBP. This study aimed to explore the association between total FV, and fruit, vegetable 
subgroups and measured BP in the NDNS RP 2008 to 2012. Total FV intake (g/day) derived 
from a four-day food diary, was obtained from 1,002 participants (aged 19 to 91 years) from 
2008 to 2012 who were not on BP lowering medication. FV intakes were also further 
grouped by (poly)phenol profile into berries, citrus, drupes, pomes and tropical fruit, and 
Allium, Brassicaceae, fruit vegetables, pod vegetables and stalk/root vegetables. BP (mmHg) 
was measured during a nurse visit. Participants were also divided into hypertensive and 
normotensive categories. Multivariate regression and logistic regression were conducted 
respectively for measured BP and hypertensive status. Higher intakes of total FV was 
associated with lower odds of BP. Greater consumption of total fruit intake was negatively 
associated with lower BP, and this persisted in subgroups of non-obese, elderly and male 
subpopulations. Moderate intake of pomes was also associated with lower SBP in general, 
and with lower DBP in the elderly population. Total vegetable and vegetable subgroups 
were not associated with lower BP. This finding is aligned with Chapter 6 investigating 
UKWCS and current literature promoting high FV intakes. Further interventions are 
recommended for consumption of pome fruits to assess its relationship with BP lowering 
effects in the normotensive population as a form of preventing HBP development. 
10.2 Background 
The relationship between FV intake was explored in the UKWCS previously in 
Chapter 6. A greater intake of total FVs, especially vegetables, pomes and fruit vegetables 
was associated with a lower odds of self-reported HBP. Chapter 8 assessed the relative 
validity of the FFQ against the food diary, and discussed the strengths and limitations of 
both dietary assessments. In comparison to the FFQ, despite only taking a snapshot of diet 
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which may or may not be reflective of habitual intake, food diaries are less likely to 
overestimate intakes, and capture higher quality dietary data. FV intakes in the UKWCS 
were also collected two decades ago, and were possibly not reflective of current diets, due 
to the increased availability and variation of foods overtime. In addition, self-reported HBP 
could likely to be subject to misreporting since many individuals would be unaware they 
have HBP. On the basis of the same literature discussed in Chapter 6, the current chapter 
aims to overcome previous limitations, and improve the quality of exposure and outcome. 
Measured BP (mmHg) using the National Diet and Nutrition Survey Rolling Programme 
(NDNS RP) 2008 – 2012, and its association with total FV intake and subgroups of FV intake 
according to similarities in (poly)phenol profile with reference to Phenol Explorer [111] 
will be explored here. 
10.3 Method 
10.3.1 Dietary exposure 
The generation of total FV intakes, fruit subgroup and vegetable subgroup intakes was 
documented in Chapter 2, Section 2.7.1. There were no missing data for both intakes. 
Consumption was expressed as grams of fruit or vegetable intake per day (g/day). 
10.3.2 Measurement outcome 
BP measurement was available for participants who gave consent to nurse visits. The 
procedures have been described in Chapter 2 Section 2.3.3.3. An average of three valid 
systolic and diastolic measurements for each eligible participant was calculated in 
millimetres of mercury (mmHg). Participants were also divided into non-hypertensive and 
hypertensive categories. Hypertension is defined by a SBP of 140 mmHg and above, and/or 
DBP of 90 mmHg and above. 
10.3.3 Statistical method and design 
10.3.3.1 Outliers and exclusions 
The procedure for omitting outliers and implementing exclusions is documented in 
Chapter 2, Section 2.5.1. In brief, participants who met the following criteria were excluded: 
1. Participants younger than 19 years (n = 2073) 
2. Participants with no valid BP readings (n = 866) 
3. Participants who consume BP related medication (n = 211). 
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 The current study intended to study a healthy population. Participants 
who consume BP related medication may have their condition 
controlled, thus potentially misclassifying them as non-hypertensive. 
These participants may also have changed their diet due to their BP 
related condition, so their dietary intake may have been different 
before they knew they were hypertensive. 
4. Participant who consumed more than 300 g alcohol on average per day (n = 
1) and participants who had less than 500 kcal/day energy intake (n = 3). 
10.3.3.2 Confounding 
The concept of confounding was explained in Chapter 2, and the current analysis is 
based on the DAG from Chapter 2, Section 2.5.1 to provide evidence for inclusion of potential 
confounders. These confounders were previously explored as a correlation matrix. Results 
showed that none of the potential confounders were correlated to each other, thus 
multicollinearity is unlikely (Table 10.1). Univariate analysis was also conducted prior to 
the DAG to explore the relationship between the variable of interest and outcome. These 
univariate analyses support findings of the literature that hypertension is related to 
increasing age, smoking status, obesity, SES and alcohol drinking, and helped to guide model 
development (Table 10.2). 
Table 10.1 Correlation between variables included in the model 
Correlation Age BMI Energy Physical 
activity 
Smoking SES Alcohol 
Age 1.00       
BMI 0.15 1.00      
Energy -0.06 -0.07 1.00     
Physical 
activity 
-0.06 -0.09 0.12 1.00    
Smoking 0.05 -0.01 0.09 -0.01 1.00   
SES -0.03 0.05 -0.02 0.01 -0.15 1.00  
Alcohol <-0.01 0.04 0.13 0.09 -0.11 -0.09 1.00 
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Table 10.2 Univariate analyses of potential confounders and BP (mmHg) and odds ratio of hypertension 
per unit increment for continuous variables or by category for categorical variables 
Variable of Interest Systolic BP (mmHg) Diastolic BP 
(mmHg) 
Hypertension (Odds 
ratio) 
Age (years) 0.37 (0.31, 0.43) 0.09 (0.05, 0.13) 1.04 (1.03, 1.06) 
BMI (kg/m2)    
Underweight 0 0 1 
Normal 4.08 (-1.46, 12.8) 5.78 (-0.02, 11.6) 1.38 (0.17, 11.0) 
Overweight 11.0 (2.28, 19.7) 10.4 (4.64, 16.2) 2.76 (0.35, 21.7) 
Obese 14.0 (5.3, 22.8) 14.8 (8.9, 20.6) 4.19 (0.53, 33.0) 
Missing 12.4 (2.59, 22.2) 11.9 (5.3, 18.4) 3.93 (0.45, 34.4) 
Energy (kcal/day) 0.003 (0.001, 0.005) 0.00 (-0.00, 0.00) 1.00 (1.00, 1.00) 
Physical Activity (hr/day)    
0 to 0.4 hours 0 0 1 
0.4 to 1.3 hours -2.11 (-4.94, 0.72) -0.26 (-2.19, 1.67) 0.59 (0.36, 0.95) 
>1.3 hours 1.36 (-1.47, 4.19) 0.48 (-1.46, 2.41) 1.06 (0.68, 1.64) 
Missing 1.09 (-1.58, 3.76) 0.58 (-1.24, 2.41) 0.89 (0.58, 1.36) 
Smoking Status    
Current smoker 0 0 1 
Ex-regular smoker 2.12 (-1.02, 5.27) 0.85 (-1.29, 3.00) 1.51 (0.92, 2.48) 
Never regular smoker -0.38 (-3.12, 2.35) 0.76 (-1.11, 2.62) 0.92 (0.58, 1.45) 
Socioeconomic Status (SES)    
Professional/Managerial 0 0 1 
Intermediate 0.89 (-1.70, 3.48) -1.16 (-2.93, 0.61) 1.00 (0.64, 1.55) 
Routine/Manual 1.46 (-0.78, 3.71) -0.07 (-1.60, 1.46) 1.48 (1.04, 2.12) 
Alcohol (g/day) 0.12 (0.07, 0.17) 0.09 (0.06, 0.13) 1.01 (1.00, 1.02) 
The models used in these analysis are: 
1. Age (years) 
2. Age (years), BMI (underweight, normal, overweight, obese and missing), physical 
activity(categorical), smoking status (current smoker v.s. ex-smoker v.s. never-
smoker), alcohol intake (g/day) and socio-economic status 
(professional/managerial, intermediate or routine/manual). 
3. In addition to model 2, energy intake (kcal/day) was also included. 
Models that investigated FV subgroups by (poly)phenol profile were further adjusted 
for total vegetable and total fruit intakes respectively. The non-exposure group was also 
adjusted for in addition to the appropriate total fruit or vegetable intakes. This is because 
of possible confounding [plausible biological mechanisms of (poly)phenols] for the 
association between the investigated exposure and outcome. In particular, it is important 
to note that participants with missing information in BMI (n = 38) and physical activity (n = 
299) were allocated in a ‘missing’ category to retain maximum number of people within the 
analysis. 
10.3.3.3 Descriptive statistics 
Characteristics of participants such as anthropometric measures, dietary habits and 
lifestyle habits were explored by dividing into tertiles or non-consumers and consumers. 
Total FVs, total fruit, total vegetables, fruit subgroups and vegetable subgroups were 
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divided into low, medium and high categories, with the exception of berries, drupes, dried 
fruit, Brassicaceae (and other leaves), and pod vegetables, which were divided into non-
consumers and consumers. Total fruit juice was categorised into non-consumers, low and 
high consumers. The characteristics were explored by dividing participants into being 
hypertensive by 140/90 mmHg and normotensive after exclusion to observe if significant 
differences exist between those groups. 
10.3.3.4 Multiple linear regression 
Multiple regression was conducted to calculate change in SBP and DBP (mmHg) 
(individually) and 95% CI (or 99% CI for secondary and sensitivity analysis). For each 
dietary exposure variable, participants were divided into appropriate groups as mentioned 
in the previous section. Difference in BP was determined by comparing each intake group 
with the reference group, which included either the lowest consumers, or non-consumers. 
Linear association was also tested by calculating increments of fruit or vegetable intake by 
80 g portions. Sensitivity analysis was performed by including adjustment for energy intake 
(kcal/day) in the models stated above, as well as exploring subgroups of variables for sex 
(male v.s. female), age groups (19 – 64 years v.s. 65+ years), BMI (obese v. non-obese), non-
smokers, participants with no long-standing CVD related illness and participants not using 
statins. 
10.3.3.5 Logistic regression 
Logistic regression was conducted to calculate the odds ratios (OR) of hypertension 
and 95% CI (or 99% CI for secondary and sensitivity analysis). The method of analysis 
including the division of participants into intake groups, linear association and sensitivity 
analysis is the same as Section 10.3.3.4. However, instead of determining change in BP in 
mmHg, logistic regression generates an odds ratio to determine the increased odds of being 
hypertensive (%). 
10.3.3.6 Testing for statistical assumptions  
Some assumptions had to be fulfilled to validate correct application of the models, 
described in Chapter 2 Section 2.4.2. The linear regression requires normality to be assessed 
as shown in Figure 10.2, while Figure 10.3 shows an example of a Q-Q plot, which is 
reasonably close to normality except for the extreme right. Figure 10.4 also depicts a typical 
scatter graph with a cloud-like distribution, which fulfils the model assumptions. 
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Figure 10.1 Summary flowchart of the current study exclusion criteria and analysis plan 
 
Figure 10.2 Histogram of studentised residuals for a fully-adjusted multiple linear regression model 
investigating fruit intake and BP (mmHg) 
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Figure 10.3 An inverse normal plot (Q-Q plot) for a fully-adjusted multiple linear regression model 
investigating fruit intake and BP (mmHg) 
 
 
Figure 10.4 Scatter plot of residuals versus fitted values for a fully-adjusted multiple linear regression 
model investigating fruit intake and BP (mmHg) 
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10.4 Results 
10.4.1 Participant characteristics 
Total FV intakes in NDNS RP prior to the application of exclusion criteria were 
described in Chapter 2 Section 2.7.1. After exclusions were applied (Table 10.3), mean age 
increased with greater total FVs consumption. The likelihood to hold a professional and 
managerial job, be a vegetarian, non-smoker, and to consume supplements was also higher 
with increasing intake of total FVs. In terms of dietary intake, energy intake tended to be 
higher with higher intake of total FVs. A similar pattern was also observed for other nutrient 
intakes. However, the percentage of energy from carbohydrates was not different across the 
tertiles, while a downward trend was observed for the percentage of energy from total fat 
and saturated fat, despite an increase in energy intake across the tertiles. 
Participant characteristics were also explored by dividing into hypertensive and 
normotensive categories, defined by a BP of 140/90 mmHg (Table 10.4). Mean age was 
higher for hypertensive individuals, compared to normotensive. The former participants 
were also more likely to be obese and have a larger waist circumference. They were also 
more likely to be smokers, consume statins and come from routine/manual SES. 
Hypertensive participants were also less likely to consume supplements, have a higher 
energy and alcohol intake. 
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Table 10.3 Participant characteristics by total FV intake in the NDNS RP  adult population 
  
 Total fruit and vegetable intake (g/day) 
 0 - 211 211 - 358 358 - 1554 
General    
Participants (n) 334 334 334 
Age (years) (SD) 42.7 (15.9) 48.2 (14.8) 50.0 (14.9) 
      19 – 64 years (%, 95% CI) 89.5 (85.7, 92.4) 83.8 (79.5, 87.4) 81.1 (76.6, 85.0) 
      65 + years (%, 95% CI) 10.5 (7.6, 14.2) 16.2 (12.6, 20.5) 18.9 (15.0, 23.4) 
BMI (kg/m2) (%, 95% CI)    
      Underweight (<18.5 kg/m2) 1.8 (0.8, 3.9) 1.5 (0.6, 3.5) 0.3 (0.0, 2.1) 
      Normal (18.5 to 24.9 kg/m2) 28.1 (23.6, 33.2) 29.9 (25.2, 35.1) 41.3 (36.1, 46.7) 
      Overweight (25.0 to 29.9 kg/m2) 38.0 (32.9, 43.4) 37.4 (32.4, 42.7) 32.0 (27.2, 37.2) 
      Obese (>30.0 kg/m2) 28.1 (23.6, 33.2) 27.8 (23.3, 32.9) 22.1 (18.0, 26.9) 
      Missing 3.9 (2.3, 6.6) 3.3 (1.8, 5.8) 4.2 (2.5, 7.0) 
      Non-obese (<29.9 kg/m2) 70.7 (65.5, 75.4) 71.2 (66.0, 75.9) 76.9 (71.9, 81.2) 
      Obese (>30.0 kg/m2) 29.3 (24.5, 34.5) 28.8 (24.1, 34.0) 23.1 (18.8, 28.1) 
Waist circumference (cm) (SD) 93.4 (14.1) 92.8 (13.6) 90.8 (13.3) 
Systolic blood pressure (mmHg) (SD) 125 (15) 126 (15) 125 (16) 
Diastolic blood pressure (mmHg) (SD) 75 (11) 75 (11) 74 (10) 
Hypertensive (140/90 mmHg) (%, 95% CI) 20.3 (16.4, 25.0) 18.9 (15.0, 23.4) 18.3 (14.5, 22.8) 
    
Dietary intake    
Total energy (kcal/d) (SD) 1722 (585) 1869 (552) 1970 (535) 
Total energy –no alcohol (kcal/d) (SD) 1621 (533) 1777 (529) 1873 (503) 
Alcohol (g/d) (SD) 14.5 (21.9) 13.3 (18.4) 13.9 (18.7) 
Carbohydrates (g/d) (SD) 204 (73) 224 (72) 239 (69) 
% Energy from carbohydrates (%) (SD) 47.2 (6.6) 47.4 (6.1) 48.0 (6.5) 
Protein (g/d) (SD) 66.7 (32.6) 75.4 (20.6) 82.8 (25.2) 
% Energy from protein (%) (SD) 16.7 (4.3) 17.4 (3.8) 18.0 (4.0) 
Total fat (g/d) (SD) 65.6 (25.0) 70.4 (26.9) 71.7 (25.4) 
% Energy from Total fat (%) (SD) 36.1 (5.8) 35.1 (5.8) 34.0 (6.3) 
Saturated fat (g/d) (SD) 24.3 (10.0) 26.6 (11.9) 25.9 (10.9) 
% Energy from Saturated fat (%) (SD) 13.4 (3.2) 13.1 (3.1) 12.2 (3.3) 
Sodium (mg/d) (SD) 2127 (797) 2291 (826) 2363 (863) 
Portions of fruits & vegetables (no./d) (SD) 2.1 (0.8) 4.1 (0.8) 7.0 (2.0) 
    
Lifestyle habits    
Vegetarian/Vegan status (%, 95% CI) 1.5 (0.6, 3.5) 3.0 (1.6, 5.5) 3.3 (1.8, 5.8) 
Non-smokers (%, 95% CI) 49.7 (44.3, 55.1) 61.4 (56.0, 66.4) 70.0 (64.9, 74.7) 
Ex-regular smoker (%, 95% CI) 19.8 (15.8, 24.4) 28.7 (24.1, 33.8) 22.7 (18.6, 27.6) 
Current smokers (%, 95% CI) 30.5 (25.8, 35.7) 9.9 (7.1, 13.6) 7.2 (4.8, 10.5) 
      Cigarettes smoked (no./d) (SD) 3.7 (6.9) 0.9 (3.3) 0.7 (3.5) 
Supplement users (%, 95% CI) 27.5 (23.0, 32.6) 37.7 (32.7, 43.1) 45.8 (40.5, 51.2) 
Statin users (%, 95% CI) 3.6 (2.0, 6.2) 6.3 (4.1, 9.5) 5.7 (3.6, 8.7) 
Moderately/Vigorously active (%, 95% CI)    
      0 to 0.4 hours 30.2 (25.5, 35.3) 24.2 (20.0, 29.1) 15.9 (12.3, 20.2) 
      0.4 to 1.3 hours 21.2 (17.2, 26.0) 24.2 (19.9, 29.1) 24.5 (20.2, 29.5) 
      >1.3 hours 21.2 (17.2, 26.0) 21.8 (17.7, 26.6) 26.9 (22.4, 32.0) 
      Missing 27.2 (22.7, 32.3) 29.6 (25.0, 34.8) 32.6 (27.8, 37.9) 
    
Socio-economic status    
      Professional & managerial (%, 95% CI) 39.4 (34.2, 44.8) 50.0 (44.3, 55.1) 53.0 (47.6, 58.3) 
      Intermediate (%, 95% CI) 17.6 (13.8, 22.1) 21.2 (17.1, 26.0) 20.8 (16.7, 25.5) 
      Routine & manual (%, 95% CI) 40.9 (35.7, 46.3) 27.6 (23.0, 32.7) 23.8 (19.5, 28.7) 
      Unemployed (%, 95% CI) 2.1 (1.0, 4.4) 1.5 (0.6, 3.6) 2.4 (1.2, 4.7) 
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Table 10.4 Characteristics by HBP status in the NDNS RP adult population 
 
  
 High Blood Pressure >140/90 
 No Yes 
General   
Participants (n) 810 192 
Age (years) (SD) 44.9 (14.9) 55.6 (15.3) 
      19 – 64 years (%, 95% CI) 88.6 (86.2, 90.6) 68.7 (86.3, 90.6) 
      65 + years (%, 95% CI) 11.3 (9.3, 13.7) 31.2 (25.1, 38.2) 
BMI (kg/m2) (%, 95% CI)   
      Underweight (<18.5 kg/m2) 1.3 (0.7, 2.4) 0.5 (0.1, 3.6) 
      Normal (18.5 to 24.9 kg/m2) 36.4 (33.2, 39.8) 19.3 (14.3, 25.5) 
      Overweight (25.0 to 29.9 kg/m2) 35.4 (32.2, 38.8) 37.5 (30.9, 44.6) 
      Obese (>30.0 kg/m2) 23.3 (20.5, 26.4) 37.5 (30.9, 44.6) 
      Missing 3.4 (2.4, 5.0) 5.2 (2.8, 9.4) 
      Non-obese (<29.9 kg/m2) 75.8 (72.7, 78.7) 60.4 (53.1, 67.3) 
      Obese (>30.0 kg/m2) 24.2 (21.3, 27.3) 39.6 (32.7, 46.9) 
Waist circumference (cm) (SD) 91.0 (13.4) 98.2 (13.2) 
Systolic blood pressure (mmHg) (SD) 120 (10) 148 (11) 
Diastolic blood pressure (mmHg) (SD) 71.5 (8.5) 86.2 (10.7) 
   
Dietary intake   
Total energy (kcal/d) (SD) 1843 (557) 1902 (602) 
Total energy –no alcohol (kcal/d) (SD) 1753 (526) 1772 (555) 
Alcohol (g/d) (SD) 12.8 (18.5) 18.5 (23.8) 
Carbohydrates (g/d) (SD) 222 (72) 222 (75) 
% Energy from carbohydrates (%) (SD) 47.6 (6.4) 47.1 (6.5) 
Protein (g/d) (SD) 74.5 (23.8) 77.1 (39.0) 
% Energy from protein (%) (SD) 17.3 (4.0) 17.5 (4.2) 
Total fat (g/d) (SD) 69.1 (26.0) 70.0 (25.2) 
% Energy from Total fat (%) (SD) 35.0 (6.1) 35.4 (5.6) 
Saturated fat (g/d) (SD) 25.5 (11.1) 26.2 (10.2) 
% Energy from Saturated fat (%) (SD) 12.9 (3.3) 13.2 (2.9) 
Sodium (mg/d) (SD) 2257 (828) 2273 (861) 
Portions of fruits & vegetables (no./d) (SD) 4.5 (2.4) 4.2 (2.3) 
Total fruit (g/d) (SD) 115 (109) 107 (106) 
Total vegetables (g/d) (SD) 193 (111) 187 (107) 
   
Lifestyle habits   
Vegetarian/Vegan status (%, 95% CI) 2.6 (1.7, 3.9) 2.6 (1.1, 6.1) 
Non-smokers (%, 95% CI)   
Ex-regular smoker (%, 95% CI) 62.0 (58.6, 65.3) 53.6 (58.6, 65.3) 
Current smokers (%, 95% CI) 22.0 (19.2, 25.0) 31.2 (25.1, 38.2) 
      Cigarettes smoked (no./d) (SD) 16.0 (13.7, 18.7) 15.1 (10.7, 20.9) 
Supplement users (%, 95% CI) 37.3 (34.0, 40.7) 35.9 (29.4, 43.0) 
Statin users (%, 95% CI) 4.4 (3.2, 6.1) 8.3 (9.4, 9.7) 
Moderately/Vigorously active (%, 95% CI)   
      0 to 0.4 hours 22.8 (20.1, 25.9) 26.0 (20.3, 32.7) 
      0.4 to 1.3 hours 24.9 (22.1, 28.0) 16.7 (12.0, 22.6) 
      >1.3 hours 22.5 (19.7, 25.5) 27.1 (21.2, 33.8) 
      Missing 29.7 (26.7, 33.0) 30.2 (24.1, 37.0) 
   
Socio-economic status   
Socio economic status (%, 95% CI)   
      Professional & managerial  48.6 (45.1, 52.0) 42.4 (35.6, 49.5) 
      Intermediate  20.3 (17.7, 23.3) 17.8 (13.0, 23.9) 
      Routine & manual  29.1 (26.0, 32.3) 37.7 (31.1, 44.8) 
      Unemployed  2.0 (1.2, 3.2) 2.1 (0.8, 5.5) 
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10.4.2 Multivariate Regression 
10.4.2.1 Full Cohort 
In the full energy adjusted model (Table 10.5), SBP and DBP was not associated with 
the consumption of total FVs by quantiles of intake. However, there was a significant linear 
association, where every portion (80 g) of fruit or vegetable was associated with lower SBP 
by -0.47 mmHg (95% CI -0.90 to -0.05). Every portion of fruit or vegetable was also 
associated with lower DBP by -0.35 mmHg (95% CI -0.65 to -0.05). When investigating FV 
intakes separately, total vegetable, total fruit juice and dried fruits were not associated with 
SBP or DBP (Table 10.6). There was a significant dose response of -0.65 mmHg DBP (95% 
CI -1.16 to -0.13) for every additional portion of fruit intake, but this relationship was not 
observed in a stepwise increase of fruit consumption by quantiles (Table 10.5). 
When FV subgroups by (poly)phenol profile were examined, a moderate intake of 
pomes was associated with a lower DBP by -3.24 mmHg (99% CI -6.23 to -0.26) (Table 10.5). 
However, no significant linear association was detected compared with non-consumers. A 
low consumption of root vegetables was associated with a lower SBP by -2.91 mmHg (99% 
CI -5.72 to -0.10), but the strength of association was attenuated with higher intakes of root 
vegetables (Table 10.6). 
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10.4.2.2 Sensitivity Analysis 
10.4.2.2.1 No longstanding illness 
No associations were found for adults with no longstanding CVD illness between SBP 
or DBP and all dietary intakes. (Table F.1). 
10.4.2.2.2 Obese v.s. non-obese 
Within non-obese participants, the association between total fruit and DBP persisted, 
lowering DBP by -0.81 mmHg (99% CI -1.59 to -0.03) for every portion of fruit consumed 
(Table F.1). Unexpectedly, obese participants had a higher SBP (3.14 mmHg, 99% CI 0.21 to 
6.06) with increasing citrus portions (Table F.1). 
10.4.2.2.3 Sex 
Participants who were male (Table F.1) had a lower DBP by -1.30 mmHg (99% CI -
2.34 to -0.34) for total fruit intake. However, female participants had a higher SBP by 5.34 
mmHg (99% CI 0.77 to 9.90) with increasing citrus intake (Table F.1). 
10.4.2.2.4 Age groups 
There were no significant associations between total FV intake and SBP or DBP within 
participants aged 19-64 years (Table F.1). With regard to participants aged 65 years and 
above, associations were observed between intake of total fruit and pomes and lower DBP 
by -1.93 mmHg (99% CI -3.27 to -0.59) and -3.29 mmHg (99% CI -5.56 to -1.03) respectively 
(Table F.1). 
10.4.2.2.5 Statins 
Interestingly, SBP was found to be adversely associated with every portion of drupes 
by 5.05 mmHg (99% CI 1.27 to 8.82) (Table F.1) in the subpopulation who do not consume 
statins. The subpopulation of participants who consume statins were too small to be 
studied. 
10.4.2.2.6 Smoking 
Likewise, the population of smokers were not large enough to be analysed as CIs 
would be too wide. No associations were found for non-smoking adults between all dietary 
intakes and SBP or DBP (Table F.1).  
Chapter 10 
267 
 
10.4.3 Logistic Regression 
10.4.3.1 Full Cohort 
In the full energy adjusted model (Table 10.7), there were no significant associations 
between the odds of HBP and total FV consumption, although generally odds of 
hypertension were lower with increasing intakes. However, there was a borderline 
significant linear trend, where every 80 g portion of fruit or vegetable was associated with 
8% lower odds of HBP (95% CI 0.83 to 1.00). No significant associations were found for 
total fruit and total vegetable intake when explored separately. When FV subgroups by 
(poly)phenol profile were examined, there were also no significant associations found for 
odds of HBP and all fruit, vegetable subgroups. 
10.4.3.2 Sensitivity Analysis 
In general, no associations were observed between odds of HBP and participants who 
were in sub-populations without longstanding CVD illness (Table F.2), were obese (Table 
F.4), female (Table F.6), by age group (Table F.7 & Table F.8), who did not consume statins 
(Table F.9) and non-smokers (Table F.10). However, every 80 g portion of total fruit was 
associated with 28% lower odds of HBP within non-obese participants (Table F.3). 
Interestingly, the odds of HBP was nearly halved with every 125 g of total fruit juice within 
male adults (Table F.5). 
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Table 10.7 Odds of HBP and FV intakes and fruit, vegetable subgroup intakes within adults in the NDNS 
RP cohort 
 
Intake (g/day) 
Odds of high blood pressure 
n = 1002 Cases a Age Adjusted Fully-Adjusted b Fully-Adjusted w/Energy c 
Total fruits & vegetables1      
Low 0 – 211 68 1 1 1 
Medium 212 – 358 63 0.71 (0.47, 1.06) 0.80 (0.52, 1.23) 0.78 (0.51, 1.20) 
High 358 – 1554 61 0.62 (0.41, 0.93) 0.72 (0.46, 1.12) 0.69 (0.44, 1.09) 
p trend 80 192 0.90 (0.83, 0.97) 0.93 (0.85, 1.01) 0.92 (0.84, 1.00) 
Total fruits1      
Low 0 – 48 70 1 1 1 
Medium 48 – 134 61 0.70 (0.47, 1.05) 0.80 (0.52, 1.23) 0.79 (0.51, 1.22) 
High 134 – 749 61 0.55 (0.36, 0.83) 0.70 (0.44, 1.10) 0.69 (0.43, 1.09) 
p trend 80 192 0.82 (0.72, 0.94) 0.88 (0.76, 1.02) 0.88 (0.76, 1.02) 
Total fruit juice2      
Non-consumers 0 50 1 1 1 
Low 0 – 37.5 76 0.72 (0.41, 1.26) 0.86 (0.47, 1.55) 0.85 (0.47, 1.54) 
High 38.2 – 1385 66 0.63 (0.36, 1.12) 0.82 (0.44, 1.53) 0.80 (0.43, 1.49) 
p trend 80 192 0.75 (0.52, 1.06) 0.84 (0.59, 1.21) 0.82 (0.57, 1.18) 
Dried fruits2      
Non-consumers 0 93 1 1 1 
Consumers 0 – 130 99 0.68 (0.44, 1.05) 0.83 (0.52, 1.33) 0.80 (0.50, 1.29) 
p trend 80 192 0.71 (0.41, 1.23) 0.97 (0.56, 1.69) 0.93 (0.53, 1.63) 
Berries2      
Non-consumers 0 127 1 1 1 
Consumers 2 – 308 65 0.80 (0.50, 1.27) 1.00 (0.61, 1.66) 1.00 (0.60, 1.66) 
p trend 80 192 0.78 (0.44, 1.37) 0.87 (0.50, 1.50) 0.87 (0.50, 1.51) 
Citrus2      
Low 0 103 1 1 1 
Medium 0 – 40 28 0.57 (0.30, 1.06) 0.64 (0.34, 1.23) 0.65 (0.34, 1.24) 
High 41 – 1344 61 0.78 (0.48, 1.26) 0.93 (0.55, 1.57) 0.92 (0.55, 1.56) 
p trend 80 192 0.87 (0.70, 1.08) 0.92 (0.74, 1.15) 0.91 (0.73, 1.14) 
Drupes2      
Non-consumers 0 155 1 1 1 
Consumers 1 – 288 37 0.75 (0.42, 1.31) 0.98 (0.53, 1.81) 0.99 (0.54, 1.82) 
p trend 80 192 0.89 (0.48, 1.64) 1.17 (0.62, 2.23) 1.17 (0.62, 2.21) 
Pomes2      
Low 0 101 1 1 1 
Medium 1.1 – 48.7 34 0.55 (0.31, 0.98) 0.66 (0.35, 1.22) 0.66 (0.35, 1.22) 
High 49.2 – 425 57 0.61 (0.37, 1.00) 0.80 (0.47, 1.39) 0.80 (0.46, 1.37) 
p trend 80 192 0.72 (0.52, 1.00) 0.84 (0.60, 1.18) 0.83 (0.59, 1.17) 
Tropical fruits2      
Low 0 94 1 1 1 
Medium 3.2 – 37.5 33 0.63 (0.35, 1.13) 0.65 (0.35, 1.22) 0.65 (0.35, 1.22) 
High 40 – 225 65 0.75 (0.46, 1.23) 0.91 (0.54, 1.53) 0.90 (0.53, 1.53) 
p trend 80 192 0.78 (0.52, 1.19) 0.92 (0.59, 1.46) 0.92 (0.58, 1.45) 
Total vegetables1      
Low 0 – 134 67 1 1 1 
Medium 134 – 217 61 0.79 (0.52, 1.18) 0.81 (0.53, 1.23) 0.79 (0.51, 1.20) 
High 217 – 1168 64 0.80 (0.53, 1.19) 0.93 (0.60, 1.44) 0.90 (0.58, 1.40) 
p trend 80 192 0.92 (0.81, 1.04) 0.97 (0.84, 1.11) 0.96 (0.83, 1.10) 
Allium2      
Low 0 – 2.5 70 1 1 1 
Medium 2.6 – 18.7 65 0.92 (0.55, 1.55) 0.96 (0.56, 1.65) 0.97 (0.56, 1.66) 
High 18.8 – 176 57 0.80 (0.47, 1.35) 0.89 (0.50, 1.59) 0.90 (0.50, 1.61) 
p trend 80 192 1.01 (0.46, 2.21) 1.33 (0.55, 3.18) 1.33 (0.55, 3.17) 
Brassicaceae2      
Non-consumers 0 43 1 1 1 
Consumers 0.4 – 201 149 0.93 (0.56, 1.57) 1.02 (0.59, 1.77) 1.04 (0.60, 1.79) 
p trend 80 192 0.75 (0.40, 1.42) 0.91 (0.46, 1.81) 0.91 (0.45, 1.81) 
Fruit vegetables2      
Low 0 – 16.4 68 1 1 1 
Medium 16.6 – 60.0 55 0.73 (0.42, 1.25) 0.89 (0.50, 1.57) 0.88 (0.50, 1.56) 
High 60.0 – 684 69 0.89 (0.53, 1.49) 1.31 (0.72, 2.36) 1.32 (0.73, 2.39) 
p trend 80 192 0.95 (0.69, 1.29) 1.15 (0.81, 1.62) 1.15 (0.82, 1.62) 
Pod vegetables 2      
Non-consumers 0 99 1 1 1 
Consumers 0.1 – 150 93 0.74 (0.48, 1.14) 0.75 (0.47, 1.18) 0.75 (0.47, 1.18) 
p trend 80 192 0.71 (0.27, 1.82) 0.75 (0.28, 2.00) 0.72 (0.27, 1.94) 
Stalk & root vegetables 2      
Low 0 67 1 1 1 
Medium 0.2 – 25 50 0.61 (0.35, 1.07) 0.67 (0.38, 1.19) 0.68 (0.38, 1.21) 
High 25 – 190 75 0.88 (0.52, 1.47) 1.11 (0.63, 1.95) 1.12 (0.63, 1.96) 
p trend 80 192 0.90 (0.49, 1.66) 1.19 (0.61, 2.35) 1.19 (0.60, 2.33) 
a Cases apply to fully-adjusted models 
b Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, alcohol intake, 
mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or vegetable not in the exposure 
category 
c Adjusted for all the above and energy intake 
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10.5 Discussion 
10.5.1 Summary of results 
The objective of the study was to investigate the association between total FV intake 
and BP in healthy adults. A lower odds of HBP with higher total FV intake was observed, and 
higher intake of total FVs was associated with lower SBP and DBP. Specifically, greater fruit 
intake, especially a moderate intake of pomes was associated with lower SBP. However, no 
evidence of association was determined for berries, drupes, tropical fruit, total vegetable 
and vegetable subgroups. 
10.5.2 General comparison to literature 
In general, findings from the current study are in line with the results from Chapter 
6, and also support previous observational studies investigating the association between 
total FV intake and HBP from different countries [296-298, 300]. Also mentioned in Chapter 
6, results are consistent with the findings from RCTs investigating dietary patterns rich in 
FVs [80, 306, 307]. The strengths and limitations for investigating FV rich dietary patterns 
and the association with BP have been discussed in detail within Chapter 6. Briefly, evidence 
for the relationship with greater potassium intakes is fairly consistent with the exception of 
a recent RCT [224, 302], while the association between sodium intakes and BP have been 
established [116, 224, 308]. Participants in the current study reported a higher sodium 
intake when FV intake was higher, however, the two might not necessarily be correlated 
(correlation co-efficient = 0.10) or causally linked, but might reflect greater energy intakes 
reported by highest FV consumers, or the presence of more under-reporting generally in 
the lowest FV consumers. There are other nutrients in FV which have a significant 
association with CVD risk including fibre [248] and “antioxidants” known as (poly)phenols, 
which may also generate certain effects on BP. Thus, like the previous chapters, separate 
examination of FVs is warranted. 
When investigating FVs separately, findings tended to vary across studies. Higher 
fruit intake was associated with lower DBP in men and higher SBP in women in a Korean 
cohort [300], compared to the association found only for lower DBP with greater fruit intake 
(as well as in men, but not women) in the current study. A significant association between 
higher vegetable intake and lower odds of HBP was also previously reported, contrasting 
with the current study [296, 297]. This could be due to the variation in consumption 
patterns between countries and dietary assessments between cohorts [296, 297, 300]. 
Studies which utilised FFQ were also more likely to report higher mean FV intakes than the 
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current study (305 g/day) [296, 300], possibly due to over-reporting on the FFQ [253]. In 
addition, total fruits and total vegetables in the current study contain food items which have 
been cooked or processed in some way, which might not be the case in other cohorts. Kim 
et al. reported higher BP in association with higher consumption of Kimchi and salty 
vegetables native to Korea [300]. While these types of vegetables are not commonly 
consumed in UK, the finding warrants further investigation into differences between raw 
and cooked/process vegetables, or with the addition of salt, and may also explain the null 
association in the current study. 
Interestingly, total fruit juice was associated with a lower odds of HBP in male, but 
not female adults, however, fruit juice was inconsistently associated with lower SBP or DBP 
in the current study. Previous MA on RCTs investigating effects of fruit juice and BP reported 
a borderline significant effect on DBP (-2.07 mmHg, 95% CI -3.75 to -0.39) was observed 
[375]. Other studies have also report null association between fruit juice and BP in Western 
countries from the INTERMAP study [376]. The null association could be due to the wide 
range of fruits incorporated into the fruit juice category, leading to a varied (poly)phenol 
profile. However, it is more likely that the diversity of fruit juice consumption is relatively 
narrow within this population. 
10.5.3 Relevance to (poly)phenol mechanisms 
With regard to subgroup analyses, moderate consumption of pomes was associated 
with lower SBP, consistent with findings from an observational study [301] and Chapter 6, 
most likely because pomes are the most commonly consumed fruit in the UK (Chapter 2). 
As elaborated before, pomes are rich in flavanols, especially catechin and 
proanthocyanidins [309, 310]. Significant associations were reported between intakes of 
apples and pears and CVD risk in observational studies [117, 254]. However, there is limited 
evidence to support the beneficial effect of (poly)phenols from apples on markers of CVD 
and BP. Apple and apple juices were reported to improve lipid profiles in some intervention 
studies [236, 255, 256], but contrasting results using freeze dried apples were also reported 
elsewhere [257]. Non-significance in the latter study could be because of a relatively smaller 
dose of apple, and differences in processing effects (freeze drying). 
Null associations for other FV subgroups, as well as for investigation by 
hypertensive status could be explained by low intake levels, limited variations in 
consumption, errors in estimation or under-reporting, low power or residual confounding. 
Furthermore, variables here contain raw and cooked variations in each FV subgroup, 
therefore it is probable that processing effects may have altered the (poly)phenol content 
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within and its bioavailability in the human body [112]. However, the separation of raw and 
cooked variations of each FV is not warranted due to low intakes. 
10.5.4 Strengths and limitations 
There are a few other limitations to the current study. The current sample size of 
the study is small, particularly for exploration of FV subgroups, or within restricted 
subpopulations. In contrast to the UKWCS, there is less variation in dietary habits. Cross-
sectional studies only contain dietary intakes from one time point, thus only reflective for 
the particular time period the analysis was conducted. The NDNS RP was never intended to 
represent habitual diets of each individual, but to provide a snapshot of intakes 
representative of the UK population. The design of the study also does not allow diet to be 
monitored over time, and would require further investigation by follow-up or intervention 
to provide further supportive evidence for the findings drawn. In addition, the study is 
limited by missing data within model variables such as physical activity. Although the 
proportion of missing data is subsequently allocated into a separate category, it may 
introduce residual confounding. Caution should also be exercised when interpreting 
causality in cross-sectional studies, as there could be potential biases acting in either 
direction from incomplete adjustment for confounding, measurement error in the exposure 
estimate, and other unknown biases in participant selection or data collection. The direction 
of causality is also unknown in cross-sectional studies. 
However, the current study has several strengths. The NDNS RP utilizes four-day 
food diaries, which capture dietary intakes in detail compared to FFQs used in other studies 
and previous chapters investigating UKWCS. Furthermore, to our knowledge, this is the first 
study that has extensively investigated the effects of subgroups of FVs by (poly)phenol 
profiles on BP. The inclusion of fresh and cooked food items also improves estimation of 
dietary intake to a certain extent, reflecting actual consumption behaviour. In addition, 
using Phenol Explorer as a reference database for sub-dividing fruit intake has certain 
advantages. This is because extensive methods were implemented to collect high-quality 
literature articles on (poly)phenol composition, the impact of food processing on 
(poly)phenols and metabolite composition in the body, which ensured that the subgroups 
applied here were sensible with regard to the variety of (poly)phenols in each fruit or 
vegetable subgroup [112]. 
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10.6 Summary 
A higher intake of total FV was associated with lower odds of BP. Greater 
consumption of total fruit intake was negatively associated with lower BP, and this 
association persisted in subgroups of non-obese, elderly and male subpopulations. 
Moderate intake of pomes was also associated with lower SBP in general, and with a lower 
DBP in the elderly population. Total vegetable and selected vegetable subgroups were not 
associated with lower BP within adults in the NDNS RP, although in general, the direction of 
point estimates indicated inverse associations, whilst not formally achieving statistical 
significance. This finding is aligned with current literature promoting high FV dietary 
patterns, as well as widely promoted guidelines promoting FVs consumption for health. 
Further interventions are recommended for the consumption of pome fruits to assess its 
relationship with BP lowering effects in the normotensive population as a form of 
preventing HBP development. 
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Chapter 11  
Final Discussion 
11.1 State of the art 
Diet is one of the key modifiable factors that affect CVD risk, and high quantities of 
FVs have been observed to lower CVD risk in observational studies [83]. However, it is 
unknown if a specific fruit or vegetable, or FV subgroup, is potentially more important than 
others. A small number of studies have investigated berries, citrus, green leafy, cruciferous 
and Allium vegetables [197, 205], whereas evidence for the remaining FV subgroups is 
limited. The evidence for total vegetable intake and CVD risk is also somewhat inconsistent 
across observational studies. The DASH trial [80] was reported to lower BP substantially in 
hypertensive and normotensive participants, but the specific effects of particular FVs were 
also unknown. In addition, the relationship between coffee, tea and CVD risk is also 
inconsistent within observational studies studying CVD risk and BP (as reported in Chapter 
5 and Chapter 7). FVs, coffee and tea are rich sources of various (poly)phenols. Chapter 1 
summarised beneficial effects of (poly)phenols on CVD risk factors within human studies, 
such as improved endothelial function and improved blood lipid profiles. Cell and animal 
studies also demonstrated the effect of (poly)phenols on biological mechanisms relating to 
BP, lipid profile, diabetes, obesity and inflammation. On the other hand, there is also missing 
information on many commonly consumed foods within the (poly)phenol database, Phenol 
Explorer, where the (poly)phenol content of processed foods is largely unquantified. 
11.2 Novel findings from this thesis 
 The first study to examine the relationship between FV and respective subgroup 
intakes by (poly)phenol profiles and the risk of CVD (Chapter 3 and Chapter 4), as 
well as the incidence of self-reported BP in the UK (Chapter 6). 
 Provided novel and missing information by investigating previously unexplored 
fruit subgroups, such as drupes and tropical fruit. 
 Provided additional evidence for the association between coffee, tea and CVD 
mortality (Chapter 5) and self-reported BP (Chapter 7) to the current inconsistent 
evidence pool. 
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 Chapter 9 provided TPC of 64 fruit concentrates and juices, and quantified major 
anthocyanins in blackcurrant concentrates, which is additional data for potential 
inclusion in the Phenol Explorer. 
 Although the association between FV intake and BP have previously been studied 
[296-298, 300], Chapter 10 presented results on the association of FVs and 
subgroup intakes by (poly)phenol profiles and measured BP using the latest NDNS 
RP dataset, and is one of the first studies to do so. 
11.3 Summary of thesis findings 
For the first time in both the UKWCS cohort and the NDNS RP population, the 
association between dietary sources of (poly)phenols by FVs and respective subgroups, as 
well as coffee and tea intake have been extensively investigated. 
Chapter 2 presented the statistical methodology and models based on the literature 
review on CVD pathophysiology, CVD risk factors, (poly)phenols overview, absorption, 
bioavailability and biological activities of (poly)phenols, as well as mechanisms of 
(poly)phenols on CVD risk factors conducted in Chapter 1. The study design of the UKWCS 
and the NDNS RP population, CVD dietary recommendations requirements were also 
reported in Chapter 2, along with participant characteristics and the intakes of dietary 
sources of (poly)phenols. Differences in the intake of (poly)phenol-rich foods, study design 
and methodology between the UKWCS and the NDNS RP were briefly compared here. Key 
findings from this thesis, ranked by the strength of evidence are summarised in Table 11.1. 
Table 11.1 Summary of key findings from this thesis 
 Exposure Outcome 
Convincing Total fruit, fresh fruit Fatal CVD 
Probable 
Citrus, grapes 
Citrus, total vegetable 
Total FV, total vegetable, 
pomes, fruit vegetables 
Fatal CVD 
Fatal stroke 
 Self-reported HBP 
Limited - Suggestive 
Berries 
Citrus fruit 
Orange juice 
Total FV, total fruit 
Chronic coronary events 
CVD incidence 
Stroke incidence 
Measured BP 
Inconclusive Coffee, tea Fatal CVD, self-reported HBP 
Convincing: Significant association with higher intakes, significant linear association 
Probable: Only one of the above; self-reported HBP 
Limited – Suggestive: Low case numbers; Cross-sectional design 
Inconclusive: Null association; inconsistent/inconclusive evidence in literature 
In addition, Chapter 8 investigated the relative validity of the FFQ and food diary in 
the UKWCS, recognising the strengths and weaknesses of the FFQ and food diary. Chapter 9 
reported the analysis of processed fruit based beverages to assess the levels of 
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(poly)phenols for updating the (poly)phenol database, Phenol Explorer. This chapter also 
evaluated the importance of including these beverages to estimate (poly)phenol intake. A 
large variability in the TPC and major anthocyanins were reported in blackcurrant 
concentrates, suggesting the presence of bias and error if estimating (poly)phenol intakes 
at an individual level. 
11.4 Summary discussion 
Summarising evidence from the thesis, the strength of evidence for higher fruit intake 
and lower CVD risk is stronger in comparison to vegetables. In particular, it is likely that a 
greater consumption of citrus fruits and grapes are associated with a lower risk of CVD. 
However, the strength of evidence for the fruit subgroups and CVD incidence is weak, due 
to low case numbers and a low diversity of fruit subgroup intakes in Chapter 4. Evidence 
from this chapter is therefore only suggestive and carries little weight. Fruit intake in 
general appeared to be more associated with CHD outcomes (with the exception of citrus 
and its relationship with stroke), while vegetables was strictly associated with stroke in this 
thesis, though the association with CVD incidence was not investigated as part of this thesis. 
It is unknown if further investigations between vegetables and CVD incidence would allow 
associations to emerge. Nevertheless, findings support the idea that the aetiology of CHD 
and stroke are different (as discussed in Chapter 3), thus CVD risk is possibly lowered by 
different (poly)phenol mechanisms elaborated in Chapter 1. Further evidence to support 
this includes the association between citrus and stroke, but not with CHD. This is further 
complimented by other cohort findings [213] and human studies which report a lower BP 
with the consumption of orange juice [150, 151]. 
When examining BP as the outcome, the overall strength of evidence indicate that a 
greater intake of total FVs is likely to be associated with a lower incidence of self-reported 
HBP, while the strength of evidence for lower measured BP is limited. Total vegetable 
intake, fruit vegetables and pomes are also likely to be associated with lower incidence of 
self-reported HBP in the UKWCS, while limited evidence suggest that total fruit was 
associated with a lower DBP in the NDNS RP. Fundamentally, these are two different 
representations of UK populations at different time points. By design, findings from the 
UKWCS carry more weight in comparison to the NDNS RP as it is a prospective cohort with 
a larger sample size, therefore evidence generated are ranked as probable. The NDNS RP 
has a smaller sample, but is more representative of the general population. Both studies 
adapted different dietary assessments where the UKWCS FFQ is more representative of 
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habitual intake, in comparison to a food diary which offers high quality snapshots (Chapter 
8). However, HBP was self-reported in the UKWCS, which was prone to different errors 
compared to a better alternative of measured BP by the nurse in the NDNS RP. Despite the 
limitations by design as a cross-sectional study, the analysis conducted using the NDNS RP 
are generally in agreement with UKWCS, thus offering limited or suggestive evidence to 
back up the findings from the UKWCS. 
As elaborated in Chapter 1, Chapter 3, Chapter 4, Chapter 5, Chapter 6 and Chapter 7, 
there is a large substantial body of evidence to support the beneficial effects of various 
(poly)phenols on CVD risk factors. (Poly)phenols may directly act on biological mechanisms 
associated with the development of atherosclerosis, such as blood lipid levels, endothelial 
function and inflammation [3], or through other diseases such as diabetes and obesity, 
where the manifestation of latter risk factors could further increase CVD risk. As previously 
stated, (poly)phenols are also not the only compounds present within FVs, coffee and tea. 
Perhaps associations observed could be the result of other nutrients or phytochemicals, 
such as dietary fibre, carotenoids, vitamin C and potassium [377]. However, evidence from 
RCTs have not been supportive of single nutrient supplementation [70]. Alternatively, 
associations detected could also be a synergistic interaction between multiple nutrients and 
(poly)phenols, but results here are unable to provide any causal evidence. Thus, further 
investigation is required from intervention studies and RCTs to confirm the mechanistic 
role of FVs. 
Null associations were reported between coffee, tea and CVD mortality and BP, 
despite both being rich in (poly)phenols. The lack of association could be due to limitations 
within dietary assessments to accurately capture and reflect levels of (poly)phenols 
consumed (discussed in Chapter 5). This is supported by Chapter 8, where coffee and tea 
intakes were strongly correlated between the FFQ and food diary. The extent of agreement 
was also better than the FVs. Coffee and tea (poly)phenols could also have acted through a 
different biological pathway instead of BP related biological factors. For example, a 
systematic review reported that coffee consumption is associated with a lower risk of type 
2 diabetes [378], and supporting evidence for the mechanisms of (poly)phenols on diabetes 
is listed in Chapter 1. In addition, Chapter 1 also reported the effects of catechins on the 
mechanisms of diabetes and obesity. 
Sensitivity analyses in both populations show attenuated associations in 
subpopulations of obese, hypertensive or smoking participants, which suggests that a high 
consumption of FVs in the presence of these CVD risk factors is could be less mechanistically 
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effective, although this could only be confirmed in an RCT among at risk populations. 
Alternatively, participants could also be consuming less FVs, or the variation in 
consumption within these at risk populations may be relatively smaller, thus leading to an 
attenuated association. In addition, sensitivity analyses reported a 99% CI to reduce type I 
error (false positive), thus associations which could have been borderline significant 
became attenuated, although the direction of risk estimates tend to be inverse. Occasionally, 
consumption of specific fruits were also significantly and adversely associated with CVD 
risk. However, it is well-known from multiple observational studies and trials that fruits are 
beneficial against CVD risk instead of exhibiting harmful effects. Thus, the observation is 
most likely due to reverse causality, in other words, participants in NDNS RP who were 
female or obese with a higher SBP tend to consume more citrus fruits, leading to the 
presumed adverse association observed. 
The relative validity study conducted in Chapter 8 provides some support for the 
methodology applied in the analysis of the UKWCS when dividing participants into quantiles 
of fruit, fruit subgroup, coffee and tea intake. This chapter concluded that the UKWCS FFQ 
was able to capture and categorise women broadly into low, medium and high intakes 
relative to the food diary (with the exception of drupes intake) with minimal gross 
misclassification. However, it is important to note the time difference (five years) between 
the completion of the FFQ and food diary as a limitation. As diet is likely to have changed 
throughout this period, a higher percentage of gross misclassification is more likely to be 
observed. The relative validity of vegetable intake was not assessed as analyses of vegetable 
intake and CVD outcomes were conducted after this relative validity study. However, based 
on the results above, observed vegetable intakes and derived CIs for the analyses, the 
relative validity for vegetables using FFQs are most likely similar to or slightly weaker in 
comparison to fruit intake, which could be the cause of null association findings in contrast 
to other studies on vegetable intake and CVD risk [205, 208, 212]. 
The presence of null associations could also be explained from the results provided in 
Chapter 9. The variance in the levels of (poly)phenols within fruit juices and concentrates 
introduced additional errors, seen in the example of the blackcurrant concentrate. As 
discussed before, the amount of (poly)phenols in coffee and tea were also subjected to 
variation by multiple processing and brewing factors. Furthermore, different cultivars of 
the same fruit or vegetable also contains varying amounts of (poly)phenols. Thus, when a 
mean value is generated within a food or (poly)phenol database to represent the particular 
food type, it is likely to introduce measurement variance and errors. In addition to the 
current gap of knowledge within (poly)phenol databases, estimated intakes could be 
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inaccurate and subjected to huge variations if estimating (poly)phenol intakes at an 
individual level. 
11.5 Strengths and limitations 
One of the key strengths of this thesis is the multidisciplinary approach to incorporate 
subclasses of (poly)phenols into classifications of FVs to study its association with CVD 
using epidemiological methods. Previous studies have either studied this association 
through intakes of total FVs [83], or (poly)phenols by subclass [118]. As emphasised in 
Chapter 1, (poly)phenols are not consumed by class. Although conclusions from studies 
conducted by Knekt et. al [116] and Mink et. al [117] could offer insight to specific classes 
of (poly)phenol which exhibit beneficial effects, they do not reflect how the food containing 
(poly)phenols were consumed and in what quantities. Thus, the work completed in this 
thesis offer a practical approach to determine which FVs, consumed in feasible quantities, 
are particularly important in the diet and may be investigated further in RCTs [379]. 
Emphasis should be placed on fruits such as berries, citrus and pomes, and vegetables such 
as fruit vegetables. 
The inclusion of cooked or processed FVs in the definition of ‘total fruit’ and ‘total 
vegetable’ also provide a relatively more comprehensive and complete estimate over 
studies which did not. This is especially important when the evidence from Chapter 9 
revealed the possibility of high TPC and high levels of quantifiable (poly)phenol compounds 
within some smoothies and fruit juices. When these products are consumed in moderate or 
high amounts, they may contribute significantly to total (poly)phenol intake. 
Since CVD aetiology may differ, this thesis examined the association between FVs, 
coffee and tea CVD outcomes by CHD and stroke separately, as well as by subtypes of CHD 
and stroke in Chapter 4. The work completed in this thesis also extends towards the 
understanding of the association between FVs, coffee and tea intake and BP (self-reported 
and measured), a major risk factor of CVD. This lends support to human studies already 
undertaken, as well as aid in the hypothesis generation for further intervention studies. 
Additionally, analyses were conducted in two UK populations. Although diet was only 
captured once at baseline in UKWCS, and once in the NDNS RP, comparison of the two 
populations can provide a bigger picture of the association between FV intake and CVD risk 
or its risk factors. The frequency of FVs consumption were also shown to remain relatively 
similar, although women in the UKWCS seem to consume more by intake. Strengths of the 
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UKWCS which have been discussed in previous chapters, include a long follow-up period 
and a wide diversity of intakes. 
One of the limitations relates to the applicability of the results described here towards 
other populations, due to the higher proportion of vegetarians, higher level of ‘health-
consciousness’ and all-women population in the UKWCS. However, results from the UKWCS 
and the NDNS RP appear to be generally similar, and perhaps even complementary. 
Although there is no hypothesis to suggest if there would be any mechanistic differences 
between men and women in the way they respond to FVs, differences detected within 
sensitivity analyses conducted in the NDNS RP population may warrant further research. 
Limitations in epidemiological methods should be noted here, in relation to the 
interpretation of the extent of causality. There is also substantial potential for biases caused 
by incomplete adjustment for confounding, measurement error in the exposure estimate, 
and other biases in participant selection or data collection. In particular, models applied 
here do not adjust for environmental factors such as the location of habitation and 
deprivation scores, or additionally for other dietary components associated with CVD, such 
as red meat intake, which may contribute to residual confounding. Instances of multiple 
testing are also present due to the extensive amount of analyses. However, this is a 
necessary approach if associations between FV subgroups and types of CVD are to be 
elucidated. Therefore, where appropriate, wider CIs were adapted in multiple chapters to 
reduce false positives, especially in secondary and sensitivity analyses. Additionally, the 
general application of dividing intakes of exposures into five categories (quintiles) despite 
the narrow range of intakes (e.g. Allium, berries, drupes, tropical fruits etc.) adds to the 
limitation of the thesis, and could also be a cause of null associations. Different approaches 
of categorisation (tertiles, consumers v.s. non-consumers) could have been adapted as a 
better fit for FV intakes with narrow ranges, such as in Chapter 10, as a more robust 
statistical approach. Lastly, alternative categorisation methods for FV subgroups, such as 
principle component analysis or cluster analyses could have been adapted as a more 
objective approach. However, findings from this approach may lead to an alternative 
research direction. 
  
Chapter 11 
280 
 
11.6 Recommendations for future work 
11.6.1 For UKWCS 
The association between vegetable, vegetable subgroup intake and CVD incidence 
could be investigated, as the increased specificity of disease outcome could reveal 
associations that were attenuated when analysing data as total CVD mortality. In addition, 
the relative validity between the FFQ and food diary for vegetable intakes within the UKWCS 
could also be studied to cast light on potential exposure misclassification. 
Other sources of (poly)phenols such as dark chocolate (cocoa), wine and beer are also 
warranted for study. In this cohort, complementary to the (poly)phenol rich foods groups 
analysed here, dietary patterns previously derived using cluster analysis [165] from the 
UKWCS could be examined for its relationship with chronic diseases. A dietary pattern 
associated with a lower risk of chronic disease based on UK diet could be recommended, 
and more easily implemented towards public health. 
Investigations into other CVD risk factors such as diabetes and obesity are also 
warranted. Obesity is a major CVD risk factor, and beneficial associations observed in non-
obese populations between (poly)phenol-rich foods and CVD risk tend to be attenuated in 
both the UKWCS and the NDNS RP populations. Bertoia et. al [380] recently reported weight 
change over four years associated with a higher consumption of fruits and non-starchy 
vegetables, specifically berries (-0.5 kg), pomes (-0.5 kg) and cauliflower (-0.6 kg). Evidence 
for berry (poly)phenols on mechanisms of obesity supports this finding, and warrants 
further research within the cohort. 
11.6.2 For NDNS RP 
The NDNS RP database grows yearly with the addition of a thousand people per year, 
and the power to detect associations will increase over time. Investigations into other CVD 
risk factors and predictors, such as obesity or weight gain, diabetes and measured blood 
lipid profiles (total cholesterol, HDL-C, LDL-C etc.) in association with (poly)phenol-rich 
foods could be investigated. Other dietary sources of (poly)phenols, such as coffee, tea, dark 
chocolate, wine and beer could also be studied to understand if any specific source of 
(poly)phenols is particularly important, and worthy of further investigation by 
interventions or RCTs. 
With regard to the improvements in methodology here, methods to disaggregate food 
diary variables with two or more inseparable fruit or vegetable intakes could be developed 
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to allow improved accuracy when estimating specific fruit or vegetable intakes, as these 
foods were excluded in the current analysis. The impact of excluding this data is unknown. 
Despite null associations detected in coffee, tea intakes and CVD risk within the UKWCS, 
other studies [96] support the association between coffee, tea intake and BP, and could be 
investigated in the NDNS RP. In addition, linkage with the MINAP, HES or by following-up 
using other case ascertainment methods could allow survival analyses to be conducted 
between diet and chronic disease.  
11.6.3 For other future studies 
Improvements in reducing measurement error in epidemiological studies is crucial in 
order to better estimate the risk of chronic diseases and its association with diet. Results 
from Chapter 9 revealed the limitation of taking an average value to represent multiple 
variations of the same product of the same name, for example, blackcurrant concentrate or 
cranberry juice. The extent that this type of error influences nutrient estimates in various 
foods is unknown, but it is an important limitation that should be recognised if (poly)phenol 
consumption in individuals are to be estimated. The application of food diaries can 
overcome this error by asking participants to provide information, such as the brand name, 
or product name of food, as well as the nutrition back-of-pack label or ingredients list. 
However, unless information on cultivars from fresh FVs are both available in the Phenol 
Explorer and in retail stores, this limitation will remain. In addition, if food databases do not 
contain the relevant nutritional information for the particular food, an alternative food most 
similar based on nutrient levels would be coded as substitute. This would reduce precision 
and accuracy of dietary estimates. Moreover, the availability of processed foods such as 
microwavable, pre-packaged foods is increasing. Recipes within these foods are also subject 
to change depending on public health policies [381]. Therefore, the first recommendation is 
to provide up-to-date and precise nutritional composition data to improve dietary intake 
estimates. Secondly, future research should also focus on quantifying (poly)phenols within 
processed foods which includes plant-based foods, as omission could possibly introduce 
under-reported (poly)phenol intakes. Until (poly)phenols are quantified in these foods, it is 
unknown to what extent the error in estimating (poly)phenol intakes are. Most importantly, 
the adaptation of mixed methods is highly recommended if individual (poly)phenol intakes 
are to be estimated. Dietary intakes should be collected through FFQs and/or 
questionnaires, and food diaries and/or (multiple) 24-hour recalls. The application of 
multiple dietary assessment methods would capture habitual and high quality dietary 
intakes, and counter limitations arising from each assessment method. Validation studies 
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can then be conducted to provide correction factors for under- or over-reporting. The 
collection of tissue samples such as urine and plasma allow (poly)phenols of interest to be 
identified simply for compliance, or as an objective measure against reported intakes from 
dietary assessments for validation or correction of intakes. 
11.6.4 For future intervention studies and clinical trials 
Evidence surrounding the beneficial association between FVs and CVD comes largely 
from observational studies, and there is a lack of interventions or clinical trials which 
directly assess the mechanistic effects of FVs on CVD risk factors or markers [379]. Such 
studies are expensive, time consuming, in addition, requires vigorous adherence to protocol 
from the participants. To effectively assess whether an increased FV consumption could 
possibly decrease CVD risk, interventions and RCTs in the UK should focus on providing a 
control diet (typical of general UK diet in terms of nutrient composition) and FV-rich diet 
[or (poly)phenol rich diet] which is strictly prepared, controlled and consumed on site, in a 
specific population (at risk or healthy only), similar to the DASH trial [80]. Endpoints such 
as BP, endothelial function, measured blood lipid profile, serum glucose levels (risk factor 
for type 2 diabetes), inflammatory markers could be measured depending on the study’s 
interest. Although such a design may not be reflective of diet consumed ad libitum in the 
general population, and the duration of the study would most likely be short- to medium-
term, such a design is best able to generate efficacy, since dietary parameters are tightly 
controlled. In combination with questionnaires to assess lifestyle factors such as physical 
activity, smoking habits, and environmental conditions, confounding could also be 
potentially adjusted for. 
Dietary biomarkers are commonly measured in blood and urine (to a lesser extent), 
and range from a high specificity for a particular food (nutritional biomarkers), to being 
broadly specific for food groups. However, global assays (such as the Folin-Ciocalteu assay) 
applied to quantify, for example TPC, is subjected to interference, while levels of vitamin C 
could be influenced by multiple factors [382]. A novel alternative such as food 
metabolomics, allow the identification of existing and novel biomarkers which could be 
associated with particular foods and dietary patterns. These could then be correlated or 
associated with disease outcome, thereby providing causal evidence between foods and 
disease risk [382]. An example of a study applying this method is the INTERMAP study, 
which identified different metabolite compositions in Western and Asian populations from 
24-hour urine samples using proton nuclear magnetic resonance. The study also identified 
a significant adverse association between alanine and BP, and a significant inverse 
Chapter 11 
283 
 
association between hippurate and BP [383]. Such an approach could be implemented in 
future trials to aid the confirmation of associations detected in observational studies, such 
as those observed in this thesis. 
11.6.5 For public health implementation 
In response to the dietary guidelines for the prevention of CVD stated in Chapter 1, 
the findings from this thesis supports the ‘five-a-day’ FV health message as stated. Current 
guidelines promoted in the National Health Service [384] include: 
 FVs, including those cooked as composite dishes, frozen, tinned, dried (no more than 
30 g recommended) and in ready meals 
 Beans and pulses (only count as one portion despite amount consumed) 
 Unsweetened, 100% pure fruit juice (a glass, 125 g, only count as one portion 
despite amount consumed) 
 Fruit smoothies (one or more portion per day, depending on recipe and serving size) 
 Excluding starchy vegetables, such as potatoes 
Firstly, the ultimate goal is to generate enough evidence from RCTs to prioritise 
certain FVs, including findings here in relation to berries, citrus, pomes and fruit vegetables 
as part of the ‘five-a-day’ health message in precedence over other subgroups. Evidence 
from prospective cohorts alone, such as the UKWCS, is unable to make an impact on policy, 
due to a lack of causal evidence. Based on the findings from Chapter 9, to maximise 
(poly)phenol delivery, fruits are recommended to be consumed raw, and not in the form of 
a juice, juice drink or concentrate. From a (poly)phenol perspective, this challenges the 
current guidelines where a glass of fruit juice is acknowledged as part of the ‘five-a-day’. 
However, from a public health perspective, for part of the population which do not consume 
any FVs, a glass of fruit juice does more benefit than none at all. Further investigation is 
needed to determine effects of processing on vegetables. Recommendations as to whether 
‘five-a-day’ should include a specific number of fruits or vegetables is not possible, until 
evidence from RCTs are available. 
In addition, because consumers might lack knowledge about [385], or have varying 
perceptions on portion sizes [386], public health recommendations should also focus on 
educating consumers about the importance of increasing the frequency of FV consumption, 
understanding and perceiving portion sizes of specific FVs. Ashfield-Watt and colleagues 
reported average serving sizes of fruits consumed from 31 to 168 g/day, and for vegetables 
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from 26 to 147 g/day within the EPIC-Norfolk cohort [386]. Variation in portion sizes 
consumed is also large within single fruits such as strawberries (60 to 150 g), or vegetables, 
such as carrots (39 to 72 g). While the authors conclude that frequency is a relatively more 
important contributor, helping consumers to understand the ’80 g’ portion size, and 
increasing FVs commonly consumed as smaller portions (such as blackcurrant, kiwi, lettuce, 
pepper and cucumber) is equally important to help boost overall intakes. Increasing 
availability of FVs in retail, and in turn informing or educating the UK population about 
greater consumption of a variety of FVs, and is also recommended to help reach the ‘five-a-
day’ target. This could be achieved in the form of an intervention or cooking classes to 
promote recipes which incorporate less commonly consumed FVs. 
11.7 Summary of conclusions 
 Fruit and vegetables are recommended as a prevention to lower CVD risk, and are 
inversely associated within multiple observational studies globally. 
 Fruits, vegetables, as well as coffee and tea are (poly)phenol-rich foods. Cell culture, 
animal and human studies support the mechanistic effects of (poly)phenols on CVD 
risk factors. 
 In a health-conscious cohort of UK women (UKWCS), total fruit and vegetables, 
especially total fruit, berries, citrus and grapes consumption is associated with a 
lower risk of CVD risk, while a greater intake of total vegetables, pomes and fruit 
vegetables are associated with a lower incidence of self-reported HBP. 
 Findings from the NDNS RP reveal a lower SBP with increasing total fruit and 
vegetables and total fruit intake, while pomes intake was associated with a lower 
DBP. 
 Attenuated associations in subpopulations with CVD risk factors suggest that 
protective effects are more apparent in healthy subpopulations, and further 
research is warranted in populations with a high risk of CVD. 
 Coffee and tea are not significantly associated with a lower risk of CVD or BP as a 
key risk factor in both UK populations, although they are (poly)phenol-rich. 
Potential mechanisms for (poly)phenols from coffee and tea may possibly act 
through other biological pathways rather than through BP. 
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Appendix D Chapter 6 sensitivity analyses 
Table D.1 Total fruit, total vegetable, fruit and vegetable subgroup intake and the odds of self-reported 
HBP incidence within obese and non-obese subpopulations 
Intake (80 g/day) Odds of high blood pressure (99% CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Obese    
Total fruit & vegetable intake 81 1.00 (0.93, 1.07) 0.96 (0.88, 1.04) 
Total fruit intake 81 1.00 (0.91, 1.11) 0.97 (0.86, 1.10) 
Fresh fruit intake 81 1.00 (0.89, 1.12) 0.97 (0.84, 1.11) 
Fresh fruit and juice intake 81 1.00 (0.91, 1.10) 0.97 (0.86, 1.09) 
Fresh and dried fruit intake 81 1.00 (0.90, 1.13) 0.97 (0.85, 1.12) 
Total dried fruit intake (25 g/day) 81 1.33 (0.83, 2.15) 1.21 (0.72, 2.03) 
Fruit juice intake (125 g/day) 81 1.02 (0.71, 1.46) 0.95 (0.64, 1.41) 
Total citrus intake 81 0.91 (0.70, 1.19) 0.92 (0.70, 1.22) 
Citrus fruit intake 81 0.83 (0.45, 1.52) 0.89 (0.46, 1.72) 
Orange Juice Intake (250 g/day) 81 0.77 (0.29, 2.09) 0.78 (0.28, 2.16) 
Total berries intake 81 1.33 (0.61, 2.93) 0.75 (0.15, 3.68) 
Total grapes intake 81 1.57 (1.04, 2.38) 1.75 (1.03, 2.99) 
Total pomes intake 81 0.77 (0.56, 1.05) 0.73 (0.52, 1.03) 
Total drupes intake 81 1.81 (0.12, 27.9) 1.85 (0.08, 41.7) 
Total tropical intake 81 1.07 (0.74, 1.55) 1.06 (0.68, 1.66) 
Total vegetable intake 81 0.97 (0.84, 1.13) 0.93 (0.77, 1.11) 
Fresh vegetable intake 81 1.01 (0.85, 1.20) 1.01 (0.81, 1.25) 
Allium intake 81 1.05 (0.16, 6.95) 1.43 (0.14, 14.9) 
Brassicaceae intake 81 1.09 (0.75, 1.57) 1.16 (0.74, 1.82) 
Fruit vegetable intake 81 0.93 (0.57, 1.49) 0.97 (0.57, 1.69) 
Pod vegetable intake 81 1.18 (0.45, 3.04) 1.05 (0.32, 3.41) 
Stalk/root vegetable intake 81 1.02 (0.45, 2.31) 0.93 (0.29, 2.97) 
Non-obese    
Total fruit & vegetable intake 603 0.98 (0.96, 1.01) 0.98 (0.95, 1.01) 
Total fruit intake 603 0.98 (0.95, 1.02) 1.00 (0.95, 1.04) 
Fresh fruit intake 603 0.97 (0.92, 1.01) 0.99 (0.94, 1.04) 
Fresh fruit and juice intake 603 0.98 (0.95, 1.02) 1.00 (0.95, 1.04) 
Fresh and dried fruit intake 603 0.97 (0.92, 1.01) 0.99 (0.94, 1.04) 
Total dried fruit intake (25 g/day) 603 0.98 (0.84, 1.14) 1.03 (0.88, 1.20) 
Fruit juice intake (125 g/day) 603 1.03 (0.92, 1.16) 1.02 (0.90, 1.16) 
Total citrus intake 603 1.03 (0.94, 1.11) 1.04 (0.96, 1.14) 
Citrus fruit intake 603 1.03 (0.87, 1.22) 1.13 (0.94, 1.35) 
Orange Juice Intake (250 g/day) 603 1.09 (0.80, 1.50) 1.07 (0.77, 1.49) 
Total berries intake 603 0.85 (0.58, 1.26) 0.88 (0.59, 1.32) 
Total grapes intake 603 0.99 (0.81, 1.20) 1.05 (0.86, 1.28) 
Total pomes intake 603 0.90 (0.81, 1.00) 0.93 (0.83, 1.04) 
Total drupes intake 603 0.75 (0.28, 1.96) 0.91 (0.30, 2.76) 
Total tropical intake 603 0.97 (0.84, 1.13) 1.02 (0.86, 1.20) 
Total vegetable intake 603 0.97 (0.92, 1.02) 0.95 (0.89, 1.01) 
Fresh vegetable intake 603 0.96 (0.90, 1.02) 0.95 (0.88, 1.02) 
Allium intake 603 0.81 (0.40, 1.63) 1.08 (0.47, 2.51) 
Brassicaceae intake 603 0.95 (0.83, 1.09) 0.94 (0.80, 1.11) 
Fruit vegetable intake 603 0.82 (0.69, 0.98) 0.81 (0.65, 1.00) 
Pod vegetable intake 603 1.15 (0.83, 1.60) 1.29 (0.87, 1.93) 
Stalk/root vegetable intake 603 0.88 (0.67, 1.16) 1.00 (0.71, 1.41) 
a Cases apply to fully adjusted model only 
b Adjusted for age, BMI, energy intake, physical activity, smoking status, socio-economic status, alcohol intake, 
total vegetable intake, and mutual adjustments for fruits that are not in the exposure category 
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Table D.2 Total fruit, total vegetable, fruit and vegetable subgroup intake and the odds of self-reported 
HBP incidence within pre-menopausal and post-menopausal subpopulations 
Intake (80 g/day) Odds of high blood pressure (99% CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Postmenopausal    
Total fruit & vegetable intake 440 0.99 (0.96, 1.02) 0.98 (0.94, 1.01) 
Total fruit intake 440 0.98 (0.94, 1.03) 0.99 (0.94, 1.04) 
Fresh fruit intake 440 0.99 (0.93, 1.04) 1.00 (0.94, 1.06) 
Fresh fruit and juice intake 440 0.98 (0.94, 1.03) 0.98 (0.94, 1.04) 
Fresh and dried fruit intake 440 0.99 (0.94, 1.04) 1.00 (0.94, 1.06) 
Total dried fruit intake (25 g/day) 440 1.02 (0.87, 1.19) 1.05 (0.89, 1.24) 
Fruit juice intake (125 g/day) 440 0.95 (0.83, 1.10) 0.92 (0.79, 1.08) 
Total citrus intake 440 0.98 (0.89, 1.08) 0.99 (0.89, 1.10) 
Citrus fruit intake 440 1.03 (0.85, 1.26) 1.10 (0.89, 1.36) 
Orange Juice Intake (250 g/day) 440 0.88 (0.59, 1.31) 0.84 (0.56, 1.28) 
Total berries intake 440 0.84 (0.55, 1.29) 0.81 (0.51, 1.29) 
Total grapes intake 440 1.08 (0.90, 1.29) 1.10 (0.91, 1.33) 
Total pomes intake 440 0.91 (0.81, 1.02) 0.91 (0.79, 1.04) 
Total drupes intake 440 1.19 (0.39, 3.64) 1.33 (0.36, 4.87) 
Total tropical intake 440 1.05 (0.89, 1.24) 1.08 (0.89, 1.30) 
Total vegetable intake 440 0.98 (0.92, 1.04) 0.96 (0.89, 1.03) 
Fresh vegetable intake 440 0.98 (0.92, 1.05) 0.97 (0.89, 1.05) 
Allium intake 440 1.09 (0.51, 2.36) 1.34( 0.53, 3.40) 
Brassicaceae intake 440 0.96 (0.83, 1.12) 0.93 (0.78, 1.12) 
Fruit vegetable intake 440 0.89 (0.73, 1.09) 0.86 (0.67, 1.10) 
Pod vegetable intake 440 1.32 (0.90, 1.93) 1.44 (0.90, 2.30) 
Stalk/root vegetable intake 440 0.88 (0.64, 1.21) 0.94 (0.63, 1.41) 
Premenopausal    
Total fruit & vegetable intake 244 0.97 (0.93, 1.02) 0.97 (0.92, 1.02) 
Total fruit intake 244 0.98 (0.92, 1.04) 1.00 (0.93, 1.07) 
Fresh fruit intake 244 0.94 (0.87, 1.01) 0.95 (0.88, 1.04) 
Fresh fruit and juice intake 244 0.98 (0.93, 1.04) 1.00 (0.93, 1.07) 
Fresh and dried fruit intake 244 0.94 (0.87, 1.01) 0.95 (0.88, 1.04) 
Total dried fruit intake (25 g/day) 244 0.88 (0.66, 1.19) 0.95 (0.70, 1.29) 
Fruit juice intake (125 g/day) 244 1.15 (0.98, 1.36) 1.16 (0.97, 1.30) 
Total citrus intake 244 1.06 (0.93, 1.20) 1.11 (0.97, 1.26) 
Citrus fruit intake 244 0.93 (0.70, 1.25) 1.11 (0.82, 1.51) 
Orange Juice Intake (250 g/day) 244 1.36 (0.87, 2.14) 1.39 (0.87, 2.21) 
Total berries intake 244 1.07 (0.58, 1.95) 1.05 (0.50, 2.21) 
Total grapes intake 244 1.06 (0.74, 1.50) 1.20 (0.83, 1.73) 
Total pomes intake 244 0.83 (0.70, 0.99) 0.86 (0.71, 1.04) 
Total drupes intake 244 0.38 (0.07, 1.89) 0.73 (0.12, 4.42) 
Total tropical intake 244 0.88 (0.69, 1.12) 0.95 (0.73, 1.24) 
Total vegetable intake 244 0.94 (0.86, 1.02) 0.93 (0.83, 1.02) 
Fresh vegetable intake 244 0.93 (0.84, 1.03) 0.93 (0.82, 1.05) 
Allium intake 244 0.42 (0.12, 1.49) 0.71 (0.16, 3.10) 
Brassicaceae intake 244 0.98 (0.78, 1.24) 1.03 (0.78, 1.35) 
Fruit vegetable intake 244 0.72 (0.54, 0.96) 0.76 (0.54, 1.06) 
Pod vegetable intake 244 0.90 (0.52, 1.57) 1.03 (0.53, 1.98) 
Stalk/root vegetable intake 244 0.88 (0.55, 1.41) 1.10 (0.62, 1.93) 
a Cases apply to fully adjusted model only 
b Adjusted for age, BMI, physical activity, smoking status, socio-economic status, alcohol intake, total vegetable 
intake, and mutual adjustments for fruits that are not in the exposure category 
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Table D.3 Total fruit, total vegetable, fruit and vegetable subgroup intake and the odds of self-reported 
HBP incidence within subpopulations with and without parental history of CVD 
Intake (80 g/day) Odds of high blood pressure (99% CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Parental history of CVD    
Total fruit & vegetable intake 383 1.00 (0.97, 1.04) 0.99 (0.95, 1.03) 
Total fruit intake 383 1.01 (0.96, 1.06) 1.01 (0.96, 1.07) 
Fresh fruit intake 383 0.99 (0.93, 1.05) 1.00 (0.93, 1.07) 
Fresh fruit and juice intake 383 1.01 (0.96, 1.06) 1.01 (0.95, 1.07) 
Fresh and dried fruit intake 383 0.99 (0.93, 1.05) 1.00 (0.93, 1.07) 
Total dried fruit intake (25 g/day) 383 1.06 (0.89, 1.25) 1.09 (0.91, 1.30) 
Fruit juice intake (125 g/day) 383 1.11 (0.95, 1.29) 1.08 (0.91, 1.27) 
Total citrus intake 383 1.07 (0.96, 1.19) 1.09 (0.97, 1.21) 
Citrus fruit intake 383 1.05 (0.84, 1.32) 1.15 (0.90, 1.46) 
Orange Juice Intake (250 g/day) 383 1.29 (0.87, 1.92) 1.26 (0.84, 1.90) 
Total berries intake 383 1.03 (0.66, 1.61) 0.92 (0.54, 1.58) 
Total grapes intake 383 0.96 (0.70, 1.30) 0.94 (0.68, 1.30) 
Total pomes intake 383 0.92 (0.80, 1.05) 0.92 (0.79, 1.08) 
Total drupes intake 383 0.60 (0.15, 2.44) 0.52 (0.10, 2.80) 
Total tropical intake 383 1.05 (0.87, 1.28) 1.08 (0.87, 1.35) 
Total vegetable intake 383 1.00 (0.93, 1.07) 0.95 (0.87, 1.04) 
Fresh vegetable intake 383 1.00 (0.92, 1.08) 0.94 (0.84, 1.04) 
Allium intake 383 1.22 (0.47, 3.17) 1.45 (0.45, 4.67) 
Brassicaceae intake 383 0.99 (0.82, 1.19) 0.91 (0.72, 1.14) 
Fruit vegetable intake 383 0.91 (0.72, 1.15) 0.88 (0.66, 1.17) 
Pod vegetable intake 383 1.30 (0.82, 2.07) 1.24 (0.69, 2.22) 
Stalk/root vegetable intake 383 0.91 (0.62, 1.33) 0.80 (0.48, 1.33) 
No parental history of CVD    
Total fruit & vegetable intake 300 0.97 (0.93, 1.00) 0.96 (0.92, 1.00) 
Total fruit intake 300 0.96 (0.92, 1.01) 0.97 (0.92, 1.03) 
Fresh fruit intake 300 0.95 (0.89, 1.01) 0.97 (0.91, 1.04) 
Fresh fruit and juice intake 300 0.96 (0.92, 1.01) 0.97 (0.92, 1.03) 
Fresh and dried fruit intake 300 0.95 (0.89, 1.01) 0.97 (0.91, 1.04) 
Total dried fruit intake (25 g/day) 300 0.89 (0.71, 1.11) 0.94 (0.74, 1.20) 
Fruit juice intake (125 g/day) 300 0.96 (0.82, 1.12) 0.96 (0.81, 1.14) 
Total citrus intake 300 0.95 (0.85, 1.06) 0.97 (0.86, 1.10) 
Citrus fruit intake 300 0.94 (0.74, 1.19) 1.05 (0.82, 1.35) 
Orange Juice Intake (250 g/day) 300 0.84 (0.54, 1.31) 0.82 (0.51, 1.32) 
Total berries intake 300 0.77 (0.44, 1.34) 0.82 (0.47, 1.45) 
Total grapes intake 300 1.14 (0.95, 1.38) 1.23 (1.02, 1.49) 
Total pomes intake 300 0.84 (0.73, 0.97) 0.87 (0.74, 1.01) 
Total drupes intake 300 0.91 (0.28, 3.00) 1.57 (0.42, 5.89) 
Total tropical intake 300 0.93 (0.77, 1.12) 0.98 (0.79, 1.21) 
Total vegetable intake 300 0.94 (0.87, 1.01) 0.94 (0.86, 1.02) 
Fresh vegetable intake 300 0.94 (0.87, 1.02) 0.96 (0.88, 1.06) 
Allium intake 300 0.60 (0.24, 1.50) 0.87 (0.30, 2.53) 
Brassicaceae intake 300 0.95 (0.80, 1.13) 1.02 (0.83, 1.25) 
Fruit vegetable intake 300 0.76 (0.60, 0.95) 0.78 (0.59, 1.03) 
Pod vegetable intake 300 1.04 (0.68, 1.58) 1.28 (0.77, 2.11) 
Stalk/root vegetable intake 300 0.86 (0.60, 1.24) 1.18 (0.76, 1.82) 
a Cases apply to fully adjusted model only 
b Adjusted for age, BMI, physical activity, smoking status, socio-economic status, alcohol intake, total vegetable 
intake, and mutual adjustments for fruits that are not in the exposure category 
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Table D.4 Total fruit, total vegetable, fruit and vegetable subgroup intake and the odds of self-reported 
HBP incidence within non-smoking women 
Intake (80 g/day) Odds of high blood pressure (99% CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Non-smokers    
Total fruit & vegetable intake 632 0.99 (0.96, 1.01) 0.97 (0.95, 1.00) 
Total fruit intake 632 0.99 (0.95, 1.02) 0.99 (0.95, 1.03) 
Fresh fruit intake 632 0.97 (0.93, 1.01) 0.98 (0.93, 1.03) 
Fresh fruit and juice intake 632 0.99 (0.95, 1.02) 0.99 (0.95, 1.03) 
Fresh and dried fruit intake 632 0.97 (0.93, 1.01) 0.98 (0.93, 1.03) 
Total dried fruit intake (25 g/day) 632 0.99 (0.86, 1.14) 1.03 (0.89, 1.19) 
Fruit juice intake (125 g/day) 632 1.05 (0.93, 1.17) 1.02 (0.90, 1.15) 
Total citrus intake 632 1.02 (0.94, 1.11) 1.04 (0.95, 1.13) 
Citrus fruit intake 632 0.99 (0.84, 1.18) 1.10 (0.92, 1.31) 
Orange Juice Intake (250 g/day) 632 1.11 (0.82, 1.51) 1.07 (0.78, 1.48) 
Total berries intake 632 0.93 (0.66, 1.31) 0.88 (0.60, 1.31) 
Total grapes intake 632 1.08 (0.92, 1.28) 1.13 (0.95, 1.35) 
Total pomes intake 632 0.88 (0.79, 0.97) 0.89 (0.79, 0.99) 
Total drupes intake 632 0.82 (0.32, 2.07) 1.01 (0.35, 2.95) 
Total tropical intake 632 1.00 (0.87, 1.15) 1.04 (0.89, 1.21) 
Total vegetable intake 632 0.97 (0.92, 1.02) 0.95 (0.89, 1.01) 
Fresh vegetable intake 632 0.97 (0.92, 1.03) 0.96 (0.89, 1.03) 
Allium intake 632 0.91 (0.47, 1.78) 1.20 (0.54, 2.69) 
Brassicaceae intake 632 0.98 (0.86, 1.11) 0.97 (0.83, 1.13) 
Fruit vegetable intake 632 0.83 (0.70, 0.98) 0.81 (0.66, 0.99) 
Pod vegetable intake 632 1.20 (0.88, 1.65) 1.32 (0.89, 1.94) 
Stalk/root vegetable intake 632 0.90 (0.69, 1.19) 1.00 (0.71, 1.41) 
a Cases apply to fully adjusted model only 
b Adjusted for age, BMI, physical activity, smoking status, socio-economic status, alcohol intake, total vegetable 
intake, and mutual adjustments for fruits that are not in the exposure category 
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Appendix E Chapter 7 sensitivity analyses 
Table E.1 Total black tea, coffee and coffee subgroup intake and the odds of self-reported HBP incidence 
stratified by coffee preference, obese/non-obese, smoking, menopausal status and parental 
history of CVD 
Intake (250 g/day) Odds of high blood pressure (95% or 99%* CI) 
 Cases a Age Adjusted Fully-Adjusted b 
Coffee preference    
Regular coffee drinkers 277 0.98 (0.88, 1.08) 0.91 (0.81, 1.02) 
Decaffeinated coffee drinkers 63 1.07 (0.86, 1.33) 1.03 (0.81, 1.31) 
Obese*    
Total coffee 82 1.08 (0.88, 1.33) 0.99 (0.79, 1.25) 
Regular coffee 82 1.10 (0.89, 1.38) 1.04 (0.82, 1.33) 
Decaffeinated coffee 82 0.99 (0.71, 1.36) 0.90 (0.63, 1.29) 
Black tea 82 0.98 (0.85, 1.12) 0.95 (0.81, 1.12) 
Regular coffee drinkers 40 0.95 (0.67, 1.33) 0.87 (0.58, 1.30) 
Non-obese*    
Total coffee 607 1.02 (0.94, 1.10) 0.98 (0.90, 1.07) 
Regular coffee 607 1.00 (0.92, 1.09) 0.96 (0.87, 1.05) 
Decaffeinated coffee 607 1.04 (0.92, 1.18) 1.03 (0.91, 1.18) 
Black tea 607 1.00 (0.95, 1.06) 1.00 (0.94, 1.06) 
Regular coffee drinkers 237 0.97 (0.85, 1.12) 0.90 (0.77, 1.06) 
Non-smokers*    
Total coffee 637 1.05 (0.97, 1.13) 1.01 (0.93, 1.10) 
Regular coffee 637 1.05 (0.96, 1.14) 1.01 (0.92, 1.10) 
Decaffeinated coffee 637 1.03 (0.91, 1.16) 1.01 (0.89, 1.15) 
Black tea 637 0.99 (0.94, 1.04) 0.99 (0.94, 1.05) 
Regular coffee drinkers 255 1.00 (0.87, 1.15) 0.92 (0.79, 1.08) 
Postmenopausal*    
Total coffee 442 1.01 (0.92, 1.11) 1.00 (0.90, 1.10) 
Regular coffee 442 1.02 (0.92, 1.13) 1.00 (0.89, 1.12) 
Decaffeinated coffee 442 1.00 (0.85, 1.17) 0.99 (0.84, 1.17) 
Black tea 442 1.02 (0.96, 1.09) 1.02 (0.95, 1.09) 
Regular coffee drinkers 194 1.01 (0.86, 1.18) 0.99 (0.82, 1.19) 
Premenopausal*    
Total coffee 247 1.05 (0.94, 1.18) 0.98 (0.86, 1.11) 
Regular coffee 247 1.02 (0.90, 1.16) 0.95 (0.83, 1.09) 
Decaffeinated coffee 247 1.10 (0.92, 1.31) 1.05 (0.87, 1.26) 
Black tea 247 0.96 (0.89, 1.04) 0.96 (0.88, 1.05) 
Regular coffee drinkers 83 0.92 (0.74, 1.15) 0.79 (0.61, 1.02) 
NO parental history of CVD*    
Total coffee 387 1.03 (0.94, 1.14) 0.99 (0.89, 1.10) 
Regular coffee 387 1.00 (0.90, 1.12) 0.96 (0.85, 1.07) 
Decaffeinated coffee 387 1.08 (0.93, 1.26) 1.07 (0.91, 1.25) 
Black tea 387 1.00 (0.94, 1.07) 0.99 (0.92, 1.07) 
Regular coffee drinkers 157 0.98 (0.83, 1.17) 0.90 (0.75, 1.10) 
WITH parental history of CVD*    
Total coffee 301 1.02 (0.92, 1.14) 0.99 (0.88, 1.12) 
Regular coffee 301 1.03 (0.92, 1.16) 1.01 (0.89, 1.15) 
Decaffeinated coffee 301 0.99 (0.82, 1.19) 0.97 (0.80, 1.17) 
Black tea 301 0.99 (0.92, 1.07) 0.99 (0.91, 1.08) 
Regular coffee drinkers 120 0.97 (0.80, 1.18) 0.93 (0.74, 1.17) 
a Cases apply to fully-adjusted models 
b Adjusted for age (categorical), BMI, energy intake, physical activity, smoking status, socio-economic status, 
alcohol intake, family history of HBP, self-reported history of hypercholesterolaemia, mutual adjustment for 
total coffee or black tea intake 
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Appendix F Chapter 10 sensitivity analyses 
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Table F.2 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within adults with no 
longstanding CVD illness in the NDNS RP cohort 
Intake (80 g/day) 
n = 175 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.90 (0.80, 1.00) 0.92 (0.82, 1.04) 0.91 (0.81, 1.03) 
Total fruits 0.83 (0.69, 0.99) 0.88 (0.72, 1.07) 0.87 (0.71, 1.06) 
Total fruit juice (125 g/day) 0.75 (0.52, 1.09) 0.87 (0.60, 1.26) 0.84 (0.58, 1.23) 
Dried fruits (25 g/day) 0.79 (0.46, 1.35) 1.06 (0.61, 1.84) 1.00 (0.56, 1.76) 
Berries 0.76 (0.42, 1.38) 0.85 (0.48, 1.51) 0.85 (0.48, 1.51) 
Citrus 0.88 (0.70, 1.10) 0.94 (0.75, 1.18) 0.93 (0.75, 1.17) 
Drupes 0.94 (0.50, 1.77) 1.22 (0.63, 2.36) 1.21 (0.63, 2.33) 
Pomes 0.71 (0.50, 1.00) 0.81 (0.57, 1.17) 0.80 (0.56, 1.14) 
Tropical fruits 0.77 (0.49, 1.20) 0.85 (0.53, 1.38) 0.84 (0.52, 1.37) 
Total vegetables 0.92 (0.77, 1.09) 0.97 (0.80, 1.17) 0.95 (0.79, 1.16) 
Allium 1.14 (0.50, 2.57) 1.53 (0.62, 3.80) 1.53 (0.62, 3.77) 
Brassicaceae 0.77 (0.40, 1.49) 0.93 (0.45, 1.91) 0.93 (0.45, 1.91) 
Fruit vegetables 0.92 (0.65, 1.29) 1.11 (0.77, 1.60) 1.11 (0.77, 1.60) 
Pod vegetables  0.73 (0.27, 1.96) 0.78 (0.28, 2.15) 0.74 (0.27, 2.07) 
Root vegetables  0.91 (0.48, 1.72) 1.19 (0.58, 2.41) 1.19 (0.58, 2.42) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
 
Table F.3 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within non-obese adults 
in the NDNS RP cohort 
Intake (80 g/day) 
n =110 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.85 (0.74, 0.98) 0.87 (0.75, 1.02) 0.87 (0.74, 1.01) 
Total fruits 0.70 (0.54, 0.91) 0.73 (0.54, 0.97) 0.72 (0.54, 0.97) 
Total fruit juice (125 g/day) 0.75 (0.49, 1.15) 0.76 (0.49, 1.20) 0.75 (0.48, 1.18) 
Dried fruits (25 g/day) 0.64 (0.32, 1.27) 0.83 (0.43, 1.63) 0.80 (0.40, 1.60) 
Berries 0.82 (0.37, 1.80) 1.02 (0.47, 2.21) 1.02 (0.47, 2.20) 
Citrus 0.80 (0.60, 1.08) 0.82 (0.60, 1.11) 0.81 (0.59, 1.10) 
Drupes 0.77 (0.36, 1.66) 0.96 (0.44, 2.12) 0.96 (0.44, 2.12) 
Pomes 0.64 (0.41, 0.99) 0.73 (0.46, 1.15) 0.73 (0.46, 1.15) 
Tropical fruits 0.69 (0.40, 1.19) 0.84 (0.46, 1.54) 0.84 (0.46, 1.54) 
Total vegetables 0.91 (0.73, 1.13) 1.01 (0.80, 1.29) 1.01 (0.79, 1.28) 
Allium 1.08 (0.41, 2.84) 1.43 (0.48, 4.25) 1.43 (0.48, 4.24) 
Brassicaceae 0.67 (0.29, 1.53) 0.89 (0.36, 2.24) 0.88 (0.35, 2.22) 
Fruit vegetables 0.87 (0.57, 1.33) 1.08 (0.67, 1.75) 1.08 (0.67, 1.75) 
Pod vegetables  0.60 (0.17, 2.14) 0.63 (0.17, 2.35) 0.61 (0.16, 2.32) 
Root vegetables  0.80 (0.36, 1.79) 1.04 (0.42, 2.57) 1.04 (0.42, 2.56) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
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Table F.4 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within obese adults in the 
NDNS RP cohort 
Intake (80 g/day) 
n = 72 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.98 (0.81, 1.18) 0.98 (0.81, 1.19) 0.96 (0.79, 1.18) 
Total fruits 1.04 (0.78, 1.38) 1.10 (0.81, 1.51) 1.09 (0.79, 1.49) 
Total fruit juice (125 g/day) 0.87 (0.42, 1.80) 1.06 (0.49, 2.28) 1.00 (0.46, 2.17) 
Dried fruits (25 g/day) 1.31 (0.41, 4.15) 1.38 (0.38, 5.08) 1.34 (0.36, 4.89) 
Berries 0.60 (0.23, 1.58) 0.59 (0.21, 1.62) 0.58 (0.21, 1.60) 
Citrus 1.11 (0.73, 1.67) 1.22 (0.79, 1.89) 1.23 (0.80, 1.90) 
Drupes 1.74 (0.44, 6.90) 1.75 (0.40, 7.65) 1.61 (0.37, 7.03) 
Pomes 1.00 (0.57, 1.73) 1.12 (0.60, 2.09) 1.07 (0.57, 2.00) 
Tropical fruits 1.12 (0.54, 2.29) 1.19 (0.54, 2.62) 1.17 (0.53, 2.58) 
Total vegetables 0.92 (0.68, 1.24) 0.87 (0.62, 1.21) 0.84 (0.60, 1.18) 
Allium 0.53 (0.09, 2.95) 0.46 (0.07, 3.16) 0.44 (0.06, 3.07) 
Brassicaceae 0.73 (0.25, 2.17) 0.68 (0.21, 2.25) 0.70 (0.21, 2.35) 
Fruit vegetables 1.17 (0.69, 1.99) 1.31 (0.74, 2.33) 1.34 (0.76, 2.38) 
Pod vegetables  0.75 (0.15, 3.78) 0.70 (0.12, 4.06) 0.63 (0.10, 3.77) 
Root vegetables  0.98 (0.29, 3.30) 1.13 (0.30, 4.23) 1.17 (0.31, 4.40) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
 
Table F.5 Total FV, fruit and vegetable subgroups intakes and odds of HBP within male adults in the 
NDNS RP cohort 
Intake (80 g/day) 
n = 102 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.93 (0.81, 1.08) 0.94 (0.81, 1.10) 0.95 (0.81, 1.11) 
Total fruits 0.89 (0.71, 1.13) 0.92 (0.71, 1.20) 0.92 (0.71, 1.21) 
Total fruit juice (125 g/day) 0.49 (0.27, 0.88) 0.53 (0.28, 0.98) 0.53 (0.28, 0.98) 
Dried fruits (25 g/day) 0.84 (0.44, 1.62) 1.18 (0.60, 2.32) 1.18 (0.60, 2.34) 
Berries 0.89 (0.43, 1.87) 0.94 (0.43, 2.03) 0.94 (0.43, 2.02) 
Citrus 0.68 (0.47, 0.98) 0.71 (0.48, 1.04) 0.71 (0.48, 1.04) 
Drupes 1.23 (0.46, 3.24) 2.39 (0.82, 6.98) 2.42 (0.82, 7.17) 
Pomes 0.85 (0.58, 1.25) 0.96 (0.62, 1.48) 0.96 (0.62, 1.48) 
Tropical fruits 0.76 (0.43, 1.36) 0.90 (0.47, 1.71) 0.90 (0.47, 1.71) 
Total vegetables 0.94 (0.75, 1.17) 0.96 (0.75, 1.23) 0.97 (0.75, 1.24) 
Allium 0.87 (0.31, 2.44) 0.99 (0.30, 3.28) 0.98 (0.29, 3.28) 
Brassicaceae 0.70 (0.29, 1.69) 0.84 (0.32, 2.20) 0.84 (0.32, 2.21) 
Fruit vegetables 1.13 (0.75, 1.70) 1.39 (0.87, 2.20) 1.39 (0.87, 2.21) 
Pod vegetables  0.43 (0.10, 1.81) 0.39 (0.09, 1.76) 0.39 (0.09, 1.80) 
Root vegetables  1.05 (0.45, 2.48) 1.45 (0.54, 3.88) 1.46 (0.54, 3.94) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
 
  
 327 
 
 
Table F.6 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within female adults in 
the NDNS RP cohort 
Intake (80 g/day) 
n = 90 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.86 (0.74, 1.01) 0.91 (0.77, 1.08) 0.91 (0.76, 1.08) 
Total fruits 0.77 (0.59, 1.00) 0.84 (0.62, 1.12) 0.83 (0.61, 1.11) 
Total fruit juice (125 g/day) 1.04 (0.67, 1.60) 1.33 (0.83, 2.12) 1.31 (0.81, 2.11) 
Dried fruits (25 g/day) 0.55 (0.22, 1.39) 0.70 (0.26, 1.88) 0.68 (0.25, 1.85) 
Berries 0.74 (0.32, 1.69) 0.84 (0.38, 1.90) 0.84 (0.37, 1.89) 
Citrus 1.03 (0.80, 1.34) 1.16 (0.88, 1.53) 1.15 (0.87, 1.52) 
Drupes 0.79 (0.35, 1.77) 0.95 (0.40, 2.28) 0.95 (0.39, 2.27) 
Pomes 0.50 (0.26, 0.94) 0.57 (0.29, 1.15) 0.57 (0.28, 1.14) 
Tropical fruits 0.84 (0.45, 1.54) 1.01 (0.52, 1.94) 1.00 (0.52, 1.93) 
Total vegetables 0.87 (0.67, 1.13) 1.00 (0.75, 1.34) 1.00 (0.74, 1.34) 
Allium 1.16 (0.35, 3.86) 2.02 (0.52, 7.84) 2.05 (0.52, 8.02) 
Brassicaceae 0.87 (0.34, 2.21) 1.19 (0.43, 3.30) 1.19 (0.43, 3.30) 
Fruit vegetables 0.79 (0.47, 1.32) 0.97 (0.56, 1.68) 0.98 (0.57, 1.68) 
Pod vegetables  1.11 (0.31, 3.99) 1.51 (0.39, 5.76) 1.46 (0.38, 5.64) 
Root vegetables  0.82 (0.34, 1.99) 0.12 (0.42, 3.00) 1.12 (0.42, 3.01) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
 
Table F.7 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within adults 19-64 years 
in the NDNS RP cohort 
Intake (80 g/day) 
n = 132 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.86 (0.75, 0.98) 0.90 (0.78, 1.03) 0.89 (0.77, 1.03) 
Total fruits 0.78 (0.63, 0.98) 0.89 (0.70, 1.14) 0.89 (0.69, 1.13) 
Total fruit juice (125 g/day) 0.70 (0.46, 1.07) 0.81 (0.53, 1.25) 0.79 (0.52, 1.22) 
Dried fruits (25 g/day) 0.66 (0.31, 1.40) 0.96 (0.46, 2.02) 0.92 (0.43, 1.95) 
Berries 0.79 (0.41, 1.53) 0.94 (0.50, 1.77) 0.94 (0.50, 1.78) 
Citrus 0.84 (0.65, 1.09) 0.92 (0.72, 1.19) 0.92 (0.72, 1.18) 
Drupes 0.90 (0.38, 2.16) 1.44 (0.56, 3.69) 1.40 (0.55, 3.57) 
Pomes 0.72 (0.48, 1.09) 0.89 (0.58, 1.37) 0.88 (0.58, 1.34) 
Tropical fruits 0.73 (0.44, 1.22) 0.96 (0.55, 1.68) 0.95 (0.54, 1.67) 
Total vegetables 0.85 (0.69, 1.04) 0.90 (0.72, 1.13) 0.89 (0.71, 1.12) 
Allium 0.88 (0.35, 2.19) 1.28 (0.45, 3.68) 1.28 (0.45, 3.67) 
Brassicaceae 0.51 (0.23, 1.15) 0.62 (0.25, 1.50) 0.62 (0.26, 1.51) 
Fruit vegetables 0.82 (0.56, 1.21) 1.08 (0.71, 1.66) 1.09 (0.71, 1.66) 
Pod vegetables  0.85 (0.29, 2.54) 0.95 (0.30, 2.97) 0.92 (0.29, 2.89) 
Root vegetables  0.74 (0.34, 1.63) 1.31 (0.54, 3.17) 1.31 (0.54, 3.18) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
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Table F.8 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within adults 65+ years 
in the NDNS RP cohort 
Intake (80 g/day) 
n = 60 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.98 (0.81, 1.18) 1.02 (0.82, 1.27) 1.02 (0.81, 1.28) 
Total fruits 0.87 (0.65, 1.16) 0.88 (0.63, 1.23) 0.88 (0.62, 1.23) 
Total fruit juice (125 g/day) 0.90 (0.43, 1.85) 0.96 (0.44, 2.08) 0.95 (0.42, 2.14) 
Dried fruits (25 g/day) 0.78 (0.34, 1.79) 0.66 (0.24, 1.84) 0.66 (0.23, 1.84) 
Berries 0.70 (0.23, 2.14) 0.89 (0.26, 3.02) 0.88 (0.26, 3.00) 
Citrus 0.95 (0.60, 1.50) 0.98 (0.60, 1.61) 0.98 (0.58, 1.65) 
Drupes 0.86 (0.36, 2.06) 0.93 (0.35, 2.45) 0.93 (0.35, 2.46) 
Pomes 0.71 (0.41, 1.24) 0.64 (0.35, 1.19) 0.64 (0.35, 1.19) 
Tropical fruits 0.90 (0.42, 1.89) 1.08 (0.45, 2.54) 1.07 (0.45, 2.54) 
Total vegetables 1.14 (0.81, 1.59) 1.25 (0.86, 1.83) 1.25 (0.84, 1.86) 
Allium 1.64 (0.31, 8.68) 1.56 (0.23, 10.8) 1.56 (0.23, 10.8) 
Brassicaceae 1.91 (0.56, 6.50) 2.73 (0.66, 11.2) 2.75 (0.66, 11.5) 
Fruit vegetables 1.41 (0.74, 2.68) 1.51 (0.72, 3.16) 1.51 (0.72, 3.18) 
Pod vegetables  0.43 (0.07, 2.78) 0.42 (0.06, 3.19) 0.40 (0.05, 3.22) 
Root vegetables  1.25 (0.45, 3.51) 1.65 (0.51, 5.30) 1.65 (0.51, 5.33) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
 
Table F.9 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within adults not 
consuming statins in the NDNS RP cohort 
Intake (80 g/day) 
n = 176 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.89 (0.80, 1.00) 0.92 (0.82, 1.04) 0.91 (0.81, 1.03) 
Total fruits 0.81 (0.68, 0.98) 0.88 (0.72, 1.07) 0.87 (0.71, 1.06) 
Total fruit juice (125 g/day) 0.77 (0.53, 1.11) 0.87 (0.60, 1.26) 0.85 (0.58, 1.23) 
Dried fruits (25 g/day) 0.72 (0.42, 1.26) 0.97 (0.56, 1.70) 0.93 (0.53, 1.65) 
Berries 0.80 (0.45, 1.43) 0.90 (0.51, 1.58) 0.90 (0.51, 1.58) 
Citrus 0.89 (0.71, 1.11) 0.95 (0.76, 1.18) 0.94 (0.75, 1.17) 
Drupes 0.98 (0.52, 1.85) 1.32 (0.68, 2.57) 1.31 (0.68, 2.53) 
Pomes 0.72 (0.51, 1.02) 0.86 (0.60, 1.22) 0.85 (0.60, 1.21) 
Tropical fruits 0.72 (0.46, 1.14) 0.85 (0.52, 1.39) 0.85 (0.52, 1.39) 
Total vegetables 0.91 (0.76, 1.09) 0.97 (0.80, 1.17) 0.96 (0.79, 1.16) 
Allium 1.13 (0.51, 2.53) 1.49 (0.61, 3.65) 1.50 (0.61, 3.67) 
Brassicaceae 0.73 (0.38, 1.43) 0.91 (0.44, 1.86) 0.90 (0.44, 1.85) 
Fruit vegetables 0.93 (0.67, 1.29) 1.13 (0.79, 1.61) 1.14 (0.80, 1.62) 
Pod vegetables  0.64 (0.24, 1.74) 0.66 (0.23, 1.86) 0.63 (0.22, 1.80) 
Root vegetables  0.97 (0.51, 1.81) 1.28 (0.64, 2.58) 1.28 (0.64, 2.56) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
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Table F.10 Total FV, fruit and vegetable subgroups intakes and the odds of HBP within non-smoking 
adults in the NDNS RP cohort 
Intake (80 g/day) 
n = 103 
Odds of high blood pressure (99% CI) 
Age Adjusted Fully-Adjusted a Full Energy Adjusted b 
Total fruits & vegetables 0.86 (0.75, 1.00) 0.89 (0.77, 1.04) 0.88 (0.75, 1.02) 
Total fruits 0.82 (0.65, 1.03) 0.89 (0.69, 1.13) 0.87 (0.67, 1.11) 
Total fruit juice (125 g/day) 0.71 (0.45, 1.13) 0.80 (0.51, 1.27) 0.77 (0.48, 1.22) 
Dried fruits (25 g/day) 0.79 (0.39, 1.59) 1.04 (0.50, 2.15) 0.94 (0.44, 2.01) 
Berries 0.88 (0.47, 1.66) 0.99 (0.52, 1.86) 0.95 (0.50, 1.81) 
Citrus 0.88 (0.68, 1.14) 0.95 (0.73, 1.22) 0.93 (0.73, 1.20) 
Drupes 0.88 (0.38, 2.04) 1.18 (0.49, 2.86) 1.13 (0.47, 2.71) 
Pomes 0.65 (0.41, 1.05) 0.81 (0.50, 1.31) 0.79 (0.49, 1.28) 
Tropical fruits 0.71 (0.41, 1.24) 0.79 (0.44, 1.43) 0.78 (0.43, 1.41) 
Total vegetables 0.84 (0.66, 1.07) 0.90 (0.70, 1.15) 0.89 (0.69, 1.14) 
Allium 0.99 (0.38, 2.57) 1.36 (0.45, 4.05) 1.33 (0.45, 3.96) 
Brassicaceae 0.70 (0.29, 1.65) 0.81 (0.33, 2.03) 0.81 (0.32, 2.04) 
Fruit vegetables 0.87 (0.56, 1.36) 1.08 (0.68, 1.71) 1.08 (0.68, 1.71) 
Pod vegetables  0.92 (0.30, 2.84) 1.08 (0.34, 3.43) 1.05 (0.33, 3.32) 
Root vegetables  0.65 (0.27, 1.58) 0.84 (0.32, 2.19) 0.85 (0.32, 2.21) 
a Adjusted for age, BMI (categorical), physical activity (categorical), smoking status, socio-economic status, 
alcohol intake, mutual adjustment for total fruit or total vegetable intake, and mutual adjustment for fruit or 
vegetable not in the exposure category 
b Adjusted for all the above and energy intake 
